{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**Requirements**\n",
    "\n",
    "Tutorial from: [web](https://www.datacamp.com/tutorial/run-llama-3-locally)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: langchain in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (0.2.16)\n",
      "Requirement already satisfied: langchainhub in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (0.1.21)\n",
      "Requirement already satisfied: langchain_community in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (0.2.16)\n",
      "Requirement already satisfied: langchain-chroma in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (0.1.3)\n",
      "Requirement already satisfied: libmagic in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (1.0)\n",
      "Requirement already satisfied: unstructured[docx] in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (0.15.9)\n",
      "Requirement already satisfied: chardet in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured[docx]) (5.2.0)\n",
      "Requirement already satisfied: filetype in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured[docx]) (1.2.0)\n",
      "Requirement already satisfied: python-magic in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured[docx]) (0.4.27)\n",
      "Requirement already satisfied: lxml in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured[docx]) (5.3.0)\n",
      "Requirement already satisfied: nltk in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured[docx]) (3.9.1)\n",
      "Requirement already satisfied: tabulate in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured[docx]) (0.9.0)\n",
      "Requirement already satisfied: requests in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured[docx]) (2.32.3)\n",
      "Requirement already satisfied: beautifulsoup4 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured[docx]) (4.12.3)\n",
      "Requirement already satisfied: emoji in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured[docx]) (2.12.1)\n",
      "Requirement already satisfied: dataclasses-json in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured[docx]) (0.6.7)\n",
      "Requirement already satisfied: python-iso639 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured[docx]) (2024.4.27)\n",
      "Requirement already satisfied: langdetect in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured[docx]) (1.0.9)\n",
      "Requirement already satisfied: numpy<2 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured[docx]) (1.26.4)\n",
      "Requirement already satisfied: rapidfuzz in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured[docx]) (3.9.7)\n",
      "Requirement already satisfied: backoff in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured[docx]) (2.2.1)\n",
      "Requirement already satisfied: typing-extensions in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured[docx]) (4.12.2)\n",
      "Requirement already satisfied: unstructured-client in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured[docx]) (0.25.7)\n",
      "Requirement already satisfied: wrapt in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured[docx]) (1.16.0)\n",
      "Requirement already satisfied: tqdm in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured[docx]) (4.66.5)\n",
      "Requirement already satisfied: psutil in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured[docx]) (6.0.0)\n",
      "Requirement already satisfied: python-oxmsg in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured[docx]) (0.0.1)\n",
      "Requirement already satisfied: python-docx>=1.1.2 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured[docx]) (1.1.2)\n",
      "Requirement already satisfied: PyYAML>=5.3 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from langchain) (6.0.2)\n",
      "Requirement already satisfied: SQLAlchemy<3,>=1.4 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from langchain) (2.0.34)\n",
      "Requirement already satisfied: aiohttp<4.0.0,>=3.8.3 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from langchain) (3.10.5)\n",
      "Requirement already satisfied: langchain-core<0.3.0,>=0.2.38 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from langchain) (0.2.38)\n",
      "Requirement already satisfied: langchain-text-splitters<0.3.0,>=0.2.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from langchain) (0.2.4)\n",
      "Requirement already satisfied: langsmith<0.2.0,>=0.1.17 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from langchain) (0.1.115)\n",
      "Requirement already satisfied: pydantic<3,>=1 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from langchain) (2.9.0)\n",
      "Requirement already satisfied: tenacity!=8.4.0,<9.0.0,>=8.1.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from langchain) (8.5.0)\n",
      "Requirement already satisfied: packaging<25,>=23.2 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from langchainhub) (24.1)\n",
      "Requirement already satisfied: types-requests<3.0.0.0,>=2.31.0.2 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from langchainhub) (2.32.0.20240905)\n",
      "Requirement already satisfied: chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from langchain-chroma) (0.5.3)\n",
      "Requirement already satisfied: fastapi<1,>=0.95.2 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from langchain-chroma) (0.113.0)\n",
      "Requirement already satisfied: aiohappyeyeballs>=2.3.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from aiohttp<4.0.0,>=3.8.3->langchain) (2.4.0)\n",
      "Requirement already satisfied: aiosignal>=1.1.2 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from aiohttp<4.0.0,>=3.8.3->langchain) (1.3.1)\n",
      "Requirement already satisfied: attrs>=17.3.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from aiohttp<4.0.0,>=3.8.3->langchain) (24.2.0)\n",
      "Requirement already satisfied: frozenlist>=1.1.1 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from aiohttp<4.0.0,>=3.8.3->langchain) (1.4.1)\n",
      "Requirement already satisfied: multidict<7.0,>=4.5 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from aiohttp<4.0.0,>=3.8.3->langchain) (6.0.5)\n",
      "Requirement already satisfied: yarl<2.0,>=1.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from aiohttp<4.0.0,>=3.8.3->langchain) (1.9.11)\n",
      "Requirement already satisfied: build>=1.0.3 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (1.2.1)\n",
      "Requirement already satisfied: chroma-hnswlib==0.7.3 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (0.7.3)\n",
      "Requirement already satisfied: uvicorn>=0.18.3 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from uvicorn[standard]>=0.18.3->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (0.30.6)\n",
      "Requirement already satisfied: posthog>=2.4.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (3.6.3)\n",
      "Requirement already satisfied: onnxruntime>=1.14.1 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (1.19.2)\n",
      "Requirement already satisfied: opentelemetry-api>=1.2.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (1.27.0)\n",
      "Requirement already satisfied: opentelemetry-exporter-otlp-proto-grpc>=1.2.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (1.27.0)\n",
      "Requirement already satisfied: opentelemetry-instrumentation-fastapi>=0.41b0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (0.48b0)\n",
      "Requirement already satisfied: opentelemetry-sdk>=1.2.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (1.27.0)\n",
      "Requirement already satisfied: tokenizers>=0.13.2 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (0.19.1)\n",
      "Requirement already satisfied: pypika>=0.48.9 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (0.48.9)\n",
      "Requirement already satisfied: overrides>=7.3.1 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (7.7.0)\n",
      "Requirement already satisfied: importlib-resources in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (6.4.4)\n",
      "Requirement already satisfied: grpcio>=1.58.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (1.66.1)\n",
      "Requirement already satisfied: bcrypt>=4.0.1 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (4.2.0)\n",
      "Requirement already satisfied: typer>=0.9.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (0.12.5)\n",
      "Requirement already satisfied: kubernetes>=28.1.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (30.1.0)\n",
      "Requirement already satisfied: mmh3>=4.0.1 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (4.1.0)\n",
      "Requirement already satisfied: orjson>=3.9.12 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (3.10.7)\n",
      "Requirement already satisfied: httpx>=0.27.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (0.27.2)\n",
      "Requirement already satisfied: marshmallow<4.0.0,>=3.18.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from dataclasses-json->unstructured[docx]) (3.22.0)\n",
      "Requirement already satisfied: typing-inspect<1,>=0.4.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from dataclasses-json->unstructured[docx]) (0.9.0)\n",
      "Requirement already satisfied: starlette<0.39.0,>=0.37.2 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from fastapi<1,>=0.95.2->langchain-chroma) (0.38.4)\n",
      "Requirement already satisfied: jsonpatch<2.0,>=1.33 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from langchain-core<0.3.0,>=0.2.38->langchain) (1.33)\n",
      "Requirement already satisfied: annotated-types>=0.4.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from pydantic<3,>=1->langchain) (0.7.0)\n",
      "Requirement already satisfied: pydantic-core==2.23.2 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from pydantic<3,>=1->langchain) (2.23.2)\n",
      "Requirement already satisfied: tzdata in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from pydantic<3,>=1->langchain) (2024.1)\n",
      "Requirement already satisfied: charset-normalizer<4,>=2 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from requests->unstructured[docx]) (3.3.2)\n",
      "Requirement already satisfied: idna<4,>=2.5 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from requests->unstructured[docx]) (3.8)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from requests->unstructured[docx]) (2.2.2)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from requests->unstructured[docx]) (2024.8.30)\n",
      "Requirement already satisfied: greenlet!=0.4.17 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from SQLAlchemy<3,>=1.4->langchain) (3.0.3)\n",
      "Requirement already satisfied: colorama in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from tqdm->unstructured[docx]) (0.4.6)\n",
      "Requirement already satisfied: soupsieve>1.2 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from beautifulsoup4->unstructured[docx]) (2.6)\n",
      "Requirement already satisfied: six in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from langdetect->unstructured[docx]) (1.16.0)\n",
      "Requirement already satisfied: click in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from nltk->unstructured[docx]) (8.1.7)\n",
      "Requirement already satisfied: joblib in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from nltk->unstructured[docx]) (1.4.2)\n",
      "Requirement already satisfied: regex>=2021.8.3 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from nltk->unstructured[docx]) (2024.7.24)\n",
      "Requirement already satisfied: olefile in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from python-oxmsg->unstructured[docx]) (0.47)\n",
      "Requirement already satisfied: deepdiff>=6.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured-client->unstructured[docx]) (8.0.1)\n",
      "Requirement already satisfied: jsonpath-python>=1.0.6 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured-client->unstructured[docx]) (1.0.6)\n",
      "Requirement already satisfied: mypy-extensions>=1.0.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured-client->unstructured[docx]) (1.0.0)\n",
      "Requirement already satisfied: nest-asyncio>=1.6.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured-client->unstructured[docx]) (1.6.0)\n",
      "Requirement already satisfied: pypdf>=4.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured-client->unstructured[docx]) (4.3.1)\n",
      "Requirement already satisfied: python-dateutil>=2.8.2 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured-client->unstructured[docx]) (2.9.0.post0)\n",
      "Requirement already satisfied: requests-toolbelt>=1.0.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from unstructured-client->unstructured[docx]) (1.0.0)\n",
      "Requirement already satisfied: pyproject_hooks in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from build>=1.0.3->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (1.1.0)\n",
      "Requirement already satisfied: orderly-set==5.2.2 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from deepdiff>=6.0->unstructured-client->unstructured[docx]) (5.2.2)\n",
      "Requirement already satisfied: anyio in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from httpx>=0.27.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (4.4.0)\n",
      "Requirement already satisfied: httpcore==1.* in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from httpx>=0.27.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (1.0.5)\n",
      "Requirement already satisfied: sniffio in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from httpx>=0.27.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (1.3.1)\n",
      "Requirement already satisfied: h11<0.15,>=0.13 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from httpcore==1.*->httpx>=0.27.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (0.14.0)\n",
      "Requirement already satisfied: jsonpointer>=1.9 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from jsonpatch<2.0,>=1.33->langchain-core<0.3.0,>=0.2.38->langchain) (3.0.0)\n",
      "Requirement already satisfied: google-auth>=1.0.1 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from kubernetes>=28.1.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (2.34.0)\n",
      "Requirement already satisfied: websocket-client!=0.40.0,!=0.41.*,!=0.42.*,>=0.32.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from kubernetes>=28.1.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (1.8.0)\n",
      "Requirement already satisfied: requests-oauthlib in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from kubernetes>=28.1.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (2.0.0)\n",
      "Requirement already satisfied: oauthlib>=3.2.2 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from kubernetes>=28.1.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (3.2.2)\n",
      "Requirement already satisfied: coloredlogs in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from onnxruntime>=1.14.1->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (15.0.1)\n",
      "Requirement already satisfied: flatbuffers in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from onnxruntime>=1.14.1->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (24.3.25)\n",
      "Requirement already satisfied: protobuf in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from onnxruntime>=1.14.1->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (4.25.4)\n",
      "Requirement already satisfied: sympy in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from onnxruntime>=1.14.1->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (1.13.2)\n",
      "Requirement already satisfied: deprecated>=1.2.6 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from opentelemetry-api>=1.2.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (1.2.14)\n",
      "Requirement already satisfied: importlib-metadata<=8.4.0,>=6.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from opentelemetry-api>=1.2.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (8.4.0)\n",
      "Requirement already satisfied: googleapis-common-protos~=1.52 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from opentelemetry-exporter-otlp-proto-grpc>=1.2.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (1.65.0)\n",
      "Requirement already satisfied: opentelemetry-exporter-otlp-proto-common==1.27.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from opentelemetry-exporter-otlp-proto-grpc>=1.2.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (1.27.0)\n",
      "Requirement already satisfied: opentelemetry-proto==1.27.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from opentelemetry-exporter-otlp-proto-grpc>=1.2.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (1.27.0)\n",
      "Requirement already satisfied: opentelemetry-instrumentation-asgi==0.48b0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from opentelemetry-instrumentation-fastapi>=0.41b0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (0.48b0)\n",
      "Requirement already satisfied: opentelemetry-instrumentation==0.48b0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from opentelemetry-instrumentation-fastapi>=0.41b0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (0.48b0)\n",
      "Requirement already satisfied: opentelemetry-semantic-conventions==0.48b0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from opentelemetry-instrumentation-fastapi>=0.41b0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (0.48b0)\n",
      "Requirement already satisfied: opentelemetry-util-http==0.48b0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from opentelemetry-instrumentation-fastapi>=0.41b0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (0.48b0)\n",
      "Requirement already satisfied: setuptools>=16.0 in c:\\program files\\windowsapps\\pythonsoftwarefoundation.python.3.11_3.11.2544.0_x64__qbz5n2kfra8p0\\lib\\site-packages (from opentelemetry-instrumentation==0.48b0->opentelemetry-instrumentation-fastapi>=0.41b0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (65.5.0)\n",
      "Requirement already satisfied: asgiref~=3.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from opentelemetry-instrumentation-asgi==0.48b0->opentelemetry-instrumentation-fastapi>=0.41b0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (3.8.1)\n",
      "Requirement already satisfied: monotonic>=1.5 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from posthog>=2.4.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (1.6)\n",
      "Requirement already satisfied: huggingface-hub<1.0,>=0.16.4 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from tokenizers>=0.13.2->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (0.24.6)\n",
      "Requirement already satisfied: shellingham>=1.3.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from typer>=0.9.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (1.5.4)\n",
      "Requirement already satisfied: rich>=10.11.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from typer>=0.9.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (13.8.0)\n",
      "Requirement already satisfied: httptools>=0.5.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from uvicorn[standard]>=0.18.3->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (0.6.1)\n",
      "Requirement already satisfied: python-dotenv>=0.13 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from uvicorn[standard]>=0.18.3->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (1.0.1)\n",
      "Requirement already satisfied: watchfiles>=0.13 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from uvicorn[standard]>=0.18.3->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (0.24.0)\n",
      "Requirement already satisfied: websockets>=10.4 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from uvicorn[standard]>=0.18.3->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (13.0.1)\n",
      "Requirement already satisfied: cachetools<6.0,>=2.0.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from google-auth>=1.0.1->kubernetes>=28.1.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (5.5.0)\n",
      "Requirement already satisfied: pyasn1-modules>=0.2.1 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from google-auth>=1.0.1->kubernetes>=28.1.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (0.4.0)\n",
      "Requirement already satisfied: rsa<5,>=3.1.4 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from google-auth>=1.0.1->kubernetes>=28.1.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (4.9)\n",
      "Requirement already satisfied: filelock in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from huggingface-hub<1.0,>=0.16.4->tokenizers>=0.13.2->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (3.15.4)\n",
      "Requirement already satisfied: fsspec>=2023.5.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from huggingface-hub<1.0,>=0.16.4->tokenizers>=0.13.2->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (2024.6.1)\n",
      "Requirement already satisfied: zipp>=0.5 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from importlib-metadata<=8.4.0,>=6.0->opentelemetry-api>=1.2.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (3.20.1)\n",
      "Requirement already satisfied: markdown-it-py>=2.2.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from rich>=10.11.0->typer>=0.9.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (3.0.0)\n",
      "Requirement already satisfied: pygments<3.0.0,>=2.13.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from rich>=10.11.0->typer>=0.9.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (2.18.0)\n",
      "Requirement already satisfied: humanfriendly>=9.1 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from coloredlogs->onnxruntime>=1.14.1->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (10.0)\n",
      "Requirement already satisfied: mpmath<1.4,>=1.1.0 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from sympy->onnxruntime>=1.14.1->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (1.3.0)\n",
      "Requirement already satisfied: pyreadline3 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from humanfriendly>=9.1->coloredlogs->onnxruntime>=1.14.1->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (3.4.1)\n",
      "Requirement already satisfied: mdurl~=0.1 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from markdown-it-py>=2.2.0->rich>=10.11.0->typer>=0.9.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (0.1.2)\n",
      "Requirement already satisfied: pyasn1<0.7.0,>=0.4.6 in c:\\users\\david\\appdata\\local\\packages\\pythonsoftwarefoundation.python.3.11_qbz5n2kfra8p0\\localcache\\local-packages\\python311\\site-packages (from pyasn1-modules>=0.2.1->google-auth>=1.0.1->kubernetes>=28.1.0->chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0->langchain-chroma) (0.6.0)\n",
      "Note: you may need to restart the kernel to use updated packages.\n"
     ]
    }
   ],
   "source": [
    "%pip install unstructured[docx] langchain langchainhub langchain_community langchain-chroma libmagic"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "#%ollama serve"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**Variables**\n",
    "Change them to your path"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "file_path = \"./input/c06.pdf\"\n",
    "fileExtToSearch = \"**/*.pdf\"\n",
    "#pdfToRead = \"C:/tmp/\""
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**Loading the documents**\n",
    "It is a best practice to develop and test your code in Jupyter Notebook before creating the app.\n",
    "\n",
    "We will load all the docx files from the folder using the DirectoryLoader."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_community.document_loaders import DirectoryLoader\n",
    "from langchain_community.document_loaders import PyPDFLoader\n",
    "\n",
    "loader = PyPDFLoader(file_path)\n",
    "books = loader.load_and_split()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**Splitting the text**\n",
    "Feeding an entire book to the model is not feasible, as it would exceed its context window. To overcome this limitation, we must divide the text into smaller, more manageable chunks that fit comfortably within the model's context window.\n",
    "\n",
    "In our case, we will convert all four books to a chunk size of 500 characters."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "import re\n",
    "def split_text(text: str) -> list[str]:\n",
    "    # Split the text into paragraphs\n",
    "    paragraphs = text.split('\\n')\n",
    "    \n",
    "    # Initialize variables\n",
    "    chunks = []\n",
    "    current_chunk = \"\"\n",
    "    \n",
    "    for paragraph in paragraphs:\n",
    "        # Check if the paragraph starts with a disorder code (e.g., 6A00.3)\n",
    "        if re.match(r'^\\s*6[A-Z]\\d+(\\.\\d+)?([A-Z])?', paragraph):\n",
    "            # If we have a current chunk, add it to the list of chunks\n",
    "            if current_chunk:\n",
    "                chunks.append(current_chunk.strip())\n",
    "            # Start a new chunk with this paragraph\n",
    "            current_chunk = paragraph\n",
    "        else:\n",
    "            # If it's not a new disorder, add to the current chunk\n",
    "            current_chunk += \"\\n\" + paragraph\n",
    "    \n",
    "    # Add the last chunk if it exists\n",
    "    if current_chunk:\n",
    "        chunks.append(current_chunk.strip())\n",
    "    \n",
    "    return chunks"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['396  ICD-11 MMS',\n",
       " '6A03.1  Developmental learning disorder with impairment in written expression  \\nDevelopmental learning disorder with impairment in written expression is \\ncharacterised by significant and persi stent difficulties in learning academic skills \\nrelated to writing, such as spelling accuracy, grammar and punctuation accuracy, \\nand organisation and coherence of ideas in writing. The individual’s performance in \\nwritten expression is markedly below what wo uld be expected for chronological age \\nand level of intellectual functioning and results in significant impairment in the \\nindividual’s academic or occupational functioning. Developmental learning disorder \\nwith impairment in written expression is not due to a disorder of intellectual \\ndevelopment, sensory impairment (vision or hearing), a neurological or motor \\ndisorder, lack of availability of education, lack of proficiency in the language of \\nacademic instruction, or psychosocial adversity.  \\nExclusions:  Disorde rs of intellectual development (6A00)',\n",
       " '6A03.2  Developmental learning disorder with impairment in mathematics  \\nDevelopmental learning disorder with impairment in mathematics is characterised \\nby significant and persistent difficulties in learning academic ski lls related to \\nmathematics or arithmetic, such as number sense, memorization of number facts, \\naccurate calculation, fluent calculation, and accurate mathematic reasoning. The \\nindividual’s performance in mathematics or arithmetic is markedly below what woul d \\nbe expected for chronological or developmental age and level of intellectual \\nfunctioning and results in significant impairment in the individual’s academic or \\noccupational functioning. Developmental learning disorder with impairment in \\nmathematics is not  due to a disorder of intellectual development, sensory \\nimpairment (vision or hearing), a neurological disorder, lack of availability of \\neducation, lack of proficiency in the language of academic instruction, or \\npsychosocial adversity.  \\nExclusions:  Disorder s of intellectual development (6A00)',\n",
       " '6A03.3  Developmental learning disorder with other specified impairment of learning  \\nDevelopmental learning disorder with other specified impairment of learning is \\ncharacterised by significant and persistent difficulties  in learning academic skills \\nother than reading, mathematics, and written expression. The individual’s \\nperformance in the relevant academic skill is markedly below what would be \\nexpected for chronological age and level of intellectual functioning and resul ts in \\nsignificant impairment in the individual’s academic or occupational functioning. \\nDevelopmental learning disorder with other specified impairment of learning is not \\ndue to a disorder of intellectual development, sensory impairment (vision or \\nhearing),  neurological disorder, lack of availability of education, lack of proficiency in \\nthe language of academic instruction, or psychosocial adversity.  \\nExclusions:  Disorders of intellectual development (6A00)',\n",
       " '6A03.Z  Developmental learning disorder, unspecified']"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "split_text(books[8].page_content)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "f = open('./input/c06.txt',encoding=\"utf-8\")\n",
    "content = f.read()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['ICD-11 MMS  389 \\n • Mental or behavioural disorders associated with pregnancy, childbirth or the puerperium  \\n• Secondary mental or behavioural syndromes associated with disorders or diseases classified \\nelsewhere  \\n \\nNeurodevelopmental disorders (6A00 ‑6A0Z)  \\nNeurodevelopmental disorders are behavioural and cognitive disorders that arise during the \\ndevelopmental period t hat involve significant difficulties in the acquisition and execution of specific \\nintellectual, motor, language, or social functions. Although behavioural and cognitive deficits are \\npresent in many mental and behavioural disorders that can arise during the  developmental period \\n(e.g., Schizophrenia, Bipolar disorder), only disorders whose core features are neurodevelopmental \\nare included in this grouping. The presumptive etiology for neurodevelopmental disorders is complex, \\nand in many individual cases is un known.  \\nCoded Elsewhere:  Primary tics or tic disorders (8A05.0)  \\nSecondary neurodevelopmental syndrome (6E60)',\n",
       " '6A00   Disorders of intellectual development  \\nDisorders of intellectual development are a group of etiologically diverse conditions \\noriginating dur ing the developmental period characterised by significantly below \\naverage intellectual functioning and adaptive behaviour that are approximately two \\nor more standard deviations below the mean (approximately less than the 2.3rd \\npercentile), based on appropr iately normed, individually administered standardized \\ntests. Where appropriately normed and standardized tests are not available, \\ndiagnosis of disorders of intellectual development requires greater reliance on \\nclinical judgment based on appropriate assessm ent of comparable behavioural \\nindicators.  \\nCoding Note:  Use additional code, if desired, to identify any known aetiology.  \\nExclusions:  Dementia  (6D80‑6D8Z)',\n",
       " '6A00.0  Disorder of intellectual development, mild  \\nA mild disorder of intellectual development is a co ndition originating during the \\ndevelopmental period characterised by significantly below average intellectual \\nfunctioning and adaptive behaviour that are approximately two to three standard \\ndeviations below the mean (approximately 0.1 – 2.3 percentile), ba sed on \\nappropriately normed, individually administered standardized tests or by \\ncomparable behavioural indicators when standardized testing is unavailable. \\nAffected persons often exhibit difficulties in the acquisition and comprehension of \\ncomplex language  concepts and academic skills. Most master basic self -care, \\ndomestic, and practical activities. Persons affected by a mild disorder of intellectual \\ndevelopment can generally achieve relatively independent living and employment \\nas adults but may require app ropriate support.  \\n 390  ICD-11 MMS',\n",
       " '6A00.1  Disorder of intellectual development, moderate  \\nA moderate disorder of intellectual development is a condition originating during the \\ndevelopmental period characterised by significantly below average intellectual \\nfunctioning and ad aptive behaviour that are approximately three to four standard \\ndeviations below the mean (approximately 0.003 – 0.1 percentile), based on \\nappropriately normed, individually administered standardized tests or by \\ncomparable behavioural indicators when standa rdized testing is unavailable. \\nLanguage and capacity for acquisition of academic skills of persons affected by a \\nmoderate disorder of intellectual development vary but are generally limited to basic \\nskills. Some may master basic self -care, domestic, and pr actical activities. Most \\naffected persons require considerable and consistent support in order to achieve \\nindependent living and employment as adults.',\n",
       " '6A00.2  Disorder of intellectual development, severe  \\nA severe disorder of intellectual development is a c ondition originating during the \\ndevelopmental period characterised by significantly below average intellectual \\nfunctioning and adaptive behaviour that are approximately four or more standard \\ndeviations below the mean (less than approximately the 0.003rd pe rcentile), based \\non appropriately normed, individually administered standardized tests or by \\ncomparable behavioural indicators when standardized testing is unavailable. \\nAffected persons exhibit very limited language and capacity for acquisition of \\nacademic  skills. They may also have motor impairments and typically require daily \\nsupport in a supervised environment for adequate care, but may acquire basic self -\\ncare skills with intensive training. Severe and profound disorders of intellectual \\ndevelopment are d ifferentiated exclusively on the basis of adaptive behaviour \\ndifferences because existing standardized tests of intelligence cannot reliably or \\nvalidly distinguish among individuals with intellectual functioning below the 0.003rd \\npercentile.',\n",
       " '6A00.3  Disord er of intellectual development, profound  \\nA profound disorder of intellectual development is a condition originating during the \\ndevelopmental period characterised by significantly below average intellectual \\nfunctioning and adaptive behaviour that are approx imately four or more standard \\ndeviations below the mean (approximately less than the 0.003rd percentile), based \\non individually administered appropriately normed, standardized tests or by \\ncomparable behavioural indicators when standardized testing is unava ilable. \\nAffected persons possess very limited communication abilities and capacity for \\nacquisition of academic skills is restricted to basic concrete skills. They may also \\nhave co -occurring motor and sensory impairments and typically require daily \\nsupport in a supervised environment for adequate care. Severe and profound \\ndisorders of intellectual development are differentiated exclusively on the basis of \\nadaptive behaviour differences because existing standardized tests of intelligence \\ncannot reliably or va lidly distinguish among individuals with intellectual functioning \\nbelow the 0.003rd percentile.  \\n ICD-11 MMS  391',\n",
       " '6A00.4  Disorder of intellectual development, provisional  \\nDisorder of intellectual development, provisional is assigned when there is evidence \\nof a disorder of intellectual development but the individual is an infant or child under \\nthe age of four or it is not possible to conduct a valid assessment of intellectual \\nfunctioning and adaptive behaviour because of sensory or physical impairments \\n(e.g., blindness, pre -lingual deafness), motor or communication impairments, \\nsevere problem behaviours or co -occurring mental and behavioural disorders.',\n",
       " '6A00.Z  Disorders of intellectual development, unspecified  \\nCoding Note:  Use additional code, if desired, to identify any known aetiology.',\n",
       " '6A01   Developmental speech or language disorders  \\nDevelopmental speech or language disorders arise during the developmental period \\nand are characterised by difficulties in understanding o r producing speech and \\nlanguage or in using language in context for the purposes of communication that \\nare outside the limits of normal variation expected for age and level of intellectual \\nfunctioning. The observed speech and language problems are not attr ibutable to \\nregional, social, or cultural/ethnic language variations and are not fully explained by \\nanatomical or neurological abnormalities. The presumptive aetiology for \\nDevelopmental speech or language disorders is complex, and in many individual \\ncases,  is unknown.',\n",
       " '6A01.0  Developmental speech sound disorder  \\nDevelopmental speech sound disorder is characterised by difficulties in the \\nacquisition, production and perception of speech that result in errors of \\npronunciation, either in number or types of speec h errors made or the overall quality \\nof speech production, that are outside the limits of normal variation expected for age \\nand level of intellectual functioning and result in reduced intelligibility and \\nsignificantly affect communication. The errors in pr onunciation arise during the early \\ndevelopmental period and cannot be explained by social, cultural, and other \\nenvironmental variations (e.g., regional dialects). The speech errors are not fully \\nexplained by a hearing impairment or a structural or neurolog ical abnormality.  \\nInclusions:  Functional speech articulation disorder  \\nExclusions:  Deafness not otherwise specified (AB52)  \\nDiseases of the nervous system  (Chapter 08)  \\nDysarthria (MA80.2)  \\nVerbal apraxia (MB4A)  \\n 392  ICD-11 MMS',\n",
       " '6A01.1  Developmental speech fluency disorder  \\nDevelopmental speech fluency disorder is characterised by frequent or pervasive \\ndisruption of the normal rhythmic flow and rate of speech characterised by \\nrepetitions and prolongations in sounds, syllables, words, and phrases, as well as \\nblocking and word avoidance or substitutions. The speech dysfluency is persistent \\nover time. The onset of speech dysfluency occurs during the developmental period \\nand speech fluency is markedly below what would be expected for age. Spee ch \\ndysfluency results in significant impairment in social communication, personal, \\nfamily, social, educational, occupational or other important areas of functioning. The \\nspeech dysfluency is not better accounted for by a Disorder of Intellectual \\nDevelopmen t, a Disease of the Nervous System, a sensory impairment, or a \\nstructural abnormality, or other speech or voice disorder.  \\nExclusions:  Tic disorders (8A05)',\n",
       " '6A01.2  Developmental language disorder  \\nDevelopmental language disorder is characterised by persisten t deficits in the \\nacquisition, understanding, production or use of language (spoken or signed), that \\narise during the developmental period, typically during early childhood, and cause \\nsignificant limitations in the individual’s ability to communicate. The individual’s \\nability to understand, produce or use language is markedly below what would be \\nexpected given the individual’s age. The language deficits are not explained by \\nanother neurodevelopmental disorder or a sensory impairment or neurological \\nconditio n, including the effects of brain injury or infection.  \\nExclusions:  Autism spectrum disorder (6A02)  \\nDiseases of the nervous system  (Chapter 08)  \\nDeafness not otherwise specified (AB52)  \\nSelective mutism (6B06)',\n",
       " '6A01.20  Developmental language disorder with imp airment of receptive and expressive \\nlanguage  \\nDevelopmental language disorder with impairment of receptive and expressive \\nlanguage is characterised by persistent difficulties in the acquisition, understanding, \\nproduction, and use of language that arise duri ng the developmental period, \\ntypically during early childhood, and cause significant limitations in the individual’s \\nability to communicate. The ability to understand spoken or signed language (i.e., \\nreceptive language) is markedly below the expected level  given the individual’s age \\nand level of intellectual functioning, and is accompanied by persistent impairment in \\nthe ability to produce and use spoken or signed language (i.e., expressive \\nlanguage).  \\nInclusions:  developmental dysphasia or aphasia, receptiv e type  \\nExclusions:  acquired aphasia with epilepsy [Landau -Kleffner] (8A62.2)  \\nAutism spectrum disorder (6A02)  \\nSelective mutism (6B06)  \\ndysphasia NOS (MA80.1)  \\nDiseases of the nervous system  (Chapter 08)  \\nDeafness not otherwise specified (AB52)  \\n ICD-11 MMS  393',\n",
       " '6A01.21  Developmental language disorder with impairment of mainly expressive language  \\nDevelopmental language disorder with impairment of mainly expressive language is \\ncharacterised by persistent difficulties in the acquisition, production, and use of \\nlanguage that arise during the developmental period, typically during early \\nchildhood, and cause significant limitations in the individual’s ability to \\ncommunicate. The ability to produce and use spoken or signed languag e (i.e., \\nexpressive language) is markedly below the expected level given the individual’s \\nage and level of intellectual functioning, but the ability to understand spoken or \\nsigned language (i.e., receptive language) is relatively intact.  \\nInclusions:  Develo pmental dysphasia or aphasia, expressive type  \\nExclusions:  acquired aphasia with epilepsy [Landau -Kleffner] (8A62.2)  \\nSelective mutism (6B06)  \\ndysphasia and aphasia: developmental, receptive type \\n(6A01.20)  \\ndysphasia NOS (MA80.1)  \\naphasia NOS (MA80.0)  \\nDiseases of the nervous system  (Chapter 08)  \\nDeafness not otherwise specified (AB52)',\n",
       " '6A01.22  Developmental language disorder with impairment of mainly pragmatic language  \\nDevelopmental language disorder with impairment of mainly pragmatic language is \\ncharacterised b y persistent and marked difficulties with the understanding and use \\nof language in social contexts, for example making inferences, understanding verbal \\nhumour, and resolving ambiguous meaning. These difficulties arise during the \\ndevelopmental period, typic ally during early childhood, and cause significant \\nlimitations in the individual’s ability to communicate. Pragmatic language abilities \\nare markedly below the expected level given the individual’s age and level of \\nintellectual functioning, but the other co mponents of receptive and expressive \\nlanguage are relatively intact. This qualifier should not be used if the pragmatic \\nlanguage impairment is better explained by Autism Spectrum Disorder or by \\nimpairments in other components of receptive or expressive lan guage.  \\nExclusions:  Diseases of the nervous system  (Chapter 08)  \\nSelective mutism (6B06)',\n",
       " '6A01.23  Developmental language disorder, with other specified language impairment  \\nDevelopmental language disorder with other specified language impairment is \\ncharacterised by persistent difficulties in the acquisition, understanding, production \\nor use of language (spoken or signed), that arise during the developmental period \\nand cause s ignificant limitations in the individual’s ability to communicate. The \\npattern of specific deficits in language abilities is not adequately captured by any of \\nthe other developmental language disorder categories.  \\nExclusions:  Autism spectrum disorder (6A02)  \\nDiseases of the nervous system  (Chapter 08)  \\nDisorders of intellectual development (6A00)  \\nSelective mutism (6B06)  \\n 394  ICD-11 MMS',\n",
       " '6A01.Y  Other specified developmental speech or language disorders',\n",
       " '6A01.Z  Developmental speech or language disorders, unspecified',\n",
       " '6A02   Autism spectrum disorder  \\nAutism spectrum disorder is characterised by persistent deficits in the ability to \\ninitiate and to sustain reciprocal social interaction and social communication, an d by \\na range of restricted, repetitive, and inflexible patterns of behaviour, interests or \\nactivities that are clearly atypical or excessive for the individual’s age and \\nsociocultural context. The onset of the disorder occurs during the developmental \\nperio d, typically in early childhood, but symptoms may not become fully manifest \\nuntil later, when social demands exceed limited capacities. Deficits are sufficiently \\nsevere to cause impairment in personal, family, social, educational, occupational or \\nother imp ortant areas of functioning and are usually a pervasive feature of the \\nindividual’s functioning observable in all settings, although they may vary according \\nto social, educational, or other context. Individuals along the spectrum exhibit a full \\nrange of in tellectual functioning and language abilities.  \\nInclusions:  Autistic disorder  \\nExclusions:  Rett syndrome (LD90.4)',\n",
       " \"6A02.0  Autism spectrum disorder without disorder of intellectual development and \\nwith mild or no impairment of functional language  \\nAll definiti onal requirements for autism spectrum disorder are met, intellectual \\nfunctioning and adaptive behaviour are found to be at least within the average \\nrange (approximately greater than the 2.3rd percentile), and there is only mild or no \\nimpairment in the indi vidual's capacity to use functional language (spoken or \\nsigned) for instrumental purposes, such as to express personal needs and desires.\",\n",
       " \"6A02.1  Autism spectrum disorder with disorder of intellectual development and with \\nmild or no impairment of functiona l language  \\nAll definitional requirements for both autism spectrum disorder and disorder of \\nintellectual development are met and there is only mild or no impairment in the \\nindividual's capacity to use functional language (spoken or signed) for instrumental \\npurposes, such as to express personal needs and desires.\",\n",
       " '6A02.2  Autism spectrum disorder without disorder of intellectual development and \\nwith impaired functional language  \\nAll definitional requirements for autism spectrum disorder are met, intellectual \\nfunctioning and adaptive behaviour are found to be at least within the average \\nrange (approximately greater than the 2.3rd percentile), and there is marked \\nimpairment in functional language (spoken or signed) relative to the individual’s age, \\nwith the indivi dual not able to use more than single words or simple phrases for \\ninstrumental purposes, such as to express personal needs and desires.',\n",
       " '6A02.3  Autism spectrum disorder with disorder of intellectual development and with \\nimpaired functional language  \\nAll def initional requirements for both autism spectrum disorder and disorder of \\nintellectual development are met and there is marked impairment in functional \\nlanguage (spoken or signed) relative to the individual’s age, with the individual not \\nable to use more th an single words or simple phrases for instrumental purposes, \\nsuch as to express personal needs and desires.  \\n ICD-11 MMS  395',\n",
       " '6A02.5  Autism spectrum disorder with disorder of intellectual development and with \\nabsence of functional language  \\nAll definitional requirements for  both autism spectrum disorder and disorder of \\nintellectual development are met and there is complete, or almost complete, \\nabsence of ability relative to the individual’s age to use functional language (spoken \\nor signed) for instrumental purposes, such as to express personal needs and \\ndesires',\n",
       " '6A02.Y  Other specified autism spectrum disorder',\n",
       " '6A02.Z  Autism spectrum disorder, unspecified',\n",
       " '6A03   Developmental learning disorder  \\nDevelopmental learning disorder is characterised by significant and persistent \\ndifficulties in learning academic skills, which may include reading, writing, or \\narithmetic. The individual’s performance in the affected academic skill(s) is \\nmarkedly below wha t would be expected for chronological age and general level of \\nintellectual functioning, and results in significant impairment in the individual’s \\nacademic or occupational functioning. Developmental learning disorder first \\nmanifests when academic skills ar e taught during the early school years. \\nDevelopmental learning disorder is not due to a disorder of intellectual \\ndevelopment, sensory impairment (vision or hearing), neurological or motor \\ndisorder, lack of availability of education, lack of proficiency in the language of \\nacademic instruction, or psychosocial adversity.  \\nExclusions:  Symbolic dysfunctions (MB4B)',\n",
       " '6A03.0  Developmental learning disorder with impairment in reading  \\nDevelopmental learning disorder with impairment in reading is characterised by \\nsignificant and persistent difficulties in learning academic skills related to reading, \\nsuch as word reading accuracy, reading fluency, and reading comprehension. The \\nindividual ’s performance in reading is markedly below what would be expected for \\nchronological age and level of intellectual functioning and results in significant \\nimpairment in the individual’s academic or occupational functioning. Developmental \\nlearning disorder w ith impairment in reading is not due to a disorder of intellectual \\ndevelopment, sensory impairment (vision or hearing), neurological disorder, lack of \\navailability of education, lack of proficiency in the language of academic instruction, \\nor psychosocial a dversity.  \\nExclusions:  Disorders of intellectual development (6A00)  \\n 396  ICD-11 MMS',\n",
       " '6A03.1  Developmental learning disorder with impairment in written expression  \\nDevelopmental learning disorder with impairment in written expression is \\ncharacterised by significant and persi stent difficulties in learning academic skills \\nrelated to writing, such as spelling accuracy, grammar and punctuation accuracy, \\nand organisation and coherence of ideas in writing. The individual’s performance in \\nwritten expression is markedly below what wo uld be expected for chronological age \\nand level of intellectual functioning and results in significant impairment in the \\nindividual’s academic or occupational functioning. Developmental learning disorder \\nwith impairment in written expression is not due to a disorder of intellectual \\ndevelopment, sensory impairment (vision or hearing), a neurological or motor \\ndisorder, lack of availability of education, lack of proficiency in the language of \\nacademic instruction, or psychosocial adversity.  \\nExclusions:  Disorde rs of intellectual development (6A00)',\n",
       " '6A03.2  Developmental learning disorder with impairment in mathematics  \\nDevelopmental learning disorder with impairment in mathematics is characterised \\nby significant and persistent difficulties in learning academic ski lls related to \\nmathematics or arithmetic, such as number sense, memorization of number facts, \\naccurate calculation, fluent calculation, and accurate mathematic reasoning. The \\nindividual’s performance in mathematics or arithmetic is markedly below what woul d \\nbe expected for chronological or developmental age and level of intellectual \\nfunctioning and results in significant impairment in the individual’s academic or \\noccupational functioning. Developmental learning disorder with impairment in \\nmathematics is not  due to a disorder of intellectual development, sensory \\nimpairment (vision or hearing), a neurological disorder, lack of availability of \\neducation, lack of proficiency in the language of academic instruction, or \\npsychosocial adversity.  \\nExclusions:  Disorder s of intellectual development (6A00)',\n",
       " '6A03.3  Developmental learning disorder with other specified impairment of learning  \\nDevelopmental learning disorder with other specified impairment of learning is \\ncharacterised by significant and persistent difficulties  in learning academic skills \\nother than reading, mathematics, and written expression. The individual’s \\nperformance in the relevant academic skill is markedly below what would be \\nexpected for chronological age and level of intellectual functioning and resul ts in \\nsignificant impairment in the individual’s academic or occupational functioning. \\nDevelopmental learning disorder with other specified impairment of learning is not \\ndue to a disorder of intellectual development, sensory impairment (vision or \\nhearing),  neurological disorder, lack of availability of education, lack of proficiency in \\nthe language of academic instruction, or psychosocial adversity.  \\nExclusions:  Disorders of intellectual development (6A00)',\n",
       " '6A03.Z  Developmental learning disorder, unspecified  \\n ICD-11 MMS  397',\n",
       " \"6A04   Developmental motor coordination disorder  \\nDevelopmental motor coordination disorder is characterised by a significant delay in \\nthe acquisition of gross and fine motor skills and impairment in the execution of \\ncoordinated motor skills that manife st in clumsiness, slowness, or inaccuracy of \\nmotor performance. Coordinated motor skills are markedly below that expected \\ngiven the individual's chronological age and level of intellectual functioning. Onset of \\ncoordinated motor skills difficulties occurs during the developmental period and is \\ntypically apparent from early childhood. Coordinated motor skills difficulties cause \\nsignificant and persistent limitations in functioning (e.g. in activities of daily living, \\nschool work, and vocational and leisure a ctivities). Difficulties with coordinated \\nmotor skills are not solely attributable to a Disease of the Nervous System, Disease \\nof the Musculoskeletal System or Connective Tissue, sensory impairment, and not \\nbetter explained by a Disorder of Intellectual De velopment.  \\nExclusions:  Abnormalities of gait and mobility (MB44)  \\nDiseases of the musculoskeletal system or connective tissue  \\n(Chapter 15)  \\nDiseases of the nervous system  (Chapter 08)\",\n",
       " '6A05   Attention deficit hyperactivity disorder  \\nAttention deficit hyperactivity disorder is characterised by a persistent pattern (at \\nleast 6 months) of inattention and/or hyperactivity -impulsivity that has a direct \\nnegative impact on academic, occupational, or s ocial functioning. There is evidence \\nof significant inattention and/or hyperactivity -impulsivity symptoms prior to age 12, \\ntypically by early to mid -childhood, though some individuals may first come to \\nclinical attention later. The degree of inattention an d hyperactivity -impulsivity is \\noutside the limits of normal variation expected for age and level of intellectual \\nfunctioning. Inattention refers to significant difficulty in sustaining attention to tasks \\nthat do not provide a high level of stimulation or f requent rewards, distractibility and \\nproblems with organisation. Hyperactivity refers to excessive motor activity and \\ndifficulties with remaining still, most evident in structured situations that require \\nbehavioural self -control. Impulsivity is a tendency to act in response to immediate \\nstimuli, without deliberation or consideration of the risks and consequences. The \\nrelative balance and the specific manifestations of inattentive and hyperactive -\\nimpulsive characteristics varies across individuals and may ch ange over the course \\nof development. In order for a diagnosis to be made, manifestations of inattention \\nand/or hyperactivity -impulsivity must be evident across multiple situations or \\nsettings (e.g., home, school, work, with friends or relatives), but are l ikely to vary \\naccording to the structure and demands of the setting. Symptoms are not better \\naccounted for by another mental, behavioural, or neurodevelopmental disorder and \\nare not due to the effect of a substance or medication.  \\nInclusions:  attention defi cit disorder with hyperactivity  \\nattention deficit syndrome with hyperactivity  \\n 398  ICD-11 MMS',\n",
       " '6A05.0  Attention deficit hyperactivity disorder, predominantly inattentive \\npresentation  \\nAll definitional requirements for attention deficit hyperactivity disorder are met and \\ninattentive symptoms are predominant in the clinical presentation. Inattention refers \\nto significant difficulty in sustaining attention to tasks that do not provide a high level \\nof stimulation or frequent rewards, distractibility and problems with organisati on. \\nSome hyperactive -impulsive symptoms may also be present, but these are not \\nclinically significant in relation to the inattentive symptoms.',\n",
       " '6A05.1  Attention deficit hyperactivity disorder, predominantly hyperactive -impulsive \\npresentation  \\nAll definition al requirements for attention deficit hyperactivity disorder are met and \\nhyperactive -impulsive symptoms are predominant in the clinical presentation. \\nHyperactivity refers to excessive motor activity and difficulties with remaining still, \\nmost evident in st ructured situations that require behavioural self -control. Impulsivity \\nis a tendency to act in response to immediate stimuli, without deliberation or \\nconsideration of the risks and consequences. Some inattentive symptoms may also \\nbe present, but these are not clinically significant in relation to the hyperactive -\\nimpulsive symptoms.',\n",
       " '6A05.2  Attention deficit hyperactivity disorder, combined presentation  \\nAll definitional requirements for attention deficit hyperactivity disorder are met. Both \\ninattentive and hyperactive -impulsive symptoms are clinically significant, with \\nneither predominating in the clinical presentation. Inattention refers to significant \\ndifficulty in sustaining attention to tasks that do not provide a high level of \\nstimulation or frequent rewards, distractibility and problems with organisation. \\nHyperactivity refers to excessive motor activity and difficulties with remaining still, \\nmost evi dent in structured situations that require behavioural self -control. Impulsivity \\nis a tendency to act in response to immediate stimuli, without deliberation or \\nconsideration of the risks and consequences.',\n",
       " '6A05.Y  Attention deficit hyperactivity disorder, o ther specified presentation',\n",
       " '6A05.Z  Attention deficit hyperactivity disorder, presentation unspecified',\n",
       " '6A06   Stereotyped movement disorder  \\nStereotyped movement disorder is characterised by the persistent (e.g., lasting \\nseveral months) presence of volun tary, repetitive, stereotyped, apparently \\npurposeless (and often rhythmic) movements that arise during the early \\ndevelopmental period, are not caused by the direct physiological effects of a \\nsubstance or medication (including withdrawal), and markedly inte rfere with normal \\nactivities or result in self -inflicted bodily injury. Stereotyped movements that are \\nnon-injurious can include body rocking, head rocking, finger -flicking mannerisms, \\nand hand flapping. Stereotyped self -injurious behaviours can include re petitive head \\nbanging, face slapping, eye poking, and biting of the hands, lips, or other body \\nparts.  \\nExclusions:  Tic disorders (8A05)  \\nTrichotillomania (6B25.0)  \\nAbnormal involuntary movements (MB46)  \\n ICD-11 MMS  399',\n",
       " '6A06.0  Stereotyped movement disorder without self -injury  \\nThis category should be applied to forms of Stereotyped movement disorder in \\nwhich stereotyped behaviours markedly interfere with normal activities, but do not \\nresult in self -inflicted bodily injury. Stereotyped movement disorder without self -\\ninjury is ch aracterised by voluntary, repetitive, stereotyped, apparently purposeless \\n(and often rhythmic) movements that arise during the early developmental period, \\nare not caused by the direct physiological effects of a substance or medication \\n(including withdrawal ), and markedly interfere with normal activities. Stereotyped \\nmovements that are non -injurious can include body rocking, head rocking, finger -\\nflicking mannerisms, and hand flapping.',\n",
       " '6A06.1  Stereotyped movement disorder with self -injury  \\nThis category should be applied to forms of Stereotyped movement disorder in \\nwhich stereotyped behaviours result in self -inflicted bodily injury that is significant \\nenough to require medical treatment, or woul d result in such injury if protective \\nmeasures (e.g., helmet to prevent head injury) were not employed. Stereotyped \\nmovement disorder with self -injury is characterised by voluntary, repetitive, \\nstereotyped, apparently purposeless (and often rhythmic) movem ents that arise \\nduring the early developmental period, are not caused by the direct physiological \\neffects of a substance or medication (including withdrawal). Stereotyped \\nmovements that are self -injurious can include head banging, face slapping, eye \\npoking , and biting of the hands, lips, or other body parts.',\n",
       " '6A06.Z  Stereotyped movement disorder, unspecified',\n",
       " '6A0Y   Other specified neurodevelopmental disorders',\n",
       " '6A0Z   Neurodevelopmental disorders, unspecified  \\n 400  ICD-11 MMS  \\n Schizophrenia or other primary psychotic di sorders (6A20 ‑6A2Z)  \\nSchizophrenia and other primary psychotic disorders are characterised by significant impairments in \\nreality testing and alterations in behaviour manifest in positive symptoms such as persistent \\ndelusions, persistent hallucinations, diso rganised thinking (typically manifest as disorganised speech), \\ngrossly disorganised behaviour, and experiences of passivity and control, negative symptoms such as \\nblunted or flat affect and avolition, and psychomotor disturbances. The symptoms occur with s ufficient \\nfrequency and intensity to deviate from expected cultural or subcultural norms. These symptoms do \\nnot arise as a feature of another mental and behavioural disorder (e.g., a mood disorder, delirium, or \\na disorder due to substance use). The categor ies in this grouping should not be used to classify the \\nexpression of ideas, beliefs, or behaviours that are culturally sanctioned.  \\nCoded Elsewhere:  Substance -induced psychotic disorders  \\nSecondary psychotic syndrome (6E61)',\n",
       " \"6A20   Schizophrenia  \\nSchizophre nia is characterised by disturbances in multiple mental modalities, \\nincluding thinking (e.g., delusions, disorganisation in the form of thought), \\nperception (e.g., hallucinations), self -experience (e.g., the experience that one's \\nfeelings, impulses, though ts, or behaviour are under the control of an external \\nforce), cognition (e.g., impaired attention, verbal memory, and social cognition), \\nvolition (e.g., loss of motivation), affect (e.g., blunted emotional expression), and \\nbehaviour (e.g., behaviour that a ppears bizarre or purposeless, unpredictable or \\ninappropriate emotional responses that interfere with the organisation of behaviour). \\nPsychomotor disturbances, including catatonia, may be present. Persistent \\ndelusions, persistent hallucinations, thought di sorder, and experiences of influence, \\npassivity, or control are considered core symptoms. Symptoms must have persisted \\nfor at least one month in order for a diagnosis of schizophrenia to be assigned. The \\nsymptoms are not a manifestation of another health c ondition (e.g., a brain tumour) \\nand are not due to the effect of a substance or medication on the central nervous \\nsystem (e.g., corticosteroids), including withdrawal (e.g., alcohol withdrawal).  \\nExclusions:  Schizotypal disorder (6A22)  \\nschizophrenic reactio n (6A22)  \\nAcute and transient psychotic disorder (6A23)\",\n",
       " '6A20.0  Schizophrenia, first episode  \\nSchizophrenia, first episode should be used to identify individuals experiencing \\nsymptoms that meet the diagnostic requirements for Schizophrenia (including \\nduratio n) but who have never before experienced an episode during which \\ndiagnostic requirements for Schizophrenia were met.',\n",
       " '6A20.00  Schizophrenia, first episode, currently symptomatic  \\nAll definitional requirements for Schizophrenia, first episode in terms of sym ptoms \\nand duration are currently met, or have been met within the past one month.  \\n ICD-11 MMS  401',\n",
       " '6A20.01  Schizophrenia, first episode, in partial remission  \\nAll definitional requirements for Schizophrenia, first episode in terms of symptoms \\nand duration were previously m et. Symptoms have ameliorated such that the \\ndiagnostic requirements for the disorder have not been met for at least one month, \\nbut some clinically significant symptoms remain, which may or may not be \\nassociated with functional impairment. The partial remis sion may have occurred in \\nresponse to medication or other treatment.',\n",
       " '6A20.02  Schizophrenia, first episode, in full remission  \\nAll definitional requirements for Schizophrenia, first episode in terms of symptoms \\nand duration were previously met. Symptoms have ameliorated such that no \\nsignificant symptoms remain. The remission may have occurred in response to \\nmedication or other tre atment.',\n",
       " '6A20.0Z  Schizophrenia, first episode, unspecified',\n",
       " '6A20.1  Schizophrenia, multiple episodes  \\nSchizophrenia, multiple episodes should be used to identify individuals experiencing \\nsymptoms that meet the diagnostic requirements for Schizophrenia and wh o have \\nalso previously experienced episodes during which diagnostic requirements were \\nmet, with substantial remission of symptoms between episodes. Some attenuated \\nsymptoms may remain during periods of remission, and remissions may have \\noccurred in respons e to medication or other treatment.',\n",
       " '6A20.10  Schizophrenia, multiple episodes, currently symptomatic  \\nAll definitional requirements for Schizophrenia, multiple episodes in terms of \\nsymptoms and duration are currently met, or have been met within the past on e \\nmonth.',\n",
       " '6A20.11  Schizophrenia, multiple episodes, in partial remission  \\nAll definitional requirements for Schizophrenia, multiple episodes in terms of \\nsymptoms and duration were previously met. Symptoms have ameliorated such that \\nthe diagnostic requiremen ts for the disorder have not been met for at least one \\nmonth, but some clinically significant symptoms remain, which may or may not be \\nassociated with functional impairment. The partial remission may have occurred in \\nresponse to medication or other treatme nt.',\n",
       " '6A20.12  Schizophrenia, multiple episodes, in full remission  \\nAll definitional requirements for Schizophrenia, multiple episodes in terms of \\nsymptoms and duration were previously met. Symptoms have ameliorated such that \\nno significant symptoms remain. T he remission may have occurred in response to \\nmedication or other treatment.',\n",
       " '6A20.1Z  Schizophrenia, multiple episodes, unspecified',\n",
       " '6A20.2  Schizophrenia, continuous  \\nSymptoms fulfilling all definitional requirements of Schizophrenia have been present \\nfor almost all of the illness course over a period of at least one year, with periods of \\nsubthreshold symptoms being very brief relative to the overall course.  \\n 402  ICD-11 MMS',\n",
       " '6A20.20  Schizophrenia, continuous, currently symptomatic  \\nAll definitional requirements for Schizophr enia, continuous in terms of symptoms \\nand duration are currently met, or have been met within the past one month.',\n",
       " '6A20.21  Schizophrenia, continuous, in partial remission  \\nAll definitional requirements for Schizophrenia, continuous in terms of symptoms \\nand duration were previously met. Symptoms have ameliorated such that the \\ndiagnostic requirements for the disorder have not been met for at least one month, \\nbut some clinically significant symptoms remain, which may or may not be \\nassociated with functional imp airment. The partial remission may have occurred in \\nresponse to medication or other treatment.',\n",
       " '6A20.22  Schizophrenia, continuous, in full remission  \\nAll definitional requirements for Schizophrenia, continuous in terms of symptoms \\nand duration were previously met. Symptoms have ameliorated such that no \\nsignificant symptoms remain. The remission may have occurred in response to \\nmedication or other treatm ent.',\n",
       " '6A20.2Z  Schizophrenia, continuous, unspecified',\n",
       " '6A20.Y  Other specified episode of schizophrenia',\n",
       " '6A20.Z  Schizophrenia, episode unspecified',\n",
       " '6A21   Schizoaffective disorder  \\nSchizoaffective disorder is an episodic disorder in which the diagnostic \\nrequirements of schizophrenia and a manic, mixed, or moderate or severe \\ndepressive episode are met within the same episode of illness, either \\nsimultaneously or within a few days of each other. Prominent symptoms of \\nschizophrenia (e.g. delusions, hallucination s, disorganisation in the form of thought, \\nexperiences of influence, passivity and control) are accompanied by typical \\nsymptoms of a moderate or severe depressive episode (e.g. depressed mood, loss \\nof interest, reduced energy), a manic episode (e.g. an ext reme mood state \\ncharacterised by euphoria, irritability, or expansiveness; increased activity or a \\nsubjective experience of increased energy) or a mixed episode. Psychomotor \\ndisturbances, including catatonia, may be present. Symptoms must have persisted \\nfor at least one month. The symptoms are not a manifestation of another medical \\ncondition (e.g. a brain tumor) and are not due to the effect of a substance or \\nmedication on the central nervous system (e.g. corticosteroids), including \\nwithdrawal (e.g. alcohol  withdrawal).',\n",
       " '6A21.0  Schizoaffective disorder, first episode  \\nSchizoaffective disorder, first episode should be used to identify individuals \\nexperiencing symptoms that meet the diagnostic requirements for Schizoaffective \\ndisorder (including duration) but w ho have never before experienced an episode \\nduring which diagnostic requirements for Schizoaffective disorder or Schizophrenia \\nwere met.  \\n ICD-11 MMS  403',\n",
       " '6A21.00  Schizoaffective disorder, first episode, currently symptomatic  \\nAll definitional requirements for Schizoaffecti ve disorder, first episode in terms of \\nsymptoms and duration are currently met, or have been met within the past one \\nmonth.',\n",
       " '6A21.01  Schizoaffective disorder, first episode, in partial remission  \\nAll definitional requirements for Schizoaffective disorder, first episode in terms of \\nsymptoms and duration were previously met. Symptoms have ameliorated such that \\nthe diagnostic requirements for the disorder have not been met for at least one \\nmonth, but some clinically significant symptoms remain, which may or may not be \\nassociated with functional impairment. The partial remission may have occurred in \\nresponse to medication or other treatment.',\n",
       " '6A21.02  Schizoaffective disorder, first episode, in full remi ssion  \\nAll definitional requirements for Schizoaffective disorder, first episode in terms of \\nsymptoms and duration were previously met. Symptoms have ameliorated such that \\nno significant symptoms remain. The remission may have occurred in response to \\nmedica tion or other treatment.',\n",
       " '6A21.0Z  Schizoaffective disorder, first episode, unspecified',\n",
       " '6A21.1  Schizoaffective disorder, multiple episodes  \\nSchizoaffective disorder, multiple episodes should be used to identify individuals \\nexperiencing symptoms that meet th e diagnostic requirements for Schizoaffective \\ndisorder and who have also previously experienced episodes during which \\ndiagnostic requirements for Schizoaffective disorder or Schizophrenia were met, \\nwith substantial remission of symptoms between episodes. S ome attenuated \\nsymptoms may remain during period of remission, and remissions may have \\noccurred in response to medication or other treatment.',\n",
       " '6A21.10  Schizoaffective disorder, multiple episodes, currently symptomatic  \\nAll definitional requirements for Schizoaffective disorder, multiple episodes in terms \\nof symptoms and duration are currently met, or have been met within the past one \\nmonth.',\n",
       " '6A21.11  Schiz oaffective disorder, multiple episodes, in partial remission  \\nAll definitional requirements for Schizoaffective disorder, multiple episodes in terms \\nof symptoms and duration were previously met. Symptoms have ameliorated such \\nthat the diagnostic requirement s for the disorder have not been met for at least one \\nmonth, but some clinically significant symptoms remain, which may or may not be \\nassociated with functional impairment. The partial remission may have occurred in \\nresponse to medication or other treatmen t.',\n",
       " '6A21.12  Schizoaffective disorder, multiple episodes, in full remission  \\nAll definitional requirements for Schizoaffective disorder, multiple episodes in terms \\nof symptoms and duration were previously met. Symptoms have ameliorated such \\nthat no significa nt symptoms remain. The remission may have occurred in response \\nto medication or other treatment.',\n",
       " '6A21.1Z  Schizoaffective disorder, multiple episodes, unspecified  \\n 404  ICD-11 MMS',\n",
       " '6A21.2  Schizoaffective disorder, continuous  \\nSymptoms fulfilling all definitional requiremen ts of Schizoaffective disorder have \\nbeen present for almost all of the illness course over a period of at least one year, \\nwith periods of subthreshold symptoms being very brief relative to the overall \\ncourse.',\n",
       " '6A21.20  Schizoaffective disorder, continuous, currently symptomatic  \\nAll definitional requirements for Schizoaffective disorder, continuous in terms of \\nsymptoms and duration are currently met, or have been met within the past one \\nmonth.',\n",
       " '6A21.21  Schizoaffective disorder, continuous, in partial remissio n \\nAll definitional requirements for Schizoaffective disorder, continuous in terms of \\nsymptoms and duration were previously met. Symptoms have ameliorated such that \\nthe diagnostic requirements for the disorder have not been met for at least one \\nmonth, but s ome clinically significant symptoms remain, which may or may not be \\nassociated with functional impairment. The partial remission may have occurred in \\nresponse to medication or other treatment.',\n",
       " '6A21.22  Schizoaffective disorder, continuous, in full remissio n \\nAll definitional requirements for Schizoaffective disorder, continuous in terms of \\nsymptoms and duration were previously met. Symptoms have ameliorated such that \\nno significant symptoms remain. The remission may have occurred in response to \\nmedication or  other treatment.',\n",
       " '6A21.2Z  Schizoaffective disorder, continuous, unspecified',\n",
       " '6A21.Y  Other specified schizoaffective disorder',\n",
       " '6A21.Z  Schizoaffective disorder, unspecified',\n",
       " '6A22   Schizotypal disorder  \\nSchizotypal disorder is characterised by an enduring pattern (i.e. characteristic of \\nthe person’s functioning over a period of at least several years) of eccentricities in \\nbehaviour, appearance and speech, accompanied by cognitive and perceptual \\ndistortion s, unusual beliefs, and discomfort with — and often reduced capacity for — \\ninterpersonal relationships. Symptoms may include constricted or inappropriate \\naffect and anhedonia. Paranoid ideas, ideas of reference, or other psychotic \\nsymptoms, including halluci nations in any modality, may occur, but are not of \\nsufficient intensity or duration to meet the diagnostic requirements of schizophrenia, \\nschizoaffective disorder, or delusional disorder. The symptoms cause distress or \\nimpairment in personal, family, socia l, educational, occupational or other important \\nareas of functioning.  \\nInclusions:  Schizotypal personality disorder  \\nExclusions:  Autism spectrum disorder (6A02)  \\nPersonality disorder (6D10)  \\n ICD-11 MMS  405',\n",
       " '6A23   Acute and transient psychotic disorder  \\nAcute and transient psychotic disorder is characterised by acute onset of psychotic \\nsymptoms that emerge without a prodrome and reach their maximal severity within \\ntwo weeks. Symptoms may include delusions, hallucinat ions, disorganisation of \\nthought processes, perplexity or confusion, and disturbances of affect and mood. \\nCatatonia -like psychomotor disturbances may be present. Symptoms typically \\nchange rapidly, both in nature and intensity, from day to day, or even with in a single \\nday. The duration of the episode does not exceed 3 months, and most commonly \\nlasts from a few days to 1 month. The symptoms are not a manifestation of another \\nmedical condition (e.g. a brain tumour) and are not due to the effect of a substance \\nor medication on the central nervous system (e.g. corticosteroids), including \\nwithdrawal (e.g. alcohol withdrawal).',\n",
       " '6A23.0  Acute and transient psychotic disorder, first episode  \\nAcute and transient psychotic disorder, first episode should be used to identi fy \\nindividuals experiencing symptoms that meet the diagnostic requirements for acute \\nand transient psychotic disorder but who have never before experienced a similar \\nepisode.',\n",
       " '6A23.00  Acute and transient psychotic disorder, first episode, currently symptom atic \\nAll definitional requirements for Acute and transient psychotic disorder, first episode \\nin terms of symptoms and duration are currently met, or have been met within the \\npast one month.',\n",
       " '6A23.01  Acute and transient psychotic disorder, first episode, in  partial remission  \\nAll definitional requirements for Acute and transient psychotic disorder, first episode \\nin terms of symptoms and duration were previously met. Symptoms have \\nameliorated such that the diagnostic requirements for the disorder have not been  \\nmet for at least one month, but some clinically significant symptoms remain, which \\nmay or may not be associated with functional impairment. The partial remission may \\nhave occurred in response to medication or other treatment.',\n",
       " '6A23.02  Acute and transient psychotic disorder, first episode, in full remission  \\nAll definitional requirements for Acute and transient psychotic disorder, first episode \\nin terms of symptoms and duration were previously met. Symptoms have \\nameliorated such that no significant symptoms remain. The remission may have \\noccurred in response to medication or other treatment.',\n",
       " '6A23.0Z  Acute and transient psychotic disorder, first episode, unspecified',\n",
       " '6A23.1  Acute and transient psychotic disorder, multiple episodes  \\nAcute and transient psychoti c disorder, multiple episodes should be used to identify \\nindividuals experiencing symptoms that meet the diagnostic requirements for acute \\nand transient psychotic disorder and who have experienced similar episodes in the \\npast.',\n",
       " '6A23.10  Acute and transient psychotic disorder, multiple episodes, currently symptomatic  \\nAll definitional requirements for Acute and transient psychotic disorder, multiple \\nepisodes in terms of symptoms and duration are currently met, or have been met \\nwithin the past one month.  \\n 406  ICD-11 MMS',\n",
       " '6A23.11  Acute and transient psychotic disorder, multiple episodes,  in partial remission  \\nAll definitional requirements for Acute and transient psychotic disorder, multiple \\nepisodes in terms of symptoms and duration were previously met. Symptoms have \\nameliorated such that the diagnostic requirements for the disorder have n ot been \\nmet for at least one month, but some clinically significant symptoms remain, which \\nmay or may not be associated with functional impairment. The partial remission may \\nhave occurred in response to medication or other treatment.',\n",
       " '6A23.12  Acute and tra nsient psychotic disorder, multiple episodes, in full remission  \\nAll definitional requirements for Acute and transient psychotic disorder, multiple \\nepisodes in terms of symptoms and duration were previously met. Symptoms have \\nameliorated such that no signif icant symptoms remain. The remission may have \\noccurred in response to medication or other treatment.',\n",
       " '6A23.1Z  Acute and transient psychotic disorder, multiple episodes, unspecified',\n",
       " '6A23.Y  Other specified acute and transient psychotic disorder',\n",
       " '6A23.Z  Acut e and transient psychotic disorder, unspecified',\n",
       " '6A24   Delusional disorder  \\nDelusional disorder is characterised by the development of a delusion or set of \\nrelated delusions, typically persisting for at least 3 months and often much longer, in \\nthe absenc e of a Depressive, Manic, or Mixed mood episode. The delusions are \\nvariable in content across individuals, but typically stable within individuals, although \\nthey may evolve over time. Other characteristic symptoms of Schizophrenia (i.e. \\nclear and persisten t hallucinations, negative symptoms, disorganised thinking, or \\nexperiences of influence, passivity, or control) are not present, although various \\nforms of perceptual disturbances (e.g. hallucinations, illusions, misidentifications of \\npersons) thematically related to the delusion are still consistent with the diagnosis. \\nApart from actions and attitudes directly related to the delusion or delusional \\nsystem, affect, speech, and behavior are typically unaffected. The symptoms are \\nnot a manifestation of another medical condition (e.g., a brain tumour) and are not \\ndue to the effect of a substance or medication on the central nervous system (e.g. \\ncorticosteroids), including withdrawal effects (e.g. alcohol withdrawal).',\n",
       " '6A24.0  Delusional disorder, currently symptom atic \\nAll definitional requirements for Delusional disorder in terms of symptoms and \\nduration are currently met, or have been met within the past one month.',\n",
       " '6A24.1  Delusional disorder, in partial remission  \\nAll definitional requirements for Delusional disorder in terms of symptoms and \\nduration were previously met. Symptoms have ameliorated such that the diagnostic \\nrequirements for the disorder have not been met for at least one month, but some \\nclinically sign ificant symptoms remain, which may or may not be associated with \\nfunctional impairment. The partial remission may have occurred in response to \\nmedication or other treatment.  \\n ICD-11 MMS  407',\n",
       " '6A24.2  Delusional disorder, in full remission  \\nAll definitional requirements for D elusional disorder in terms of symptoms and \\nduration were previously met. Symptoms have ameliorated such that no significant \\nsymptoms remain. The remission may have occurred in response to medication or \\nother treatment.',\n",
       " '6A24.Z  Delusional disorder, unspeci fied',\n",
       " '6A25   Symptomatic manifestations of primary psychotic disorders  \\nThese categories may be used to characterize the current clinical presentation in \\nindividuals diagnosed with Schizophrenia or another primary psychotic disorder, \\nand should not be used in individuals without such a diagnosis. Multiple categories \\nmay be app lied. Symptoms attributable to the direct pathophysiological \\nconsequences of a health condition or injury not classified under Mental, \\nbehavioural or neurodevelopmental disorders (e.g., a brain tumour or traumatic \\nbrain injury), or to the direct effects of  a substance or medication on the central \\nnervous system, including withdrawal effects, should not be considered as \\nexamples of the respective types of symptoms.  \\nCoding Note:  These categories should never be used in primary coding. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of these symptoms in primary psychotic disorders.',\n",
       " \"6A25.0  Positive symptoms in primary psychotic disorders  \\nPositive symptoms in primary psychotic disorders include pers istent delusions, \\npersistent hallucinations (most commonly verbal auditory hallucinations), \\ndisorganised thinking (formal thought disorder such as loose associations, thought \\nderailment, or incoherence), grossly disorganised behaviour (behaviour that \\nappea rs bizarre, purposeless and not goal -directed) and experiences of passivity \\nand control (the experience that one's feelings, impulses, or thoughts are under the \\ncontrol of an external force). The rating should be made based on the severity of \\npositive symp toms during the past week.  \\nCoding Note:  These categories should never be used in primary coding. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of these symptoms in primary psychotic disorder s.\",\n",
       " '6A25.1  Negative symptoms in primary psychotic disorders  \\nNegative symptoms in primary psychotic disorders include constricted, blunted, or \\nflat affect, alogia or paucity of speech, avolition (general lack of drive, or lack of \\nmotivation to pursue meanin gful goals), asociality (reduced or absent engagement \\nwith others and interest in social interaction) and anhedonia (inability to experience \\npleasure from normally pleasurable activities). To be considered negative psychotic \\nsymptoms, relevant symptoms sho uld not be entirely attributable to antipsychotic \\ndrug treatment, a depressive disorder, or an under -stimulating environment, and \\nshould not be a direct consequence of a positive symptom (e.g., persecutory \\ndelusions causing a person to become socially isol ated due to fear of harm). The \\nrating should be made based on the severity of negative symptoms during the past \\nweek.  \\nCoding Note:  These categories should never be used in primary coding. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of these symptoms in primary psychotic disorders.  \\n 408  ICD-11 MMS',\n",
       " '6A25.2  Depressive mood symptoms in primary psychotic disorders  \\nDepressive mood symptoms in primary psychotic disorders refer to depressed \\nmood as reported by the  individual (feeling down, sad) or manifested as a sign (e.g. \\ntearful, defeated appearance). If only non -mood symptoms of a depressive episode \\nare present (e.g., anhedonia, psychomotor slowing), this descriptor should not be \\nused. This descriptor may be us ed whether or not depressive symptoms meet the \\ndiagnostic requirements of a separately diagnosed Depressive disorder. The rating \\nshould be made based on the severity of depressive mood symptoms during the \\npast week.  \\nCoding Note:  These categories should nev er be used in primary coding. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of these symptoms in primary psychotic disorders.',\n",
       " \"6A25.3  Manic mood symptoms in primary psychotic disorders  \\nManic  mood symptoms in primary psychotic disorders refer to elevated, euphoric, \\nirritable, or expansive mood states, including rapid changes among different mood \\nstates (i.e., mood lability). It also includes increased subjective experience of \\nenergy, which may  be accompanied by increased goal -directed activity. The \\nseverity of associated non -mood symptoms of a Manic or Hypomanic Episode (e.g., \\ndecreased need for sleep, distractibility) should not be considered in making a \\nrating. Increased non -goal-directed psy chomotor activity should be considered as \\npart of the rating of the 'psychomotor symptoms in primary psychotic disorders' \\nrather than here. This descriptor may be used whether or not the manic symptoms \\nmeet the diagnostic requirements of a separately diagn osed bipolar disorder. The \\nrating should be made based on the severity of manic mood symptoms during the \\npast week.  \\nCoding Note:  These categories should never be used in primary coding. The codes are provided \\nfor use as supplementary or additional codes wh en it is desired to identify the \\npresence of these symptoms in primary psychotic disorders.\",\n",
       " '6A25.4  Psychomotor symptoms in primary psychotic disorders  \\nPsychomotor symptoms in primary psychotic disorders include psychomotor \\nagitation or excessive motor act ivity, usually manifested by purposeless behaviours \\nsuch as fidgeting, shifting, fiddling, inability to sit or stand still, wringing of the hands, \\npsychomotor retardation, or a visible generalised slowing of movements and \\nspeech, and catatonic symptoms suc h as excitement, posturing, waxy flexibility, \\nnegativism, mutism, or stupor. The rating should be made based on the severity of \\npsychomotor symptoms during the past week.  \\nCoding Note:  These categories should never be used in primary coding. The codes are p rovided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of these symptoms in primary psychotic disorders.  \\n ICD-11 MMS  409',\n",
       " '6A25.5  Cognitive symptoms in primary psychotic disorders  \\nCognitive symptoms in primary psychotic disorders r efer to cognitive impairment in \\nany of the following domains: speed of processing, attention/concentration, \\norientation, judgment, abstraction, verbal or visual learning, and working memory. \\nThe cognitive impairment is not attributable to a neurodevelopmen tal disorder, a \\ndelirium or other neurocognitive disorder, or the direct effects of a substance or \\nmedication on the central nervous system, including withdrawal effects. Ideally, use \\nof this category should be based on the results of locally validated, st andardized \\nneuropsychological assessments, although such measures may not be available in \\nall settings. The rating should be made based on the severity of cognitive symptoms \\nduring the past week.  \\nCoding Note:  These categories should never be used in primar y coding. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of these symptoms in primary psychotic disorders.  \\nExclusions:  Neurocognitive disorders  (6D70‑6E0Z)  \\nNeurodevelopmental disorders  (6A00‑6A0Z)',\n",
       " '6A2Y   Other specified primary psychotic disorder',\n",
       " '6A2Z   Schizophrenia or other primary psychotic disorders, unspecified  \\n \\nCatatonia (6A40 ‑6A4Z)  \\nCatatonia is a syndrome of primarily psychomotor disturbances, characterized by the co -occurrence \\nof several symptoms of decreased, increased, or abnormal psychomotor activity. The assessment of \\ncatatonia is complex and requires observation, interview and physical exam. Catatonia can occur in \\nthe context of another mental disorder, such as Schizophrenia or Other Primary Psychotic Disorders, \\nMood Disorders, and Neurodevelopmental Disorders, especially Autism Spectrum Disorder. Catatonia \\ncan also develop duri ng or soon after intoxication or withdrawal from certain psychoactive substances, \\nincluding phencyclidine (PCP), cannabis, hallucinogens such as mescaline or LSD, cocaine and \\nMDMA or related drugs, or during the use of certain psychoactive and non -psychoac tive medications \\n(e.g. antipsychotic medications, benzodiazepines, steroids, disulfiram, ciprofloxacin). Finally, \\nCatatonia can occur as a direct pathophysiological consequence of a medical condition not classified \\nunder Mental, Behavioural or Neurodevelop mental Disorders. Examples of medical conditions that \\nmay be associated with Catatonia include diabetic ketoacidosis, hypercalcemia, hepatic \\nencephalopathy, homocystinuria, neoplasms head trauma, cerebrovascular disease, and encephalitis.  \\nExclusions:  Harmf ul effects of drugs, medicaments or biological substances, not elsewhere \\nclassified (NE60)  \\nCoded Elsewhere:  Secondary catatonia syndrome (6E69)',\n",
       " '6A40   Catatonia associated with another mental disorder  \\nCatatonia associated with another mental disorder is a syndrome of primarily \\npsychomotor disturbances, characterized by the co -occurrence of several \\nsymptoms of decreased, increased, or abnormal psychomotor activity, which occurs \\nin the context of another mental disorder, such as Schizophrenia or Other Prima ry \\nPsychotic Disorders, Mood Disorders, and Neurodevelopmental Disorders, \\nespecially Autism Spectrum Disorder.  \\n 410  ICD-11 MMS',\n",
       " '6A41   Catatonia induced by substances or medications  \\nCatatonia induced by substances or medications is a syndrome of primarily \\npsychomotor di sturbances, characterized by the co -occurrence of several \\nsymptoms of decreased, increased, or abnormal psychomotor activity, which \\ndevelops during or soon after intoxication or withdrawal from certain psychoactive \\nsubstances, including phencyclidine (PCP) , cannabis, hallucinogens such as \\nmescaline or LSD, cocaine and MDMA or related drugs, or during the use of certain \\npsychoactive and non -psychoactive medications (e.g. antipsychotic medications, \\nbenzodiazepines, steroids, disulfiram, ciprofloxacin).  \\nExclus ions:  Neuroleptic malignant syndrome  (8A00‑8A0Z)  \\nSerotonin syndrome (8D85)',\n",
       " '6A4Z   Catatonia, unspecified  \\nCoding Note:  Code also the causing condition  \\n ICD-11 MMS  411 \\n Mood disorders (6A60 ‑6A8Z)  \\nMood Disorders refers to a superordinate grouping of Bipolar and Depressive  Disorders. Mood \\ndisorders are defined according to particular types of mood episodes and their pattern over time. The \\nprimary types of mood episodes are Depressive episode, Manic episode, Mixed episode, and \\nHypomanic episode. Mood episodes are not indepen dently diagnosable entities, and therefore do not \\nhave their own diagnostic codes. Rather, mood episodes make up the primary components of most of \\nthe Depressive and Bipolar Disorders.  \\nCoded Elsewhere:  Substance -induced mood disorders  \\nSecondary mood syndro me (6E62)  \\nBipolar or related disorders (6A60 ‑6A6Z)  \\nBipolar and related disorders are episodic mood disorders defined by the occurrence of Manic, Mixed \\nor Hypomanic episodes or symptoms. These episodes typically alternate over the course of these \\ndisorders with Depressive episodes or periods of depressive symptoms.',\n",
       " '6A60   Bipolar type I disorder  \\nBipolar type I disorder is an episodic mood disorder defined by the occurrence of \\none or more manic or mixed episodes. A manic episode is an extreme mood state \\nlasting at least one week unless shortened by a treatment intervention \\ncharacterised by euphoria , irritability, or expansiveness, and by increased activity or \\na subjective experience of increased energy, accompanied by other characteristic \\nsymptoms such as rapid or pressured speech, flight of ideas, increased self -esteem \\nor grandiosity, decreased nee d for sleep, distractibility, impulsive or reckless \\nbehaviour, and rapid changes among different mood states (i.e., mood lability). A \\nmixed episode is characterised by the presence of several prominent manic and \\nseveral prominent depressive symptoms consis tent with those observed in manic \\nepisodes and depressive episodes, which either occur simultaneously or alternate \\nvery rapidly (from day to day or within the same day). Symptoms must include an \\naltered mood state consistent with a manic and/or depressive episode (i.e., \\ndepressed, dysphoric, euphoric or expansive mood), and be present most of the \\nday, nearly every day, during a period of at least 2 weeks, unless shortened by a \\ntreatment intervention. Although the diagnosis can be made based on evidence of a  \\nsingle manic or mixed episode, typically manic or mixed episodes alternate with \\ndepressive episodes over the course of the disorder.  \\nExclusions:  Cyclothymia (6A62)  \\nBipolar type II disorder (6A61)  \\n 412  ICD-11 MMS',\n",
       " '6A60.0  Bipolar type I disorder, current episode manic, wit hout psychotic symptoms  \\nBipolar type I disorder, current episode manic, without psychotic symptoms is \\ndiagnosed when the definitional requirements for Bipolar type I disorder are met, the \\ncurrent episode is manic, and there are no delusions or hallucinatio ns present \\nduring the episode. A manic episode is an extreme mood state lasting at least one \\nweek unless shortened by a treatment intervention characterised by euphoria, \\nirritability, or expansiveness, and by increased activity or a subjective experience o f \\nincreased energy, accompanied by other characteristic symptoms such as rapid or \\npressured speech, flight of ideas, increased self -esteem or grandiosity, decreased \\nneed for sleep, distractibility, impulsive or reckless behaviour, and rapid changes \\namong d ifferent mood states (i.e., mood lability). If the individual has experienced \\nManic or Mixed Episodes in the past, a duration of one week is not required in order \\nto diagnose a current episode if all other diagnostic requirements are met.',\n",
       " '6A60.1  Bipolar t ype I disorder, current episode manic, with psychotic symptoms  \\nBipolar type I disorder, current episode manic with psychotic symptoms is \\ndiagnosed when the definitional requirements for Bipolar type I Disorder have been \\nmet, the current episode is Manic an d there are delusions or hallucinations present \\nduring the episode. A manic episode is an extreme mood state lasting at least one \\nweek unless shortened by a treatment intervention characterised by euphoria, \\nirritability, or expansiveness, and by increased activity or a subjective experience of \\nincreased energy, accompanied by other characteristic symptoms such as rapid or \\npressured speech, flight of ideas, increased self -esteem or grandiosity, decreased \\nneed for sleep, distractibility, impulsive or reckless  behaviour, and rapid changes \\namong different mood states (i.e., mood lability). If the individual has experienced \\nManic or Mixed Episodes in the past, a duration of one week is not required in order \\nto diagnose a current episode if all other diagnostic re quirements are met.',\n",
       " '6A60.2  Bipolar type I disorder, current episode hypomanic  \\nBipolar type I disorder, current episode hypomanic is diagnosed when the \\ndefinitional requirements for Bipolar type I disorder have been met and the current \\nepisode is hypomanic . A hypomanic episode is a persistent mood state lasting at \\nleast several days characterised by mild elevation of mood or increased irritability \\nand increased activity or a subjective experience of increased energy, accompanied \\nby other characteristic symp toms such as rapid speech, rapid or racing thoughts, \\nincreased self -esteem, an increase in sexual drive or sociability, decreased need for \\nsleep, distractibility, or impulsive or reckless behaviour. The symptoms are not \\nsevere enough to cause marked impair ment in occupational functioning or in usual \\nsocial activities or relationships with others, does not necessitate hospitalization, \\nand there are no accompanying delusions or hallucinations.  \\n ICD-11 MMS  413',\n",
       " '6A60.3  Bipolar type I disorder, current episode depressive, mild  \\nBipolar type I disorder, current episode depressive, mild is diagnosed when the \\ndefinitional requirements for Bipolar type I disorder have been met and the current \\nepisode is depressive at a mild level of severity. A depressive episode is \\ncharacterised by a period of depressed mood or diminished interest in activities \\noccurring most of the day, nearly every day during a period lasting at least two \\nweeks accompanied by other symptoms such as difficulty concentrating, feelings of \\nworthlessness or excessive or  inappropriate guilt, hopelessness, recurrent thoughts \\nof death or suicide, changes in appetite or sleep, psychomotor agitation or \\nretardation, and reduced energy or fatigue. In a mild depressive episode, the \\nindividual is usually distressed by the symptom s and has some difficulty in \\ncontinuing to function in one or more domains (personal, family, social, educational, \\noccupational, or other important domains). There are no delusions or hallucinations \\nduring the episode.',\n",
       " '6A60.4  Bipolar type I disorder, current episode depressive, moderate without \\npsychotic symptoms  \\nBipolar type I disorder, current episode depressive, moderate, without psychotic \\nsymptoms is diagnosed when the definitional requirements for Bipolar type I \\ndisorder h ave been met and the current episode is depressive at a moderate level \\nof severity and there are no delusions or hallucinations during the episode. A \\ndepressive episode is characterised by a period of depressed mood or diminished \\ninterest in activities occ urring most of the day, nearly every day during a period \\nlasting at least two weeks accompanied by other symptoms such as difficulty \\nconcentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. In a moderate \\ndepressive episode, several symptoms of a depressive episode are present to a \\nmarked degree, or a large number of depressive symptoms of lesser severity are \\npresent overall. The individual typically has considerable difficulty functioning in \\nmultiple domains (personal, family, social, educational, occupational, or other \\nimportant domains).',\n",
       " '6A60.5  Bipolar type I disorder, current episode  depressive, moderate with psychotic \\nsymptoms  \\nBipolar type I disorder, current episode depressive, moderate, with psychotic \\nsymptoms diagnosed when the definitional requirements for Bipolar type I disorder \\nhave been met and the current episode is depressiv e at a moderate level of severity \\nand there are delusions or hallucinations during the episode. A depressive episode \\nis characterised by a period of depressed mood or diminished interest in activities \\noccurring most of the day, nearly every day during a pe riod lasting at least two \\nweeks accompanied by other symptoms such as difficulty concentrating, feelings of \\nworthlessness or excessive or inappropriate guilt, hopelessness, recurrent thoughts \\nof death or suicide, changes in appetite or sleep, psychomotor a gitation or \\nretardation, and reduced energy or fatigue. In a moderate depressive episode, \\nseveral symptoms of a depressive episode are present to a marked degree, or a \\nlarge number of depressive symptoms of lesser severity are present overall. The \\nindividu al typically has considerable difficulty functioning in multiple domains \\n(personal, family, social, educational, occupational, or other important domains).  \\n 414  ICD-11 MMS',\n",
       " '6A60.6  Bipolar type I disorder, current episode depressive, severe without psychotic \\nsymptoms  \\nBipol ar type I disorder, current episode depressive, severe, without psychotic \\nsymptoms is diagnosed when the definitional requirements for Bipolar type I \\ndisorder are met and the current episode is severe and there are no delusions or \\nhallucinations during the  episode. A depressive episode is characterised by a period \\nof depressed mood or diminished interest in activities occurring most of the day, \\nnearly every day during a period lasting at least two weeks accompanied by other \\nsymptoms such as difficulty conce ntrating, feelings of worthlessness or excessive or \\ninappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in \\nappetite or sleep, psychomotor agitation or retardation, and reduced energy or \\nfatigue. In a severe depressive episode , many or most symptoms of a Depressive \\nEpisode are present to a marked degree, or a smaller number of symptoms are \\npresent and manifest to an intense degree. The individual has serious difficulty \\ncontinuing to function in most domains (personal, family, s ocial, educational, \\noccupational, or other important domains).',\n",
       " '6A60.7  Bipolar type I disorder, current episode depressive, severe with psychotic \\nsymptoms  \\nBipolar type I disorder, current episode depressive, severe, with psychotic \\nsymptoms is diagnosed whe n the definitional requirements for Bipolar type I \\ndisorder are met and the current episode is severe and there are delusions or \\nhallucinations during the episode. A depressive episode is characterised by a period \\nof depressed mood or diminished interest i n activities occurring most of the day, \\nnearly every day during a period lasting at least two weeks accompanied by other \\nsymptoms such as difficulty concentrating, feelings of worthlessness or excessive or \\ninappropriate guilt, hopelessness, recurrent thoug hts of death or suicide, changes in \\nappetite or sleep, psychomotor agitation or retardation, and reduced energy or \\nfatigue. In a severe depressive episode, many or most symptoms of a Depressive \\nEpisode are present to a marked degree, or a smaller number of  symptoms are \\npresent and manifest to an intense degree. The individual has serious difficulty \\ncontinuing to function in most domains (personal, family, social, educational, \\noccupational, or other important domains).',\n",
       " '6A60.8  Bipolar type I disorder, current episode depressive, unspecified severity  \\nBipolar type I disorder, current episode depressive, unspecified severity is \\ndiagnosed when the definitional requirements for Bipolar type I disorder have been \\nmet and the current ep isode is depressive, but there is insufficient information to \\ndetermine the severity of the current depressive episode. A depressive episode is \\ncharacterised by a period of depressed mood or diminished interest in activities \\noccurring most of the day, near ly every day during a period lasting at least two \\nweeks accompanied by other symptoms such as difficulty concentrating, feelings of \\nworthlessness or excessive or inappropriate guilt, hopelessness, recurrent thoughts \\nof death or suicide, changes in appetite  or sleep, psychomotor agitation or \\nretardation, and reduced energy or fatigue. The symptoms are associated with at \\nleast some difficulty in continuing with ordinary work, social, or domestic activities.  \\n ICD-11 MMS  415',\n",
       " '6A60.9  Bipolar type I disorder, current episode mix ed, without psychotic symptoms  \\nBipolar type I disorder, current episode mixed, without psychotic symptoms is \\ndiagnosed when the definitional requirements for Bipolar type I disorder are met and \\nthe current episode is mixed and there are no delusions or hal lucinations present \\nduring the episode. A mixed episode is characterised by the presence of several \\nprominent manic and several prominent depressive symptoms consistent with those \\nobserved in manic episodes and depressive episodes, which either occur \\nsimul taneously or alternate very rapidly (from day to day or within the same day). \\nSymptoms must include an altered mood state consistent with a manic and/or \\ndepressive episode (i.e., depressed, dysphoric, euphoric or expansive mood), and \\nbe present most of the  day, nearly every day, during a period of at least 2 weeks, \\nunless shortened by a treatment intervention. If the individual has experienced \\nManic or Mixed Episodes in the past, a duration of 2 weeks is not required in order \\nto diagnose a current episode i f all other diagnostic requirements are met.',\n",
       " '6A60.A  Bipolar type I disorder, current episode mixed, with psychotic symptoms  \\nBipolar type I disorder, current episode mixed, with psychotic symptoms is \\ndiagnosed when the definitional requirements for Bipolar  type I disorder are met and \\nthe current episode is mixed and there are delusions or hallucinations present \\nduring the episode. A mixed episode is characterised by the presence of several \\nprominent manic and several prominent depressive symptoms consistent  with those \\nobserved in manic episodes and depressive episodes, which either occur \\nsimultaneously or alternate very rapidly (from day to day or within the same day). \\nSymptoms must include an altered mood state consistent with a manic and/or \\ndepressive epis ode (i.e., depressed, dysphoric, euphoric or expansive mood), and \\nbe present most of the day, nearly every day, during a period of at least 2 weeks, \\nunless shortened by a treatment intervention. If the individual has experienced \\nManic or Mixed Episodes in the past, a duration of 2 weeks is not required in order \\nto diagnose a current episode if all other diagnostic requirements are met.',\n",
       " '6A60.B  Bipolar type I disorder, currently in partial remission, most recent episode \\nmanic or hypomanic  \\nBipolar type I diso rder, currently in partial remission, most recent episode manic or \\nhypomanic is diagnosed when the definitional requirements for Bipolar type I \\ndisorder have been met and the most recent episode was a manic or hypomanic \\nepisode. The full definitional requi rements for a manic or hypomanic episode are no \\nlonger met but some significant mood symptoms remain. In some cases, residual \\nmood symptoms may be depressive rather than manic or hypomanic, but do not \\nsatisfy the definitional requirements for a depressive episode.',\n",
       " '6A60.C  Bipolar type I disorder, currently in partial remission, most recent episode \\ndepressive  \\nBipolar type I disorder, currently in partial remission, most recent episode \\ndepressive is diagnosed when the definitional requirements for Bipolar typ e I \\ndisorder have been met and the most recent episode was a depressive episode. \\nThe full definitional requirements for the episode are no longer met but some \\nsignificant depressive symptoms remain.  \\n 416  ICD-11 MMS',\n",
       " '6A60.D  Bipolar type I disorder, currently in partial rem ission, most recent episode \\nmixed  \\nBipolar type I disorder, currently in partial remission, most recent episode mixed is \\ndiagnosed when the definitional requirements for Bipolar type I disorder have been \\nmet and the most recent episode was a mixed episode. The full definitional \\nrequirements for the episode are no longer met but some significant mood \\nsymptoms remain.',\n",
       " '6A60.E  Bipolar type I disorder, currently in partial remission, most recent episode \\nunspecified  \\nBipolar type I disorder, currently in partial r emission, most recent episode \\nunspecified is diagnosed when the definitional requirements for Bipolar type I \\ndisorder have been met but there is insufficient information to determine the nature \\nof the most recent mood episode. The full definitional require ments for a mood \\nepisode are no longer met but some significant mood symptoms remain.',\n",
       " '6A60.F  Bipolar type I disorder, currently in full remission  \\nBipolar type I disorder, currently in full remission is diagnosed when the full \\ndefinitional requirements for  Bipolar I disorder have been met in the past but there \\nare no longer any significant mood symptoms.',\n",
       " '6A60.Y  Other specified bipolar type I disorder',\n",
       " '6A60.Z  Bipolar type I disorder, unspecified',\n",
       " '6A61   Bipolar type II disorder  \\nBipolar type II disorder is an episodic mood disorder defined by the occurrence of \\none or more hypomanic episodes and at least one depressive episode. A \\nhypomanic episode is a persistent mood state lasting for at least several days \\ncharacterised by persist ent elevation of mood or increased irritability as well as \\nincreased activity or a subjective experience of increased energy, accompanied by \\nother characteristic symptoms such as increased talkativeness, rapid or racing \\nthoughts, increased self -esteem, dec reased need for sleep, distractability, and \\nimpulsive or reckless behavior. The symptoms represent a change from the \\nindividual’s typical mood, energy level, and behavior but are not severe enough to \\ncause marked impairment in functioning. A depressive epi sode is characterised by \\na period of depressed mood or diminished interest in activities occurring most of the \\nday, nearly every day during a period lasting at least two weeks accompanied by \\nother symptoms such as changes in appetite or sleep, psychomotor agitation or \\nretardation, fatigue, feelings of worthless or excessive or inappropriate guilt, feelings \\nor hopelessness, difficulty concentrating, and suicidality. There is no history of \\nmanic or mixed episodes.  \\n ICD-11 MMS  417',\n",
       " '6A61.0  Bipolar type II disorder, current epi sode hypomanic  \\nBipolar type II disorder, current episode hypomanic is diagnosed when the \\ndefinitional requirements for Bipolar type II disorder have been met and the current \\nepisode is hypomanic. A hypomanic episode is a persistent mood state lasting at \\nleast several days characterised by mild elevation of mood or increased irritability \\nand increased activity or a subjective experience of increased energy, accompanied \\nby other characteristic symptoms such as rapid speech, rapid or racing thoughts, \\nincreased  self-esteem, an increase in sexual drive or sociability, decreased need for \\nsleep, distractibility, or impulsive or reckless behaviour. The symptoms are not \\nsevere enough to cause marked impairment in occupational functioning or in usual \\nsocial activities  or relationships with others, does not necessitate hospitalization, \\nand there are no accompanying delusions or hallucinations.',\n",
       " '6A61.1  Bipolar type II disorder, current episode depressive, mild  \\nBipolar type II disorder, current episode depressive, mild is diagnosed when the \\ndefinitional requirements for Bipolar type II disorder have been met and the current \\nepisode is depressive at a mild level of severity. A depressive episode is \\ncharacterised b y a period of depressed mood or diminished interest in activities \\noccurring most of the day, nearly every day during a period lasting at least two \\nweeks accompanied by other symptoms such as difficulty concentrating, feelings of \\nworthlessness or excessive or inappropriate guilt, hopelessness, recurrent thoughts \\nof death or suicide, changes in appetite or sleep, psychomotor agitation or \\nretardation, and reduced energy or fatigue. In a mild depressive episode, the \\nindividual is usually distressed by the sympt oms and has some difficulty in \\ncontinuing to function in one or more domains (personal, family, social, educational, \\noccupational, or other important domains). There are no delusions or hallucinations \\nduring the episode.',\n",
       " '6A61.2  Bipolar type II disorder, c urrent episode depressive, moderate without \\npsychotic symptoms  \\nBipolar type II disorder, current episode depressive, moderate, without psychotic \\nsymptoms is diagnosed when the definitional requirements for Bipolar type II \\ndisorder have been met and the cur rent episode is depressive at a moderate level \\nof severity and there are no delusions or hallucinations during the episode. A \\ndepressive episode is characterised by a period of depressed mood or diminished \\ninterest in activities occurring most of the day, nearly every day during a period \\nlasting at least two weeks accompanied by other symptoms such as difficulty \\nconcentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appe tite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. In a moderate \\ndepressive episode, several symptoms of a depressive episode are present to a \\nmarked degree, or a large number of depressive symptoms of lesser severity are \\npresent overall. The individual typically has considerable difficulty functioning in \\nmultiple domains (personal, family, social, educational, occupational, or other \\nimportant domains).  \\n 418  ICD-11 MMS',\n",
       " '6A61.3  Bipolar type II disorder, current episode depressive, moderate w ith psychotic \\nsymptoms  \\nBipolar type II disorder, current episode depressive, moderate, with psychotic \\nsymptoms diagnosed when the definitional requirements for Bipolar type II disorder \\nhave been met and the current episode is depressive at a moderate level  of severity \\nand there are delusions or hallucinations during the episode. A depressive episode \\nis characterised by a period of depressed mood or diminished interest in activities \\noccurring most of the day, nearly every day during a period lasting at least  two \\nweeks accompanied by other symptoms such as difficulty concentrating, feelings of \\nworthlessness or excessive or inappropriate guilt, hopelessness, recurrent thoughts \\nof death or suicide, changes in appetite or sleep, psychomotor agitation or \\nretardati on, and reduced energy or fatigue. In a moderate depressive episode, \\nseveral symptoms of a depressive episode are present to a marked degree, or a \\nlarge number of depressive symptoms of lesser severity are present overall. The \\nindividual typically has cons iderable difficulty functioning in multiple domains \\n(personal, family, social, educational, occupational, or other important domains).',\n",
       " '6A61.4  Bipolar type II disorder, current episode depressive, severe without psychotic \\nsymptoms  \\nBipolar type II disorder,  current episode depressive, severe, without psychotic \\nsymptoms is diagnosed when the definitional requirements for Bipolar type II \\ndisorder are met and the current episode is severe and there are no delusions or \\nhallucinations during the episode. A depres sive episode is characterised by a period \\nof depressed mood or diminished interest in activities occurring most of the day, \\nnearly every day during a period lasting at least two weeks accompanied by other \\nsymptoms such as difficulty concentrating, feelings  of worthlessness or excessive or \\ninappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in \\nappetite or sleep, psychomotor agitation or retardation, and reduced energy or \\nfatigue. In a severe depressive episode, many or most sym ptoms of a Depressive \\nEpisode are present to a marked degree, or a smaller number of symptoms are \\npresent and manifest to an intense degree. The individual has serious difficulty \\ncontinuing to function in most domains (personal, family, social, educational , \\noccupational, or other important domains).',\n",
       " '6A61.5  Bipolar type II disorder, current episode depressive, severe with psychotic \\nsymptoms  \\nBipolar type II disorder, current episode depressive, severe, with psychotic \\nsymptoms is diagnosed when the definition al requirements for Bipolar type II \\ndisorder are met and the current episode is severe and there are delusions or \\nhallucinations during the episode. A depressive episode is characterised by a period \\nof depressed mood or diminished interest in activities oc curring most of the day, \\nnearly every day during a period lasting at least two weeks accompanied by other \\nsymptoms such as difficulty concentrating, feelings of worthlessness or excessive or \\ninappropriate guilt, hopelessness, recurrent thoughts of death or  suicide, changes in \\nappetite or sleep, psychomotor agitation or retardation, and reduced energy or \\nfatigue. In a severe depressive episode, many or most symptoms of a Depressive \\nEpisode are present to a marked degree, or a smaller number of symptoms are \\npresent and manifest to an intense degree. The individual has serious difficulty \\ncontinuing to function in most domains (personal, family, social, educational, \\noccupational, or other important domains).  \\n ICD-11 MMS  419',\n",
       " '6A61.6  Bipolar type II disorder, current episode depr essive, unspecified severity  \\nBipolar type II disorder, current episode depressive, unspecified severity is \\ndiagnosed when the definitional requirements for Bipolar type II disorder have been \\nmet and the current episode is depressive, but there is insuffici ent information to \\ndetermine the severity of the current depressive episode. A depressive episode is \\ncharacterised by a period of depressed mood or diminished interest in activities \\noccurring most of the day, nearly every day during a period lasting at lea st two \\nweeks accompanied by other symptoms such as difficulty concentrating, feelings of \\nworthlessness or excessive or inappropriate guilt, hopelessness, recurrent thoughts \\nof death or suicide, changes in appetite or sleep, psychomotor agitation or \\nretarda tion, and reduced energy or fatigue. The symptoms are associated with at \\nleast some difficulty in continuing with ordinary work, social, or domestic activities.',\n",
       " '6A61.7  Bipolar type II disorder, currently in partial remission, most recent episode \\nhypomanic  \\nBipolar type II disorder, currently in partial remission, most recent episode \\nhypomanic is diagnosed when the definitional requirements for Bipolar type II \\ndisorder have been met and the most recent episode was a hypomanic episode. \\nThe full definitional r equirements for a hypomanic episode are no longer met but \\nsome significant mood symptoms remain. In some cases, residual mood symptoms \\nmay be depressive rather than hypomanic, but do not satisfy the definitional \\nrequirements for a depressive episode.',\n",
       " '6A61 .8 Bipolar type II disorder, currently in partial remission, most recent episode \\ndepressive  \\nBipolar type II disorder, currently in partial remission, most recent episode \\ndepressive is diagnosed when the definitional requirements for Bipolar type II \\ndisorder have been met and the most recent episode was a depressive episode. \\nThe full definitional requirements for the episode are no longer met but some \\nsignificant depressive symptoms remain.',\n",
       " '6A61.9  Bipolar type II disorder, currently in partial remission, most recent episode \\nunspecified  \\nBipolar type II disorder, currently in partial remission, most  recent episode \\nunspecified is diagnosed when the definitional requirements for Bipolar type II \\ndisorder have been met but there is insufficient information to determine the nature \\nof the most recent mood episode. The full definitional requirements for a m ood \\nepisode are no longer met but some significant mood symptoms remain.',\n",
       " '6A61.A  Bipolar type II disorder, currently in full remission  \\nBipolar type II disorder, currently in full remission, is diagnosed when the definitional \\nrequirements for Bipolar type I I disorder have been met but there are no longer any \\nsignificant mood symptoms.',\n",
       " '6A61.Y  Other specified bipolar type II disorder',\n",
       " '6A61.Z  Bipolar type II disorder, unspecified  \\n 420  ICD-11 MMS',\n",
       " '6A62   Cyclothymic disorder  \\nCyclothymic disorder is characterised by a persist ent instability of mood over a \\nperiod of at least 2 years, involving numerous periods of hypomanic (e.g., euphoria, \\nirritability, or expansiveness, psychomotor activation) and depressive (e.g., feeling \\ndown, diminished interest in activities, fatigue) symp toms that are present during \\nmore of the time than not. The hypomanic symptomatology may or may not be \\nsufficiently severe or prolonged to meet the full definitional requirements of a \\nhypomanic episode (see Bipolar type II disorder), but there is no histor y of manic or \\nmixed episodes (see Bipolar type I disorder). The depressive symptomatology has \\nnever been sufficiently severe or prolonged to meet the diagnostic requirements for \\na depressive episode (see Bipolar type II disorder). The symptoms result in \\nsignificant distress or significant impairment in personal, family, social, educational, \\noccupational or other important areas of functioning.  \\nInclusions:  Cycloid personality  \\nCyclothymic personality',\n",
       " '6A6Y   Other specified bipolar or related disorders',\n",
       " '6A6Z   Bipolar or related disorders, unspecified  \\n \\nDepressive disorders (6A70 ‑6A7Z)  \\nDepressive disorders are characterised by depressive mood (e.g., sad, irritable, empty) or loss of \\npleasure accompanied by other cognitive, behavioural, or neurovegetative sy mptoms that significantly \\naffect the individual’s ability to function. A depressive disorder should not be diagnosed in individuals \\nwho have ever experienced a manic, mixed or hypomanic episode, which would indicate the presence \\nof a bipolar disorder.  \\nCode d Elsewhere:  Premenstrual dysphoric disorder (GA34.41)',\n",
       " '6A70   Single episode depressive disorder  \\nSingle episode depressive disorder is characterised by the presence or history of \\none depressive episode when there is no history of prior depressive episodes. A \\ndepressive episode is characterised by a period of depressed mood or diminished \\ninterest in ac tivities occurring most of the day, nearly every day during a period \\nlasting at least two weeks accompanied by other symptoms such as difficulty \\nconcentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. There have \\nnever been any prior manic, hypomanic, or mixed episodes, which would indicate \\nthe presence of a bipolar disorder.  \\nExclusions : recurrent depressive disorder (6A71)  \\nAdjustment disorder (6B43)  \\nBipolar or related disorders  (6A60‑6A6Z)  \\n ICD-11 MMS  421',\n",
       " '6A70.0  Single episode depressive disorder, mild  \\nSingle episode depressive disorder, mild, is diagnosed when the definitional \\nrequirements of a Depressive episode are met and the episode is of mild severity. A \\ndepressive episode is characterised by a period of depressed mood or diminished \\ninterest in act ivities occurring most of the day, nearly every day during a period \\nlasting at least two weeks accompanied by other symptoms such as difficulty \\nconcentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts o f death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. In a mild \\ndepressive episode, the individual is usually distressed by the symptoms and has \\nsome difficulty in continuing to function in o ne or more domains (personal, family, \\nsocial, educational, occupational, or other important domains). There are no \\ndelusions or hallucinations during the episode.',\n",
       " '6A70.1  Single episode depressive disorder, moderate, without psychotic symptoms  \\nSingle episo de depressive disorder, moderate, without psychotic symptoms is \\ndiagnosed when the definitional requirements of a depressive episode have been \\nmet, there is no history of prior depressive episodes, the episode is of moderate \\nseverity, and there are no delu sions or hallucinations during the episode. A \\ndepressive episode is characterised by a period of depressed mood or diminished \\ninterest in activities occurring most of the day, nearly every day during a period \\nlasting at least two weeks accompanied by other  symptoms such as difficulty \\nconcentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatig ue. In a moderate \\ndepressive episode, several symptoms of a depressive episode are present to a \\nmarked degree, or a large number of depressive symptoms of lesser severity are \\npresent overall. The individual typically has considerable difficulty functioning  in \\nmultiple domains (personal, family, social, educational, occupational, or other \\nimportant domains).',\n",
       " '6A70.2  Single episode depressive disorder, moderate, with psychotic symptoms  \\nSingle episode depressive disorder, moderate, with psychotic symptoms is \\ndiagnosed when the definitional requirements of a depressive episode have been \\nmet, there is no history of prior depressive episodes, the episode is of moderate \\nseverity, and there are delusions or hallucinations during the episode. A depressive \\nepisode is characterised by a period of depressed mood or diminished interest in \\nactivities occurring most of the day, nearly every day during a period lasting at least \\ntwo weeks accompanied by other symptoms such as difficulty concentrating, \\nfeelings of worthlessnes s or excessive or inappropriate guilt, hopelessness, \\nrecurrent thoughts of death or suicide, changes in appetite or sleep, psychomotor \\nagitation or retardation, and reduced energy or fatigue. In a moderate depressive \\nepisode, several symptoms of a depressi ve episode are present to a marked \\ndegree, or a large number of depressive symptoms of lesser severity are present \\noverall. The individual typically has considerable difficulty functioning in multiple \\ndomains (personal, family, social, educational, occupat ional, or other important \\ndomains).  \\n 422  ICD-11 MMS',\n",
       " '6A70.3  Single episode depressive disorder, severe, without psychotic symptoms  \\nSingle episode depressive disorder, severe, without psychotic symptoms is \\ndiagnosed when the definitional requirements for Single episode dep ressive \\ndisorder are met and the current episode is severe and there are no delusions or \\nhallucinations during the episode. A depressive episode is characterised by a period \\nof depressed mood or diminished interest in activities occurring most of the day, \\nnearly every day during a period lasting at least two weeks accompanied by other \\nsymptoms such as difficulty concentrating, feelings of worthlessness or excessive or \\ninappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in \\nappe tite or sleep, psychomotor agitation or retardation, and reduced energy or \\nfatigue. In a severe depressive episode, many or most symptoms of a Depressive \\nEpisode are present to a marked degree, or a smaller number of symptoms are \\npresent and manifest to an  intense degree. The individual has serious difficulty \\ncontinuing to function in most domains (personal, family, social, educational, \\noccupational, or other important domains).  \\nInclusions:  Major depression single episode without psychotic symptoms  \\nVital de pression single episode without psychotic symptoms',\n",
       " '6A70.4  Single episode depressive disorder, severe, with psychotic symptoms  \\nSingle episode depressive disorder, severe, with psychotic symptoms is diagnosed \\nwhen the definitional requirements for Single ep isode depressive disorder are met \\nand the current episode is severe and there are delusions or hallucinations during \\nthe episode. A depressive episode is characterised by a period of depressed mood \\nor diminished interest in activities occurring most of the  day, nearly every day during \\na period lasting at least two weeks accompanied by other symptoms such as \\ndifficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes i n appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. In a severe \\ndepressive episode, many or most symptoms of a Depressive Episode are present \\nto a marked degree, or a smaller number of symptoms are present and manifest  to \\nan intense degree. The individual has serious difficulty continuing to function in \\nmost domains (personal, family, social, educational, occupational, or other \\nimportant domains). In a severe depressive episode, many or most symptoms of a \\nDepressive Epi sode are present to a marked degree, or a smaller number of \\nsymptoms are present and manifest to an intense degree. The individual has \\nserious difficulty continuing to function in most domains (personal, family, social, \\neducational, occupational, or other important domains).',\n",
       " '6A70.5  Single episode depressive disorder, unspecified severity  \\nSingle episode depressive disorder, unspecified severity is diagnosed when the \\ndefinitional requirements of a depressive episode have been met, there is no history \\nof prio r depressive episodes, and there is insufficient information to determine the \\nseverity of the current depressive episode. A depressive episode is characterised \\nby a period of depressed mood or diminished interest in activities occurring most of \\nthe day, ne arly every day during a period lasting at least two weeks accompanied \\nby other symptoms such as difficulty concentrating, feelings of worthlessness or \\nexcessive or inappropriate guilt, hopelessness, recurrent thoughts of death or \\nsuicide, changes in appeti te or sleep, psychomotor agitation or retardation, and \\nreduced energy or fatigue. The symptoms are associated with at least some \\ndifficulty in continuing with ordinary work, social, or domestic activities.  \\n ICD-11 MMS  423',\n",
       " '6A70.6  Single episode depressive disorder, curren tly in partial remission  \\nSingle episode depressive disorder, currently in partial remission, is diagnosed \\nwhen the full definitional requirements for a depressive episode have been met and \\nthere is no history of prior depressive episodes. The full definiti onal requirements for \\na depressive episode are no longer met but some significant mood symptoms \\nremain.',\n",
       " '6A70.7  Single episode depressive disorder, currently in full remission  \\nSingle episode depressive disorder, currently in full remission is diagnosed whe n \\nthe full definitional requirements for one depressive episode have been met in the \\npast and there are no longer any significant mood symptoms. There is no history of \\ndepressive episodes preceding the episode under consideration.',\n",
       " '6A70.Y  Other specified single episode depressive disorder',\n",
       " '6A70.Z  Single episode depressive disorder, unspecified',\n",
       " '6A71   Recurrent depressive disorder  \\nRecurrent depressive disorder is characterised by a history of at least two \\ndepressive episodes separated by at least several months without significant mood \\ndisturbance. A depressive episode is characterised by a period of depressed mood \\nor diminished interest in activities occurring most of the day, nearly every day during \\na period lasting at least two weeks ac companied by other symptoms such as \\ndifficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduc ed energy or fatigue. There have \\nnever been any prior manic, hypomanic, or mixed episodes, which would indicate \\nthe presence of a Bipolar disorder.  \\nInclusions:  seasonal depressive disorder  \\nExclusions:  Adjustment disorder (6B43)  \\nBipolar or related disorders  (6A60‑6A6Z)  \\nSingle episode depressive disorder (6A70)',\n",
       " '6A71.0  Recurrent depressive disorder, current episode mild  \\nRecurrent depressive disorder, current episode mild is diagnosed when the \\ndefinitional requirements for Recurrent  depressive disorder have been met and \\nthere is currently a depressive episode of mild severity. A depressive episode is \\ncharacterised by a period of depressed mood or diminished interest in activities \\noccurring most of the day, nearly every day during a p eriod lasting at least two \\nweeks accompanied by other symptoms such as difficulty concentrating, feelings of \\nworthlessness or excessive or inappropriate guilt, hopelessness, recurrent thoughts \\nof death or suicide, changes in appetite or sleep, psychomotor agitation or \\nretardation, and reduced energy or fatigue. In a mild depressive episode, the \\nindividual is usually distressed by the symptoms and has some difficulty in \\ncontinuing to function in one or more domains (personal, family, social, educational, \\noccupational, or other important domains). There are no delusions or hallucinations \\nduring the episode.  \\n 424  ICD-11 MMS',\n",
       " '6A71.1  Recurrent depressive disorder, current episode moderate, without psychotic \\nsymptoms  \\nRecurrent depressive disorder, current episode moderate, withou t psychotic \\nsymptoms is diagnosed when the definitional requirements for recurrent depressive \\ndisorder have been met and there is currently a depressive episode of moderate \\nseverity, and there are no delusions or hallucinations during the episode. A \\ndepres sive episode is characterised by a period of depressed mood or diminished \\ninterest in activities occurring most of the day, nearly every day during a period \\nlasting at least two weeks accompanied by other symptoms such as difficulty \\nconcentrating, feelings  of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. In a moderate \\ndepressive episode, several sympto ms of a depressive episode are present to a \\nmarked degree, or a large number of depressive symptoms of lesser severity are \\npresent overall. The individual typically has considerable difficulty functioning in \\nmultiple domains (personal, family, social, educ ational, occupational, or other \\nimportant domains).',\n",
       " '6A71.2  Recurrent depressive disorder, current episode moderate, with psychotic \\nsymptoms  \\nRecurrent depressive disorder, current episode moderate, with psychotic symptoms \\nis diagnosed when the definitional  requirements for Recurrent depressive disorder \\nhave been met and there is currently a depressive episode of moderate severity, \\nand there are delusions or hallucinations during the episode. A depressive episode \\nis characterised by a period of depressed moo d or diminished interest in activities \\noccurring most of the day, nearly every day during a period lasting at least two \\nweeks accompanied by other symptoms such as difficulty concentrating, feelings of \\nworthlessness or excessive or inappropriate guilt, hop elessness, recurrent thoughts \\nof death or suicide, changes in appetite or sleep, psychomotor agitation or \\nretardation, and reduced energy or fatigue. In a moderate depressive episode, \\nseveral symptoms of a depressive episode are present to a marked degree,  or a \\nlarge number of depressive symptoms of lesser severity are present overall. The \\nindividual typically has considerable difficulty functioning in multiple domains \\n(personal, family, social, educational, occupational, or other important domains).  \\n ICD-11 MMS  425',\n",
       " '6A71. 3 Recurrent depressive disorder, current episode severe, without psychotic \\nsymptoms  \\nRecurrent depressive disorder, current episode severe, without psychotic symptoms \\nis diagnosed when the definitional requirements for Recurrent depressive disorder \\nare met and the current episode is severe and there are no delusions or \\nhallucinations during the episode. A depressive episode is characterised by a period \\nof depressed mood or diminished interest in activities occurring most of the day, \\nnearly every day during a  period lasting at least two weeks accompanied by other \\nsymptoms such as difficulty concentrating, feelings of worthlessness or excessive or \\ninappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in \\nappetite or sleep, psychomoto r agitation or retardation, and reduced energy or \\nfatigue. In a severe depressive episode, many or most symptoms of a Depressive \\nEpisode are present to a marked degree, or a smaller number of symptoms are \\npresent and manifest to an intense degree. The indi vidual has serious difficulty \\ncontinuing to function in most domains (personal, family, social, educational, \\noccupational, or other important domains).  \\nInclusions:  Endogenous depression without psychotic symptoms  \\nMajor depression, recurrent without psychot ic symptoms  \\nManic -depressive psychosis, depressed type without psychotic \\nsymptoms  \\nVital depression, recurrent without psychotic symptoms',\n",
       " '6A71.4  Recurrent depressive disorder, current episode severe, with psychotic \\nsymptoms  \\nRecurrent depressive disorder, current episode severe, with psychotic symptoms is \\ndiagnosed when the definitional requirements for Recurrent depressive disorder are \\nmet and the current episode is severe and there are delusions or hallucinations \\nduring the episode. A depressive episode is characterised by a period of depressed \\nmood or diminished interest in activities occurring most of the day, nearly every day \\nduring a period las ting at least two weeks accompanied by other symptoms such as \\ndifficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation  or retardation, and reduced energy or fatigue. In a severe \\ndepressive episode, many or most symptoms of a Depressive Episode are present \\nto a marked degree, or a smaller number of symptoms are present and manifest to \\nan intense degree. The individual has serious difficulty continuing to function in \\nmost domains (personal, family, social, educational, occupational, or other \\nimportant domains). In a severe depressive episode, many or most symptoms of a \\nDepressive Episode are present to a marked degree, or a smaller number of \\nsymptoms are present and manifest to an intense degree. The individual has \\nserious difficulty continuing to function in most domains (personal, family, social, \\neducational, occupational, or other important domains).  \\nInclusions:  Endogenous  depression with psychotic symptoms  \\nManic -depressive psychosis, depressed type with psychotic \\nsymptoms  \\n 426  ICD-11 MMS',\n",
       " '6A71.5  Recurrent depressive disorder, current episode, unspecified severity  \\nRecurrent depressive disorder current episode, unspecified severity is diagn osed \\nwhen the definitional requirements of a depressive episode have been met and \\nthere is a history of prior depressive episodes, but there is insufficient information to \\ndetermine the severity of the current depressive episode. A depressive episode is \\ncharacterised by a period of almost daily depressed mood or diminished interest in \\nactivities lasting at least two weeks accompanied by other symptoms such as \\ndifficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessne ss, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. The symptoms \\nare associated with at least some difficulty in continuing with ordinary work, social, \\nor domestic a ctivities.',\n",
       " '6A71.6  Recurrent depressive disorder, currently in partial remission  \\nRecurrent depressive disorder, currently in partial remission, is diagnosed when the \\ndefinitional requirements for Recurrent depressive disorder have been met; the full \\ndefini tional requirements for a depressive episode are no longer met but some \\nsignificant mood symptoms remain.',\n",
       " '6A71.7  Recurrent depressive disorder, currently in full remission  \\nRecurrent depressive disorder, currently in full remission is diagnosed when the \\ndefinitional requirements for recurrent depressive disorder have been met but \\ncurrently there are no significant mood symptoms.',\n",
       " '6A71.Y  Other specified recurrent depressive disorder',\n",
       " '6A71.Z  Recurrent depressive disorder, unspecified',\n",
       " '6A72   Dysthymic disor der \\nDysthymic disorder is characterised by a persistent depressive mood (i.e., lasting 2 \\nyears or more), for most of the day, for more days than not. In children and \\nadolescents depressed mood can manifest as pervasive irritability. The depressed \\nmood is a ccompanied by additional symptoms such as markedly diminished interest \\nor pleasure in activities, reduced concentration and attention or indecisiveness, low \\nself-worth or excessive or inappropriate guilt, hopelessness about the future, \\ndisturbed sleep or i ncreased sleep, diminished or increased appetite, or low energy \\nor fatigue. During the first 2 years of the disorder, there has never been a 2 -week \\nperiod during which the number and duration of symptoms were sufficient to meet \\nthe diagnostic requirements for a Depressive Episode. There is no history of Manic, \\nMixed, or Hypomanic Episodes.  \\nInclusions:  Dysthymia  \\nExclusions:  anxiety depression (mild or not persistent) (6A73)  \\n ICD-11 MMS  427',\n",
       " '6A73   Mixed depressive and anxiety disorder  \\nMixed depressive and anxiety disorder is characterised by symptoms of both \\nanxiety and depression more days than not for a period of two weeks or more. \\nDepressive symptoms include depressed mood or markedly diminished interest or \\npleasure in activities. Th ere are multiple anxiety symptoms, which may include \\nfeeling nervous, anxious, or on edge, not being able to control worrying thoughts, \\nfear that something awful will happen, having trouble relaxing, muscle tension, or \\nsympathetic autonomic symptoms. Neith er set of symptoms, considered separately, \\nis sufficiently severe, numerous, or persistent to justify a diagnosis of another \\ndepressive disorder or an anxiety or fear -related disorder. The symptoms result in \\nsignificant distress or significant impairment i n personal, family, social, educational, \\noccupational or other important areas of functioning. There is no history of manic or \\nmixed episodes, which would indicate the presence of a bipolar disorder.',\n",
       " '6A7Y   Other specified depressive disorders',\n",
       " '6A7Z   Depressive disorders, unspecified',\n",
       " '6A80   Symptomatic and course presentations for mood episodes in mood \\ndisorders  \\nThese categories may be applied to describe the presentation and characteristics of \\nmood episodes in the context of single episode  depressive disorder, recurrent \\ndepressive disorder, bipolar type I disorder, or bipolar type II disorder. These \\ncategories indicate the presence of specific, important features of the clinical \\npresentation or of the course, onset, and pattern of mood epis odes. These \\ncategories are not mutually exclusive, and as many may be added as apply.  \\nCoding Note:  These categories should never be used in primary coding. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify s pecific \\nclinically important features of mood episodes in mood disorders.  \\nCoded Elsewhere:  Mental or behavioural disorders associated with pregnancy, \\nchildbirth or the puerperium, without psychotic symptoms \\n(6E20)  \\nMental or behavioural disorders associated  with pregnancy, \\nchildbirth or the puerperium, with psychotic symptoms \\n(6E21)',\n",
       " '6A80.0  Prominent anxiety symptoms in mood episodes  \\nIn the context of a current depressive, manic, mixed, or hypomanic episode, \\nprominent and clinically significant anxiety sympt oms (e.g., feeling nervous, anxious \\nor on edge, not being able to control worrying thoughts, fear that something awful \\nwill happen, having trouble relaxing, motor tension, autonomic symptoms) have \\nbeen present for most of the time during the episode. If th ere have been panic \\nattacks during a current depressive or mixed episode, these should be recorded \\nseparately.  \\nWhen the diagnostic requirements for both a mood disorder and an anxiety or fear -\\nrelated disorder are met, the anxiety or fear -related disorder s hould also be \\ndiagnosed.  \\nCoding Note:  These categories should never be used in primary coding. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify specific \\nclinically important features of mood episodes in moo d disorders.  \\n 428  ICD-11 MMS',\n",
       " '6A80.1  Panic attacks in mood episodes  \\nIn the context of a current mood episode (manic, depressive, mixed, or hypomanic), \\nthere have been recurrent panic attacks (i.e., at least two) during the past month \\nthat occur specifically in response to  anxiety -provoking cognitions that are features \\nof the mood episode. If panic attacks occur exclusively in response to such \\nthoughts, panic attacks should be recorded using this qualifier rather than assigning \\nan additional co -occurring diagnosis of panic disorder.  \\nIf some panic attacks over the course of the depressive or mixed episode have \\nbeen unexpected and not exclusively in response to depressive or anxiety -\\nprovoking thoughts, a separate diagnosis of panic disorder should be assigned.  \\nCoding Note:  These categories should never be used in primary coding. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify specific \\nclinically important features of mood episodes in mood disorders.  \\nExclusions:  Panic disorder ( 6B01)',\n",
       " '6A80.2  Current depressive episode persistent  \\nThe diagnostic requirements for a depressive episode are currently met and have \\nbeen met continuously for at least the past 2 years.  \\nCoding Note:  These categories should never be used in primary coding. T he codes are provided \\nfor use as supplementary or additional codes when it is desired to identify specific \\nclinically important features of mood episodes in mood disorders.',\n",
       " '6A80.3  Current depressive episode with melancholia  \\nIn the context of a current Dep ressive Episode, several of the following symptoms \\nhave been present during the worst period of the current episode: loss of interest or \\npleasure in most activities that are normally enjoyable to the individual (i.e., \\npervasive anhedonia); lack of emotiona l reactivity to normally pleasurable stimuli or \\ncircumstances (i.e., mood does not lift even transiently with exposure); terminal \\ninsomnia (i.e., waking in the morning two hours or more before the usual time); \\ndepressive symptoms are worse in the morning; marked psychomotor retardation or \\nagitation; marked loss of appetite or loss of weight.  \\nCoding Note:  These categories should never be used in primary coding. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify  specific \\nclinically important features of mood episodes in mood disorders.',\n",
       " '6A80.4  Seasonal pattern of mood episode onset  \\nIn the context of recurrent depressive disorder, bipolar type I or bipolar type II \\ndisorder, there has been a regular seasonal pattern of onset and remission of at \\nleast one type of episode (i.e., depressive, manic, mixed, or hypomanic episodes), \\nwith a su bstantial majority of the relevant mood episodes corresponding to the \\nseasonal pattern. (In bipolar type I and bipolar type II disorder, all types of mood \\nepisodes may not follow this pattern.) A seasonal pattern should be differentiated \\nfrom an episode th at is coincidental with a particular season but predominantly \\nrelated to a psychological stressor that regularly occurs at that time of the year (e.g., \\nseasonal unemployment).  \\nCoding Note:  These categories should never be used in primary coding. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify specific \\nclinically important features of mood episodes in mood disorders.  \\n ICD-11 MMS  429',\n",
       " '6A80.5  Rapid cycling  \\nIn the context of bipolar type I or bipolar type II disorder, there ha s been a high \\nfrequency of mood episodes (at least four) over the past 12 months. There may be \\na switch from one polarity of mood to the other, or the mood episodes may be \\ndemarcated by a period of remission. In individuals with a high frequency of mood \\nepisodes, some may have a shorter duration than those usually observed in bipolar \\ntype I or bipolar type II disorder. In particular, depressive periods may only last \\nseveral days. If depressive and manic symptoms alternate very rapidly (i.e., from \\nday to day  or within the same day), a mixed episode should be diagnosed rather \\nthan rapid cycling.  \\nCoding Note:  These categories should never be used in primary coding. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identif y specific \\nclinically important features of mood episodes in mood disorders.',\n",
       " '6A8Y   Other specified mood disorders',\n",
       " '6A8Z   Mood disorders, unspecified  \\n \\nAnxiety or fear -related disorders (6B00 ‑6B0Z)  \\nAnxiety and fear -related disorders are characterised by excessive fear and anxiety and related \\nbehavioural disturbances, with symptoms that are severe enough to result in significant distress or \\nsignificant impairment in personal, family, social, education al, occupational, or other important areas \\nof functioning. Fear and anxiety are closely related phenomena; fear represents a reaction to \\nperceived imminent threat in the present, whereas anxiety is more future -oriented, referring to \\nperceived anticipated t hreat. A key differentiating feature among the Anxiety and fear -related \\ndisorders are disorder -specific foci of apprehension, that is, the stimulus or situation that triggers the \\nfear or anxiety. The clinical presentation of Anxiety and fear -related disord ers typically includes \\nspecific associated cognitions that can assist in differentiating among the disorders by clarifying the \\nfocus of apprehension.  \\nCoded Elsewhere:  Substance -induced anxiety disorders  \\nHypochondriasis (6B23)  \\nSecondary anxiety syndrome (6E 63)',\n",
       " '6B00   Generalised anxiety disorder  \\nGeneralised anxiety disorder is characterised by marked symptoms of anxiety that \\npersist for at least several months, for more days than not, manifested by either \\ngeneral apprehension (i.e. ‘free -floating anxiety’)  or excessive worry focused on \\nmultiple everyday events, most often concerning family, health, finances, and \\nschool or work, together with additional symptoms such as muscular tension or \\nmotor restlessness, sympathetic autonomic over -activity, subjective e xperience of \\nnervousness, difficulty maintaining concentration, irritability, or sleep disturbance. \\nThe symptoms result in significant distress or significant impairment in personal, \\nfamily, social, educational, occupational, or other important areas of fu nctioning. \\nThe symptoms are not a manifestation of another health condition and are not due \\nto the effects of a substance or medication on the central nervous system.  \\n 430  ICD-11 MMS',\n",
       " '6B01   Panic disorder  \\nPanic disorder is characterised by recurrent unexpected panic at tacks that are not \\nrestricted to particular stimuli or situations. Panic attacks are discrete episodes of \\nintense fear or apprehension accompanied by the rapid and concurrent onset of \\nseveral characteristic symptoms (e.g. palpitations or increased heart ra te, sweating, \\ntrembling, shortness of breath, chest pain, dizziness or lightheadedness, chills, hot \\nflushes, fear of imminent death). In addition, panic disorder is characterised by \\npersistent concern about the recurrence or significance of panic attacks, or \\nbehaviours intended to avoid their recurrence, that results in significant impairment \\nin personal, family, social, educational, occupational, or other important areas of \\nfunctioning. The symptoms are not a manifestation of another medical condition and \\nare not due to the effects of a substance or medication on the central nervous \\nsystem.  \\nExclusions:  Panic attack (MB23.H)',\n",
       " '6B02   Agoraphobia  \\nAgoraphobia is characterised by marked and excessive fear or anxiety that occurs \\nin response to multiple situatio ns where escape might be difficult or help might not \\nbe available, such as using public transportation, being in crowds, being outside the \\nhome alone (e.g., in shops, theatres, standing in line). The individual is consistently \\nanxious about these situation s due to a fear of specific negative outcomes (e.g., \\npanic attacks, other incapacitating or embarrassing physical symptoms). The \\nsituations are actively avoided, entered only under specific circumstances such as \\nin the presence of a trusted companion, or e ndured with intense fear or anxiety. The \\nsymptoms persist for at least several months, and are sufficiently severe to result in \\nsignificant distress or significant impairment in personal, family, social, educational, \\noccupational, or other important areas of functioning.',\n",
       " '6B03   Specific phobia  \\nSpecific phobia is characterised by a marked and excessive fear or anxiety that \\nconsistently occurs upon exposure or anticipation of exposure to one or more \\nspecific objects or situations (e.g., proximity to certain animals, flying, heights, \\nclosed spaces,  sight of blood or injury) that is out of proportion to actual danger. \\nThe phobic objects or situations are avoided or else endured with intense fear or \\nanxiety. Symptoms persist for at least several months and are sufficiently severe to \\nresult in signific ant distress or significant impairment in personal, family, social, \\neducational, occupational, or other important areas of functioning.  \\nInclusions:  Simple phobia  \\nExclusions:  Body dysmorphic disorder (6B21)  \\nHypochondriasis (6B23)  \\n ICD-11 MMS  431',\n",
       " '6B04   Social anxiety di sorder  \\nSocial anxiety disorder is characterised by marked and excessive fear or anxiety \\nthat consistently occurs in one or more social situations such as social interactions \\n(e.g. having a conversation), doing something while feeling observed (e.g. eating or \\ndrinking in the presence of others), or performing in front of others (e.g. giving a \\nspeech). The individual is concerned that he or she will act in a way, or show \\nanxiety symptoms, that will be negatively evaluated by others. Relevant social \\nsituations  are consistently avoided or else endured with intense fear or anxiety. The \\nsymptoms persist for at least several months and are sufficiently severe to result in \\nsignificant distress or significant impairment in personal, family, social, educational, \\noccup ational, or other important areas of functioning.',\n",
       " '6B05   Separation anxiety disorder  \\nSeparation anxiety disorder is characterised by marked and excessive fear or \\nanxiety about separation from specific attachment figures. In children and \\nadolescents, sep aration anxiety typically focuses on caregivers, parents or other \\nfamily members and the fear or anxiety is beyond what would be considered \\ndevelopmentally normative. In adults, the focus is typically a romantic partner or \\nchildren. Manifestations of separ ation anxiety may include thoughts of harm or \\nuntoward events befalling the attachment figure, reluctance to go to school or work, \\nrecurrent excessive distress upon separation, reluctance or refusal to sleep away \\nfrom the attachment figure, and recurrent n ightmares about separation. The \\nsymptoms persist for at least several months and are sufficiently severe to result in \\nsignificant distress or significant impairment in personal, family, social, educational, \\noccupational, or other important areas of functio ning.  \\nExclusions:  mood [affective] disorders  (6A60‑6A8Z)  \\nSelective mutism (6B06)  \\nSocial anxiety disorder (6B04)',\n",
       " '6B06   Selective mutism  \\nSelective mutism is characterised by consistent selectivity in speaking, such that a \\nchild demonstrates adequate lang uage competence in specific social situations, \\ntypically at home, but consistently fails to speak in others, typically at school. The \\ndisturbance lasts for at least one month, is not limited to the first month of school, \\nand is of sufficient severity to in terfere with educational achievement or with social \\ncommunication. Failure to speak is not due to a lack of knowledge of, or comfort \\nwith, the spoken language required in the social situation (e.g. a different language \\nspoken at school than at home).  \\nExclu sions:  Schizophrenia (6A20)  \\ntransient mutism as part of separation anxiety in young \\nchildren (6B05)  \\nAutism spectrum disorder (6A02)',\n",
       " '6B0Y   Other specified anxiety or fear -related disorders',\n",
       " '6B0Z   Anxiety or fear -related disorders, unspecified  \\n 432  ICD-11 MMS  \\n Obsessive -compulsive or related disorders (6B20 ‑6B2Z)  \\nObsessive -compulsive and related disorders is a group of disorders characterised by repetitive \\nthoughts and behaviours that are believed to share similari ties in aetiology and key diagnostic \\nvalidators. Cognitive phenomena such as obsessions, intrusive thoughts and preoccupations are \\ncentral to a subset of these conditions (i.e., obsessive -compulsive disorder, body dysmorphic \\ndisorder, hypochondriasis, and olfactory reference disorder) and are accompanied by related \\nrepetitive behaviours. Hoarding Disorder is not associated with intrusive unwanted thoughts but rather \\nis characterised by a compulsive need to accumulate possessions and distress related to disc arding \\nthem. Also included in the grouping are body -focused repetitive behaviour disorders, which are \\nprimarily characterised by recurrent and habitual actions directed at the integument (e.g., hair -pulling, \\nskin-picking) and lack a prominent cognitive asp ect. The symptoms result in significant distress or \\nsignificant impairment in personal, family, social, educational, occupational, or other important areas \\nof functioning.  \\nCoded Elsewhere:  Substance -induced obsessive -compulsive or related disorders  \\nSecondary obsessive -compulsive or related syndrome (6E64)  \\nTourette syndrome (8A05.00)',\n",
       " '6B20   Obsessive -compulsive disorder  \\nObsessive -Compulsive Disorder is characterised by the presence of persistent \\nobsessions or compulsions, or most commonly both. Obse ssions are repetitive and \\npersistent thoughts, images, or impulses/urges that are intrusive, unwanted, and are \\ncommonly associated with anxiety. The individual attempts to ignore or suppress \\nobsessions or to neutralize them by performing compulsions. Compu lsions are \\nrepetitive behaviours including repetitive mental acts that the individual feels driven \\nto perform in response to an obsession, according to rigid rules, or to achieve a \\nsense of ‘completeness’. In order for obsessive -compulsive disorder to be \\ndiagnosed, obsessions and compulsions must be time consuming (e.g. taking more \\nthan an hour per day) or result in significant distress or significant impairment in \\npersonal, family, social, educational, occupational or other important areas of \\nfunctioning.  \\nInclusions:  anankastic neurosis  \\nobsessive -compulsive neurosis  \\nExclusions:  obsessive compulsive behaviour (MB23.4)',\n",
       " '6B20.0  Obsessive -compulsive disorder with fair to good insight  \\nAll definitional requirements of obsessive -compulsive disorder are met. Much o f the \\ntime, the individual is able to entertain the possibility that his or her disorder -specific \\nbeliefs may not be true and is willing to accept an alternative explanation for his or \\nher experience. At circumscribed times (e.g., when highly anxious), the  individual \\nmay demonstrate no insight.',\n",
       " '6B20.1  Obsessive -compulsive disorder with poor to absent insight  \\nAll definitional requirements of obsessive -compulsive disorder are met. Most or all \\nof the time, the individual is convinced that the disorder -specifi c beliefs are true and \\ncannot accept an alternative explanation for their experience. The lack of insight \\nexhibited by the individual does not vary markedly as a function of anxiety level.',\n",
       " '6B20.Z  Obsessive -compulsive disorder, unspecified  \\n ICD-11 MMS  433',\n",
       " '6B21   Body d ysmorphic disorder  \\nBody Dysmorphic Disorder is characterised by persistent preoccupation with one or \\nmore perceived defects or flaws in appearance that are either unnoticeable or only \\nslightly noticeable to others. Individuals experience excessive self -consciousness, \\noften with ideas of reference (i.e., the conviction that people are taking notice, \\njudging, or talking about the perceived defect or flaw). In response to their \\npreoccupation, individuals engage in repetitive and excessive behaviours that \\ninclude repeated examination of the appearance or severity of the perceived defect \\nor flaw, excessive attempts to camouflage or alter the perceived defect, or marked \\navoidance of social situations or triggers that increase distress about the perceived \\ndefect or  flaw. The symptoms are sufficiently severe to result in significant distress \\nor significant impairment in personal, family, social, educational, occupational or \\nother important areas of functioning.  \\nExclusions:  Anorexia Nervosa (6B80)  \\nBodily distress diso rder (6C20)  \\nConcern about body appearance  (QD30‑QD3Z)',\n",
       " '6B21.0  Body dysmorphic disorder with fair to good insight  \\nAll definitional requirements of body dysmorphic disorder are met. Much of the time, \\nthe individual is able to entertain the possibility that h is or her disorder -specific \\nbeliefs may not be true and is willing to accept an alternative explanation for his or \\nher experience. At circumscribed times (e.g., when highly anxious), the individual \\nmay demonstrate no insight.',\n",
       " '6B21.1  Body dysmorphic disord er with poor to absent insight  \\nAll definitional requirements of body dysmorphic disorder are met. Most or all of the \\ntime, the individual is convinced that the disorder -specific beliefs are true and \\ncannot accept an alternative explanation for their experi ence. The lack of insight \\nexhibited by the individual does not vary markedly as a function of anxiety level.',\n",
       " '6B21.Z  Body dysmorphic disorder, unspecified',\n",
       " '6B22   Olfactory reference disorder  \\nOlfactory Reference Disorder is characterised by persistent preoccupation with the \\nbelief that one is emitting a perceived foul or offensive body odour or breath that is \\neither unnoticeable or only slightly noticeable to others. Individuals experience \\nexce ssive self -consciousness about the perceived odour, often with ideas of \\nreference (i.e., the conviction that people are taking notice, judging, or talking about \\nthe odour). In response to their preoccupation, individuals engage in repetitive and \\nexcessive behaviours such as repeatedly checking for body odour or checking the \\nperceived source of the smell, or repeatedly seeking reassurance, excessive \\nattempts to camouflage, alter, or prevent the perceived odour, or marked avoidance \\nof social situations or tri ggers that increase distress about the perceived foul or \\noffensive odour. The symptoms are sufficiently severe to result in significant \\ndistress or significant impairment in personal, family, social, educational, \\noccupational or other important areas of fu nctioning.  \\n 434  ICD-11 MMS',\n",
       " '6B22.0  Olfactory reference disorder with fair to good insight  \\nAll definitional requirements of olfactory reference disorder are met. Much of the \\ntime, the individual is able to entertain the possibility that his or her disorder -specific \\nbeliefs may not be true and is willing to accept an alternative explanation for h is or \\nher experience. At circumscribed times (e.g., when highly anxious), the individual \\nmay demonstrate no insight.',\n",
       " '6B22.1  Olfactory reference disorder with poor to absent insight  \\nAll definitional requirements of olfactory reference disorder are met. Mos t or all of \\nthe time, the individual is convinced that the disorder -specific beliefs are true and \\ncannot accept an alternative explanation for their experience. The lack of insight \\nexhibited by the individual does not vary markedly as a function of anxiety  level.',\n",
       " '6B22.Z  Olfactory reference disorder, unspecified',\n",
       " '6B23   Hypochondriasis  \\nHypochondriasis is characterised by persistent preoccupation or fear about the \\npossibility of having one or more serious, progressive or life -threatening illnesses. \\nThe pre occupation is accompanied by either: 1) repetitive and excessive health -\\nrelated behaviours, such as repeatedly checking the body for evidence of illness, \\nspending inordinate amounts of time searching for information about the feared \\nillness, repeatedly see king reassurance (e.g. arranging multiple medical \\nconsultations); or 2) maladaptive avoidance behaviour related to health (e.g. avoids \\nmedical appointments). The symptoms result in significant distress or significant \\nimpairment in personal, family, social,  educational, occupational or other important \\nareas of functioning.  \\nInclusions:  Hypochondriacal neurosis  \\nIllness anxiety disorder  \\nExclusions:  Body dysmorphic disorder (6B21)  \\nBodily distress disorder (6C20)  \\nFear of cancer (MG24.0)',\n",
       " '6B23.0  Hypochondriasis wi th fair to good insight  \\nAll definitional requirements of hypochondriasis are met. Much of the time, the \\nindividual is able to entertain the possibility that his or her disorder -specific beliefs \\nmay not be true and is willing to accept an alternative explan ation for his or her \\nexperience. At circumscribed times (e.g., when highly anxious), the individual may \\ndemonstrate no insight.',\n",
       " '6B23.1  Hypochondriasis with poor to absent insight  \\nAll definitional requirements of hypochondriasis are met. Most or all of the  time, the \\nindividual is convinced that the disorder -specific beliefs are true and cannot accept \\nan alternative explanation for their experience. The lack of insight exhibited by the \\nindividual does not vary markedly as a function of anxiety level.',\n",
       " '6B23.Z  Hypochondriasis, unspecified  \\n ICD-11 MMS  435',\n",
       " '6B24   Hoarding disorder  \\nHoarding disorder is characterised by accumulation of possessions that results in \\nliving spaces becoming cluttered to the point that their use or safety is \\ncompromised. Accumulation occurs due to both repetitive urges or behaviours \\nrelated to amassing item s and difficulty discarding possessions due to a perceived \\nneed to save items and distress associated with discarding them. If living areas are \\nuncluttered this is only due to the intervention of third parties (e.g., family members, \\ncleaners, authorities).  Amassment may be passive (e.g. accumulation of incoming \\nflyers or mail) or active (e.g. excessive acquisition of free, purchased, or stolen \\nitems). The symptoms result in significant distress or significant impairment in \\npersonal, family, social, educatio nal, occupational or other important areas of \\nfunctioning.',\n",
       " '6B24.0  Hoarding disorder with fair to good insight  \\nAll definitional requirements of hoarding disorder are met. The individual recognizes \\nthat hoarding -related beliefs and behaviours (pertaining to  excessive acquisition, \\ndifficulty discarding, or clutter) are problematic. This qualifier level may still be \\napplied if, at circumscribed times (e.g., when being forced to discard items), the \\nindividual demonstrates no insight.',\n",
       " '6B24.1  Hoarding disorder w ith poor to absent insight  \\nAll definitional requirements of hoarding disorder are met. Most or all of the time, the \\nindividual is convinced that that hoarding -related beliefs and behaviours (pertaining \\nto excessive acquisition, difficulty discarding, or cl utter) are not problematic, despite \\nevidence to the contrary. The lack of insight exhibited by the individual does not \\nvary markedly as a function of anxiety level.',\n",
       " '6B24.Z  Hoarding disorder, unspecified',\n",
       " '6B25   Body -focused repetitive behaviour disorder s \\nBody focused repetitive behaviour disorders are characterised by recurrent and \\nhabitual actions directed at the integument (e.g. hair -pulling, skin -picking, lip -biting), \\ntypically accompanied by unsuccessful attempts to decrease or stop the behaviour \\ninvolved, and which lead to dermatological sequelae (e.g., hair loss, skin lesions, lip \\nabrasions). The behaviour may occur in brief episodes scattered throughout the day \\nor in less frequent but more sustained periods. The symptoms result in significant \\ndistress or significant impairment in personal, family, social, educational, \\noccupational or other important areas of functioning.',\n",
       " '6B25.0  Trichotillomania  \\nTrichotillomania is characterised by recurrent pulling of one’s own hair leading to \\nsignificant hair loss , accompanied by unsuccessful attempts to decrease or stop the \\nbehaviour. Hair pulling may occur from any region of the body in which hair grows \\nbut the most common sites are the scalp, eyebrows, and eyelids. Hair pulling may \\noccur in brief episodes scatte red throughout the day or in less frequent but more \\nsustained periods. The symptoms result in significant distress or significant \\nimpairment in personal, family, social, educational, occupational or other important \\nareas of functioning.  \\nInclusions:  Compuls ive hair plucking  \\nExclusions:  stereotyped movement disorder with hair -plucking (6A06)  \\n 436  ICD-11 MMS',\n",
       " '6B25.1  Excoriation disorder  \\nExcoriation disorder is characterised by recurrent picking of one’s own skin leading \\nto skin lesions, accompanied by unsuccessful attempts to decrease or stop the \\nbehaviour. The most commonly picked sites are the face, arms and hands, but \\nmany individuals pick from multiple body sites. Skin picking may occur in brief \\nepisodes scattered throughout the day or in less frequent but more sustained \\nperiods. The symptoms result in significant distress or significant impairment in \\npersonal, family, social, educatio nal, occupational or other important areas of \\nfunctioning.  \\nInclusions:  skin picking disorder  \\nExclusions:  Stereotyped movement disorder (6A06)  \\nAcute excoriation of skin (ME62.9)  \\nChronic excoriation of skin (ME63.7)',\n",
       " '6B25.Y  Other specified body -focused repet itive behaviour disorders',\n",
       " '6B25.Z  Body -focused repetitive behaviour disorders, unspecified',\n",
       " '6B2Y   Other specified obsessive -compulsive or related disorders',\n",
       " '6B2Z   Obsessive -compulsive or related disorders, unspecified  \\n ICD-11 MMS  437 \\n Disorders specifically associated with stress (6B40 ‑6B4Z)  \\nDisorders specifically associated with stress are directly related to exposure to a stressful or traumatic \\nevent, or a series of such events o r adverse experiences. For each of the disorders in this grouping, \\nan identifiable stressor is a necessary, though not sufficient, causal factor. Although not all individuals \\nexposed to an identified stressor will develop a disorder, the disorders in this grouping would not have \\noccurred without experiencing the stressor. Stressful events for some disorders in this grouping are \\nwithin the normal range of life experiences (e.g., divorce, socio -economic problems, bereavement). \\nOther disorders require the expe rience of a stressor of an extremely threatening or horrific nature (i.e., \\npotentially traumatic events). With all disorders in this grouping, it is the nature, pattern, and duration \\nof the symptoms that arise in response to the stressful events —together w ith associated functional \\nimpairment —that distinguishes the disorders.  \\nExclusions:  Burnout (QD85)  \\nAcute stress reaction (QE84)',\n",
       " '6B40   Post traumatic stress disorder  \\nPost traumatic stress disorder (PTSD) may develop following exposure to an \\nextremely thre atening or horrific event or series of events. It is characterised by all \\nof the following: 1) re -experiencing the traumatic event or events in the present in \\nthe form of vivid intrusive memories, flashbacks, or nightmares. Re -experiencing \\nmay occur via on e or multiple sensory modalities and is typically accompanied by \\nstrong or overwhelming emotions, particularly fear or horror, and strong physical \\nsensations; 2) avoidance of thoughts and memories of the event or events, or \\navoidance of activities, situati ons, or people reminiscent of the event(s); and 3) \\npersistent perceptions of heightened current threat, for example as indicated by \\nhypervigilance or an enhanced startle reaction to stimuli such as unexpected \\nnoises. The symptoms persist for at least sever al weeks and cause significant \\nimpairment in personal, family, social, educational, occupational or other important \\nareas of functioning.  \\nInclusions:  Traumatic neurosis  \\nExclusions:  Acute stress reaction (QE84)  \\nComplex post traumatic stress disorder (6B41)',\n",
       " '6B41   Complex post traumatic stress disorder  \\nComplex post traumatic stress disorder (Complex PTSD) is a disorder that may \\ndevelop following exposure to an event or series of events of an extremely \\nthreatening or horrific nature, most commonly prolonged  or repetitive events from \\nwhich escape is difficult or impossible (e.g. torture, slavery, genocide campaigns, \\nprolonged domestic violence, repeated childhood sexual or physical abuse). All \\ndiagnostic requirements for PTSD are met. In addition, Complex PTS D is \\ncharacterised by severe and persistent 1) problems in affect regulation; 2) beliefs \\nabout oneself as diminished, defeated or worthless, accompanied by feelings of \\nshame, guilt or failure related to the traumatic event; and 3) difficulties in sustainin g \\nrelationships and in feeling close to others. These symptoms cause significant \\nimpairment in personal, family, social, educational, occupational or other important \\nareas of functioning.  \\nExclusions:  Post traumatic stress disorder (6B40)  \\nPersonality disord er (6D10)  \\n 438  ICD-11 MMS',\n",
       " '6B42   Prolonged grief disorder  \\nProlonged grief disorder is a disturbance in which, following the death of a partner, \\nparent, child, or other person close to the bereaved, there is persistent and \\npervasive grief response characterised by longi ng for the deceased or persistent \\npreoccupation with the deceased accompanied by intense emotional pain (e.g. \\nsadness, guilt, anger, denial, blame, difficulty accepting the death, feeling one has \\nlost a part of one’s self, an inability to experience positi ve mood, emotional \\nnumbness, difficulty in engaging with social or other activities). The grief response \\nhas persisted for an atypically long period of time following the loss (more than 6 \\nmonths at a minimum) and clearly exceeds expected social, cultural or religious \\nnorms for the individual’s culture and context. Grief reactions that have persisted for \\nlonger periods that are within a normative period of grieving given the person’s \\ncultural and religious context are viewed as normal bereavement responses and are \\nnot assigned a diagnosis. The disturbance causes significant impairment in \\npersonal, family, social, educational, occupational or other important areas of \\nfunctioning.',\n",
       " '6B43   Adjustment disorder  \\nAdjustment disorder is a maladaptive reaction to a n identifiable psychosocial \\nstressor or multiple stressors (e.g. divorce, illness or disability, socio -economic \\nproblems, conflicts at home or work) that usually emerges within a month of the \\nstressor. The disorder is characterised by preoccupation with th e stressor or its \\nconsequences, including excessive worry, recurrent and distressing thoughts about \\nthe stressor, or constant rumination about its implications, as well as by failure to \\nadapt to the stressor that causes significant impairment in personal, family, social, \\neducational, occupational or other important areas of functioning. The symptoms \\nare not better explained by another mental disorder (e.g., Mood Disorder, another \\nDisorder Specifically Associated with Stress) and typically resolve within 6 m onths, \\nunless the stressor persists for a longer duration.  \\nExclusions:  separation anxiety disorder of childhood (6B05)  \\nRecurrent depressive disorder (6A71)  \\nSingle episode depressive disorder (6A70)  \\nProlonged grief disorder (6B42)  \\nUncomplicated bereavement (QE62)  \\nBurnout (QD85)  \\nAcute stress reaction (QE84)  \\n ICD-11 MMS  439',\n",
       " '6B44   Reactive attachment disorder  \\nReactive attachment disorder is characterised by grossly abnormal attachment \\nbehaviours in early childhood, occurring in the context of a history of grossly \\ninadequate child care (e.g., severe neglect, maltreatment, institutional deprivation). \\nEven when an  adequate primary caregiver is newly available, the child does not \\nturn to the primary caregiver for comfort, support and nurture, rarely displays \\nsecurity -seeking behaviours towards any adult, and does not respond when comfort \\nis offered. Reactive attachm ent disorder can only be diagnosed in children, and \\nfeatures of the disorder develop within the first 5 years of life. However, the disorder \\ncannot be diagnosed before the age of 1 year (or a developmental age of less than \\n9 months), when the capacity for selective attachments may not be fully developed, \\nor in the context of Autism spectrum disorder.  \\nExclusions:  Asperger syndrome (6A02)  \\ndisinhibited attachment disorder of childhood (6B45)',\n",
       " '6B45   Disinhibited social engagement disorder  \\nDisinhibited social  engagement disorder is characterised by grossly abnormal social \\nbehaviour, occurring in the context of a history of grossly inadequate child care \\n(e.g., severe neglect, institutional deprivation). The child approaches adults \\nindiscriminately, lacks retice nce to approach, will go away with unfamiliar adults, \\nand exhibits overly familiar behaviour towards strangers. Disinhibited social \\nengagement disorder can only be diagnosed in children, and features of the \\ndisorder develop within the first 5 years of life . However, the disorder cannot be \\ndiagnosed before the age of 1 year (or a developmental age of less than 9 months), \\nwhen the capacity for selective attachments may not be fully developed, or in the \\ncontext of Autism spectrum disorder.  \\nExclusions:  Asperger  syndrome (6A02)  \\nAdjustment disorder (6B43)  \\nAttention deficit hyperactivity disorder (6A05)  \\nreactive attachment disorder of childhood (6B44)',\n",
       " '6B4Y   Other specified disorders specifically associated with stress',\n",
       " '6B4Z   Disorders specifically associated  with stress, unspecified  \\n 440  ICD-11 MMS  \\n Dissociative disorders (6B60 ‑6B6Z)  \\nDissociative disorders are characterised by involuntary disruption or discontinuity in the normal \\nintegration of one or more of the following: identity, sensations, perceptions, affects, thought s, \\nmemories, control over bodily movements, or behaviour. Disruption or discontinuity may be complete, \\nbut is more commonly partial, and can vary from day to day or even from hour to hour. The symptoms \\nof dissociative disorders are not due to the direct ef fects of a medication or substance, including \\nwithdrawal effects, are not better explained by another Mental, behavioural, or neurodevelopmental \\ndisorder, a Sleep -wake disorder, a Disease of the nervous system or other health condition, and are \\nnot part of  an accepted cultural, religious, or spiritual practice. Dissociative symptoms in dissociative \\ndisorders are sufficiently severe to result in significant impairment in personal, family, social, \\neducational, occupational or other important areas of function ing. \\nCoded Elsewhere:  Secondary dissociative syndrome (6E65)',\n",
       " '6B60   Dissociative neurological symptom disorder  \\nDissociative neurological symptom disorder is characterised by the presentation of \\nmotor, sensory, or cognitive symptoms that imply an involuntary discontinuity in the \\nnormal integration of motor, sensory, or cognitive functions and are not consistent \\nwith a recognised disease of the nervous system, other mental or behavioural \\ndisorder, or other medical condition. The symptoms do not occur exclusively during \\nanother dissociative disorder and are not due to the effects of a substance or \\nmedication on the cen tral nervous system, including withdrawal effects, or a Sleep -\\nWake disorder.  \\nExclusions:  Factitious disorders  (6D50‑6D5Z)',\n",
       " '6B60.0  Dissociative neurological symptom disorder, with visual disturbance  \\nDissociative neurological symptom disorder, with visual di sturbance is characterised \\nby visual symptoms such as blindness, tunnel vision, diplopia, visual distortions or \\nhallucinations that are not consistent with a recognised disease of the nervous \\nsystem, other mental, behavioural or neurodevelopmental disorder , or other medical \\ncondition and do not occur exclusively during another dissociative disorder.',\n",
       " '6B60.1  Dissociative neurological symptom disorder, with auditory disturbance  \\nDissociative neurological symptom disorder, with auditory disturbance is \\ncharacter ised by auditory symptoms such as loss of hearing or auditory \\nhallucinations that are not consistent with a recognised disease of the nervous \\nsystem, other mental, behavioural or neurodevelopmental disorder, or other medical \\ncondition and do not occur excl usively during another dissociative disorder.',\n",
       " '6B60.2  Dissociative neurological symptom disorder, with vertigo or dizziness  \\nDissociative neurological symptom disorder, with vertigo or dizziness is \\ncharacterised by a sensation of spinning while stationary ( vertigo) or dizziness that \\nis not consistent with a recognised disease of the nervous system, other mental, \\nbehavioural or neurodevelopmental disorder, or other medical condition and does \\nnot occur exclusively during another dissociative disorder.  \\n ICD-11 MMS  441',\n",
       " '6B60.3  Dissociative neurological symptom disorder, with other sensory disturbance  \\nDissociative neurological symptom disorder, with other sensory disturbance is \\ncharacterised by sensory symptoms not identified in other specific categories in this \\ngrouping such as numbness, tightness, tingling, burning, pain, or other symptoms \\nrelated to touch, smell, taste, balance, proprioception, kinesthesia, or \\nthermoception. The symptoms are not consistent with a recognised disease of the \\nnervous system, other mental, behaviour al or neurodevelopmental disorder, or \\nother medical condition and do not occur exclusively during another dissociative \\ndisorder.',\n",
       " '6B60.4  Dissociative neurological symptom disorder, with non -epileptic seizures  \\nDissociative neurological symptom disorder, wit h non -epileptic seizures is \\ncharacterised by a symptomatic presentation of seizures or convulsions that are not \\nconsistent with a recognised disease of the nervous system, other mental, \\nbehavioural or neurodevelopmental disorder, or other medical condition  and do not \\noccur exclusively during another dissociative disorder.',\n",
       " '6B60.5  Dissociative neurological symptom disorder, with speech disturbance  \\nDissociative neurological symptom disorder, with speech disturbance is \\ncharacterised by symptoms such as difficulty with speaking (dysphonia), loss of the \\nability to speak (aphonia) or difficult or unclear articulation of speech (dysarthria) \\nthat are not c onsistent with a recognised disease of the nervous system, a \\nneurodevelopmental or neurocognitive disorder, other mental, behavioural or \\nneurodevelopmental disorder, or other medical condition and do not occur \\nexclusively during another dissociative disord er.',\n",
       " '6B60.6  Dissociative neurological symptom disorder, with paresis or weakness  \\nDissociative neurological symptom disorder, with paresis or weakness is \\ncharacterised by a difficulty or inability to intentionally move parts of the body or to \\ncoordinate mov ements that is not consistent with a recognised disease of the \\nnervous system, other mental, behavioural or neurodevelopmental disorder, or \\nother medical condition and does not occur exclusively during another dissociative \\ndisorder.',\n",
       " '6B60.7  Dissociative ne urological symptom disorder, with gait disturbance  \\nDissociative neurological symptom disorder, with gait disturbance is characterised \\nby symptoms involving the individual’s ability or manner of walking, including ataxia \\nand the inability to stand unaided, that are not consistent with a recognised disease \\nof the nervous system, other mental, behavioural or neurodevelopmental disorder, \\nor other medical condition and do not occur exclusively during another dissociative \\ndisorder.',\n",
       " '6B60.8  Dissociative neurological symptom disorder, with movement disturbance  \\nDissociative neurological symptom disorder, with movement disturbance is \\ncharacterised by symptoms such as chorea, myoclonus, tremor, dystonia, facial \\nspasm, parkinsonism, or dyskinesia that are not consistent with a recognised \\ndisease of the nervous system, other mental, behavioural or neurodevelopmental \\ndisorder, or other medical condition and do not occur exclusively during another \\ndissociative disorder.  \\n 442  ICD-11 MMS',\n",
       " '6B60.80  Dissociative neurologi cal symptom disorder, with chorea  \\nDissociative neurological symptom disorder, with chorea is characterised by \\nirregular, non -repetitive, brief, jerky, flowing movements that move randomly from \\none part of the body to another that are not consistent with a recognised disease of \\nthe nervous system, other mental, behavioural or neurodevelopmental disorder, or \\nother medical condition and do not occur exclusively during another dissociative \\ndisorder.',\n",
       " '6B60.81  Dissociative neurological symptom disorder, with myoc lonus  \\nDissociative neurological symptom disorder, with myoclonus is characterised by \\nsudden rapid jerks that may be focal, multifocal or generalised that are not \\nconsistent with a recognised disease of the nervous system, other mental, \\nbehavioural or neuro developmental disorder, or other medical condition and do not \\noccur exclusively during another dissociative disorder.',\n",
       " '6B60.82  Dissociative neurological symptom disorder, with tremor  \\nDissociative neurological symptom disorder, with tremor is characterised by \\ninvoluntary oscillation of a body part that is not consistent with a recognised disease \\nof the nervous system, other mental, behavioural or neurodevelopmental disorder, \\nor other medical condition and does not occur exclusively during another \\ndissociativ e disorder.',\n",
       " '6B60.83  Dissociative neurological symptom disorder, with dystonia  \\nDissociative neurological symptom disorder, with dystonia is characterised by \\nsustained muscle contractions that frequently cause twisting and repetitive \\nmovements or abnormal p ostures that are not consistent with a recognised disease \\nof the nervous system, other mental, behavioural or neurodevelopmental disorder, \\nor other medical condition and do not occur exclusively during another dissociative \\ndisorder.',\n",
       " '6B60.84  Dissociative n eurological symptom disorder, with facial spasm  \\nDissociative neurological symptom disorder, with facial spasm is characterised by \\ninvoluntary muscle contractions or twitching of the face that is not consistent with a \\nrecognised disease of the nervous syste m, other mental, behavioural or \\nneurodevelopmental disorder, or other medical condition and does not occur \\nexclusively during another dissociative disorder.',\n",
       " '6B60.85  Dissociative neurological symptom disorder, with Parkinsonism  \\nDissociative neurological sy mptom disorder, with Parkinsonism is characterised by \\na symptomatic presentation of a Parkinson -like syndrome in the absence of \\nconfirmed Parkinson disease that does not occur exclusively during another mental, \\nbehavioural or neurodevelopmental disorder, o ther medical condition, or another \\ndissociative disorder. Dissociative neurological symptom disorder, with \\nParkinsonism can be distinguished from Parkinson disease by features such as \\nabrupt onset, early disability, bilateral shaking and slowness, nondecre mental \\nslowness when performing repetitive movements, voluntary resistance against \\npassive movement without cogwheel rigidity, distractability, ‘give -way’ weakness, \\nstuttering speech, bizarre gait, and a variety of behavioural symptoms.',\n",
       " '6B60.8Y  Dissociati ve neurological symptom disorder, with other specified movement \\ndisturbance  \\n ICD-11 MMS  443',\n",
       " '6B60.8Z  Dissociative neurological symptom disorder, with unspecified movement \\ndisturbance',\n",
       " '6B60.9  Dissociative neurological symptom disorder, with cognitive symptoms  \\nDissociative neurological symptom disorder, with cognitive symptoms is \\ncharacterised by impaired cognitive performance in memory, language or other \\ncognitive domains that is internally inconsistent and not consistent with a \\nrecognised disease of the nervous system, a n eurodevelopmental or neurocognitive \\ndisorder, other mental, behavioural or neurodevelopmental disorder, or another \\nmedical condition and does not occur exclusively during another dissociative \\ndisorder.  \\nExclusions:  Dissociative amnesia (6B61)',\n",
       " '6B60.Y  Dissociative neurological symptom disorder, with other specified symptoms',\n",
       " '6B60.Z  Dissociative neurological symptom disorder, with unspecified symptoms',\n",
       " '6B61   Dissociative amnesia  \\nDissociative amnesia is characterised by an inability to recall important \\nautobiographical memories, typically of recent traumatic or stressful events, that is \\ninconsistent with ordinary forgetting. The amnesia does not occur exclusively during \\nanother dis sociative disorder and is not better explained by another mental, \\nbehavioural or neurodevelopmental disorder. The amnesia is not due to the direct \\neffects of a substance or medication on the central nervous system, including \\nwithdrawal effects, and is not due to a disease of the nervous system or to head \\ntrauma. The amnesia results in significant impairment in personal, family, social, \\neducational, occupational or other important areas of functioning.  \\nExclusions:  amnesia NOS (MB21.1)  \\nAmnestic disorder due t o use of alcohol (6D72.10)  \\nAnterograde amnesia (MB21.10)  \\nRetrograde amnesia (MB21.11)  \\nnonalcoholic organic amnesic syndrome (6D72.0)  \\npostictal amnesia in epilepsy  (8A60‑8A6Z)',\n",
       " '6B61.0  Dissociative amnesia with dissociative fugue  \\nDissociative amnesia with di ssociative fugue is characterised by all of the features \\nof Dissociative Amnesia, accompanied by dissociative fugue, i.e., a loss of a sense \\nof personal identity and sudden travel away from home, work, or significant others \\nfor an extended period of time ( days or weeks). A new identity may be assumed.  \\nExclusions:  postictal fugue in epilepsy  (8A60‑8A6Z)',\n",
       " '6B61.1  Dissociative amnesia without dissociative fugue  \\nDissociative amnesia without dissociative fugue is characterised by all of the \\nfeatures of dissociati ve amnesia occurring in the absence of symptoms of \\ndissociative fugue.',\n",
       " '6B61.Z  Dissociative amnesia, unspecified  \\n 444  ICD-11 MMS',\n",
       " '6B62   Trance disorder  \\nTrance disorder is characterised by trance states in which there is a marked \\nalteration in the individual’s state of consciousness or a loss of the individual’s \\ncustomary sense of personal identity in which the individual experiences a \\nnarrowing of awareness of immediate surroundings or unusually narrow and \\nselective focusing on environmental stimuli and restriction of m ovements, postures, \\nand speech to repetition of a small repertoire that is experienced as being outside of \\none’s control. The trance state is not characterised by the experience of being \\nreplaced by an alternate identity. Trance episodes are recurrent or, if the diagnosis \\nis based on a single episode, the episode has lasted for at least several days. The \\ntrance state is involuntary and unwanted and is not accepted as a part of a \\ncollective cultural or religious practice. The symptoms do not occur exclusivel y \\nduring another dissociative disorder and are not better explained by another mental, \\nbehavioural or neurodevelopmental disorder. The symptoms are not due to the \\ndirect effects of a substance or medication on the central nervous system, including \\nwithdraw al effects, exhaustion, or to hypnagogic or hypnopompic states, and are \\nnot due to a disease of the nervous system, head trauma, or a sleep -wake disorder. \\nThe symptoms result in significant distress or significant impairment in personal, \\nfamily, social, ed ucational, occupational or other important areas of functioning.',\n",
       " '6B63   Possession trance disorder  \\nPossession trance disorder is characterised by trance states in which there is a \\nmarked alteration in the individual’s state of consciousness and the indi vidual’s \\ncustomary sense of personal identity is replaced by an external ‘possessing’ identity \\nand in which the individual’s behaviours or movements are experienced as being \\ncontrolled by the possessing agent. Possession trance episodes are recurrent or, i f \\nthe diagnosis is based on a single episode, the episode has lasted for at least \\nseveral days. The possession trance state is involuntary and unwanted and is not \\naccepted as a part of a collective cultural or religious practice. The symptoms do not \\noccur exclusively during another dissociative disorder and are not better explained \\nby another mental, behavioural or neurodevelopmental disorder. The symptoms are \\nnot due to the direct effects of a substance or medication on the central nervous \\nsystem, includin g withdrawal effects, exhaustion, or to hypnagogic or hypnopompic \\nstates, and are not due to a disease of the nervous system or a sleep -wake \\ndisorder. The symptoms result in significant distress or significant impairment in \\npersonal, family, social, educat ional, occupational or other important areas of \\nfunctioning.  \\nExclusions:  Schizophrenia (6A20)  \\nDisorders due to use of other specified psychoactive \\nsubstances, including medications (6C4E)  \\nAcute and transient psychotic disorder (6A23)  \\nSecondary personality change (6E68)  \\n ICD-11 MMS  445',\n",
       " '6B64   Dissociative identity disorder  \\nDissociative identity disorder is chara cterised by disruption of identity in which there \\nare two or more distinct personality states (dissociative identities) associated with \\nmarked discontinuities in the sense of self and agency. Each personality state \\nincludes its own pattern of experiencing,  perceiving, conceiving, and relating to self, \\nthe body, and the environment. At least two distinct personality states recurrently \\ntake executive control of the individual’s consciousness and functioning in \\ninteracting with others or with the environment, such as in the performance of \\nspecific aspects of daily life such as parenting, or work, or in response to specific \\nsituations (e.g., those that are perceived as threatening). Changes in personality \\nstate are accompanied by related alterations in sensation , perception, affect, \\ncognition, memory, motor control, and behaviour. There are typically episodes of \\namnesia, which may be severe. The symptoms are not better explained by another \\nmental, behavioural or neurodevelopmental disorder and are not due to the direct \\neffects of a substance or medication on the central nervous system, including \\nwithdrawal effects, and are not due to a disease of the nervous system or a sleep -\\nwake disorder. The symptoms result in significant impairment in personal, family, \\nsocial,  educational, occupational or other important areas of functioning.',\n",
       " '6B65   Partial dissociative identity disorder  \\nPartial dissociative identity disorder is characterised by disruption of identity in \\nwhich there are two or more distinct personality state s (dissociative identities) \\nassociated with marked discontinuities in the sense of self and agency. Each \\npersonality state includes its own pattern of experiencing, perceiving, conceiving, \\nand relating to self, the body, and the environment. One personalit y state is \\ndominant and normally functions in daily life, but is intruded upon by one or more \\nnon-dominant personality states (dissociative intrusions). These intrusions may be \\ncognitive, affective, perceptual, motor, or behavioural. They are experienced a s \\ninterfering with the functioning of the dominant personality state and are typically \\naversive. The non -dominant personality states do not recurrently take executive \\ncontrol of the individual’s consciousness and functioning, but there may be \\noccasional, l imited and transient episodes in which a distinct personality state \\nassumes executive control to engage in circumscribed behaviours, such as in \\nresponse to extreme emotional states or during episodes of self -harm or the \\nreenactment of traumatic memories. T he symptoms are not better explained by \\nanother mental, behavioural or neurodevelopmental disorder and are not due to the \\ndirect effects of a substance or medication on the central nervous system, including \\nwithdrawal effects, and are not due to a disease of the nervous system or a sleep -\\nwake disorder. The symptoms result in significant impairment in personal, family, \\nsocial, educational, occupational or other important areas of functioning.  \\n 446  ICD-11 MMS',\n",
       " '6B66   Depersonalization -derealization disorder  \\nDepersonalizati on-derealization disorder is characterised by persistent or recurrent \\nexperiences of depersonalization, derealization, or both. Depersonalization is \\ncharacterised by experiencing the self as strange or unreal, or feeling detached \\nfrom, or as though one wer e an outside observer of, one’s thoughts, feelings, \\nsensations, body, or actions. Derealization is characterised by experiencing other \\npersons, objects, or the world as strange or unreal (e.g., dreamlike, distant, foggy, \\nlifeless, colourless, or visually d istorted) or feeling detached from one’s \\nsurroundings. During experiences of depersonalization or derealization, reality \\ntesting remains intact. The experiences of depersonalization or derealization do not \\noccur exclusively during another dissociative diso rder and are not better explained \\nby another mental, behavioural or neurodevelopmental disorder. The experiences of \\ndepersonalization or derealization are not due to the direct effects of a substance or \\nmedication on the central nervous system, including w ithdrawal effects, and are not \\ndue to a disease of the nervous system or to head trauma. The symptoms result in \\nsignificant distress or impairment in personal, family, social, educational, \\noccupational or other important areas of functioning.',\n",
       " '6B6Y   Other specified dissociative disorders',\n",
       " '6B6Z   Dissociative disorders, unspecified  \\n \\nFeeding or eating disorders (6B80 ‑6B8Z)  \\nFeeding and Eating Disorders involve abnormal eating or feeding behaviours that are not explained \\nby another health condition and are  not developmentally appropriate or culturally sanctioned. Feeding \\ndisorders involve behavioural disturbances that are not related to body weight and shape concerns, \\nsuch as eating of non -edible substances or voluntary regurgitation of foods. Eating disord ers involve \\nabnormal eating behaviour and preoccupation with food as well as prominent body weight and shape \\nconcerns.',\n",
       " \"6B80   Anorexia Nervosa  \\nAnorexia Nervosa is characterised by significantly low body weight for the \\nindividual’s height, age and developmental stage that is not due to another health \\ncondition or to the unavailability of food. A commonly used threshold is body mass \\nindex (BMI) les s than 18.5 kg/m² in adults and BMI -for-age under 5th percentile in \\nchildren and adolescents. Rapid weight loss (e.g. more than 20% of total body \\nweight within 6 months) may replace the low body weight guideline as long as other \\ndiagnostic requirements are  met. Children and adolescents may exhibit failure to \\ngain weight as expected based on the individual developmental trajectory rather \\nthan weight loss. Low body weight is accompanied by a persistent pattern of \\nbehaviours to prevent restoration of normal we ight, which may include behaviours \\naimed at reducing energy intake (restricted eating), purging behaviours (e.g. self -\\ninduced vomiting, misuse of laxatives), and behaviours aimed at increasing energy \\nexpenditure (e.g. excessive exercise), typically associa ted with a fear of weight \\ngain. Low body weight or shape is central to the person's self -evaluation or is \\ninaccurately perceived to be normal or even excessive.  \\n ICD-11 MMS  447\",\n",
       " '6B80.0  Anorexia Nervosa with significantly low body weight  \\nAnorexia Nervosa with significantly  low body weight meets all definitional \\nrequirements for Anorexia Nervosa, with BMI between 18.5 kg/m2 and 14.0 kg/m² \\nfor adults or between the fifth percentile and the 0.3 percentile for BMI -for-age in \\nchildren and adolescents.',\n",
       " '6B80.00  Anorexia Nervosa w ith significantly low body weight, restricting pattern  \\nAnorexia Nervosa with significantly low body weight, restricting pattern refers to \\nindividuals who meet the definitional requirements of Anorexia Nervosa with \\nsignificantly low body weight and who induce weight loss and maintain low body \\nweight through res tricted food intake or fasting alone or in combination with \\nincreased energy expenditure (such as through excessive exercise) but who do not \\nengage in binge eating or purging behaviours.',\n",
       " '6B80.01  Anorexia Nervosa with significantly low body weight, binge -purge pattern  \\nAnorexia Nervosa with significantly low body weight, binge -purge pattern refers to \\nindividuals who meet the definitional requirements of Anorexia Nervosa with \\nsignificantly low body weight and who present with episodes of binge eating or \\npurgi ng behaviours. These individuals induce weight loss and maintain low body \\nweight through restricted food intake, commonly accompanied by significant purging \\nbehaviours aimed at getting rid of ingested food (e.g. self -induced vomiting, laxative \\nabuse or ene mas). This pattern also includes individuals who exhibit binge eating \\nepisodes but do not purge.',\n",
       " '6B80.0Z  Anorexia Nervosa with significantly low body weight, unspecified',\n",
       " '6B80.1  Anorexia Nervosa with dangerously low body weight  \\nAnorexia Nervosa with dange rously low body weight meets all definitional \\nrequirements for Anorexia Nervosa, with BMI under 14.0 kg/m² in adults or under \\nthe 0.3rd percentile for BMI -for-age in children and adolescents. In the context of \\nAnorexia Nervosa, severe underweight status is  an important prognostic factor that \\nis associated with high risk of physical complications and substantially increased \\nmortality.',\n",
       " '6B80.10  Anorexia Nervosa with dangerously low body weight, restricting pattern  \\nAnorexia Nervosa with dangerously low body we ight, restricting pattern refers to \\nindividuals who meet the definitional requirements of Anorexia Nervosa with \\ndangerously low body weight and who induce weight loss and maintain low body \\nweight through restricted food intake or fasting alone or in combin ation with \\nincreased energy expenditure (such as through excessive exercise) but who do not \\nengage in binge eating or purging behaviours.',\n",
       " '6B80.11  Anorexia Nervosa with dangerously low body weight, binge -purge pattern  \\nAnorexia Nervosa with dangerously low body weight, binge -purge pattern refers to \\nindividuals who meet the definitional requirements of Anorexia Nervosa with \\ndangerously low body weight and who present with episodes of binge eating or \\npurging behaviours. These individuals induce weight loss and  maintain low body \\nweight through restricted food intake, commonly accompanied by significant purging \\nbehaviours aimed at getting rid of ingested food (e.g. self -induced vomiting, laxative \\nabuse or enemas). This pattern also includes individuals who exhibi t binge eating \\nepisodes but do not purge.  \\n 448  ICD-11 MMS',\n",
       " '6B80.1Z  Anorexia Nervosa with dangerously low body weight, unspecified',\n",
       " '6B80.2  Anorexia Nervosa in recovery with normal body weight  \\nAmong individuals who are recovering from Anorexia Nervosa and whose body \\nweight is more than 18.5 kg/m2 for adults or over the fifth percentile for BMI -for-age \\nfor children and adolescents, the diagnosis should be retained until a full and lasting \\nrecovery is achieved, as indicated by the maintenance of a healthy weight and the \\ncessat ion of behaviours aimed at reducing body weight independent of the provision \\nof treatment (e.g., for at least 1 year after intensive treatment is withdrawn).',\n",
       " '6B80.Y  Other specified anorexia Nervosa',\n",
       " '6B80.Z  Anorexia Nervosa, unspecified',\n",
       " '6B81   Bulimia N ervosa  \\nBulimia Nervosa is characterised by frequent, recurrent episodes of binge eating \\n(e.g. once a week or more over a period of at least one month). A binge eating \\nepisode is a distinct period of time during which the individual experiences a \\nsubjective  loss of control over eating, eating notably more or differently than usual, \\nand feels unable to stop eating or limit the type or amount of food eaten. Binge \\neating is accompanied by repeated inappropriate compensatory behaviours aimed \\nat preventing weight  gain (e.g. self -induced vomiting, misuse of laxatives or \\nenemas, strenuous exercise). The individual is preoccupied with body shape or \\nweight, which strongly influences self -evaluation. There is marked distress about \\nthe pattern of binge eating and inappr opriate compensatory behaviour or significant \\nimpairment in personal, family, social, educational, occupational or other important \\nareas of functioning. The individual does not meet the diagnostic requirements of \\nAnorexia Nervosa.  \\nExclusions:  Binge eating disorder (6B82)',\n",
       " '6B82   Binge eating disorder  \\nBinge eating disorder is characterised by frequent, recurrent episodes of binge \\neating (e.g. once a week or more over a period of several months). A binge eating \\nepisode is a distinct period of time during which the individual experiences a \\nsubjective loss  of control over eating, eating notably more or differently than usual, \\nand feels unable to stop eating or limit the type or amount of food eaten. Binge \\neating is experienced as very distressing, and is often accompanied by negative \\nemotions such as guilt or disgust. However, unlike in Bulimia Nervosa, binge eating \\nepisodes are not regularly followed by inappropriate compensatory behaviours \\naimed at preventing weight gain (e.g. self -induced vomiting, misuse of laxatives or \\nenemas, strenuous exercise). There  is marked distress about the pattern of binge \\neating or significant impairment in personal, family, social, educational, occupational \\nor other important areas of functioning.  \\nExclusions:  Bulimia Nervosa (6B81)  \\n ICD-11 MMS  449',\n",
       " '6B83   Avoidant -restrictive food intake di sorder  \\nAvoidant -restrictive food intake disorder (ARFID) is characterised by avoidance or \\nrestriction of food intake that results in: 1) the intake of an insufficient quantity or \\nvariety of food to meet adequate energy or nutritional requirements that has \\nresulted in significant weight loss, clinically significant nutritional deficiencies, \\ndependence on oral nutritional supplements or tube feeding, or has otherwise \\nnegatively affected the physical health of the individual; or 2) significant impairment \\nin pe rsonal, family, social, educational, occupational or other important areas of \\nfunctioning (e.g., due to avoidance or distress related to participating in social \\nexperiences involving eating). The pattern of eating behaviour is not motivated by \\npreoccupatio n with body weight or shape. Restricted food intake and its effects on \\nweight, other aspects of health, or functioning are not due to unavailability of food, \\nnot a manifestation of another medical condition (e.g. food allergies, \\nhyperthyroidism) or mental disorder, and are not due to the effect of a substance or \\nmedication on the central nervous system including withdrawal effects.  \\nExclusions:  Anorexia Nervosa (6B80)  \\nFeeding problem of infant (MG43.30)  \\nFeeding problems of newborn (KD32)',\n",
       " '6B84   Pica  \\nPica is characterised by the regular consumption of non -nutritive substances, such \\nas non -food objects and materials (e.g., clay, soil, chalk, plaster, plastic, metal and \\npaper) or raw food ingredients (e.g ., large quantities of salt or corn flour) that is \\npersistent or severe enough to require clinical attention in an individual who has \\nreached a developmental age at which they would be expected to distinguish \\nbetween edible and non -edible substances (appro ximately 2 years). That is, the \\nbehaviour causes damage to health, impairment in functioning, or significant risk \\ndue to the frequency, amount or nature of the substances or objects ingested.',\n",
       " '6B85   Rumination -regurgitation disorder  \\nRumination -regurgita tion disorder is characterised by the intentional and repeated \\nbringing up of previously swallowed food back to the mouth (i.e., regurgitation), \\nwhich may be re -chewed and re -swallowed (i.e. rumination), or may be deliberately \\nspat out (but not as in vomit ing). The regurgitation behaviour is frequent (at least \\nseveral times per week) and sustained over a period of at least several weeks. The \\nregurgitation behaviour is not fully accounted for by another medical condition that \\ndirectly causes regurgitation (e .g., oesophageal strictures or neuromuscular \\ndisorders affecting oesophageal functioning) or causes nausea or vomiting (e.g. \\npyloric stenosis). Rumination -regurgitation disorder should only be diagnosed in \\nindividuals who have reached a developmental age o f at least 2 years.  \\nExclusions:  Adult rumination syndrome (DD90.6)  \\nNausea or vomiting (MD90)',\n",
       " '6B8Y   Other specified feeding or eating disorders',\n",
       " '6B8Z   Feeding or eating disorders, unspecified  \\n 450  ICD-11 MMS  \\n Elimination disorders (6C00 ‑6C0Z)  \\nElimination disorders i nclude the repeated voiding of urine into clothes or bed (enuresis) and the \\nrepeated passage of faeces in inappropriate places (encopresis). Elimination disorders should only be \\ndiagnosed after the individual has reached a developmental age when continence  is ordinarily \\nexpected (5 years for enuresis and 4 years for encopresis). The urinary or faecal incontinence may \\nhave been present from birth (i.e., an atypical extension of normal infantile incontinence), or may have \\narisen following a period of acquired  bladder or bowel control. An Elimination disorder should not be \\ndiagnosed if the behaviour is fully attributable to another health condition that causes incontinence, \\ncongenital or acquired abnormalities of the urinary tract or bowel, or excessive use of laxatives or \\ndiuretics.',\n",
       " '6C00   Enuresis  \\nEnuresis is the repeated voiding of urine into clothes or bed, which may occur \\nduring the day or at night, in an individual who has reached a developmental age \\nwhen urinary continence is ordinarily expected (5 year s). The urinary incontinence \\nmay have been present from birth (i.e., an atypical extension of normal infantile \\nincontinence), or may have arisen following a period of acquired bladder control. In \\nmost cases, the behaviour is involuntary but in some cases i t appears intentional. \\nEnuresis should not be diagnosed if unintentional voiding of urine is due to a health \\ncondition that interferes with continence (e.g., diseases of the nervous system or \\nmusculoskeletal disorders) or by congenital or acquired abnormal ities of the urinary \\ntract.  \\nInclusions:  Functional enuresis  \\nPsychogenic enuresis  \\nUrinary incontinence of nonorganic origin  \\nExclusions:  Stress incontinence (MF50.20)  \\nUrge Incontinence (MF50.21)  \\nFunctional urinary incontinence (MF50.23)  \\nOverflow Incontinence (MF50.2)  \\nReflex incontinence (MF50.24)  \\nExtraurethral urinary incontinence (MF50.2)',\n",
       " '6C00.0  Nocturnal enuresis  \\nNocturnal enuresis refers to repeated voiding of urine into clothes or bed that oc curs \\nonly during sleep (i.e., during the night) in an individual who has reached a \\ndevelopmental age when urinary continence is ordinarily expected (5 years). The \\nurinary incontinence may have been present from birth (i.e., an atypical extension of \\nnormal infantile incontinence), or may have arisen following a period of acquired \\nbladder control. In most cases, the behaviour is involuntary but in some cases it \\nappears intentional.',\n",
       " '6C00.1  Diurnal enuresis  \\nDiurnal enuresis refers to repeated voiding of urine into clothes that occurs only \\nduring waking hours in an individual who has reached a developmental age when \\nurinary continence is ordinarily expected (5 years). The urinary incontinence may \\nhave been present from birth (i.e., an atypical extension of norma l infantile \\nincontinence), or may have arisen following a period of acquired bladder control. In \\nmost cases, the behaviour is involuntary but in some cases it appears intentional.  \\n ICD-11 MMS  451',\n",
       " '6C00.2  Nocturnal and diurnal enuresis  \\nNocturnal and diurnal enuresis refers  to repeated voiding of urine into clothes or \\nbed that occurs both during sleep (i.e., during the night) and during waking hours in \\nan individual who has reached a developmental age when urinary continence is \\nordinarily expected (5 years). The urinary inco ntinence may have been present from \\nbirth (i.e., an atypical extension of normal infantile incontinence), or may have \\narisen following a period of acquired bladder control. In most cases, the behaviour \\nis involuntary but in some cases it appears intentiona l.',\n",
       " '6C00.Z  Enuresis, unspecified',\n",
       " '6C01   Encopresis  \\nEncopresis is the repeated passage of faeces in inappropriate places. Encopresis \\nshould be diagnosed if inappropriate passage of faeces occurs repeatedly (e.g., at \\nleast once per month over a period of several months) in an individual who has \\nreached the d evelopmental age when faecal continence is ordinarily expected (4 \\nyears). The faecal incontinence may have been present from birth (i.e., an atypical \\nextension of normal infantile incontinence), or may have arisen following a period of \\nacquired bowel contr ol. Encopresis should not be diagnosed if faecal soiling is fully \\nattributable to another health condition (e.g., aganglionic megacolon, spina bifida, \\ndementia), congenital or acquired abnormalities of the bowel, gastrointestinal \\ninfection, or excessive us e of laxatives.',\n",
       " '6C01.0  Encopresis with constipation or overflow incontinence  \\nEncopresis is the repeated passage of faeces in inappropriate places occurring \\nrepeatedly (e.g., at least once per month over a period of several months) in an \\nindividual who has  reached the developmental age when faecal continence is \\nordinarily expected (4 years). The faecal incontinence may have been present from \\nbirth (i.e., an atypical extension of normal infantile incontinence), or may have \\narisen following a period of acquir ed bowel control. Encopresis with constipation \\nand overflow incontinence is the most common form of faecal soiling, and involves \\nretention and impaction of faeces. Stools are typically — but not always — poorly \\nformed (loose or liquid) and leakage may rang e from occasional to continuous. \\nThere is often a history of toilet avoidance leading to constipation.',\n",
       " '6C01.1  Encopresis without constipation or overflow incontinence  \\nEncopresis is the repeated passage of faeces in inappropriate places occurring \\nrepeatedl y (e.g., at least once per month over a period of several months) in an \\nindividual who has reached the developmental age when faecal continence is \\nordinarily expected (4 years). The faecal incontinence may have been present from \\nbirth (i.e., an atypical ex tension of normal infantile incontinence), or may have \\narisen following a period of acquired bowel control. Encopresis without constipation \\nand overflow is not associated with retention and impaction of faeces, but rather \\nreflects reluctance, resistance or  failure to conform to social norms in defecating in \\nacceptable places in the context of normal physiological control over defecation. \\nStools are typically of normal consistency and inappropriate defecation is likely to \\nbe intermittent.',\n",
       " '6C01.Z  Encopresis, unspecified',\n",
       " '6C0Z   Elimination disorders, unspecified  \\n 452  ICD-11 MMS  \\n Disorders of bodily distress or bodily experience (6C20 ‑6C2Z)  \\nDisorders of bodily distress and bodily experience are characterised by disturbances in the person’s \\nexperience of his or he r body. Bodily distress disorder involves bodily symptoms that the individual \\nfinds distressing and to which excessive attention is directed. Body integrity dysphoria involves a \\ndisturbance in the person’s experience of the body manifested by the persisten t desire to have a \\nspecific physical disability accompanied by persistent discomfort, or intense feelings of \\ninappropriateness concerning current non -disabled body configuration.  \\nExclusions:  Dissociative neurological symptom disorder (6B60)  \\nConcern about b ody appearance  (QD30‑QD3Z)',\n",
       " '6C20   Bodily distress disorder  \\nBodily distress disorder is characterised by the presence of bodily symptoms that \\nare distressing to the individual and excessive attention directed toward the \\nsymptoms, which may be manifest by repeated contact with health care providers. If \\nanother health condition is causing or contributing to the symptoms, the degree of \\nattention is clearly excessive in relation to its nature and progression. Excessive \\nattention is not alleviated by appropriat e clinical examination and investigations and \\nappropriate reassurance. Bodily symptoms are persistent, being present on most \\ndays for at least several months. Typically, bodily distress disorder involves multiple \\nbodily symptoms that may vary over time. Oc casionally there is a single symptom —\\nusually pain or fatigue —that is associated with the other features of the disorder. \\nThe symptoms and associated distress and preoccupation have at least some \\nimpact on the individual’s functioning (e.g. strain in relati onships, less effective \\nacademic or occupational functioning, abandonment of specific leisure activities).  \\nExclusions:  Tourette syndrome (8A05.00)  \\nHair pulling disorder (6B25.0)  \\nDissociative disorders  (6B60‑6B6Z)  \\nhair-plucking (6B25.0)  \\nHypochondriasis (6B2 3) \\nBody dysmorphic disorder (6B21)  \\nExcoriation disorder (6B25.1)  \\nGender incongruence  (HA60‑HA6Z)  \\nSexual dysfunctions  (HA00‑HA0Z)  \\nTic disorders (8A05)  \\nSexual pain -penetration disorder (HA20)  \\nPostviral fatigue syndrome (8E49)  \\nChronic fatigue syndrome (8E49)  \\nMyalgic encephalomyelitis (8E49)  \\n ICD-11 MMS  453',\n",
       " '6C20.0  Mild bodily distress disorder  \\nAll definitional requirements of bodily distress disorder are present. There is \\nexcessive attention to distressing symptoms and their consequences, which may \\nresult in frequent medical visits, but the person is not preoccupied with the \\nsymptoms (e.g., the individual spends less than an hour per day focusing on them). \\nAlthough the individual expresses distress about the symptoms and they may have \\nsome impact on his or her life (e.g., strain in relationships, less effective academic \\nor occupational functionin g, abandonment of specific leisure activities), there is no \\nsubstantial impairment in the person’s personal, family, social, educational, \\noccupational, or other important areas of functioning.',\n",
       " '6C20.1  Moderate bodily distress disorder  \\nAll definitional requ irements of bodily distress disorder are present. There is \\npersistent preoccupation with the distressing symptoms and their consequences \\n(e.g., the individual spends more than an hour a day thinking about them), typically \\nassociated with frequent medical v isits. The person devotes much of his or her \\nenergy to focusing on the symptoms and their consequences. The symptoms and \\nassociated distress and preoccupation cause moderate impairment in personal, \\nfamily, social, educational, occupational, or other import ant areas of functioning \\n(e.g., relationship conflict, performance problems at work, abandonment of a range \\nof social and leisure activities).',\n",
       " '6C20.2  Severe bodily distress disorder  \\nAll definitional requirements of Bodily distress disorder are present. Th ere is \\npervasive and persistent preoccupation with the symptoms and their consequences \\nto the extent that these may become the focal point of the person’s life, typically \\nresulting in extensive interactions with the health care system. The symptoms and \\nassociated distress and preoccupation cause serious impairment in personal, \\nfamily, social, educational, occupational, or other important areas of functioning \\n(e.g., unable to work, alienation of friends and family, abandonment of nearly all \\nsocial and leisur e activities). The person’s interests may become so narrow as to \\nfocus almost exclusively on his or her bodily symptoms and their negative \\nconsequences.',\n",
       " '6C20.Z  Bodily distress disorder, unspecified',\n",
       " '6C21   Body integrity dysphoria  \\nBody integrity dysphoria is characterised by an intense and persistent desire to \\nbecome physically disabled in a significant way (e.g. major limb amputee, \\nparaplegic, blind), with onset by early adolescence accompanied by persisten t \\ndiscomfort, or intense feelings of inappropriateness concerning current non -disabled \\nbody configuration. The desire to become physically disabled results in harmful \\nconsequences, as manifested by either the preoccupation with the desire (including \\ntime s pent pretending to be disabled) significantly interfering with productivity, with \\nleisure activities, or with social functioning (e.g. person is unwilling to have a close \\nrelationship because it would make it difficult to pretend) or by attempts to actuall y \\nbecome disabled having resulted in the person putting his or her health or life in \\nsignificant jeopardy. The disturbance is not better accounted for by another mental, \\nbehavioural or neurodevelopmental disorder, by a Disease of the Nervous System \\nor by a nother medical condition, or by Malingering.  \\nExclusions:  Gender incongruence of adolescence or adulthood (HA60)  \\n 454  ICD-11 MMS',\n",
       " '6C2Y   Other specified disorders of bodily distress or bodily experience',\n",
       " '6C2Z   Disorders of bodily distress or bodily experience, unspeci fied  \\n \\nDisorders due to substance use or addictive behaviours (6C40 ‑6C5Z)  \\nDisorders due to substance use and addictive behaviours are mental and behavioural disorders that \\ndevelop as a result of the use of predominantly psychoactive substances, including me dications, or \\nspecific repetitive rewarding and reinforcing behaviours.  \\nDisorders due to substance use (6C40 ‑6C4Z)  \\nDisorders due to substance use include disorders that result from a single occasion or repeated use \\nof substances that have psychoactive prop erties, including certain medications. Disorders related to \\nfourteen classes or groups of psychoactive substances are included. Typically, initial use of these \\nsubstances produces pleasant or appealing psychoactive effects that are rewarding and reinforcin g \\nwith repeated use. With continued use, many of the included substances have the capacity to \\nproduce dependence. They also have the potential to cause numerous forms of harm, both to mental \\nand physical health. Disorders due to harmful non -medical use of non-psychoactive substances are \\nalso included in this grouping.  \\nCoded Elsewhere:  Catatonia induced by substances or medications (6A41)',\n",
       " '6C40   Disorders due to use of alcohol  \\nDisorders due to use of alcohol are characterised by the pattern and consequence s \\nof alcohol use. Alcohol —more specifically termed ethyl alcohol or ethanol —is an \\nintoxicating compound produced by fermentation of sugars usually in agricultural \\nproducts such as fruits, cereals, and vegetables with or without subsequent \\ndistillation. The re are a wide variety of alcoholic drinks, with alcohol concentrations \\ntypically ranging from 1.5% to 60%. Alcohol is predominantly a central nervous \\nsystem depressant. In addition to ability to produce Alcohol Intoxication, alcohol has \\ndependence -producin g properties, resulting in Alcohol Dependence in some people \\nand Alcohol Withdrawal when alcohol use is reduced or discontinued. Unlike most \\nother substances, elimination of alcohol from the body occurs at a constant rate, \\nsuch that its clearance follows a  linear rather than a logarithmic course. Alcohol is \\nimplicated in a wide range of harms affecting most organs and systems of the body \\n(e.g., cirrhosis of the liver, gastrointestinal cancers, pancreatitis). Harm to others \\nresulting from behaviour during Al cohol Intoxication is well recognized and is \\nincluded in the definitions of harmful use of alcohol (i.e., Episode of Harmful Use of \\nAlcohol and Harmful Pattern of Use of Alcohol). Several alcohol -induced mental \\ndisorders (e.g., Alcohol -Induced Psychotic Di sorder) and alcohol -related forms of \\nneurocognitive impairment (e.g., Dementia Due to Use of Alcohol) are recognized.  \\nExclusions:  Hazardous alcohol use (QE10)  \\n ICD-11 MMS  455',\n",
       " '6C40.0  Episode of harmful use of alcohol  \\nAn episode of use of alcohol that has caused damage to a person’s physical or \\nmental health or has resulted in behaviour leading to harm to the health of others. \\nHarm to health of the individual occurs due to one or more of the following: (1) \\nbehaviour rel ated to intoxication; (2) direct or secondary toxic effects on body \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including trauma, or mental disorder that \\nis directly attributabl e to behaviour due to alcohol intoxication on the part of the \\nperson to whom the diagnosis of single episode of harmful use applies. This \\ndiagnosis should not be made if the harm is attributed to a known pattern of alcohol \\nuse. \\nExclusions:  Harmful pattern of use of alcohol (6C40.1)  \\nAlcohol dependence (6C40.2)',\n",
       " '6C40.1  Harmful pattern of use of alcohol  \\nA pattern of alcohol use that has caused damage to a person’s physical or mental \\nhealth or has resulted in behaviour leading to harm to the health of others. T he \\npattern of alcohol use is evident over a period of at least 12 months if substance \\nuse is episodic or at least one month if use is continuous. Harm to health of the \\nindividual occurs due to one or more of the following: (1) behaviour related to \\nintoxica tion; (2) direct or secondary toxic effects on body organs and systems; or (3) \\na harmful route of administration. Harm to health of others includes any form of \\nphysical harm, including trauma, or mental disorder that is directly attributable to \\nbehaviour r elated to alcohol intoxication on the part of the person to whom the \\ndiagnosis of Harmful pattern of use of alcohol applies.  \\nExclusions:  Alcohol dependence (6C40.2)  \\nEpisode of harmful use of alcohol (6C40.0)',\n",
       " '6C40.10  Harmful pattern of use of alcohol, epis odic \\nA pattern of episodic or intermittent alcohol use that has caused damage to a \\nperson’s physical or mental health or has resulted in behaviour leading to harm to \\nthe health of others. The pattern of episodic alcohol use is evident over a period of \\nat least 12 months. Harm to health of the individual occurs due to one or more of \\nthe following: (1) behaviour related to intoxication; (2) direct or secondary toxic \\neffects on body organs and systems; or (3) a harmful route of administration. Harm \\nto health o f others includes any form of physical harm, including trauma, or mental \\ndisorder that is directly attributable to behaviour related to alcohol intoxication on \\nthe part of the person to whom the diagnosis of Harmful pattern of use of alcohol \\napplies.  \\nExclu sions:  Episode of harmful use of alcohol (6C40.0)  \\nAlcohol dependence (6C40.2)  \\n 456  ICD-11 MMS',\n",
       " '6C40.11  Harmful pattern of use of alcohol, continuous  \\nA pattern of continuous (daily or almost daily) alcohol use that has caused damage \\nto a person’s physical or mental health or has resulted in behaviour leading to harm \\nto the health of others. The pattern of continuous alcohol use is evident over a \\nperiod of at least one month. Harm to health of the individual occurs due to one or \\nmore of the following: (1) behaviour related t o intoxication; (2) direct or secondary \\ntoxic effects on body organs and systems; or (3) a harmful route of administration. \\nHarm to health of others includes any form of physical harm, including trauma, or \\nmental disorder that is directly attributable to b ehaviour related to alcohol \\nintoxication on the part of the person to whom the diagnosis of Harmful pattern of \\nuse of alcohol applies.  \\nExclusions:  Episode of harmful use of alcohol (6C40.0)  \\nAlcohol dependence (6C40.2)',\n",
       " '6C40.1Z  Harmful pattern of use of alcohol, unspecified',\n",
       " '6C40.2  Alcohol dependence  \\nAlcohol dependence is a disorder of regulation of alcohol use arising from repeated \\nor continuous use of alcohol. The characteristic feature is a strong internal drive to \\nuse alcohol , which is manifested by impaired ability to control use, increasing \\npriority given to use over other activities and persistence of use despite harm or \\nnegative consequences. These experiences are often accompanied by a subjective \\nsensation of urge or crav ing to use alcohol. Physiological features of dependence \\nmay also be present, including tolerance to the effects of alcohol, withdrawal \\nsymptoms following cessation or reduction in use of alcohol, or repeated use of \\nalcohol or pharmacologically similar sub stances to prevent or alleviate withdrawal \\nsymptoms. The features of dependence are usually evident over a period of at least \\n12 months but the diagnosis may be made if alcohol use is continuous (daily or \\nalmost daily) for at least 3 months.  \\nInclusions:  Chronic alcoholism  \\nDipsomania  \\nExclusions:  Episode of harmful use of alcohol (6C40.0)  \\nHarmful pattern of use of alcohol (6C40.1)',\n",
       " '6C40.20  Alcohol dependence, current use, continuous  \\nAlcohol dependence with continuous consumption of alcohol (daily or almost daily) \\nover a period of at least 1 month.  \\nExclusions:  Episode of harmful use of alcohol (6C40.0)  \\nHarmful pattern of use of alcohol (6C40.1)',\n",
       " '6C40.21  Alcohol dependence, current use,  episodic  \\nDuring the past 12 months, there has been alcohol dependence with intermittent \\nheavy drinking, with periods of abstinence from alcohol. If current use is continuous \\n(daily or almost daily over at least the past 1 month), the diagnosis of Alcohol \\ndependence, current use, continuous should be made instead.  \\nExclusions:  Episode of harmful use of alcohol (6C40.0)  \\nHarmful pattern of use of alcohol (6C40.1)  \\n ICD-11 MMS  457',\n",
       " '6C40.22  Alcohol dependence, early full remission  \\nAfter a diagnosis of alcohol dependence, and oft en following a treatment episode or \\nother intervention (including self -help intervention), the individual has been \\nabstinent from alcohol during a period lasting between 1 and 12 months.  \\nExclusions:  Episode of harmful use of alcohol (6C40.0)  \\nHarmful patter n of use of alcohol (6C40.1)',\n",
       " '6C40.23  Alcohol dependence, sustained partial remission  \\nAfter a diagnosis of alcohol dependence, and often following a treatment episode or \\nother intervention (including self -help intervention), there is a significant reductio n in \\nalcohol consumption for more than 12 months, such that even though intermittent or \\ncontinuing drinking has occurred during this period, the definitional requirements for \\ndependence have not been met.  \\nExclusions:  Episode of harmful use of alcohol (6C40 .0) \\nHarmful pattern of use of alcohol (6C40.1)',\n",
       " '6C40.24  Alcohol dependence, sustained full remission  \\nAfter a diagnosis of alcohol dependence, and often following a treatment episode or \\nother intervention (including self -intervention), the person has been a bstinent from \\nalcohol for 12 months or longer.  \\nExclusions:  Episode of harmful use of alcohol (6C40.0)  \\nHarmful pattern of use of alcohol (6C40.1)',\n",
       " '6C40.2Z  Alcohol dependence, unspecified',\n",
       " '6C40.3  Alcohol intoxication  \\nAlcohol intoxication is a clinically significant transient condition that develops during \\nor shortly after the consumption of alcohol that is characterised by disturbances in \\nconsciousness, cognition, perception, affect, behaviour, or coordination. These \\ndisturbances are caused by the known pharmacological effects of alcohol and their \\nintensity is closely related to the amount of alcohol consumed. They are time -limited \\nand abate as alcohol is cleared from the body. Presenting features may include \\nimpaired a ttention, inappropriate or aggressive behaviour, lability of mood and \\nemotions, impaired judgment, poor coordination, unsteady gait, fine nystagmus and \\nslurred speech. At more severe levels of intoxication, stupor or coma may occur. \\nAlcohol intoxication ma y facilitate suicidal ideation or behaviour.  \\nCoding Note:  Code also the causing condition  \\nExclusions:  alcohol poisoning (NE61)  \\nPossession trance disorder (6B63)  \\n 458  ICD-11 MMS',\n",
       " '6C40.4  Alcohol withdrawal  \\nAlcohol withdrawal is a clinically significant cluster of symptoms, behaviours and/or \\nphysiological features, varying in degree of severity and duration, that occurs upon \\ncessation or reduction of use of alcohol in individuals who have developed Alcohol \\ndependence or have used alcohol for a prolonged period or in large amounts. \\nPresenting features of Alcohol withdrawal may include autonomic hyperactivity (e.g. \\ntachycardia, hypertension, perspiration), increased hand tremor, nausea, retching or \\nvomiting, ins omnia, anxiety, psychomotor agitation, depressed or dysphoric mood, \\ntransient visual, tactile or auditory illusions or hallucinations, and distractability. Less \\ncommonly, the withdrawal state is complicated by generalised tonic -clonic seizures. \\nThe withdra wal state may progress to a very severe form of delirium characterised \\nby confusion and disorientation, delusions, and prolonged visual, tactile or auditory \\nhallucinations. In such cases, a separate diagnosis of Alcohol -induced delirium \\nshould also be assi gned.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C40.40  Alcohol withdrawal, uncomplicated  \\nAll diagnostic requirements for Alcohol Withdrawal are met and the withdrawal state \\nis not accompanied by perceptual disturbances or seizures.  \\nCoding Note:  Code a lso the causing condition',\n",
       " '6C40.41  Alcohol withdrawal with perceptual disturbances  \\nAll diagnostic requirements for Alcohol withdrawal are met and the withdrawal state \\nis accompanied by perceptual disturbances (e.g., visual or tactile hallucinations or \\nillusions) with intact reality testing. There is no evidence of confusion and other \\ndiagnostic requirements for Delirium are not met. The withdrawal state is not \\naccompanied by seizures.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C40.42  Alcohol withdrawal with seizures  \\nAll diagnostic requirements for Alcohol withdrawal are met and the withdrawal state \\nis accompanied by seizures (i.e., generalised tonic -clonic seizures) but not by \\nperceptual disturbances.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C40.43  Alcohol withdrawal with perceptual disturbances and seizures  \\nAll diagnostic requirements for Alcohol withdrawal are met and the withdrawal state \\nis accompanied by both seizures (i.e., generalised tonic -clonic seizures) and \\nperceptual disturbances (e.g., v isual or tactile hallucinations or illusions) with intact \\nreality testing. Diagnostic requirements for Delirium are not met.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C40.4Z  Alcohol withdrawal, unspecified  \\nCoding Note:  Code also the causing condition  \\n ICD-11 MMS  459',\n",
       " '6C40.5  Alcohol -induced delirium  \\nAlcohol -induced delirium is characterised by an acute state of disturbed attention \\nand awareness with specific features of delirium that develops during or soon after \\nsubstance intoxication or withdrawal or during the use o f alcohol. The amount and \\nduration of alcohol use must be capable of producing delirium. Specific features of \\nalcohol -induced delirium may include impaired consciousness with disorientation, \\nvivid hallucinations and illusions, insomnia, delusions, agitatio n, disturbances of \\nattention, and accompanying tremor and physiological symptoms of alcohol \\nwithdrawal. In some cases of alcohol withdrawal, the withdrawal state may progress \\nto a very severe form of Alcohol -induced delirium. The symptoms are not better \\nexplained by a primary mental disorder, by use of or withdrawal from a different \\nsubstance, or by another health condition that is not classified under Mental, \\nbehavioural and neurodevelopmental disorders.  \\nCoding Note:  Code also the causing condition  \\nInclusi ons:  Delirium tremens (alcohol -induced)  \\nDelirium induced by alcohol withdrawal',\n",
       " '6C40.6  Alcohol -induced psychotic disorder  \\nAlcohol -induced psychotic disorder is characterised by psychotic symptoms (e.g. \\ndelusions, hallucinations, disorganised thinking, gros sly disorganised behaviour) \\nthat develop during or soon after intoxication with or withdrawal from alcohol. The \\nintensity or duration of the symptoms is substantially in excess of psychotic -like \\ndisturbances of perception, cognition, or behaviour that are characteristic of Alcohol \\nintoxication or Alcohol withdrawal. The amount and duration of alcohol use must be \\ncapable of producing psychotic symptoms. The symptoms are not better explained \\nby a primary mental disorder (e.g. Schizophrenia, a Mood disorder wi th psychotic \\nsymptoms), as might be the case if the psychotic symptoms preceded the onset of \\nthe alcohol use, if the symptoms persist for a substantial period of time after \\ncessation of the alcohol use or withdrawal, or if there is other evidence of a pre -\\nexisting primary mental disorder with psychotic symptoms (e.g. a history of prior \\nepisodes not associated with alcohol use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C40.60  Alcohol -induced psychotic disorder with hallucinations  \\nAlcohol -induced psycho tic disorder with hallucinations is characterised by the \\npresence of hallucinations that are judged to be the direct consequence of alcohol \\nuse. Neither delusions nor other psychotic symptoms are present. The symptoms \\ndo not occur exclusively during hypnog ogic or hypnopompic states, are not better \\naccounted for by another mental and behavioural disorder (e.g., schizophrenia), and \\nare not due to another disorder or disease classified elsewhere (e.g., epilepsies with \\nvisual symptoms).  \\nCoding Note:  Code also the causing condition  \\n 460  ICD-11 MMS',\n",
       " '6C40.61  Alcohol -induced psychotic disorder with delusions  \\nAlcohol -induced psychotic disorder with delusions is characterised by the presence \\nof delusions that are judged to be the direct consequence of alcohol use. Neither \\nhallucinations nor other psychotic symptoms are present. The symptoms do not \\noccur exclusively during hypnogogic or hypnopompic states, are not better \\naccounted for by another mental and behavioural disorder (e.g., schizophrenia), and \\nare not due to anothe r disorder or disease classified elsewhere (e.g., epilepsies with \\nvisual symptoms).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C40.62  Alcohol -induced psychotic disorder with mixed psychotic symptoms  \\nAlcohol -induced psychotic disorder with mixed psychot ic symptoms is characterised \\nby the presence of multiple psychotic symptoms, primarily hallucinations and \\ndelusions, when these are judged to be the direct consequence of alcohol use. The \\nsymptoms do not occur exclusively during hypnogogic or hypnopompic s tates, are \\nnot better accounted for by another mental and behavioural disorder (e.g., \\nschizophrenia), and are not due to another disorder or disease classified elsewhere \\n(e.g., epilepsies with visual symptoms).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C40.6Z  Alcohol -induced psychotic disorder, unspecified  \\nCoding Note:  Code also the causing condition',\n",
       " '6C40.7  Certain specified alcohol -induced mental or behavioural disorders  \\nCoding Note:  Code also the causing condition  \\nCoded Elsewhere:  Amnestic disorder due to use of alcohol (6D72.10)  \\nDementia due to use of alcohol (6D84.0)',\n",
       " '6C40.70  Alcohol -induced mood disorder  \\nAlcohol -induced mood disorder is characterised by mood symptoms (e.g., \\ndepressed or elevated mood, decreased engagement in plea surable activities, \\nincreased or decreased energy levels) that develop during or soon after intoxication \\nwith or withdrawal from alcohol. The intensity or duration of the symptoms is \\nsubstantially in excess of mood disturbances that are characteristic of A lcohol \\nintoxication or Alcohol withdrawal. The amount and duration of alcohol use must be \\ncapable of producing mood symptoms. The symptoms are not better explained by a \\nprimary mental disorder (e.g., a Depressive disorder, a Bipolar disorder, \\nSchizoaffecti ve disorder), as might be the case if the mood symptoms preceded the \\nonset of the alcohol use, if the symptoms persist for a substantial period of time \\nafter cessation of the alcohol use or withdrawal, or if there is other evidence of a \\npre-existing primar y mental disorder with mood symptoms (e.g., a history of prior \\nepisodes not associated with alcohol use).  \\nCoding Note:  Code also the causing condition  \\n ICD-11 MMS  461',\n",
       " '6C40.71  Alcohol -induced anxiety disorder  \\nAlcohol -induced anxiety disorder is characterised by anxiety sy mptoms (e.g., \\napprehension or worry, fear, physiological symptoms of excessive autonomic \\narousal, avoidance behaviour) that develop during or soon after intoxication with or \\nwithdrawal from alcohol. The intensity or duration of the symptoms is substantiall y in \\nexcess of anxiety symptoms that are characteristic of Alcohol intoxication or Alcohol \\nwithdrawal. The amount and duration of alcohol use must be capable of producing \\nanxiety symptoms. The symptoms are not better explained by a primary mental \\ndisorder (e.g., an Anxiety and Fear -Related Disorder, a Depressive Disorder with \\nprominent anxiety symptoms), as might be the case if the anxiety symptoms \\npreceded the onset of the alcohol use, if the symptoms persist for a substantial \\nperiod of time after cessatio n of the alcohol use or withdrawal, or if there is other \\nevidence of a pre -existing primary mental disorder with anxiety symptoms (e.g., a \\nhistory of prior episodes not associated with alcohol use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C40.Y  Othe r specified disorders due to use of alcohol',\n",
       " '6C40.Z  Disorders due to use of alcohol, unspecified',\n",
       " '6C41   Disorders due to use of cannabis  \\nDisorders due to use of cannabis are characterised by the pattern and \\nconsequences of cannabis use. Cannabis is the collective term for a range of \\npsychoactive preparations of the cannabis plant, Cannabis sativa, and related \\nspecies and hybrids. Cannabis contains cannabinoids, a class of diverse chemical \\ncompounds that act on endogenous cannabinoid receptors that modula te \\nneurotransmitter release in the brain. The principal psychoactive cannabinoid is δ -9-\\ntetrahydrocannabinol (THC). Cannabis is typically smoked in the form of the \\nflowering heads or leaves of the marijuana plant; tobacco is often mixed with \\ncannabis when smoked. There are also cannabis oils that are prepared from these \\nsame sources. These preparations vary considerably in their THC potency. \\nCannabis has predominantly central nervous system depressant effects and \\nproduces a characteristic euphoria that may be part of the presenting features of \\nCannabis Intoxication, which may also include impairment in cognitive and \\npsychomotor functioning. Cannabis has dependence -producing properties resulting \\nin Cannabis Dependence in some people and Cannabis Withdrawal wh en use is \\nreduced or discontinued. Cannabis is associated with a range of Cannabis -Induced \\nMental Disorders.  \\nExclusions:  Disorders due to use of synthetic cannabinoids (6C42)  \\nHazardous use of cannabis (QE11.1)  \\n 462  ICD-11 MMS',\n",
       " '6C41.0  Episode of harmful use of cannabis  \\nAn episode of use of cannabis that has caused damage to a person’s physical or \\nmental health or has resulted in behaviour leading to harm to the health of others. \\nHarm to health of the individual occurs due to one or more of the following: (1) \\nbehaviour relat ed to intoxication; (2) direct or secondary toxic effects on body \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including trauma, or mental disorder that \\nis directly attributable to behaviour due to cannabis intoxication on the part of the \\nperson to whom the diagnosis of single episode of harmful use applies. This \\ndiagnosis should not be made if the harm is attributed to a known pattern of \\ncannabis use.  \\nExclusions:  Cannabis depende nce (6C41.2)  \\nHarmful pattern of use of cannabis (6C41.1)',\n",
       " '6C41.1  Harmful pattern of use of cannabis  \\nA pattern of cannabis use that has caused damage to a person’s physical or mental \\nhealth or has resulted in behaviour leading to harm to the health of others. The \\npattern of cannabis use is evident over a period of at least 12 months if substance \\nuse is ep isodic or at least one month if use is continuous (i.e., daily or almost daily). \\nHarm to health of the individual occurs due to one or more of the following: (1) \\nbehaviour related to intoxication; (2) direct or secondary toxic effects on body \\norgans and sy stems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including trauma, or mental disorder that \\nis directly attributable to behaviour related to cannabis intoxication on the part of the \\nperson to whom  the diagnosis of Harmful pattern of use of cannabis applies.  \\nExclusions:  Cannabis dependence (6C41.2)  \\nEpisode of harmful use of cannabis (6C41.0)',\n",
       " '6C41.10  Harmful pattern of use of cannabis, episodic  \\nA pattern of episodic or intermittent cannabis use that has caused damage to a \\nperson’s physical or mental health or has resulted in behaviour leading to harm to \\nthe health of others. The pattern of episodic cannabis use is evident over a period of \\nat leas t 12 months. Harm to health of the individual occurs due to one or more of \\nthe following: (1) behaviour related to intoxication; (2) direct or secondary toxic \\neffects on body organs and systems; or (3) a harmful route of administration. Harm \\nto health of o thers includes any form of physical harm, including trauma, or mental \\ndisorder that is directly attributable to behaviour related to cannabis intoxication on \\nthe part of the person to whom the diagnosis of Harmful pattern of use of cannabis \\napplies.  \\nExclus ions:  Episode of harmful use of cannabis (6C41.0)  \\nCannabis dependence (6C41.2)  \\n ICD-11 MMS  463',\n",
       " '6C41.11  Harmful pattern of use of cannabis, continuous  \\nA pattern of continuous (daily or almost daily) cannabis use that has caused \\ndamage to a person’s physical or mental heal th or has resulted in behaviour leading \\nto harm to the health of others. The pattern of continuous cannabis use is evident \\nover a period of at least one month. Harm to health of the individual occurs due to \\none or more of the following: (1) behaviour relat ed to intoxication; (2) direct or \\nsecondary toxic effects on body organs and systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour related \\nto cannabis intoxication on the part of the person to whom the diagnosis of Harmful \\npattern of use of cannabis applies.  \\nExclusions:  Episode of harmful use of cannabis (6C41.0)  \\nCannabis dependence (6C41.2)',\n",
       " '6C41.1Z  Harmful pattern of us e of cannabis, unspecified',\n",
       " '6C41.2  Cannabis dependence  \\nCannabis dependence is a disorder of regulation of cannabis use arising from \\nrepeated or continuous use of cannabis. The characteristic feature is a strong \\ninternal drive to use cannabis, which is mani fested by impaired ability to control use, \\nincreasing priority given to use over other activities and persistence of use despite \\nharm or negative consequences. These experiences are often accompanied by a \\nsubjective sensation of urge or craving to use cann abis. Physiological features of \\ndependence may also be present, including tolerance to the effects of cannabis, \\nwithdrawal symptoms following cessation or reduction in use of cannabis, or \\nrepeated use of cannabis or pharmacologically similar substances to prevent or \\nalleviate withdrawal symptoms. The features of dependence are usually evident \\nover a period of at least 12 months but the diagnosis may be made if cannabis use \\nis continuous (daily or almost daily) for at least 3 months.  \\nExclusions:  Episode of h armful use of cannabis (6C41.0)  \\nHarmful pattern of use of cannabis (6C41.1)',\n",
       " '6C41.20  Cannabis dependence, current use  \\nCurrent cannabis dependence with use of cannabis within the past month.  \\nExclusions:  Episode of harmful use of cannabis (6C41.0)  \\nHarmful pa ttern of use of cannabis (6C41.1)',\n",
       " '6C41.21  Cannabis dependence, early full remission  \\nAfter a diagnosis of cannabis dependence, and often following a treatment episode \\nor other intervention (including self -help intervention), the individual has been \\nabstine nt from cannabis during a period lasting between 1 and 12 months.  \\nExclusions:  Episode of harmful use of cannabis (6C41.0)  \\nHarmful pattern of use of cannabis (6C41.1)  \\n 464  ICD-11 MMS',\n",
       " '6C41.22  Cannabis dependence, sustained partial remission  \\nAfter a diagnosis of cannabis dependence, and often following a treatment episode \\nor other intervention (including self -help intervention), there is a significant reduction \\nin cannabis consumption for more t han 12 months, such that even though cannabis \\nuse has occurred during this period, the definitional requirements for dependence \\nhave not been met.  \\nExclusions:  Episode of harmful use of cannabis (6C41.0)  \\nHarmful pattern of use of cannabis (6C41.1)',\n",
       " '6C41.23  Cannabis dependence, sustained full remission  \\nAfter a diagnosis of cannabis dependence, and often following a treatment episode \\nor other intervention (including self -intervention), the person has been abstinent \\nfrom cannabis for 12 months or longer.  \\nExclusions:  Episode of harmful use of cannabis (6C41 .0) \\nHarmful pattern of use of cannabis (6C41.1)',\n",
       " '6C41.2Z  Cannabis dependence, unspecified',\n",
       " '6C41.3  Cannabis intoxication  \\nCannabis intoxication is a clinically significant transient condition that develops \\nduring or shortly after the consumption of cannabis that is characterised by \\ndisturbances in consciousness, cognition, perception, affect, behaviour, or \\ncoordination. These disturbances are caused by the known pharmacological effects \\nof cannabis and their intensity is closely related to the amount of cannab is \\nconsumed. They are time -limited and abate as cannabis is cleared from the body. \\nPresenting features may include inappropriate euphoria, impaired attention, \\nimpaired judgment, perceptual alterations (such as the sensation of floating, altered \\nperception of time), changes in sociability, increased appetite, anxiety, \\nintensification of ordinary experiences, impaired short -term memory, and \\nsluggishness. Physical signs include conjunctival injection (red or bloodshot eyes) \\nand tachycardia.  \\nCoding Note:  Code a lso the causing condition  \\nInclusions:  \"Bad trips\" due to cannabinoids  \\nExclusions:  cannabinoid poisoning (NE60)  \\nPossession trance disorder (6B63)',\n",
       " '6C41.4  Cannabis withdrawal  \\nCannabis withdrawal is a clinically significant cluster of symptoms, behaviours \\nand/or physiological features, varying in degree of severity and duration, that occurs \\nupon cessation or reduction of use of cannabis in individuals who have developed \\nCannabis dependence or have used cannabis for a prolonged period or in large \\namounts. Prese nting features of Cannabis withdrawal may include irritability, anger \\nor aggressive behaviour, shakiness, insomnia, restlessness, anxiety, depressed or \\ndysphoric mood, decreased appetite and weight loss, headache, sweating or chills, \\nabdominal cramps and m uscle aches.  \\nCoding Note:  Code also the causing condition  \\n ICD-11 MMS  465',\n",
       " '6C41.5  Cannabis -induced delirium  \\nCannabis -induced delirium is characterised by an acute state of disturbed attention \\nand awareness with specific features of delirium that develops during or soon af ter \\nsubstance intoxication or withdrawal or during the use of cannabis. The amount and \\nduration of cannabis use must be capable of producing delirium. The symptoms are \\nnot better explained by a primary mental disorder, by use of or withdrawal from a \\ndiffer ent substance, or by another health condition that is not classified under \\nMental, behavioural and neurodevelopmental disorders.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C41.6  Cannabis -induced psychotic disorder  \\nCannabis -induced psychotic disorder is characterised by psychotic symptoms (e.g. \\ndelusions, hallucinations, disorganised thinking, grossly disorganised behaviour) \\nthat develop during or soon after intoxication with or withdrawal from cannabis. The \\nintensit y or duration of the symptoms is substantially in excess of psychotic -like \\ndisturbances of perception, cognition, or behaviour that are characteristic of \\nCannabis intoxication or Cannabis withdrawal. The amount and duration of \\ncannabis use must be capable of producing psychotic symptoms. The symptoms \\nare not better explained by a primary mental disorder (e.g. Schizophrenia, a Mood \\ndisorder with psychotic symptoms), as might be the case if the psychotic symptoms \\npreceded the onset of the cannabis use, if the  symptoms persist for a substantial \\nperiod of time after cessation of the cannabis use or withdrawal, or if there is other \\nevidence of a pre -existing primary mental disorder with psychotic symptoms (e.g. a \\nhistory of prior episodes not associated with cann abis use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C41.7  Certain specified cannabis -induced mental or behavioural disorders  \\nCoding Note:  Code also the causing condition',\n",
       " '6C41.70  Cannabis -induced mood disorder  \\nCannabis -induced mood disorder is charac terised by mood symptoms (e.g., \\ndepressed or elevated mood, decreased engagement in pleasurable activities, \\nincreased or decreased energy levels) that develop during or soon after intoxication \\nwith or withdrawal from cannabis. The intensity or duration of the symptoms is \\nsubstantially in excess of mood disturbances that are characteristic of Cannabis \\nintoxication or Cannabis withdrawal. The amount and duration of cannabis use must \\nbe capable of producing mood symptoms. The symptoms are not better explained \\nby a primary mental disorder (e.g., a Depressive disorder, a Bipolar disorder, \\nSchizoaffective disorder), as might be the case if the mood symptoms preceded the \\nonset of the cannabis use, if the symptoms persist for a substantial period of time \\nafter cessa tion of the cannabis use or withdrawal, or if there is other evidence of a \\npre-existing primary mental disorder with mood symptoms (e.g., a history of prior \\nepisodes not associated with cannabis use).  \\nCoding Note:  Code also the causing condition  \\n 466  ICD-11 MMS',\n",
       " '6C41.71  Cannabis -induced anxiety disorder  \\nCannabis -induced anxiety disorder is characterised by anxiety symptoms (e.g., \\napprehension or worry, fear, physiological symptoms of excessive autonomic \\narousal, avoidance behaviour) that develop during or soon after intoxi cation with or \\nwithdrawal from cannabis. The intensity or duration of the symptoms is substantially \\nin excess of anxiety symptoms that are characteristic of Cannabis intoxication or \\nCannabis withdrawal. The amount and duration of cannabis use must be capab le of \\nproducing anxiety symptoms. The symptoms are not better explained by a primary \\nmental disorder (e.g., an Anxiety and Fear -Related Disorder, a Depressive Disorder \\nwith prominent anxiety symptoms), as might be the case if the anxiety symptoms \\npreceded the onset of the cannabis use, if the symptoms persist for a substantial \\nperiod of time after cessation of the cannabis use or withdrawal, or if there is other \\nevidence of a pre -existing primary mental disorder with anxiety symptoms (e.g., a \\nhistory of pri or episodes not associated with cannabis use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C41.Y  Other specified disorders due to use of cannabis',\n",
       " '6C41.Z  Disorders due to use of cannabis, unspecified',\n",
       " '6C42   Disorders due to use of synthetic cannabinoids  \\nDisorders due to use of synthetic cannabinoids are characterised by the pattern and \\nconsequences of synthetic cannabinoid use. Synthetic cannabinoids are \\nsynthesized diverse chemical compounds that are potent agonists for endogenous \\ncannabinoid receptors. There are several hundred such compounds. The synthetic \\ncompound is typically sprayed onto a vehicle such as cannabis or tea leaves and \\nthen smoked. The effect of these compounds is distinctly different from s moking \\nnaturally cultivated cannabis in that the euphoric effects are typically accompanied \\nor dominated by psychotic -like symptoms (e.g., paranoia, hallucinations, and \\ndisorganized behavior). Synthetic Cannabinoid Intoxication may therefore present \\nmore f requently with psychotic symptoms in addition to the more typical effects of \\ncannabis. Synthetic cannabinoids are also dependence -producing and Synthetic \\nCannabinoid Dependence and Synthetic Cannabinoid Withdrawal are recognized. \\nSynthetic Cannabinoid -Induced Mental Disorders also occur; in particular Synthetic \\nCannabinoid -Induced Psychotic Disorder is recognized.  \\nExclusions:  Disorders due to use of cannabis (6C41)',\n",
       " '6C42.0  Episode of harmful use of synthetic cannabinoids  \\nAn episode of use of a synthetic can nabinoid that has caused damage to a person’s \\nphysical or mental health or has resulted in behaviour leading to harm to the health \\nof others. Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) behaviour related to intoxication ; (2) direct or secondary toxic effects \\non body organs and systems; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of physical harm, including trauma, or mental \\ndisorder that is directly attributable to behaviour due t o synthetic cannabinoid \\nintoxication on the part of the person to whom the diagnosis of single episode of \\nharmful use applies. This diagnosis should not be made if the harm is attributed to a \\nknown pattern of synthetic cannabinoid use.  \\nExclusions:  Harmful pattern of use of synthetic cannabinoids (6C42.1)  \\nSynthetic cannabinoid dependence (6C42.2)  \\n ICD-11 MMS  467',\n",
       " '6C42.1  Harmful pattern of use of synthetic cannabinoids  \\nA pattern of use of synthetic cannabinoids that has caused damage to a person’s \\nphysical or mental health or has resulted in behaviour leading to harm to the health \\nof others. The pattern of synthetic cannabinoid use is evident over a period of at \\nleast 12  months if substance use is episodic or at least one month if use is \\ncontinuous (i.e., daily or almost daily). Harm to health of the individual occurs due to \\none or more of the following: (1) behaviour related to intoxication; (2) direct or \\nsecondary toxic  effects on body organs and systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour related \\nto synthetic cannabinoid int oxication on the part of the person to whom the \\ndiagnosis of Harmful pattern of use of synthetic cannabinoids applies.  \\nExclusions:  Episode of harmful use of synthetic cannabinoids (6C42.0)  \\nSynthetic cannabinoid dependence (6C42.2)',\n",
       " '6C42.10  Harmful pattern of use of synthetic cannabinoids, episodic  \\nA pattern of episodic or intermittent use of synthetic cannabinoids that has caused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of episodic synthetic cannabinoid use is \\nevident over a period of at least 12 months. Harm to health of the individual occurs \\ndue to one or more of the following: (1) behaviour related to intoxication; (2) direct \\nor secondary toxic effects on body organs a nd systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour related \\nto synthetic cannabinoid intoxication on the part of the person to whom the \\ndiagnosis of Harmful pattern of use of synthetic cannabinoids applies.  \\nExclusions:  Episode of harmful use of synthetic cannabinoids (6C42.0)  \\nSynthetic cannabinoid dependence (6C42.2)',\n",
       " '6C42.11  Harmful pattern of use of synthetic canna binoids, continuous  \\nA pattern of continuous (daily or almost daily) use of synthetic cannabinoids that \\nhas caused damage to a person’s physical or mental health or has resulted in \\nbehaviour leading to harm to the health of others. The pattern of continuous  \\nsynthetic cannabinoid use is evident over a period of at least one month. Harm to \\nhealth of the individual occurs due to one or more of the following: (1) behaviour \\nrelated to intoxication; (2) direct or secondary toxic effects on body organs and \\nsystems;  or (3) a harmful route of administration. Harm to health of others includes \\nany form of physical harm, including trauma, or mental disorder that is directly \\nattributable to behaviour related to synthetic cannabinoid intoxication on the part of \\nthe person to whom the diagnosis of Harmful pattern of use of synthetic \\ncannabinoids applies.  \\nExclusions:  Episode of harmful use of synthetic cannabinoids (6C42.0)  \\nSynthetic cannabinoid dependence (6C42.2)',\n",
       " '6C42.1Y  Other specified harmful pattern of use of synthetic cannabinoids',\n",
       " '6C42.1Z  Harmful pattern of use of synthetic cannabinoids, unspecified  \\n 468  ICD-11 MMS',\n",
       " '6C42.2  Synthetic cannabinoid dependence  \\nSynthetic cannabinoid dependence is a disorder of regulation of synthetic \\ncannabinoid use arising from repeated or continuous use o f synthetic cannabinoids. \\nThe characteristic feature is a strong internal drive to use synthetic cannabinoids, \\nwhich is manifested by impaired ability to control use, increasing priority given to \\nuse over other activities and persistence of use despite har m or negative \\nconsequences. These experiences are often accompanied by a subjective \\nsensation of urge or craving to use synthetic cannabinoids. Physiological features of \\ndependence may also be present, including tolerance to the effects of synthetic \\ncannab inoids, withdrawal symptoms following cessation or reduction in use of \\nsynthetic cannabinoids, or repeated use of synthetic cannabinoids or \\npharmacologically similar substances to prevent or alleviate withdrawal symptoms. \\nThe features of dependence are usu ally evident over a period of at least 12 months \\nbut the diagnosis may be made if synthetic cannabinoid use is continuous (daily or \\nalmost daily) for at least 3 months.  \\nExclusions:  Episode of harmful use of synthetic cannabinoids (6C42.0)  \\nHarmful pattern o f use of synthetic cannabinoids (6C42.1)',\n",
       " '6C42.20  Synthetic cannabinoid dependence, current use  \\nCurrent synthetic cannabinoid dependence with use of synthetic cannabinoids \\nwithin the past month.  \\nExclusions:  Episode of harmful use of synthetic cannabinoids (6C42.0)  \\nHarmful pattern of use of synthetic cannabinoids (6C42.1)',\n",
       " '6C42.21  Synthetic cannabinoid dependence, early full remission  \\nAfter a diagnosis of synthetic cannabinoid dependence, and often following a \\ntreatment episode or other intervention (including self -help intervention), the \\nindividual has been abstinent from synthetic cannabinoid use during a period lasting \\nbetween 1 and 12 months.  \\nExclusions:  Episode of harmful use of synthetic cannabinoids (6C42.0)  \\nHarmful pattern of use of synthetic cannabinoids (6C42.1)',\n",
       " '6C42.22  Synthetic cannabinoid dependence, sustained partial remission  \\nAfter a diagnosis of synthetic cannabinoid dep endence, and often following a \\ntreatment episode or other intervention (including self -help intervention), there is a \\nsignificant reduction in synthetic cannabinoid consumption for more than 12 months, \\nsuch that even though synthetic cannabinoid use has oc curred during this period, \\nthe definitional requirements for dependence have not been met.  \\nExclusions:  Episode of harmful use of synthetic cannabinoids (6C42.0)  \\nHarmful pattern of use of synthetic cannabinoids (6C42.1)',\n",
       " '6C42.23  Synthetic cannabinoid depend ence, sustained full remission  \\nAfter a diagnosis of synthetic cannabinoid dependence, and often following a \\ntreatment episode or other intervention (including self -intervention), the person has \\nbeen abstinent from synthetic cannabinoid use for 12 months or  longer.  \\nExclusions:  Episode of harmful use of synthetic cannabinoids (6C42.0)  \\nHarmful pattern of use of synthetic cannabinoids (6C42.1)  \\n ICD-11 MMS  469',\n",
       " '6C42.2Y  Other specified synthetic cannabinoid dependence',\n",
       " '6C42.2Z  Synthetic cannabinoid dependence, unspecified',\n",
       " '6C42. 3 Synthetic cannabinoid intoxication  \\nSynthetic cannabinoid intoxication is a clinically significant transient condition that \\ndevelops during or shortly after the consumption of synthetic cannabinoids that is \\ncharacterised by disturbances in consciousness, cognition, perception, affect, \\nbehaviour, or coordination. These disturbances are caused by the known \\npharmacological effects of synthetic cannabinoids and their intensity is closely \\nrelated to the amount of synthetic cannabinoid consumed. They are time -limited and \\nabate as synthetic cannabinoid is cleared from the body. Presenting features may \\ninclude inappropriate euphoria, impaired attention, impaired judgment, perceptual \\nalterations (such as the sensation of floating, altered perception of time), change s in \\nsociability, increased appetite, anxiety, intensification of ordinary experiences, \\nimpaired short -term memory, and sluggishness. Physical signs include conjunctival \\ninjection (red or bloodshot eyes) and tachycardia. Intoxication with synthetic \\ncannabi noids may also cause delirium or acute psychosis.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C42.4  Synthetic cannabinoid withdrawal  \\nSynthetic cannabinoid withdrawal is a clinically significant cluster of symptoms, \\nbehaviours and/or physiological featur es, varying in degree of severity and duration, \\nthat occurs upon cessation or reduction of use of synthetic cannabinoids in \\nindividuals who have developed Synthetic cannabinoid dependence or have used \\nsynthetic cannabinoids for a prolonged period or in lar ge amounts. Presenting \\nfeatures of Synthetic cannabinoid withdrawal may include irritability, anger, \\naggression, shakiness, insomnia and disturbing dreams, restlessness, anxiety, \\ndepressed mood and appetite disturbance. In the early phase, Synthetic \\ncannab inoid withdrawal may be accompanied by residual features of intoxication \\nfrom the drug, such as paranoid ideation and auditory and visual hallucinations.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C42.5  Synthetic cannabinoid -induced delirium  \\nSynthetic cannabinoid -induced delirium is characterised by an acute state of \\ndisturbed attention and awareness with specific features of delirium that develops \\nduring or soon after substance intoxication or withdrawal  or during the use of \\nsynthetic cannabinoids. The amount and duration of synthetic cannabinoid use must \\nbe capable of producing delirium. The symptoms are not better explained by a \\nprimary mental disorder, by use of or withdrawal from a different substance , or by \\nanother health condition that is not classified under Mental, behavioural and \\nneurodevelopmental disorders.  \\nCoding Note:  Code also the causing condition  \\n 470  ICD-11 MMS',\n",
       " '6C42.6  Synthetic cannabinoid -induced psychotic disorder  \\nSynthetic cannabinoid -induced psychoti c disorder is characterised by psychotic \\nsymptoms (e.g., delusions, hallucinations, disorganised thinking, grossly \\ndisorganised behaviour) that develop during or soon after intoxication with or \\nwithdrawal from synthetic cannabinoids. The intensity or durat ion of the symptoms \\nis substantially in excess of psychotic -like disturbances of perception, cognition, or \\nbehaviour that are characteristic of Synthetic cannabinoid intoxication or Synthetic \\ncannabinoid withdrawal. The amount and duration of synthetic can nabinoid use \\nmust be capable of producing psychotic symptoms. The symptoms are not better \\nexplained by a primary mental disorder (e.g., Schizophrenia, a Mood disorder with \\npsychotic symptoms), as might be the case if the psychotic symptoms preceded the \\nonset of the synthetic cannabinoid use, if the symptoms persist for a substantial \\nperiod of time after cessation of the synthetic cannabinoid use or withdrawal, or if \\nthere is other evidence of a pre -existing primary mental disorder with psychotic \\nsymptoms (e .g., a history of prior episodes not associated with synthetic \\ncannabinoid use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C42.7  Certain specified synthetic cannabinoids -induced mental or behavioural \\ndisorders  \\nCoding Note:  Code also the causing condit ion',\n",
       " '6C42.70  Synthetic cannabinoid -induced mood disorder  \\nSynthetic cannabinoid -induced mood disorder is characterised by mood symptoms \\n(e.g., depressed or elevated mood, decreased engagement in pleasurable activities, \\nincreased or decreased energy levels) that develop during or soon after intoxication \\nwith or withdrawal from synthetic cannabinoids. The intensity or duration of the \\nsymptoms is substantially in excess of mood disturbances that are characteristic of \\nSynthetic cannabinoid intoxication or Synthe tic cannabinoid withdrawal. The amount \\nand duration of synthetic cannabinoid use must be capable of producing mood \\nsymptoms. The symptoms are not better explained by a primary mental disorder \\n(e.g., a Depressive disorder, a Bipolar disorder, Schizoaffectiv e disorder), as might \\nbe the case if the mood symptoms preceded the onset of the synthetic cannabinoid \\nuse, if the symptoms persist for a substantial period of time after cessation of the \\nsynthetic cannabinoid use or withdrawal, or if there is other eviden ce of a pre -\\nexisting primary mental disorder with mood symptoms (e.g., a history of prior \\nepisodes not associated with synthetic cannabinoid use).  \\nCoding Note:  Code also the causing condition  \\n ICD-11 MMS  471',\n",
       " '6C42.71  Synthetic cannabinoid -induced anxiety disorder  \\nSynthetic cannabinoid -induced anxiety disorder is characterised by anxiety \\nsymptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive \\nautonomic arousal, avoidance behaviour) that develop during or soon after \\nintoxication with or withdrawal from synthetic cannabinoids. The intensity or duration \\nof the symptoms is substantially in excess of anxiety symptoms that are \\ncharacteristic of Synthetic cannabinoid intoxication or Synthetic cannabinoi d \\nwithdrawal. The amount and duration of synthetic cannabinoid use must be capable \\nof producing anxiety symptoms. The symptoms are not better explained by a \\nprimary mental disorder (e.g., an Anxiety and Fear -Related Disorder, a Depressive \\nDisorder with pro minent anxiety symptoms), as might be the case if the anxiety \\nsymptoms preceded the onset of the synthetic cannabinoid use, if the symptoms \\npersist for a substantial period of time after cessation of the synthetic cannabinoid \\nuse or withdrawal, or if there  is other evidence of a pre -existing primary mental \\ndisorder with anxiety symptoms (e.g., a history of prior episodes not associated with \\nsynthetic cannabinoid use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C42.Y  Other specified disorders due to use of synthetic cannabinoids',\n",
       " '6C42.Z  Disorders due to use of synthetic cannabinoids, unspecified',\n",
       " '6C43   Disorders due to use of opioids  \\nDisorders due to use of opioids are characterised by the pattern and consequences \\nof opioid use. Opioids is a generic te rm that encompasses the constituents or \\nderivatives of the opium poppy Papaver somniferum as well as a range of synthetic \\nand semisynthetic compounds, some related to morphine and others chemically \\ndistinct but all having their primary actions on the µ opi oid receptor. Examples of \\nopioids include morphine, diacetylmorphine (heroin), fentanyl, pethidine, \\noxycodone, hydromorphone, methadone, buprenorphine, codeine and d -\\npropoxyphene. The opioids all have analgesic properties of different potencies and \\nare pri marily central nervous system depressants. They suppress respiration as well \\nas other vital functions and are a common cause of overdose and related deaths. \\nCertain opioids are used or administered parenterally, including heroin, a common \\nand potent opioid  that is primarily used non -medically. Therapeutic opioids are \\nprescribed for a range of indications worldwide, and are essential for pain \\nmanagement in cancer pain and palliative care, although they are also used for \\nnon-therapeutic reasons. In some count ries morbidity and mortality related to \\ntherapeutic opioids is greater than that related to heroin. All opioids may result in \\nOpioid Intoxication, Opioid Dependence and Opioid Withdrawal. A range of Opioid -\\nInduced Disorders occur, some of which occur follo wing Opioid Withdrawal.  \\nExclusions:  Hazardous use of opioids (QE11.0)  \\n 472  ICD-11 MMS',\n",
       " '6C43.0  Episode of harmful use of opioids  \\nAn episode of opioid use that has caused damage to a person’s physical or mental \\nhealth or has resulted in behaviour leading to harm to the health of others. Harm to \\nhealth of the individual occurs due to one or more of the following: (1) behaviour \\nrelated  to intoxication; (2) direct or secondary toxic effects on body organs and \\nsystems; or (3) a harmful route of administration. Harm to health of others includes \\nany form of physical harm, including trauma, or mental disorder that is directly \\nattributable to  behaviour due to opioid intoxication on the part of the person to \\nwhom the diagnosis of single episode of harmful use applies. This diagnosis should \\nnot be made if the harm is attributed to a known pattern of opioid use.  \\nExclusions:  Harmful pattern of use  of opioids (6C43.1)  \\nOpioid dependence (6C43.2)',\n",
       " '6C43.1  Harmful pattern of use of opioids  \\nA pattern of use of opioids that has caused damage to a person’s physical or mental \\nhealth or has resulted in behaviour leading to harm to the health of others. The \\npattern of opioid use is evident over a period of at least 12 months if substance use \\nis episodic or at least one month if use is continuous (i.e., daily or almost daily). \\nHarm to health of the individual occurs due to one or more of the following: (1) \\nbeha viour related to intoxication; (2) direct or secondary toxic effects on body \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including trauma, or mental disorder that \\nis directly at tributable to behaviour related to opioid intoxication on the part of the \\nperson to whom the diagnosis of Harmful pattern of use of opioids applies.  \\nExclusions:  Episode of harmful use of opioids (6C43.0)  \\nOpioid dependence (6C43.2)',\n",
       " '6C43.10  Harmful pattern of use of opioids, episodic  \\nA pattern of episodic or intermittent use of opioids that has caused damage to a \\nperson’s physical or mental health or has resulted in behaviour leading to harm to \\nthe health of others. The pattern of episodic opioid use is evid ent over a period of at \\nleast 12 months. Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effects \\non body organs and systems; or (3) a harmful route of adminis tration. Harm to \\nhealth of others includes any form of physical harm, including trauma, or mental \\ndisorder that is directly attributable to behaviour related to opioid intoxication on the \\npart of the person to whom the diagnosis of Harmful pattern of use o f opioids \\napplies.  \\nExclusions:  Episode of harmful use of opioids (6C43.0)  \\nOpioid dependence (6C43.2)  \\n ICD-11 MMS  473',\n",
       " '6C43.11  Harmful pattern of use of opioids, continuous  \\nA pattern of continuous (daily or almost daily) use of opioids that has caused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of continuous opioid use is evident over \\na period of at least one month. Harm to health of the individual occurs due to one or \\nmore of the following : (1) behaviour related to intoxication; (2) direct or secondary \\ntoxic effects on body organs and systems; or (3) a harmful route of administration. \\nHarm to health of others includes any form of physical harm, including trauma, or \\nmental disorder that is d irectly attributable to behaviour related to opioid intoxication \\non the part of the person to whom the diagnosis of Harmful pattern of use of opioids \\napplies.  \\nExclusions:  Episode of harmful use of opioids (6C43.0)  \\nOpioid dependence (6C43.2)',\n",
       " '6C43.1Z  Harmfu l pattern of use of opioids, unspecified',\n",
       " '6C43.2  Opioid dependence  \\nOpioid dependence is a disorder of regulation of opioid use arising from repeated or \\ncontinuous use of opioids. The characteristic feature is a strong internal drive to use \\nopioids, which i s manifested by impaired ability to control use, increasing priority \\ngiven to use over other activities and persistence of use despite harm or negative \\nconsequences. These experiences are often accompanied by a subjective \\nsensation of urge or craving to us e opioids. Physiological features of dependence \\nmay also be present, including tolerance to the effects of opioids, withdrawal \\nsymptoms following cessation or reduction in use of opioids, or repeated use of \\nopioids or pharmacologically similar substances t o prevent or alleviate withdrawal \\nsymptoms. The features of dependence are usually evident over a period of at least \\n12 months but the diagnosis may be made if opioid use is continuous (daily or \\nalmost daily) for at least 3 months.  \\nExclusions:  Episode of harmful use of opioids (6C43.0)  \\nHarmful pattern of use of opioids (6C43.1)',\n",
       " '6C43.20  Opioid dependence, current use  \\nOpioid dependence, with use of an opioid within the past month.  \\nExclusions:  Episode of harmful use of opioids (6C43.0)  \\nHarmful pattern of use of opioids (6C43.1)',\n",
       " '6C43.21  Opioid dependence, early full remission  \\nAfter a diagnosis of opioid dependence, and often following a treatment episode or \\nother intervention (including self -help intervention), the individual has been \\nabstinent from opioid use during a period lasting between 1 and 12 months.  \\nExclusions:  Episode of harmful use of opioids (6C43.0)  \\nHarmful pattern of use of opioids (6C43.1)  \\n 474  ICD-11 MMS',\n",
       " '6C43.22  Opioid dependence, sustained part ial remission  \\nAfter a diagnosis of Opioid dependence, and often following a treatment episode or \\nother intervention (including self -help intervention), there is a significant reduction in \\nopioid consumption for more than 12 months, such that even though op ioid use has \\noccurred during this period, the definitional requirements for dependence have not \\nbeen met.  \\nExclusions:  Episode of harmful use of opioids (6C43.0)  \\nHarmful pattern of use of opioids (6C43.1)',\n",
       " '6C43.23  Opioid dependence, sustained full remission  \\nAfter a diagnosis of Opioid dependence, and often following a treatment episode or \\nother intervention (including self -intervention), the person has been abstinent from \\nopioids for 12 months or longer.  \\nExclusions:  Episode of harmful use of opioids (6C43.0)  \\nHarmful pattern of use of opioids (6C43.1)',\n",
       " '6C43.2Z  Opioid dependence, unspecified',\n",
       " '6C43.3  Opioid intoxication  \\nOpioid intoxication is a clinically significant transient condition that develops during \\nor shortly after the consumption of opioids that is cha racterised by disturbances in \\nconsciousness, cognition, perception, affect, behaviour, or coordination. These \\ndisturbances are caused by the known pharmacological effects of opioids and their \\nintensity is closely related to the amount of opioids consumed. They are time -limited \\nand abate as opioids are cleared from the body. Presenting features may include \\nsomnolence, stupor, mood changes (e.g. euphoria followed by apathy and \\ndysphoria), psychomotor retardation, impaired judgment, respiratory depression, \\nslurred speech, and impairment of memory and attention. In severe intoxication \\ncoma may ensue. A characteristic physical sign is pupillary constriction but this sign \\nmay be absent when intoxication is due to synthetic opioids. Severe opioid \\nintoxication can l ead to death due to respiratory depression.  \\nCoding Note:  Code also the causing condition  \\nExclusions:  opioid poisoning (NE60)  \\nPossession trance disorder (6B63)  \\nfentanyl poisoning (NE60)  \\noxycodone poisoning (NE60)  \\n ICD-11 MMS  475',\n",
       " '6C43.4  Opioid withdrawal  \\nOpioid withdrawal is a clinically significant cluster of symptoms, behaviours and/or \\nphysiological features, varying in degree of severity and duration, that occurs upon \\ncessation or reduction of use of opioids in individuals who have developed Opioid \\ndepe ndence or have used opioids for a prolonged period or in large amounts. \\nOpioid withdrawal can also occur when prescribed opioids have been used in \\nstandard therapeutic doses. Presenting features of Opioid withdrawal may include \\ndysphoric mood, craving for an opioid, anxiety, nausea or vomiting, abdominal \\ncramps, muscle aches, yawning, perspiration, hot and cold flushes, lacrimation, \\nrhinorrhea, hypersomnia (typically in the initial phase) or insomnia, diarrhea, \\npiloerection, and pupillary dilatation.  \\nCoding  Note:  Code also the causing condition',\n",
       " '6C43.5  Opioid -induced delirium  \\nOpioid -induced delirium is characterised by an acute state of disturbed attention \\nand awareness with specific features of delirium that develops during or soon after \\nsubstance intoxicat ion or withdrawal or during the use of opioids. The amount and \\nduration of opioid use must be capable of producing delirium. The symptoms are \\nnot better explained by a primary mental disorder, by use of or withdrawal from a \\ndifferent substance, or by anoth er health condition that is not classified under \\nMental, Behavioural, and Neurodevelopmental Disorders.  \\nCoding Note:  Code also the causing condition  \\nInclusions:  Delirium induced by opioid withdrawal',\n",
       " '6C43.6  Opioid -induced psychotic disorder  \\nOpioid -induced psychotic disorder is characterised by psychotic symptoms (e.g. \\ndelusions, hallucinations, disorganised thinking, grossly disorganised behaviour) \\nthat develop during or soon after intoxication with or withdr awal from opioids. The \\nintensity or duration of the symptoms is substantially in excess of psychotic -like \\ndisturbances of perception, cognition, or behaviour that are characteristic of Opioid \\nintoxication or Opioid withdrawal. The amount and duration of op ioid use must be \\ncapable of producing psychotic symptoms. The symptoms are not better explained \\nby a primary mental disorder (e.g. Schizophrenia, a Mood disorder with psychotic \\nsymptoms), as might be the case if the psychotic symptoms preceded the onset of  \\nthe opioid use, if the symptoms persist for a substantial period of time after \\ncessation of the opioid use or withdrawal, or if there is other evidence of a pre -\\nexisting primary mental disorder with psychotic symptoms (e.g. a history of prior \\nepisodes not  associated with opioid use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C43.7  Certain specified opioid -induced mental or behavioural disorders  \\nCoding Note:  Code also the causing condition  \\n 476  ICD-11 MMS',\n",
       " '6C43.70  Opioid -induced mood disorder  \\nOpioid -induced mood disor der is characterised by mood symptoms (e.g., depressed \\nor elevated mood, decreased engagement in pleasurable activities, increased or \\ndecreased energy levels) that develop during or soon after intoxication with or \\nwithdrawal from opioids. The intensity or duration of the symptoms is substantially in \\nexcess of mood disturbances that are characteristic of Opioid intoxication or Opioid \\nwithdrawal. The amount and duration of opioid use must be capable of producing \\nmood symptoms. The symptoms are not better expl ained by a primary mental \\ndisorder (e.g., a Depressive disorder, a Bipolar disorder, Schizoaffective disorder), \\nas might be the case if the mood symptoms preceded the onset of the opioid use, if \\nthe symptoms persist for a substantial period of time after c essation of the opioid \\nuse or withdrawal, or if there is other evidence of a pre -existing primary mental \\ndisorder with mood symptoms (e.g., a history of prior episodes not associated with \\nopioid use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C43.71  Opioid -induced anxiety disorder  \\nOpioid -induced anxiety disorder is characterised by anxiety symptoms (e.g., \\napprehension or worry, fear, physiological symptoms of excessive autonomic \\narousal, avoidance behaviour) that develop during or soon after intoxicati on with or \\nwithdrawal from opioids. The intensity or duration of the symptoms is substantially in \\nexcess of anxiety symptoms that are characteristic of Opioid intoxication or Opioid \\nwithdrawal. The amount and duration of opioid use must be capable of produ cing \\nanxiety symptoms. The symptoms are not better explained by a primary mental \\ndisorder (e.g., an Anxiety and Fear -Related Disorder, a Depressive Disorder with \\nprominent anxiety symptoms), as might be the case if the anxiety symptoms \\npreceded the onset o f the opioid use, if the symptoms persist for a substantial \\nperiod of time after cessation of the opioid use or withdrawal, or if there is other \\nevidence of a pre -existing primary mental disorder with anxiety symptoms (e.g., a \\nhistory of prior episodes not  associated with opioid use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C43.Y  Other specified disorders due to use of opioids',\n",
       " '6C43.Z  Disorders due to use of opioids, unspecified',\n",
       " '6C44   Disorders due to use of sedatives, hypnotics or anxiolytics  \\nDisorders due to use of sedatives, hypnotics or anxiolytics are characterised by the \\npattern and consequences of use of these substances. Sedatives, hypnotics, and \\nanxiolytics are typically prescr ibed for the short -term treatment of anxiety or \\ninsomnia and are also employed to provide sedation for medical procedures. They \\ninclude the benzodiazepines and the non -benzodiazepine positive allosteric \\nmodulators of GABA receptors (i.e., ‘Z -drugs’) as wel l as many other compounds. \\nSedatives, hypnotics, and anxiolytics include barbiturates, which are available much \\nless commonly now than in previous decades. Sedatives, hypnotics, and anxiolytics \\nhave dependence -inducing properties that are related to the do se and duration of \\ntheir use. They may cause intoxication, dependence and withdrawal. Several other \\nmental disorders induced by sedatives, hypnotics, or anxiolytics are recognized.  \\nExclusions:  Hazardous use of sedatives, hypnotics or anxiolytics (QE11.2)  \\n ICD-11 MMS  477',\n",
       " '6C44.0  Episode of harmful use of sedatives, hypnotics or anxiolytics  \\nAn episode of use of a sedative, hypnotic or anxiolytic that has caused damage to a \\nperson’s physical or mental health or has resulted in behaviour leading to harm to \\nthe health of others . Harm to health of the individual occurs due to one or more of \\nthe following: (1) behaviour related to intoxication; (2) direct or secondary toxic \\neffects on body organs and systems; or (3) a harmful route of administration. Harm \\nto health of others inclu des any form of physical harm, including trauma, or mental \\ndisorder that is directly attributable to behaviour due to sedative, hypnotic or \\nanxiolytic intoxication on the part of the person to whom the diagnosis of single \\nepisode of harmful use applies. Th is diagnosis should not be made if the harm is \\nattributed to a known pattern of sedative, hypnotic or anxiolytic use.  \\nExclusions:  Sedative, hypnotic or anxiolytic dependence (6C44.2)  \\nHarmful pattern of use of sedatives, hypnotics or anxiolytics \\n(6C44.1)',\n",
       " '6C44.1  Harmful pattern of use of sedatives, hypnotics or anxiolytics  \\nA pattern of sedative, hypnotic, or anxiolytic use that has caused clinically \\nsignificant harm to a person’s physical or mental health or in which behaviour \\ninduced by sedatives, hypnotics  or anxiolytics has caused clinically significant harm \\nto the health of other people. The pattern of sedative, hypnotic, or anxiolytic use is \\nevident over a period of at least 12 months if use is episodic and at least one month \\nif use is continuous (i.e., daily or almost daily). Harm may be caused by the \\nintoxicating effects of sedatives, hypnotics or anxiolytics, the direct or secondary \\ntoxic effects on body organs and systems, or a harmful route of administration.  \\nExclusions:  Sedative, hypnotic or anxioly tic dependence (6C44.2)  \\nEpisode of harmful use of sedatives, hypnotics or anxiolytics \\n(6C44.0)',\n",
       " '6C44.10  Harmful pattern of use of sedatives, hypnotics or anxiolytics, episodic  \\nA pattern of episodic or intermittent use of sedatives, hypnotics or anxiolytics  that \\nhas caused clinically significant harm to a person’s physical or mental health or in \\nwhich behaviour induced by sedatives, hypnotics or anxiolytics has caused clinically \\nsignificant harm to the health of other people. The pattern of episodic or inter mittent \\nuse of sedatives, hypnotics or anxiolytics is evident over a period of at least 12 \\nmonths. Harm may be caused by the intoxicating effects of sedatives, hypnotics or \\nanxiolytics, the direct or secondary toxic effects on body organs and systems, or a  \\nharmful route of administration.  \\nExclusions:  Episode of harmful use of sedatives, hypnotics or anxiolytics \\n(6C44.0)  \\nSedative, hypnotic or anxiolytic dependence (6C44.2)  \\n 478  ICD-11 MMS',\n",
       " '6C44.11  Harmful pattern of use of sedatives, hypnotics or anxiolytics, continuous  \\nA pattern of continuous use of sedatives, hypnotics or anxiolytics (daily or almost \\ndaily) that has caused clinically significant harm to a person’s physical or mental \\nhealth or in w hich behaviour induced by sedatives, hypnotics or anxiolytics has \\ncaused clinically significant harm to the health of other people. The pattern of \\ncontinuous use of sedatives, hypnotics or anxiolytics is evident over a period of at \\nleast one month. Harm ma y be caused by the intoxicating effects of sedatives, \\nhypnotics or anxiolytics, the direct or secondary toxic effects on body organs and \\nsystems, or a harmful route of administration.  \\nExclusions:  Episode of harmful use of sedatives, hypnotics or anxiolytic s \\n(6C44.0)  \\nSedative, hypnotic or anxiolytic dependence (6C44.2)',\n",
       " '6C44.1Z  Harmful pattern of use of sedatives, hypnotics or anxiolytics, unspecified',\n",
       " '6C44.2  Sedative, hypnotic or anxiolytic dependence  \\nSedative, hypnotic or anxiolytic dependence is a disorde r of regulation of sedative \\nuse arising from repeated or continuous use of these substances. The characteristic \\nfeature is a strong internal drive to use sedatives, hypnotics, or anxiolytics, which is \\nmanifested by impaired ability to control use, increasi ng priority given to use over \\nother activities and persistence of use despite harm or negative consequences. \\nThese experiences are often accompanied by a subjective sensation of urge or \\ncraving to use these substances. Physiological features of dependence may also be \\npresent, including tolerance to the effects of sedatives, hypnotics or anxiolytics, \\nwithdrawal symptoms following cessation or reduction in use, or repeated use of \\nsedatives or pharmacologically similar substances to prevent or alleviate withdr awal \\nsymptoms. The features of dependence are usually evident over a period of at least \\n12 months but the diagnosis may be made if sedative use is continuous (daily or \\nalmost daily) for at least 3 months.  \\nExclusions:  Episode of harmful use of sedatives, hypnotics or anxiolytics \\n(6C44.0)  \\nHarmful pattern of use of sedatives, hypnotics or anxiolytics \\n(6C44.1)',\n",
       " '6C44.20  Sedative, hypnotic or anxiolytic dependence, current use  \\nCurrent Sedative, hypnotic or anxiolytic depende nce with use of a sedative, \\nhypnotic or anxiolytic drug within the past month.  \\nExclusions:  Episode of harmful use of sedatives, hypnotics or anxiolytics \\n(6C44.0)  \\nHarmful pattern of use of sedatives, hypnotics or anxiolytics \\n(6C44.1)  \\n ICD-11 MMS  479',\n",
       " '6C44.21  Sedative, hypn otic or anxiolytic dependence, early full remission  \\nAfter a diagnosis of Sedative, hypnotic or anxiolytic dependence, and often \\nfollowing a treatment episode or other intervention (including self -help intervention), \\nthe individual has been abstinent from s edatives, hypnotics or anxiolytics during a \\nperiod lasting between 1 and 12 months.  \\nExclusions:  Episode of harmful use of sedatives, hypnotics or anxiolytics \\n(6C44.0)  \\nHarmful pattern of use of sedatives, hypnotics or anxiolytics \\n(6C44.1)',\n",
       " '6C44.22  Sedative,  hypnotic or anxiolytic dependence, sustained partial remission  \\nAfter a diagnosis of Sedative, hypnotic or anxiolytic dependence, and often \\nfollowing a treatment episode or other intervention (including self -help intervention), \\nthere is a significant reduc tion in sedative, hypnotic or anxiolytic consumption for \\nmore than 12 months, such that even though sedative, hypnotic or anxiolytic use \\nhas occurred during this period, the definitional requirements for dependence have \\nnot been met.  \\nExclusions:  Episode of  harmful use of sedatives, hypnotics or anxiolytics \\n(6C44.0)  \\nHarmful pattern of use of sedatives, hypnotics or anxiolytics \\n(6C44.1)',\n",
       " '6C44.23  Sedative, hypnotic or anxiolytic dependence, sustained full remission  \\nAfter a diagnosis of sedative, hypnotic or an xiolytic dependence, and often following \\na treatment episode or other intervention (including self -intervention), the person \\nhas been abstinent from sedative, hypnotic or anxiolytic for 12 months or longer.  \\nExclusions:  Episode of harmful use of sedatives, hypnotics or anxiolytics \\n(6C44.0)  \\nHarmful pattern of use of sedatives, hypnotics or anxiolytics \\n(6C44.1)',\n",
       " '6C44.2Z  Sedative, hypnotic or anxiolytic dependence, unspecified  \\n 480  ICD-11 MMS',\n",
       " '6C44.3  Sedative, hypnotic or anxiolytic intoxication  \\nSedative, hypnotic or anxiolyti c intoxication is a clinically significant transient \\ncondition that develops during or shortly after the consumption of sedatives, \\nhypnotics or anxiolytics that is characterised by disturbances in consciousness, \\ncognition, perception, affect, behaviour, or  coordination. These disturbances are \\ncaused by the known pharmacological effects of sedatives, hypnotics or anxiolytics \\nand their intensity is closely related to the amount of sedatives, hypnotics or \\nanxiolytics consumed. They are time -limited and abate a s sedatives, hypnotics or \\nanxiolytics are cleared from the body. Presenting features may include somnolence, \\nimpaired judgment, inappropriate behavior (including sexual behavior or \\naggression), slurred speech, impaired motor coordination, unsteady gait, mo od \\nchanges, as well as impaired memory, attention and concentration. Nystagmus \\n(repetitive, uncontrolled eye movements) is a common physical sign. In severe \\ncases stupor or coma may occur.  \\nCoding Note:  Code also the causing condition  \\nInclusions:  \"Bad trips\" due to sedatives, hypnotics or anxiolytics  \\nExclusions:  sedative, hypnotic drugs and other CNS depressants \\npoisoning (NE60)  \\nPossession trance disorder (6B63)',\n",
       " '6C44.4  Sedative, hypnotic or anxiolytic withdrawal  \\nSedative, hypnotic or anxiolytic wi thdrawal is a clinically significant cluster of \\nsymptoms, behaviours and/or physiological features, varying in degree of severity \\nand duration, that occurs upon cessation or reduction of use of sedatives, hypnotics \\nor anxiolytics in individuals who have de veloped dependence or have used \\nsedatives, hypnotics or anxiolytics for a prolonged period or in large amounts. \\nSedative, hypnotic or anxiolytic withdrawal can also occur when prescribed \\nsedatives, hypnotics or anxiolytics have been used in standard therap eutic doses. \\nPresenting features of Sedative, hypnotic or anxiolytic withdrawal may include \\nanxiety, psychomotor agitation, insomnia, increased hand tremor, nausea or \\nvomiting, and transient visual, tactile or auditory illusions or hallucinations. There \\nmay be signs of autonomic hyperactivity (e.g., tachycardia, hypertension, sweating), \\nor postural hypotension. The withdrawal state may be complicated by seizures. \\nLess commonly, there may be progression to a more severe withdrawal state \\ncharacterised by conf usion and disorientation, delusions, and more prolonged \\nvisual, tactile or auditory hallucinations. In such cases, a separate diagnosis of \\nSedative, hypnotic, or anxiolytic -induced delirium should be assigned.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C44.40  Sedative, hypnotic or anxiolytic withdrawal, uncomplicated  \\nAll diagnostic requirements for Sedative, hypnotic or anxiolytic withdrawal are met \\nand the withdrawal state is not accompanied by perceptual disturbances or \\nseizures.  \\nCoding Note:  Code als o the causing condition  \\n ICD-11 MMS  481',\n",
       " '6C44.41  Sedative, hypnotic or anxiolytic withdrawal, with perceptual disturbances  \\nAll diagnostic requirements for Sedative, hypnotic or anxiolytic withdrawal are met \\nand the withdrawal state is accompanied by perceptual disturbance s (e.g., visual or \\ntactile hallucinations or illusions) with intact reality testing. There is no evidence of \\nconfusion and other diagnostic requirements for Delirium are not met. The \\nwithdrawal state is not accompanied by seizures.  \\nCoding Note:  Code also t he causing condition',\n",
       " '6C44.42  Sedative, hypnotic or anxiolytic withdrawal, with seizures  \\nAll diagnostic requirements for Sedative, hypnotic or anxiolytic withdrawal are met \\nand the withdrawal state is accompanied by seizures (i.e., generalised tonic -clonic  \\nseizures) but not by perceptual disturbances.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C44.43  Sedative, hypnotic or anxiolytic withdrawal, with perceptual disturbances and \\nseizures  \\nAll diagnostic requirements for Sedative, hypnotic or anxiolytic wit hdrawal are met \\nand the withdrawal state is accompanied by both seizures (i.e., generalised tonic -\\nclonic seizures) and perceptual disturbances (e.g., visual or tactile hallucinations or \\nillusions) with intact reality testing. Diagnostic requirements for De lirium are not met.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C44.4Z  Sedative, hypnotic or anxiolytic withdrawal, unspecified  \\nCoding Note:  Code also the causing condition',\n",
       " '6C44.5  Sedative, hypnotic or anxiolytic -induced delirium  \\nSedative, hypnotic or anxiolytic -induced delirium is characterised by an acute state \\nof disturbed attention and awareness with specific features of delirium that develops \\nduring or soon after substance intoxication or withdrawal or during the use of \\nsedati ves, hypnotics, or anxiolytics. Specific features of Sedative, hypnotic or \\nanxiolytic -induced delirium may include confusion and disorientation, paranoid \\ndelusions, and recurrent visual, tactile or auditory hallucinations. The amount and \\nduration of sedati ve, hypnotic, or anxiolytic use must be capable of producing \\ndelirium. The symptoms are not better explained by a primary mental disorder, by \\nuse of or withdrawal from a different substance, or by another health condition that \\nis not classified under Menta l, behavioural and neurodevelopmental disorders.  \\nCoding Note:  Code also the causing condition  \\nInclusions:  Delirium induced by sedative, hypnotic or anxiolytic withdrawal  \\n 482  ICD-11 MMS',\n",
       " '6C44.6  Sedative, hypnotic or anxiolytic -induced psychotic disorder  \\nSedative, hypnotic  or anxiolytic -induced psychotic disorder is characterised by \\npsychotic symptoms (e.g. delusions, hallucinations, disorganised thinking, grossly \\ndisorganised behaviour) that develop during or soon after intoxication with or \\nwithdrawal from sedatives, hypno tics or anxiolytics. The intensity or duration of the \\nsymptoms is substantially in excess of psychotic -like disturbances of perception, \\ncognition, or behaviour that are characteristic of intoxication or withdrawal due to \\nsedatives, hypnotics or anxiolytics . The amount and duration of sedative, hypnotic \\nor anxiolytic use must be capable of producing psychotic symptoms. The symptoms \\nare not better explained by a primary mental disorder (e.g. Schizophrenia, a Mood \\ndisorder with psychotic symptoms), as might be  the case if the psychotic symptoms \\npreceded the onset of the sedative, hypnotic or anxiolytic use, if the symptoms \\npersist for a substantial period of time after cessation of the sedative, hypnotic or \\nanxiolytic use or withdrawal, or if there is other evi dence of a pre -existing primary \\nmental disorder with psychotic symptoms (e.g. a history of prior episodes not \\nassociated with sedative, hypnotic or anxiolytic use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C44.7  Certain specified sedatives, hypnotics  or anxiolytic -induced mental or \\nbehavioural disorders  \\nCoding Note:  Code also the causing condition  \\nCoded Elsewhere:  Amnestic disorder due to use of sedatives, hypnotics or \\nanxiolytics (6D72.11)  \\nDementia due to use of sedatives, hypnotics or anxiolytics \\n(6D84.1)',\n",
       " '6C44.70  Sedative, hypnotic or anxiolytic -induced mood disorder  \\nSedative, hypnotic or anxiolytic -induced mood disorder is characterised by mood \\nsymptoms (e.g., depressed or elevated mood, decreased engagement in \\npleasurable activities, increased or decreased energy levels) that develop during or \\nsoon after intoxication with or withdrawal from sedatives, hypnotics or anxiolytics. \\nThe intensity or duration of the symptoms is substantially in excess of mood \\ndisturbances that are characteristic of intoxication or withdrawal due to sedatives, \\nhypnotics or anxiolytics. The amount and duration of sedative, hypnotic or anx iolytic \\nuse must be capable of producing mood symptoms. The symptoms are not better \\nexplained by a primary mental disorder (e.g., a Depressive disorder, a Bipolar \\ndisorder, Schizoaffective disorder), as might be the case if the mood symptoms \\npreceded the o nset of the sedative, hypnotic or anxiolytic use, if the symptoms \\npersist for a substantial period of time after cessation of the sedative, hypnotic or \\nanxiolytic use or withdrawal, or if there is other evidence of a pre -existing primary \\nmental disorder wi th mood symptoms (e.g., a history of prior episodes not \\nassociated with sedative, hypnotic or anxiolytic use).  \\nCoding Note:  Code also the causing condition  \\n ICD-11 MMS  483',\n",
       " '6C44.71  Sedative, hypnotic or anxiolytic -induced anxiety disorder  \\nSedative, hypnotic or anxiolytic -induced anxiety disorder is characterised by anxiety \\nsymptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive \\nautonomic arousal, avoidance behaviour) that develop during or soon after \\nintoxication with or withdrawal from sedatives, hypnotics or anxiolytics. The intensity \\nor duration of the symptoms is substantially in excess of anxiety symptoms that are \\ncharacteristic of intoxication or withdrawal due to sedatives, hypnotics or anxiolytics. \\nThe amount and duration of sedative, hypnot ic or anxiolytic use must be capable of \\nproducing anxiety symptoms. The symptoms are not better explained by a primary \\nmental disorder (e.g., an Anxiety and Fear -Related Disorder, a Depressive Disorder \\nwith prominent anxiety symptoms), as might be the case  if the anxiety symptoms \\npreceded the onset of the sedative, hypnotic or anxiolytic use, if the symptoms \\npersist for a substantial period of time after cessation of the sedative, hypnotic or \\nanxiolytic use or withdrawal, or if there is other evidence of a pre-existing primary \\nmental disorder with anxiety symptoms (e.g., a history of prior episodes not \\nassociated with sedative, hypnotic or anxiolytic use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C44.Y  Other specified disorders due to use of sedatives,  hypnotics or anxiolytics',\n",
       " '6C44.Z  Disorders due to use of sedatives, hypnotics or anxiolytics, unspecified',\n",
       " '6C45   Disorders due to use of cocaine  \\nDisorders due to use of cocaine are characterised by the pattern and consequences \\nof cocaine use. Cocaine i s a compound found in the leaves of the coca plant, \\nErythroxylum coca, which is indigenous to countries in northern regions of South \\nAmerica. Cocaine has a limited place in medical treatment as an anaesthetic and \\nvasoconstrictive agent. It is commonly used  illicitly and widely available across the \\nworld, where it is found in two main forms: cocaine hydrochloride and cocaine \\nfreebase (also known as ‘crack’). Cocaine is a central nervous system stimulant, \\nand Cocaine Intoxication typically includes a state of  euphoria and hyperactivity. \\nCocaine has potent dependence -producing properties and Cocaine Dependence is \\na common cause of morbidity and of clinical presentations. Cocaine Withdrawal has \\na characteristic course that includes lethargy and depressed mood. A  range of \\nCocaine -Induced Mental Disorders is described.  \\nExclusions:  Disorders due to use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46)  \\nHazardous use of cocaine (QE11.3)  \\n 484  ICD-11 MMS',\n",
       " '6C45.0  Episode of harmful use of cocaine  \\nAn episode of use of cocaine that has caused damage to a person’s physical or \\nmental health or has resulted in behaviour leading to harm to the health of others. \\nHarm to health of the individual occurs due to one or more o f the following: (1) \\nbehaviour related to intoxication; (2) direct or secondary toxic effects on body \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including trauma, or mental dis order that \\nis directly attributable to behaviour due to cocaine intoxication on the part of the \\nperson to whom the diagnosis of single episode of harmful use applies. This \\ndiagnosis should not be made if the harm is attributed to a known pattern of cocaine  \\nuse. \\nExclusions:  Cocaine dependence (6C45.2)  \\nHarmful pattern of use of cocaine (6C45.1)',\n",
       " '6C45.1  Harmful pattern of use of cocaine  \\nA pattern of use of cocaine that has caused damage to a person’s physical or \\nmental health or has resulted in behaviour leadi ng to harm to the health of others. \\nThe pattern of cocaine use is evident over a period of at least 12 months if \\nsubstance use is episodic or at least one month if use is continuous (i.e., daily or \\nalmost daily). Harm to health of the individual occurs due  to one or more of the \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effects \\non body organs and systems; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of physical harm, including trau ma, or mental \\ndisorder that is directly attributable to behaviour related to cocaine intoxication on \\nthe part of the person to whom the diagnosis of Harmful pattern of use of cocaine \\napplies.  \\nExclusions:  Cocaine dependence (6C45.2)  \\nEpisode of harmful use o f cocaine (6C45.0)',\n",
       " '6C45.10  Harmful pattern of use of cocaine, episodic  \\nA pattern of episodic or intermittent cocaine use that has caused damage to a \\nperson’s physical or mental health or has resulted in behaviour leading to harm to \\nthe health of others. T he pattern of episodic cocaine use is evident over a period of \\nat least 12 months. Harm to health of the individual occurs due to one or more of \\nthe following: (1) behaviour related to intoxication; (2) direct or secondary toxic \\neffects on body organs and systems; or (3) a harmful route of administration. Harm \\nto health of others includes any form of physical harm, including trauma, or mental \\ndisorder that is directly attributable to behaviour related to cocaine intoxication on \\nthe part of the person to who m the diagnosis of Harmful pattern of use of cocaine \\napplies.  \\nExclusions:  Episode of harmful use of cocaine (6C45.0)  \\nCocaine dependence (6C45.2)  \\n ICD-11 MMS  485',\n",
       " '6C45.11  Harmful pattern of use of cocaine, continuous  \\nA pattern of continuous (daily or almost daily) cocaine use that has caused damage \\nto a person’s physical or mental health or has resulted in behaviour leading to harm \\nto the health of others. The pattern of continuous cocaine use is evident over a \\nperiod of at least one month. Harm to health of the individual occurs due to one or \\nmore of the following: (1) behaviour related to intoxication; (2) direct or secondary \\ntoxic effects on body organs and systems; or (3) a harmful route of administration. \\nHarm to health of others includes any form of physical harm, incl uding trauma, or \\nmental disorder that is directly attributable to behaviour related to cocaine \\nintoxication on the part of the person to whom the diagnosis of Harmful pattern of \\nuse of cocaine applies.  \\nExclusions:  Episode of harmful use of cocaine (6C45.0)  \\nCocaine dependence (6C45.2)',\n",
       " '6C45.1Z  Harmful pattern of use of cocaine, unspecified',\n",
       " '6C45.2  Cocaine dependence  \\nCocaine dependence is a disorder of regulation of cocaine use arising from \\nrepeated or continuous use of cocaine. The characteristic feature is a strong \\ninternal drive to use cocaine, which is manifested by impaired ability to control use, \\nincreasing prior ity given to use over other activities and persistence of use despite \\nharm or negative consequences. These experiences are often accompanied by a \\nsubjective sensation of urge or craving to use cocaine. Physiological features of \\ndependence may also be prese nt, including tolerance to the effects of cocaine, \\nwithdrawal symptoms following cessation or reduction in use of cocaine, or \\nrepeated use of cocaine or pharmacologically similar substances to prevent or \\nalleviate withdrawal symptoms. The features of depen dence are usually evident \\nover a period of at least 12 months but the diagnosis may be made if cocaine use is \\ncontinuous (daily or almost daily) for at least 3 months.  \\nExclusions:  Episode of harmful use of cocaine (6C45.0)  \\nHarmful pattern of use of cocaine  (6C45.1)',\n",
       " '6C45.20  Cocaine dependence, current use  \\nCurrent cocaine dependence with cocaine use within the past month.  \\nExclusions:  Episode of harmful use of cocaine (6C45.0)  \\nHarmful pattern of use of cocaine (6C45.1)',\n",
       " '6C45.21  Cocaine dependence, early full remission  \\nAfter a diagnosis of Cocaine dependence, and often following a treatment episode \\nor other intervention (including self -help intervention), the individual has been \\nabstinent from cocaine during a period lasting between 1 and 12 months.  \\nExclusions:  Episode of harmful use of cocaine (6C45.0)  \\nHarmful pattern of use of cocaine (6C45.1)  \\n 486  ICD-11 MMS',\n",
       " '6C45.22  Cocaine dependence, sustained partial remission  \\nAfter a diagnosis of Cocaine dependence, and often following a treatment episode \\nor other intervention (including self -help intervention), there is a significant reduction \\nin cocaine consumption for more than 12 months, such that even though cocaine \\nuse has occurred during this period , the definitional requirements for dependence \\nhave not been met.  \\nExclusions:  Episode of harmful use of cocaine (6C45.0)  \\nHarmful pattern of use of cocaine (6C45.1)',\n",
       " '6C45.23  Cocaine dependence, sustained full remission  \\nAfter a diagnosis of cocaine dependenc e, and often following a treatment episode \\nor other intervention (including self -intervention), the person has been abstinent \\nfrom cocaine for 12 months or longer.  \\nExclusions:  Episode of harmful use of cocaine (6C45.0)  \\nHarmful pattern of use of cocaine (6C 45.1)',\n",
       " '6C45.2Z  Cocaine dependence, unspecified',\n",
       " '6C45.3  Cocaine intoxication  \\nCocaine intoxication is a clinically significant transient condition that develops during \\nor shortly after the consumption of cocaine that is characterised by disturbances in \\nconsc iousness, cognition, perception, affect, behaviour, or coordination. These \\ndisturbances are caused by the known pharmacological effects of cocaine and their \\nintensity is closely related to the amount of cocaine consumed. They are time -\\nlimited and abate as cocaine is cleared from the body. Presenting features may \\ninclude inappropriate euphoria, anxiety, anger, impaired attention, hypervigilance, \\npsychomotor agitation, paranoid ideation (sometimes of delusional intensity), \\nauditory hallucinations, confusion, and changes in sociability. Perspiration or chills, \\nnausea or vomiting, and palpitations and chest pain may be experienced. Physical \\nsigns may include tachycardia, elevated blood pressure, and pupillary dilatation. In \\nrare instances, usually in severe into xication, cocaine use can result in seizures, \\nmuscle weakness, dyskinesia, or dystonia.  \\nCoding Note:  Code also the causing condition  \\nExclusions:  cocaine poisoning (NE60)  \\nPossession trance disorder (6B63)',\n",
       " '6C45.4  Cocaine withdrawal  \\nCocaine withdrawal is a clinically significant cluster of symptoms, behaviours and/or \\nphysiological features, varying in degree of severity and duration, that occurs upon \\ncessation or reduction of use of cocaine in individuals who have developed Cocaine \\ndependence or have used cocaine for a prolonged period or in large amounts. \\nPresenting features of Cocaine withdrawal may include dysphoric mood, irritability, \\nfatigue, psychomotor retardation, vivid unpleasant dreams, insomnia or \\nhypersomnia, increased appe tite, anxiety, psychomotor agitation or retardation, and \\ncraving for cocaine.  \\nCoding Note:  Code also the causing condition  \\n ICD-11 MMS  487',\n",
       " '6C45.5  Cocaine -induced delirium  \\nCocaine -induced delirium is characterised by an acute state of disturbed attention \\nand awareness with specific features of delirium that develops during or soon after \\nsubstance intoxication or withdrawal or during the use of cocaine. The amount and \\nduratio n of cocaine use must be capable of producing delirium. The symptoms are \\nnot better explained by a primary mental disorder, by use of or withdrawal from a \\ndifferent substance, or by another health condition that is not classified under \\nMental, behavioural,  and neurodevelopmental disorders.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C45.6  Cocaine -induced psychotic disorder  \\nCocaine -induced psychotic disorder is characterised by psychotic symptoms (e.g. \\ndelusions, hallucinations, disorganised thinking, gro ssly disorganised behaviour) \\nthat develop during or soon after intoxication with or withdrawal from cocaine. The \\nintensity or duration of the symptoms is substantially in excess of psychotic -like \\ndisturbances of perception, cognition, or behaviour that are  characteristic of \\nCocaine intoxication or Cocaine withdrawal. The amount and duration of cocaine \\nuse must be capable of producing psychotic symptoms. The symptoms are not \\nbetter explained by a primary mental disorder (e.g. Schizophrenia, a Mood disorder \\nwith psychotic symptoms), as might be the case if the psychotic symptoms \\npreceded the onset of the cocaine use, if the symptoms persist for a substantial \\nperiod of time after cessation of the cocaine use or withdrawal, or if there is other \\nevidence of a pre -existing primary mental disorder with psychotic symptoms (e.g. a \\nhistory of prior episodes not associated with cocaine use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C45.60  Cocaine -induced psychotic disorder with hallucinations  \\nCocaine -induced psych otic disorder with hallucinations is characterised by the \\npresence of hallucinations that are judged to be the direct consequence of cocaine \\nuse. Neither delusions nor other psychotic symptoms are present. The symptoms \\ndo not occur exclusively during hypno gogic or hypnopompic states, are not better \\naccounted for by another mental and behavioural disorder (e.g., schizophrenia), and \\nare not due to another disorder or disease classified elsewhere (e.g., epilepsies with \\nvisual symptoms).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C45.61  Cocaine -induced psychotic disorder with delusions  \\nCocaine -induced psychotic disorder with delusions is characterised by the by the \\npresence of delusions that are judged to be the direct consequence of cocaine use. \\nNeither hal lucinations nor other psychotic symptoms are present. The symptoms do \\nnot occur exclusively during hypnogogic or hypnopompic states, are not better \\naccounted for by another mental and behavioural disorder (e.g., schizophrenia), and \\nare not due to another d isorder or disease classified elsewhere (e.g., epilepsies with \\nvisual symptoms).  \\nCoding Note:  Code also the causing condition  \\n 488  ICD-11 MMS',\n",
       " '6C45.62  Cocaine -induced psychotic disorder with mixed psychotic symptoms  \\nCocaine -induced psychotic disorder with mixed psychotic symptoms is \\ncharacterised by the presence of multiple psychotic symptoms, primarily \\nhallucinations and delusions, when these are judged to be the direct consequence \\nof cocaine use. The symptoms do not occur exclusively during hypnogogic or \\nhypnopompic stat es, are not better accounted for by another mental and \\nbehavioural disorder (e.g., Schizophrenia), and are not due to another disorder or \\ndisease classified elsewhere (e.g., epilepsies with visual symptoms).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C45.6Z  Cocaine -induced psychotic disorder, unspecified  \\nCoding Note:  Code also the causing condition',\n",
       " '6C45.7  Certain specified cocaine -induced mental or behavioural disorders  \\nCoding Note:  Code also the causing condition',\n",
       " '6C45.70  Cocaine -induced mood disorder  \\nCocaine -induced mood disorder is characterised by mood symptoms (e.g., \\ndepressed or elevated mood, decreased engagement in pleasurable activities, \\nincreased or decreased energy levels) that develop during or soon after intoxic ation \\nwith or withdrawal from cocaine. The intensity or duration of the symptoms is \\nsubstantially in excess of mood disturbances that are characteristic of Cocaine \\nintoxication or Cocaine withdrawal. The amount and duration of cocaine use must \\nbe capable o f producing mood symptoms. The symptoms are not better explained \\nby a primary mental disorder (e.g., a Depressive disorder, a Bipolar disorder, \\nSchizoaffective disorder), as might be the case if the mood symptoms preceded the \\nonset of the cocaine use, if t he symptoms persist for a substantial period of time \\nafter cessation of the cocaine use or withdrawal, or if there is other evidence of a \\npre-existing primary mental disorder with mood symptoms (e.g., a history of prior \\nepisodes not associated with cocaine  use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C45.71  Cocaine -induced anxiety disorder  \\nCocaine -induced anxiety disorder is characterised by anxiety symptoms (e.g., \\napprehension or worry, fear, physiological symptoms of excessive autonomic \\narousal, a voidance behaviour) that develop during or soon after intoxication with or \\nwithdrawal from cocaine. The intensity or duration of the symptoms is substantially \\nin excess of anxiety symptoms that are characteristic of Cocaine intoxication or \\nCocaine withdraw al. The amount and duration of cocaine use must be capable of \\nproducing anxiety symptoms. The symptoms are not better explained by a primary \\nmental disorder (e.g., an Anxiety and fear -related disorder, a Depressive disorder \\nwith prominent anxiety symptoms) , as might be the case if the anxiety symptoms \\npreceded the onset of the cocaine use, if the symptoms persist for a substantial \\nperiod of time after cessation of the cocaine use or withdrawal, or if there is other \\nevidence of a pre -existing primary mental disorder with anxiety symptoms (e.g., a \\nhistory of prior episodes not associated with cocaine use).  \\nCoding Note:  Code also the causing condition  \\n ICD-11 MMS  489',\n",
       " '6C45.72  Cocaine -induced obsessive -compulsive or related disorder  \\nCocaine -induced obsessive -compulsive or relat ed disorder is characterised by \\neither repetitive intrusive thoughts or preoccupations, normally associated with \\nanxiety and typically accompanied by repetitive behaviours performed in response, \\nor by recurrent and habitual actions directed at the integume nt (e.g., hair pulling, \\nskin picking) that develop during or soon after intoxication with or withdrawal from \\ncocaine. The intensity or duration of the symptoms is substantially in excess of \\nanalogous disturbances that are characteristic of Cocaine intoxica tion or Cocaine \\nwithdrawal. The amount and duration of cocaine use must be capable of producing \\nobsessive -compulsive or related symptoms. The symptoms are not better explained \\nby a primary mental disorder (in particular an Obsessive -compulsive or related \\ndisorder), as might be the case if the symptoms preceded the onset of the cocaine \\nuse, if the symptoms persist for a substantial period of time after cessation of the \\ncocaine use or withdrawal, or if there is other evidence of a pre -existing primary \\nmental disorder with obsessive -compulsive or related symptoms (e.g., a history of \\nprior episodes not associated with cocaine use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C45.73  Cocaine -induced impulse control disorder  \\nCocaine -induced impulse control disor der is characterised by persistently repeated \\nbehaviours in which there is recurrent failure to resist an impulse, drive, or urge to \\nperform an act that is rewarding to the person, at least in the short -term, despite \\nlonger -term harm either to the individu al or to others (e.g., fire setting or stealing \\nwithout apparent motive, repetitive sexual behaviour, aggressive outbursts) that \\ndevelop during or soon after intoxication with or withdrawal from cocaine. The \\nintensity or duration of the symptoms is substan tially in excess of disturbances of \\nimpulse control that are characteristic of Cocaine intoxication or Cocaine \\nwithdrawal. The amount and duration of cocaine use must be capable of producing \\ndisturbances of impulse control. The symptoms are not better expl ained by a \\nprimary mental disorder (e.g., an Impulse control disorder, a Disorder due to \\naddictive behaviours), as might be the case if the impulse control disturbances \\npreceded the onset of the cocaine use, if the symptoms persist for a substantial \\nperiod  of time after cessation of the cocaine use or withdrawal, or if there is other \\nevidence of a pre -existing primary mental disorder with impulse control symptoms \\n(e.g., a history of prior episodes not associated with cocaine use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C45.Y  Other specified disorders due to use of cocaine',\n",
       " '6C45.Z  Disorders due to use of cocaine, unspecified  \\n 490  ICD-11 MMS',\n",
       " '6C46   Disorders due to use of stimulants including amphetamines, \\nmethamphetamine or methcathinone  \\nDisorders due  to use of stimulants including amphetamines, methamphetamine or \\nmethcathinone are characterised by the pattern and consequences of use of these \\nsubstances. There is a wide array of naturally occurring and synthetically produced \\npsychostimulants other than  cocaine. The most numerous of this group are the \\namphetamine -type substances, including methamphetamine. Prescribed stimulants \\nincluding dexamphetamine are indicated for a limited number of conditions such as \\nfor Attention Deficit Hyperactivity Disorder. Methcathinone, known in many countries \\nas ephedrone, is a synthetic potent stimulant that is a structural analogue of \\nmethamphetamine and is related to cathinone. All these drugs have primarily \\npsychostimulant properties and are also vasoconstrictors to a varying degree. They \\ninduce euphoria and hyperactivity as may be seen in Stimulant Intoxication. They \\nhave potent dependence -producing properties, which may lead to the diagnosis of \\nStimulant Dependence and Stimulant Withdrawal following the cessation of u se. \\nSeveral Stimulant -Induced Mental Disorders are described.  \\nExclusions:  Disorders due to use of synthetic cathinones (6C47)  \\nDisorders due to use of caffeine (6C48)  \\nDisorders due to use of cocaine (6C45)  \\nHazardous use of stimulants including amphetamines or \\nmethamphetamine (QE11.4)',\n",
       " '6C46.0  Episode of harmful use of stimulants including amphetamines, \\nmethamphetamine or methcathinone  \\nAn episode of use of a stimulant including amphetamines, methamphetamine an d \\nmethcathinone that has caused damage to a person’s physical or mental health or \\nhas resulted in behaviour leading to harm to the health of others. Harm to health of \\nthe individual occurs due to one or more of the following: (1) behaviour related to \\nintox ication; (2) direct or secondary toxic effects on body organs and systems; or (3) \\na harmful route of administration. Harm to health of others includes any form of \\nphysical harm, including trauma, or mental disorder that is directly attributable to \\nbehaviou r due to stimulant intoxication on the part of the person to whom the \\ndiagnosis of single episode of harmful use applies. This diagnosis should not be \\nmade if the harm is attributed to a known pattern of stimulant including \\namphetamines, methamphetamine an d methcathinone use.  \\nExclusions:  Harmful pattern of use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46.1)  \\nStimulant dependence including amphetamines, \\nmethamphetamine or methcathinone (6C46.2)  \\n ICD-11 MMS  491',\n",
       " '6C46.1  Harmful pattern of use of  stimulants including amphetamines, \\nmethamphetamine or methcathinone  \\nA pattern of use of stimulants including amphetamines, methamphetamine and \\nmethcathinone but excluding caffeine, cocaine and synthetic cathinones that has \\ncaused damage to a person’s phys ical or mental health or has resulted in behaviour \\nleading to harm to the health of others. The pattern of stimulant use is evident over \\na period of at least 12 months if substance use is episodic or at least one month if \\nuse is continuous. Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effects \\non body organs and systems; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of p hysical harm, including trauma, or mental \\ndisorder that is directly attributable to behaviour related to stimulant intoxication on \\nthe part of the person to whom the diagnosis of Harmful pattern of use of stimulants \\nincluding amphetamines, methamphetamine and methcathinone applies.  \\nExclusions:  Harmful pattern of use of caffeine (6C48.1)  \\nHarmful pattern of use of cocaine (6C45.1)  \\nHarmful pattern of use of synthetic cathinones (6C47.1)  \\nEpisode of harmful use of stimulants including amphetamines, \\nmethamphetami ne or methcathinone (6C46.0)  \\nStimulant dependence including amphetamines, \\nmethamphetamine or methcathinone (6C46.2)',\n",
       " '6C46.10  Harmful pattern of use of stimulants including amphetamines, methamphetamine or \\nmethcathinone, episodic  \\nA pattern of episodic or in termittent use of stimulants including amphetamines, \\nmethamphetamine and methcathinone but excluding caffeine, cocaine and synthetic \\ncathinones that has caused damage to a person’s physical or mental health or has \\nresulted in behaviour leading to harm to t he health of others. The pattern of episodic \\nstimulant use is evident over a period of at least 12 months. Harm to health of the \\nindividual occurs due to one or more of the following: (1) behaviour related to \\nintoxication; (2) direct or secondary toxic eff ects on body organs and systems; or (3) \\na harmful route of administration. Harm to health of others includes any form of \\nphysical harm, including trauma, or mental disorder that is directly attributable to \\nbehaviour related to stimulant intoxication on the  part of the person to whom the \\ndiagnosis of Harmful pattern of use of stimulants including amphetamines, \\nmethamphetamine and methcathinone applies.  \\nExclusions:  Episode of harmful use of stimulants including amphetamines, \\nmethamphetamine or methcathinone ( 6C46.0)  \\nStimulant dependence including amphetamines, \\nmethamphetamine or methcathinone (6C46.2)  \\n 492  ICD-11 MMS',\n",
       " '6C46.11  Harmful pattern of use of stimulants including amphetamines, methamphetamine or \\nmethcathinone, continuous  \\nA pattern of use of stimulants including amphe tamines, methamphetamine and \\nmethcathinone but excluding caffeine, cocaine and synthetic cathinones that has \\ncaused damage to a person’s physical or mental health or has resulted in behaviour \\nleading to harm to the health of others. The pattern of stimulan t use is evident over \\na period of at least 12 months if substance use is episodic or at least one month if \\nuse is continuous (i.e., daily or almost daily). Harm to health of the individual occurs \\ndue to one or more of the following: (1) behaviour related t o intoxication; (2) direct \\nor secondary toxic effects on body organs and systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to b ehaviour related \\nto stimulant intoxication on the part of the person to whom the diagnosis of Harmful \\npattern of use of stimulants including amphetamines, methamphetamine and \\nmethcathinone applies.  \\nExclusions:  Episode of harmful use of stimulants including  amphetamines, \\nmethamphetamine or methcathinone (6C46.0)  \\nStimulant dependence including amphetamines, \\nmethamphetamine or methcathinone (6C46.2)',\n",
       " '6C46.1Z  Harmful pattern of use of stimulants including amphetamines, methamphetamine \\nand methcathinone, unspeci fied',\n",
       " '6C46.2  Stimulant dependence including amphetamines, methamphetamine or \\nmethcathinone  \\nStimulant dependence including amphetamines, methamphetamine or \\nmethcathinone is a disorder of regulation of stimulant use arising from repeated or \\ncontinuous use of stimulants. The characteristic feature is a strong internal drive to \\nuse stimulants, which  is manifested by impaired ability to control use, increasing \\npriority given to use over other activities and persistence of use despite harm or \\nnegative consequences. These experiences are often accompanied by a subjective \\nsensation of urge or craving to use stimulants. Physiological features of \\ndependence may also be present, including tolerance to the effects of stimulants, \\nwithdrawal symptoms following cessation or reduction in use of stimulants, or \\nrepeated use of stimulants or pharmacologically simila r substances to prevent or \\nalleviate withdrawal symptoms. The features of dependence are usually evident \\nover a period of at least 12 months but the diagnosis may be made if stimulant use \\nis continuous (daily or almost daily) for at least 3 months.  \\nExclusions:  Cocaine dependence (6C45.2)  \\nSynthetic cathinone dependence (6C47.2)  \\nEpisode of harmful use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46.0)  \\nHarmful pattern of use of stimulants including amphetamines, \\nmethamphetam ine or methcathinone (6C46.1)  \\n ICD-11 MMS  493',\n",
       " '6C46.20  Stimulant dependence including amphetamines, methamphetamine or \\nmethcathinone, current use  \\nStimulant dependence including amphetamines, methamphetamine and \\nmethcathinone but excluding caffeine, cocaine and synthetic c athinones refers to \\namphetamine or other stimulant use within the past month.  \\nExclusions:  Harmful pattern of use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46.1)  \\nEpisode of harmful use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46.0)',\n",
       " '6C46.21  Stimulant dependence including amphetamines, methamphetamine or \\nmethcathinone, early full remission  \\nAfter a diagnosis of Stimulant dependence including amphetamines, \\nmethamphetamine and methcathinone but exc luding caffeine, cocaine and synthetic \\ncathinones, and often following a treatment episode or other intervention (including \\nself-help intervention), the individual has been abstinent from stimulants during a \\nperiod lasting between 1 and 12 months.  \\nExclusio ns: Episode of harmful use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46.0)  \\nHarmful pattern of use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46.1)',\n",
       " '6C46.22  Stimulant dependence including amphet amines, methamphetamine or \\nmethcathinone, sustained partial remission  \\nAfter a diagnosis of Stimulant dependence including amphetamines, \\nmethamphetamine and methcathinone but excluding caffeine, cocaine and synthetic \\ncathinones, and often following a treatm ent episode or other intervention (including \\nself-help intervention), there is a significant reduction in amphetamine or other \\nstimulant consumption for more than 12 months, such that even though \\namphetamine or other stimulant use has occurred during this period, the definitional \\nrequirements for dependence have not been met.  \\nExclusions:  Episode of harmful use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46.0)  \\nHarmful pattern of use of stimulants including amphetamines, \\nmethamph etamine or methcathinone (6C46.1)',\n",
       " '6C46.23  Stimulant dependence including amphetamines, methamphetamine or \\nmethcathinone, sustained full remission  \\nAfter a diagnosis of Stimulant dependence including amphetamines, \\nmethamphetamine and methcathinone but exclu ding caffeine, cocaine and synthetic \\ncathinones, and often following a treatment episode or other intervention (including \\nself-intervention), the person has been abstinent from amphetamine or other \\nstimulants for 12 months or longer.  \\nExclusions:  Episode of  harmful use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46.0)  \\nHarmful pattern of use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46.1)',\n",
       " '6C46.2Z  Stimulant dependence including amphetamines, metham phetamine or \\nmethcathinone, unspecified  \\n 494  ICD-11 MMS',\n",
       " '6C46.3  Stimulant intoxication including amphetamines, methamphetamine or \\nmethcathinone  \\nStimulant intoxication including amphetamines, methamphetamine and \\nmethcathinone but excluding caffeine, cocaine and synthetic cathinones is a \\nclinically significant transient condition that develops during or shortly after the \\nconsumption of amphetamine o r other stimulants that is characterised by \\ndisturbances in consciousness, cognition, perception, affect, behaviour, or \\ncoordination. These disturbances are caused by the known pharmacological effects \\nof amphetamine or other stimulants and their intensity is closely related to the \\namount of amphetamine or other stimulant consumed. They are time -limited and \\nabate as amphetamine or another stimulant is cleared from the body. Presenting \\nfeatures may include anxiety, anger, impaired attention, hypervigilance, \\npsychomotor agitation, paranoid ideation (possibly of delusional intensity), transient \\nauditory hallucinations, transitory confusion, and changes in sociability. Perspiration \\nor chills, nausea or vomiting, and palpitations may be experienced. Physical signs  \\nmay include tachycardia, elevated blood pressure, pupillary dilatation, dyskinesias \\nand dystonias, and skin sores. In rare instances, usually in severe intoxication, use \\nof stimulants including amphetamines, methamphetamine and methcathinone can \\nresult in  seizures.  \\nCoding Note:  Code also the causing condition  \\nExclusions:  amphetamine poisoning (NE60)  \\nCaffeine intoxication (6C48.2)  \\nCocaine intoxication (6C45.3)  \\nSynthetic cathinone intoxication (6C47.3)  \\nPossession trance disorder (6B63)',\n",
       " '6C46.4  Stimulant with drawal including amphetamines, methamphetamine or \\nmethcathinone  \\nStimulant withdrawal including amphetamines, methamphetamine and \\nmethcathinone is a clinically significant cluster of symptoms, behaviours and/or \\nphysiological features, varying in degree of s everity and duration, that occurs upon \\ncessation or reduction of use of stimulants in individuals who have developed \\nStimulant dependence or have used stimulants for a prolonged period or in large \\namounts. Stimulant withdrawal can also occur when prescribe d stimulants have \\nbeen used in standard therapeutic doses. Presenting features of stimulant \\nwithdrawal may include dysphoric mood, irritability, fatigue, insomnia or (more \\ncommonly) hypersomnia, vivid and unpleasant dreams, increased appetite, \\npsychomotor agitation or retardation, and craving for amphetamine or related \\nstimulants.  \\nCoding Note:  Code also the causing condition  \\nExclusions:  Cocaine withdrawal (6C45.4)  \\nCaffeine withdrawal (6C48.3)  \\nSynthetic cathinone withdrawal (6C47.4)  \\n ICD-11 MMS  495',\n",
       " '6C46.5  Stimulant -induced delirium including amphetamines, methamphetamine or \\nmethcathinone  \\nStimulant -induced delirium including amphetamines, methamphetamine and \\nmethcathinone is characterised by an acute state of d isturbed attention and \\nawareness with specific features of delirium that develops during or soon after \\nsubstance intoxication or withdrawal or during the use of stimulants. The amount \\nand duration of stimulant use must be capable of producing delirium. The  symptoms \\nare not better explained by a primary mental disorder, by use of or withdrawal from \\na different substance, or by another health condition that is not classified under \\nMental, behavioural and neurodevelopmental disorders.  \\nCoding Note:  Code also th e causing condition  \\nExclusions:  Cocaine -induced delirium (6C45.5)  \\nSynthetic cathinone -induced delirium (6C47.5)  \\nDisorders due to use of caffeine (6C48)',\n",
       " '6C46.6  Stimulant -induced psychotic disorder including amphetamines, \\nmethamphetamine or methcathinone  \\nStimulant -induced psychotic disorder including amphetamines, methamphetamine \\nand methcathinone is characterised by psychotic symptoms (e.g., delusions, \\nhallucinations, disorganised thinking, grossly disorganised behaviour) that develop \\nduring or soon after i ntoxication or withdrawal due to stimulants. The intensity or \\nduration of the symptoms is substantially in excess of psychotic -like disturbances of \\nperception, cognition, or behaviour that are characteristic of Stimulant intoxication or \\nStimulant withdrawa l. The amount and duration of stimulant use must be capable of \\nproducing psychotic symptoms. The symptoms are not better explained by a \\nprimary mental disorder (e.g., Schizophrenia, a Mood disorder with psychotic \\nsymptoms), as might be the case if the psyc hotic symptoms preceded the onset of \\nthe stimulant use, if the symptoms persist for a substantial period of time after \\ncessation of the stimulant use or withdrawal, or if there is other evidence of a pre -\\nexisting primary mental disorder with psychotic symp toms (e.g., a history of prior \\nepisodes not associated with use of stimulants).  \\nCoding Note:  Code also the causing condition  \\nExclusions:  Cocaine -induced psychotic disorder (6C45.6)  \\nSynthetic cathinone -induced psychotic disorder (6C47.6)  \\nDisorders due to use of caffeine (6C48)  \\n 496  ICD-11 MMS',\n",
       " '6C46.60  Stimulant -induced psychotic disorder including amphetamines, methamphetamine \\nor methcathinone with hallucinations  \\nStimulant -induced psychotic disorder with hallucinations is characterised by the \\npresence of hallucinations that are judged to be the direct consequence of stimulant \\nuse. Neither delusions nor other psychotic symptoms are present. The symptoms \\ndo not occur exclusively during hypnogogic or hypnopompic states, are not better \\naccounted for by another  mental and behavioural disorder (e.g., schizophrenia), and \\nare not due to another disorder or disease classified elsewhere (e.g., epilepsies with \\nvisual symptoms).  \\nCoding Note:  Code also the causing condition  \\nExclusions:  Cocaine -induced psychotic disorder  with hallucinations \\n(6C45.60)  \\nDisorders due to use of caffeine (6C48)  \\nSynthetic cathinone -induced psychotic disorder with \\nhallucinations (6C47.60)',\n",
       " '6C46.61  Stimulant -induced psychotic disorder including amphetamines, methamphetamine \\nor methcathinone with delusions  \\nStimulant -induced psychotic disorder including amphetamines, methamphetamine \\nand methcathinone is characterised by psychotic symptoms (e.g., delusions, \\nhallucinations, disorganised thinking, grossly disorganised behaviour) that develop \\nduring or soon after intoxication or withdrawal due to stimulants. The intensity or \\nduration of the symptoms is substantially in excess of psychotic -like disturbances of \\nperception, cognition, or behaviour that are characteristic of Stimulant intoxication or \\nStimula nt withdrawal. The amount and duration of stimulant use must be capable of \\nproducing psychotic symptoms. The symptoms are not better explained by a \\nprimary mental disorder (e.g., Schizophrenia, a Mood disorder with psychotic \\nsymptoms), as might be the case  if the psychotic symptoms preceded the onset of \\nthe stimulant use, if the symptoms persist for a substantial period of time after \\ncessation of the stimulant use or withdrawal, or if there is other evidence of a pre -\\nexisting primary mental disorder with ps ychotic symptoms (e.g., a history of prior \\nepisodes not associated with use of stimulants).  \\nCoding Note:  Code also the causing condition  \\nExclusions:  Disorders due to use of caffeine (6C48)  \\nCocaine -induced psychotic disorder with delusions (6C45.61)  \\nSynthet ic cathinone -induced psychotic disorder with delusions \\n(6C47.61)  \\n ICD-11 MMS  497',\n",
       " '6C46.62  Stimulant -induced psychotic disorder including amphetamines but excluding \\ncaffeine or cocaine with mixed psychotic symptoms  \\nStimulant -induced psychotic disorder with mixed psychotic symptoms is \\ncharacterised by the presence of multiple psychotic symptoms, primarily \\nhallucinations and delusions, when these are judged to be the direct consequence \\nof stimulant use. The symptoms do not occur exclusively during hypnogogic or \\nhypnopompic st ates, are not better accounted for by another mental and \\nbehavioural disorder (e.g., Schizophrenia), and are not due to another disorder or \\ndisease classified elsewhere (e.g., epilepsies with visual symptoms).  \\nCoding Note:  Code also the causing condition  \\nExclusions:  Disorders due to use of caffeine (6C48)  \\nCocaine -induced psychotic disorder with mixed psychotic \\nsymptoms (6C45.62)  \\nSynthetic cathinone -induced psychotic disorder with mixed \\npsychotic symptoms (6C47.62)',\n",
       " '6C46.6Z  Stimulant -induced psychotic disorder including amphetamines, methamphetamine \\nor methcathinone, unspecified  \\nCoding Note:  Code also the causing condition',\n",
       " '6C46.7  Certain specified stimulant -induced mental or behavioural disorders including \\namphetamines, meth amphetamine or methcathinone  \\nCoding Note:  Code also the causing condition',\n",
       " '6C46.70  Stimulant -induced mood disorder including amphetamines, methamphetamine or \\nmethcathinone  \\nStimulant -induced mood disorder including amphetamines, methamphetamine and \\nmethcathinone is characterised by mood symptoms (e.g., depressed or elevated \\nmood, decrease d engagement in pleasurable activities, increased or decreased \\nenergy levels) that develop during or soon after intoxication or withdrawal due to \\nstimulants. The intensity or duration of the symptoms is substantially in excess of \\nmood disturbances that are  characteristic of Stimulant intoxication or Stimulant \\nwithdrawal. The amount and duration of stimulant use must be capable of producing \\nmood symptoms. The symptoms are not better explained by a primary mental \\ndisorder (e.g., a Depressive disorder, a Bipol ar disorder, Schizoaffective disorder), \\nas might be the case if the mood symptoms preceded the onset of the stimulant \\nuse, if the symptoms persist for a substantial period of time after cessation of the \\nstimulant use or withdrawal, or if there is other evi dence of a pre -existing primary \\nmental disorder with mood symptoms (e.g., a history of prior episodes not \\nassociated with use of stimulants).  \\nCoding Note:  Code also the causing condition  \\nExclusions:  Synthetic cathinone -induced mood disorder (6C47.70)  \\nCocai ne-induced mood disorder (6C45.70)  \\nDisorders due to use of caffeine (6C48)  \\n 498  ICD-11 MMS',\n",
       " '6C46.71  Stimulant -induced anxiety disorder including amphetamines, methamphetamine or \\nmethcathinone  \\nStimulant -induced anxiety disorder including amphetamines, methamphetamine and \\nmethcathinone is characterised by anxiety symptoms (e.g., apprehension or worry, \\nfear, physiological symptoms of excessive autonomic arousal, avoidance behaviour) \\nthat develop during or soon after intoxication or withdrawal due to stimulants. The \\nintensity or duration of the symptoms is substantially in excess of anxiety symptoms \\nthat are characteristic of Stimulant intoxication or Stimulant withdrawal. The amount \\nand duration of stimulant use must be capable of producing anxiety symptoms. The \\nsymptoms are n ot better explained by a primary mental disorder (e.g., an Anxiety \\nand fear -related disorder, a Depressive disorder with prominent anxiety symptoms), \\nas might be the case if the anxiety symptoms preceded the onset of the stimulant \\nuse, if the symptoms pers ist for a substantial period of time after cessation of the \\nstimulant use or withdrawal, or if there is other evidence of a pre -existing primary \\nmental disorder with anxiety symptoms (e.g., a history of prior episodes not \\nassociated with use of stimulants) . \\nCoding Note:  Code also the causing condition  \\nExclusions:  Cocaine -induced anxiety disorder (6C45.71)  \\nCaffeine -induced anxiety disorder (6C48.40)  \\nSynthetic cathinone -induced anxiety disorder (6C47.71)',\n",
       " '6C46.72  Stimulant -induced obsessive -compulsive or rela ted disorder including \\namphetamines, methamphetamine or methcathinone  \\nStimulant -induced obsessive -compulsive or related disorder including \\namphetamines, methamphetamine and methcathinone is characterised by either \\nrepetitive intrusive thoughts or preoccupa tions, normally associated with anxiety \\nand typically accompanied by repetitive behaviours performed in response, or by \\nrecurrent and habitual actions directed at the integument (e.g., hair pulling, skin \\npicking) that develop during or soon after intoxicat ion with or withdrawal from \\nstimulants. The intensity or duration of the symptoms is substantially in excess of \\nanalogous disturbances that are characteristic of Stimulant intoxication or Stimulant \\nwithdrawal. The amount and duration of stimulant use must be capable of producing \\nobsessive -compulsive or related symptoms. The symptoms are not better explained \\nby a primary mental disorder (in particular an Obsessive -compulsive or related \\ndisorder), as might be the case if the symptoms preceded the onset of the  stimulant \\nuse, if the symptoms persist for a substantial period of time after cessation of the \\nstimulant use or withdrawal, or if there is other evidence of a pre -existing primary \\nmental disorder with obsessive -compulsive or related symptoms (e.g., a hist ory of \\nprior episodes not associated with stimulant use).  \\nCoding Note:  Code also the causing condition  \\nExclusions:  Cocaine -induced obsessive -compulsive or related disorder \\n(6C45.72)  \\nSynthetic cathinone -induced obsessive -compulsive or related \\nsyndrome (6C47 .72) \\nDisorders due to use of caffeine (6C48)  \\n ICD-11 MMS  499',\n",
       " '6C46.73  Stimulant -induced impulse control disorder including amphetamines, \\nmethamphetamine or methcathinone  \\nStimulant -induced impulse control disorder including amphetamines, \\nmethamphetamine and methcathinone i s characterised by persistently repeated \\nbehaviours in which there is recurrent failure to resist an impulse, drive, or urge to \\nperform an act that is rewarding to the person, at least in the short -term, despite \\nlonger -term harm either to the individual or  to others (e.g., fire setting or stealing \\nwithout apparent motive, repetitive sexual behaviour, aggressive outbursts) that \\ndevelop during or soon after intoxication with or withdrawal from stimulants. The \\nintensity or duration of the symptoms is substanti ally in excess of disturbances of \\nimpulse control that are characteristic of Stimulant intoxication or Stimulant \\nwithdrawal. The amount and duration of stimulant use must be capable of producing \\ndisturbances of impulse control. The symptoms are not better explained by a \\nprimary mental disorder (e.g., an Impulse control disorder, a Disorder due to \\naddictive behaviours), as might be the case if the impulse control disturbances \\npreceded the onset of the stimulant use, if the symptoms persist for a substantial \\nperiod of time after cessation of the stimulant use or withdrawal, or if there is other \\nevidence of a pre -existing primary mental disorder with impulse control symptoms \\n(e.g., a history of prior episodes not associated with stimulant use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C46.Y  Other specified disorders due to use of stimulants including amphetamines, \\nmethamphetamine or methcathinone',\n",
       " '6C46.Z  Disorders due to use of stimulants including amphetamines, \\nmethamphetamine or methcathinone, unspecified',\n",
       " '6C47   Disorders due to use of synthetic cathinones  \\nDisorders due to use of synthetic cathinones are characterised by the pattern and \\nconsequences o f synthetic cathinone use. Synthetic cathinones (also known as \\n‘bath salts’) are synthetic compounds with stimulant properties related to cathinone \\nfound in the khat plant, Catha edulis. The use of synthetic cathinones is common in \\nyoung populations in man y countries. They may produce a range of disorders \\nincluding Synthetic Cathinone Intoxication, Synthetic Cathinone Dependence and \\nSynthetic Cathinone Withdrawal. Several synthetic cathinone -induced mental \\ndisorders are recognised.',\n",
       " '6C47.0  Episode of harmful use of synthetic cathinones  \\nAn episode of synthetic cathinone use that has caused damage to a person’s \\nphysical or mental health or has resulted in behaviour leading to harm to the health \\nof others. Harm to health of the individual occur s due to one or more of the \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effects \\non body organs and systems; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of physical harm, including  trauma, or mental \\ndisorder that is directly attributable to behaviour due to synthetic cathinone \\nintoxication on the part of the person to whom the diagnosis of single episode of \\nharmful use applies. This diagnosis should not be made if the harm is attrib uted to a \\nknown pattern of synthetic cathinone use.  \\nExclusions:  Harmful pattern of use of synthetic cathinones (6C47.1)  \\nSynthetic cathinone dependence (6C47.2)  \\n 500  ICD-11 MMS',\n",
       " '6C47.1  Harmful pattern of use of synthetic cathinones  \\nA pattern of use of synthetic cathinones that has caused damage to a person’s \\nphysical or mental health or has resulted in behaviour leading to harm to the health \\nof others. The pattern of synthetic cathinone use is evident over a period of at least \\n12 months if substance use is episodic or at le ast one month if use is continuous \\n(i.e., daily or almost daily). Harm to health of the individual occurs due to one or \\nmore of the following: (1) behaviour related to intoxication; (2) direct or secondary \\ntoxic effects on body organs and systems; or (3) a  harmful route of administration. \\nHarm to health of others includes any form of physical harm, including trauma, or \\nmental disorder that is directly attributable to behaviour related to synthetic \\ncathinone intoxication on the part of the person to whom the  diagnosis of Harmful \\npattern of use of synthetic cathinones applies.  \\nExclusions:  Episode of harmful use of synthetic cathinones (6C47.0)  \\nSynthetic cathinone dependence (6C47.2)',\n",
       " '6C47.10  Harmful pattern of use of synthetic cathinones, episodic  \\nA pattern of  episodic or intermittent use of synthetic cathinones that has caused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of episodic synthetic cathinone use is \\nevident over a per iod of at least 12 months. Harm to health of the individual occurs \\ndue to one or more of the following: (1) behaviour related to intoxication; (2) direct \\nor secondary toxic effects on body organs and systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour related \\nto synthetic cathinone intoxication on the part of the person to whom the diagnosis \\nof Harmful pattern of use of  synthetic cathinones applies.  \\nExclusions:  Episode of harmful use of synthetic cathinones (6C47.0)  \\nSynthetic cathinone dependence (6C47.2)',\n",
       " '6C47.11  Harmful use of synthetic cathinones, continuous  \\nA pattern of continuous (daily or almost daily) use of synth etic cathinones that has \\ncaused damage to a person’s physical or mental health or has resulted in behaviour \\nleading to harm to the health of others. The pattern of continuous synthetic \\ncathinone use is evident over a period of at least one month. Harm to h ealth of the \\nindividual occurs due to one or more of the following: (1) behaviour related to \\nintoxication; (2) direct or secondary toxic effects on body organs and systems; or (3) \\na harmful route of administration. Harm to health of others includes any for m of \\nphysical harm, including trauma, or mental disorder that is directly attributable to \\nbehaviour related to synthetic cathinone intoxication on the part of the person to \\nwhom the diagnosis of Harmful use of synthetic cathinones applies.  \\nExclusions:  Episode of harmful use of synthetic cathinones (6C47.0)  \\nSynthetic cathinone dependence (6C47.2)',\n",
       " '6C47.1Y  Other specified harmful pattern of use of synthetic cathinones',\n",
       " '6C47.1Z  Harmful pattern of use of synthetic cathinones, unspecified  \\n ICD-11 MMS  501',\n",
       " '6C47.2  Synthetic cathinone dependence  \\nSynthetic cathinone dependence is a disorder of regulation of synthetic cathinone \\nuse arising from repeated or continuous use of synthetic cathinones. The \\ncharacteristic feature is a strong internal drive to use synthetic cat hinones, which is \\nmanifested by impaired ability to control use, increasing priority given to use over \\nother activities and persistence of use despite harm or negative consequences. \\nThese experiences are often accompanied by a subjective sensation of urge or \\ncraving to use synthetic cathinones. Physiological features of dependence may also \\nbe present, including tolerance to the effects of synthetic cathinones, withdrawal \\nsymptoms following cessation or reduction in use of synthetic cathinones, or \\nrepeated u se of synthetic cathinones or pharmacologically similar substances to \\nprevent or alleviate withdrawal symptoms. The features of dependence are usually \\nevident over a period of at least 12 months but the diagnosis may be made if \\nsynthetic cathinone use is c ontinuous (daily or almost daily) for at least 3 months.  \\nExclusions:  Harmful pattern of use of synthetic cathinones (6C47.1)  \\nEpisode of harmful use of synthetic cathinones (6C47.0)',\n",
       " '6C47.20  Synthetic cathinone dependence, current use  \\nCurrent synthetic cath inone dependence with use of synthetic cathinones within the \\npast month.  \\nExclusions:  Episode of harmful use of synthetic cathinones (6C47.0)  \\nHarmful pattern of use of synthetic cathinones (6C47.1)',\n",
       " '6C47.21  Synthetic cathinone dependence, early full remissi on \\nAfter a diagnosis of synthetic cathinone dependence, and often following a \\ntreatment episode or other intervention (including self -help intervention), the \\nindividual has been abstinent from synthetic cathinone use during a period lasting \\nbetween 1 and 1 2 months.  \\nExclusions:  Episode of harmful use of synthetic cathinones (6C47.0)  \\nHarmful pattern of use of synthetic cathinones (6C47.1)',\n",
       " '6C47.22  Synthetic cathinone dependence, sustained partial remission  \\nAfter a diagnosis of synthetic cathinone dependence, and often following a \\ntreatment episode or other intervention (including self -help intervention), there is a \\nsignificant reduction in synthetic  cathinone consumption for more than 12 months, \\nsuch that even though synthetic cathinone use has occurred during this period, the \\ndefinitional requirements for dependence have not been met.  \\nExclusions:  Episode of harmful use of synthetic cathinones (6C47. 0) \\nHarmful pattern of use of synthetic cathinones (6C47.1)',\n",
       " '6C47.23  Synthetic cathinone dependence, sustained full remission  \\nAfter a diagnosis of synthetic cathinone dependence, and often following a \\ntreatment episode or other intervention (including self -intervention), the person has \\nbeen abstinent from synthetic cathinone use for 12 months or longer.  \\nExclusions:  Episode of harmful use of synthetic cathinones (6C47.0)  \\nHarmful pattern of use of synthetic cathinones (6C47.1)',\n",
       " '6C47.2Y  Other specified syntheti c cathinone dependence  \\n 502  ICD-11 MMS',\n",
       " '6C47.2Z  Synthetic cathinone dependence, unspecified',\n",
       " '6C47.3  Synthetic cathinone intoxication  \\nSynthetic cathinone intoxication is a clinically significant transient condition that \\ndevelops during or shortly after the consumption of synthetic cathinones that is \\ncharacterised by disturbances in consciousness, cognition, perception, affect, \\nbehaviour,  or coordination. These disturbances are caused by the known \\npharmacological effects of synthetic cathinones and their intensity is closely related \\nto the amount of synthetic cathinones consumed. They are time -limited and abate \\nas the synthetic cathinone i s cleared from the body. Presenting features may \\ninclude anxiety, anger, impaired attention, hypervigilance, psychomotor agitation, \\nparanoid ideation (possibly of delusional intensity), transient auditory hallucinations, \\ntransitory confusion, and changes i n sociability. Perspiration or chills, nausea or \\nvomiting, and palpitations may be experienced. Physical signs may include \\ntachycardia, elevated blood pressure, pupillary dilatation, dyskinesias and \\ndystonias, and skin sores. In rare instances, usually in severe intoxication, use of \\nsynthetic cathinones can result in seizures.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C47.4  Synthetic cathinone withdrawal  \\nSynthetic cathinone withdrawal is a clinically significant cluster of symptoms, \\nbehaviours and/or p hysiological features, varying in degree of severity and duration, \\nthat occurs upon cessation or reduction of use of synthetic cathinones in individuals \\nwho have developed Synthetic cathinone dependence or have used synthetic \\ncathinones for a prolonged per iod or in large amounts. Presenting features of \\nSynthetic cathinone withdrawal may include dysphoric mood, irritability, fatigue, \\ninsomnia or (more commonly) hypersomnia, vivid and unpleasant dreams, \\nincreased appetite, psychomotor agitation or retardation , and craving for stimulants, \\nincluding synthetic cathinones.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C47.5  Synthetic cathinone -induced delirium  \\nSynthetic cathinone -induced delirium is characterised by an acute state of disturbed \\nattention and aware ness with specific features of delirium that develops during or \\nsoon after substance intoxication or withdrawal or during the use of synthetic \\ncathinones. The amount and duration of synthetic cathinone use must be capable of \\nproducing delirium. The symptom s are not better explained by a primary mental \\ndisorder, by use of or withdrawal from a different substance, or by another health \\ncondition that is not classified under Mental, behavioural and neurodevelopmental \\ndisorders.  \\nCoding Note:  Code also the causin g condition  \\n ICD-11 MMS  503',\n",
       " '6C47.6  Synthetic cathinone -induced psychotic disorder  \\nSynthetic cathinone -induced psychotic disorder is characterised by psychotic \\nsymptoms (e.g., delusions, hallucinations, disorganised thinking, grossly \\ndisorganised behaviour) that develop d uring or soon after intoxication with or \\nwithdrawal from synthetic cathinones. The intensity or duration of the symptoms is \\nsubstantially in excess of psychotic -like disturbances of perception, cognition, or \\nbehaviour that are characteristic of Synthetic c athinone intoxication or Synthetic \\ncathinone withdrawal. The amount and duration of synthetic cathinone use must be \\ncapable of producing psychotic symptoms. The symptoms are not better explained \\nby a primary mental disorder (e.g., Schizophrenia, a Mood dis order with psychotic \\nsymptoms), as might be the case if the psychotic symptoms preceded the onset of \\nthe synthetic cathinone use, if the symptoms persist for a substantial period of time \\nafter cessation of the synthetic cathinone use or withdrawal, or if t here is other \\nevidence of a pre -existing primary mental disorder with psychotic symptoms (e.g., a \\nhistory of prior episodes not associated with synthetic cathinone use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C47.60  Synthetic cathinone -induced psyc hotic disorder with hallucinations  \\nSynthetic cathinone -induced psychotic disorder with hallucinations is characterised \\nby the presence of hallucinations that are judged to be the direct consequence of \\nsynthetic cathinone use. Neither delusions nor other ps ychotic symptoms are \\npresent. The symptoms do not occur exclusively during hypnogogic or hypnopompic \\nstates, are not better accounted for by another mental and behavioural disorder \\n(e.g., schizophrenia), and are not due to another disorder or disease class ified \\nelsewhere (e.g., epilepsies with visual symptoms).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C47.61  Synthetic cathinone -induced psychotic disorder with delusions  \\nSynthetic cathinone psychotic disorder with delusions is characterised by the \\nprese nce of delusions that are judged to be the direct consequence of synthetic \\ncathinone use. Neither hallucinations nor other psychotic symptoms are present. \\nThe symptoms do not occur exclusively during hypnogogic or hypnopompic states, \\nare not better account ed for by another mental and behavioural disorder (e.g., \\nschizophrenia), and are not due to another disorder or disease classified elsewhere \\n(e.g., epilepsies with visual symptoms).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C47.62  Synthetic cathinone -induced psychotic disorder with mixed psychotic symptoms  \\nSynthetic cathinone -induced psychotic disorder with mixed psychotic symptoms is \\ncharacterised by the presence of multiple psychotic symptoms, primarily \\nhallucinations and delusions, when these are ju dged to be the direct consequence \\nof synthetic cathinone use. The symptoms do not occur exclusively during \\nhypnogogic or hypnopompic states, are not better accounted for by another mental \\nand behavioural disorder (e.g., Schizophrenia), and are not due to a nother disorder \\nor disease classified elsewhere (e.g., epilepsies with visual symptoms).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C47.6Z  Synthetic cathinone -induced psychotic disorder, unspecified  \\nCoding Note:  Code also the causing condition  \\n 504  ICD-11 MMS',\n",
       " '6C47.7  Certain specified synthetic cathinone -induced mental or behavioural \\ndisorders  \\nCoding Note:  Code also the causing condition',\n",
       " '6C47.70  Synthetic c athinone -induced mood disorder  \\nSynthetic cathinone -induced mood disorder is characterised by mood symptoms \\n(e.g., depressed or elevated mood, decreased engagement in pleasurable activities, \\nincreased or decreased energy levels) that develop during or soon after intoxication \\nwith or withdrawal from synthetic cathinones. The intensity or duration of the \\nsymptoms is substantially in excess of mood disturbances that are characteristic of \\nSynthetic cathinone intoxication or Synthetic cathinone withdrawal. The am ount and \\nduration of synthetic cathinone use must be capable of producing mood symptoms. \\nThe symptoms are not better explained by a primary mental disorder (e.g., a \\nDepressive disorder, a Bipolar disorder, Schizoaffective disorder), as might be the \\ncase if  the mood symptoms preceded the onset of the synthetic cathinone use, if \\nthe symptoms persist for a substantial period of time after cessation of the synthetic \\ncathinone use or withdrawal, or if there is other evidence of a pre -existing primary \\nmental diso rder with mood symptoms (e.g., a history of prior episodes not \\nassociated with synthetic cathinone use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C47.71  Synthetic cathinone -induced anxiety disorder  \\nSynthetic cathinone -induced anxiety disorder is char acterised by anxiety symptoms \\n(e.g., apprehension or worry, fear, physiological symptoms of excessive autonomic \\narousal, avoidance behaviour) that develop during or soon after intoxication with or \\nwithdrawal from synthetic cathinones. The intensity or dura tion of the symptoms is \\nsubstantially in excess of anxiety symptoms that are characteristic of Synthetic \\ncathinone intoxication or Synthetic cathinone withdrawal. The amount and duration \\nof synthetic cathinone use must be capable of producing anxiety sympt oms. The \\nsymptoms are not better explained by a primary mental disorder (e.g., an Anxiety \\nand fear -related disorder, a Depressive disorder with prominent anxiety symptoms), \\nas might be the case if the anxiety symptoms preceded the onset of the synthetic \\ncathinone use, if the symptoms persist for a substantial period of time after \\ncessation of the synthetic cathinone use or withdrawal, or if there is other evidence \\nof a pre -existing primary mental disorder with anxiety symptoms (e.g., a history of \\nprior epis odes not associated with synthetic cathinone use).  \\nCoding Note:  Code also the causing condition  \\n ICD-11 MMS  505',\n",
       " '6C47.72  Synthetic cathinone -induced obsessive -compulsive or related syndrome  \\nSynthetic cathinone -induced obsessive -compulsive or related disorder is \\ncharacteri sed by either repetitive intrusive thoughts or preoccupations, normally \\nassociated with anxiety and typically accompanied by repetitive behaviours \\nperformed in response, or by recurrent and habitual actions directed at the \\nintegument (e.g., hair pulling, s kin picking) that develop during or soon after \\nintoxication with or withdrawal from synthetic cathinones. The intensity or duration \\nof the symptoms is substantially in excess of analogous disturbances that are \\ncharacteristic of Synthetic cathinone intoxica tion or Synthetic cathinone withdrawal. \\nThe amount and duration of synthetic cathinone use must be capable of producing \\nobsessive -compulsive or related symptoms. The symptoms are not better explained \\nby a primary mental disorder (in particular an Obsessive -compulsive or related \\ndisorder), as might be the case if the symptoms preceded the onset of the synthetic \\ncathinone use, if the symptoms persist for a substantial period of time after \\ncessation of the synthetic cathinone use or withdrawal, or if there is other evidence \\nof a pre -existing primary mental disorder with obsessive -compulsive or related \\nsymptoms (e.g., a history of prior episodes not associated with synthetic cathinone \\nuse).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C47.73  Synthetic cathinon e-induced impulse control disorder  \\nSynthetic cathinone -induced impulse control disorder is characterised by \\npersistently repeated behaviours in which there is recurrent failure to resist an \\nimpulse, drive, or urge to perform an act that is rewarding to the  person, at least in \\nthe short -term, despite longer -term harm either to the individual or to others (e.g., \\nfire setting or stealing without apparent motive, repetitive sexual behaviour, \\naggressive outbursts) that develop during or soon after intoxication w ith or \\nwithdrawal from synthetic cathinones. The intensity or duration of the symptoms is \\nsubstantially in excess of disturbances of impulse control that are characteristic of \\nSynthetic cathinone intoxication or Synthetic cathinone withdrawal. The amount a nd \\nduration of synthetic cathinone use must be capable of producing disturbances of \\nimpulse control. The symptoms are not better explained by a primary mental \\ndisorder (e.g., an Impulse control disorder, a Disorder due to addictive behaviours), \\nas might be  the case if the impulse control disturbances preceded the onset of the \\nsynthetic cathinone use, if the symptoms persist for a substantial period of time after \\ncessation of the synthetic cathinone use or withdrawal, or if there is other evidence \\nof a pre -existing primary mental disorder with impulse control symptoms (e.g., a \\nhistory of prior episodes not associated with synthetic cathinone use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C47.Y  Other specified disorders due to use of synthetic cathinones',\n",
       " '6C47.Z  Disorders due to use of synthetic cathinones, unspecified  \\n 506  ICD-11 MMS',\n",
       " \"6C48   Disorders due to use of caffeine  \\nDisorders due to use of caffeine are characterised by the pattern and consequences \\nof caffeine use. Caffeine is a mild psychostimulant and diuretic that is found in the \\nbeans of the coffee plant (Coffea species) and is a constituent of coffee, cola drinks,  \\nchocolate, a range of proprietary 'energy drinks' and weight -loss aids. It is the most \\ncommonly used psychoactive substance worldwide and several clinical conditions \\nrelated to its use are described, although severe disorders are comparatively rare \\nconsid ering its ubiquity. Caffeine Intoxication related to consumption of relatively \\nhigher doses (i.e., > 1 g per day) is described. Caffeine Withdrawal is common upon \\ncessation of use among individuals who have used caffeine for a prolonged period \\nor in large amounts. Caffeine -Induced Anxiety Disorder has been described, often \\nfollowing intoxication or heavy use.  \\nExclusions:  Disorders due to use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46)  \\nHazardous use of caffeine (QE11.5)\",\n",
       " '6C48.0 Episode of harmful use of caffeine  \\nAn episode of caffeine use that has caused damage to a person’s physical or \\nmental health. Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) direct or secondary toxic effects on body org ans and systems; or (2) a \\nharmful route of administration. This diagnosis should not be made if the harm is \\nattributed to a known pattern of caffeine use.  \\nExclusions:  Harmful pattern of use of caffeine (6C48.1)',\n",
       " '6C48.1  Harmful pattern of use of caffeine  \\nA pattern of caffeine use that has caused clinically significant harm to a person’s \\nphysical or mental health or in which caffeine -induced behaviour has caused \\nclinically significant harm to the health of other people. The pattern of caffeine use is \\nevident over a period of at least 12 months if use is episodic and at least one month \\nif use is continuous (i.e., daily or almost daily). Harm may be caused by the \\nintoxicating effects of caffeine, the direct or secondary toxic effects on body organs \\nand systems, or a harmful route of administration.  \\nExclusions:  Episode of harmful use of caffeine (6C48.0)',\n",
       " '6C48.10  Harmful pattern of use of caffeine, episodic  \\nA pattern of episodic or intermittent caffeine use that has caused damage to a \\nperson’s physical or mental health. The pattern of episodic caffeine use is evident \\nover a period of at least 12 months. Harm to health of the individual occurs due to \\none or mo re of the following: (1) direct or secondary toxic effects on body organs \\nand systems; or (2) a harmful route of administration.  \\nExclusions:  Episode of harmful use of caffeine (6C48.0)',\n",
       " '6C48.11  Harmful pattern of use of caffeine, continuous  \\nA pattern of co ntinuous (daily or almost daily) caffeine use that has caused damage \\nto a person’s physical or mental health. The pattern of continuous caffeine use is \\nevident over a period of at least one month. Harm to health of the individual occurs \\ndue to one or more of the following: (1) direct or secondary toxic effects on body \\norgans and systems; or (2) a harmful route of administration.  \\nExclusions:  Episode of harmful use of caffeine (6C48.0)  \\n ICD-11 MMS  507',\n",
       " '6C48.1Z  Harmful pattern of use of caffeine, unspecified',\n",
       " '6C48.2  Caffeine intoxication  \\nCaffeine intoxication is a clinically significant transient condition that develops \\nduring or shortly after the consumption of caffeine that is characterised by \\ndisturbances in consciousness, cognition, perception, affect, behaviour, or \\ncoordi nation. These disturbances are caused by the known pharmacological effects \\nof caffeine and their intensity is closely related to the amount of caffeine consumed. \\nThey are time -limited and abate as caffeine is cleared from the body. Presenting \\nfeatures may include restlessness, anxiety, excitement, insomnia, flushed face, \\ntachycardia, diuresis, gastrointestinal disturbances, muscle twitching, psychomotor \\nagitation, perspiration or chills, and nausea or vomiting. Cardiac arrhythmias may \\noccur. Disturbances ty pical of intoxication tend to occur at relatively higher doses \\n(e.g., > 1 g per day). Very high doses of caffeine (e.g., > 5 g) can result in \\nrespiratory distress or seizures and can be fatal.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C48.3  Caffeine w ithdrawal  \\nCaffeine withdrawal is a clinically significant cluster of symptoms, behaviours and/or \\nphysiological features, varying in degree of severity and duration, that occurs upon \\ncessation or reduction of use of caffeine (typically in the form of coffee, caffeina ted \\ndrinks, or as an ingredient in certain over -the-counter medications) in individuals \\nwho have used caffeine for a prolonged period or in large amounts. Presenting \\nfeatures of Caffeine withdrawal may include headache, marked fatigue or \\ndrowsiness, irrita bility, depressed or dysphoric mood, nausea or vomiting, and \\ndifficulty concentrating.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C48.4  Certain specified caffeine -induced mental or behavioural disorders  \\nCoding Note:  Code also the causing condition',\n",
       " '6C48.40  Caffeine -induced anxiety disorder  \\nCaffeine -induced anxiety disorder is characterised by anxiety symptoms (e.g., \\napprehension or worry, fear, physiological symptoms of excessive autonomic \\narousal, avoidance behaviour) that develop during or soon after intoxication with or \\nwithdrawal from caffeine. The intensity or duration of the symptoms is substantially \\nin excess of anxiety symptoms that are characteristic of Caffeine intoxication or \\nCaffeine withdrawal. The amount and duration of caffeine use must be  capable of \\nproducing anxiety symptoms. The symptoms are not better explained by a primary \\nmental disorder (e.g., an Anxiety and fear -related disorder, a Depressive disorder \\nwith prominent anxiety symptoms), as might be the case if the anxiety symptoms \\npreceded the onset of the caffeine use, if the symptoms persist for a substantial \\nperiod of time after cessation of the caffeine use or withdrawal, or if there is other \\nevidence of a pre -existing primary mental disorder with anxiety symptoms (e.g., a \\nhistory of prior episodes not associated with caffeine use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C48.Y  Other specified disorders due to use of caffeine',\n",
       " '6C48.Z  Disorders due to use of caffeine, unspecified  \\n 508  ICD-11 MMS',\n",
       " '6C49   Disorders due to use of hallucinogens  \\nDisorders due to use of hallucinogens are characterised by the pattern and \\nconsequences of hallucinogen use. Several thousand compounds have \\nhallucinogenic properties, many of which are found in plants (e.g., mescaline) and \\nfungi (e.g., psilocybin) or are  chemically synthesized (e.g., lysergic acid \\ndiethylamide [LSD]). These compounds have primarily hallucinogenic properties, \\nbut some may also be stimulants. Much of the morbidity associated with these \\ncompounds arises from the acute effects related to Hall ucinogen Intoxication. \\nHallucinogen Dependence is rare and Hallucinogen Withdrawal is not described. \\nAmong the mental disorders related to hallucinogen use, Hallucinogen -Induced \\nPsychotic Disorder is the most frequently seen, although worldwide it is still  fairly \\nuncommon.',\n",
       " '6C49.0  Episode of harmful use of hallucinogens  \\nAn episode of hallucinogen use that has caused damage to a person’s physical or \\nmental health or has resulted in behaviour leading to harm to the health of others. \\nHarm to health of the indi vidual occurs due to one or more of the following: (1) \\nbehaviour related to intoxication; (2) direct or secondary toxic effects on body \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical har m, including trauma, or mental disorder that \\nis directly attributable to behaviour due to hallucinogen intoxication on the part of \\nthe person to whom the diagnosis of single episode of harmful use applies. This \\ndiagnosis should not be made if the harm is a ttributed to a known pattern of \\nhallucinogen use.  \\nExclusions:  Hallucinogen dependence (6C49.2)  \\nHarmful pattern of use of hallucinogens (6C49.1)',\n",
       " '6C49.1  Harmful pattern of use of hallucinogens  \\nA pattern of use of hallucinogens that has caused damage to a person’s physical or \\nmental health or has resulted in behaviour leading to harm to the health of others. \\nThe pattern of hallucinogen use is evident over a period of at least 12 months if \\nsubstan ce use is episodic or at least one month if use is continuous (i.e., daily or \\nalmost daily). Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effects \\non body o rgans and systems; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of physical harm, including trauma, or mental \\ndisorder that is directly attributable to behaviour related to hallucinogen intoxication \\non the part of th e person to whom the diagnosis of Harmful pattern of use of \\nhallucinogens applies.  \\nExclusions:  Hallucinogen dependence (6C49.2)  \\nEpisode of harmful use of hallucinogens (6C49.0)  \\n ICD-11 MMS  509',\n",
       " '6C49.10  Harmful pattern of use of hallucinogens, episodic  \\nA pattern of episodic or intermittent use of hallucinogens that has caused damage \\nto a person’s physical or mental health or has resulted in behaviour leading to harm \\nto the health of others. The pattern of episodic hallucinogen use is evident over a \\nperio d of at least 12 months. Harm to health of the individual occurs due to one or \\nmore of the following: (1) behaviour related to intoxication; (2) direct or secondary \\ntoxic effects on body organs and systems; or (3) a harmful route of administration. \\nHarm to  health of others includes any form of physical harm, including trauma, or \\nmental disorder that is directly attributable to behaviour related to hallucinogen \\nintoxication on the part of the person to whom the diagnosis of Harmful pattern of \\nuse of hallucin ogens applies.  \\nExclusions:  Episode of harmful use of hallucinogens (6C49.0)  \\nHallucinogen dependence (6C49.2)',\n",
       " '6C49.11  Harmful pattern of use of hallucinogens, continuous  \\nA pattern of continuous (daily or almost daily) use of hallucinogens that has caused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of continuous hallucinogen use is \\nevident over a period of at least one month. Harm to health of the individual occurs \\ndue to on e or more of the following: (1) behaviour related to intoxication; (2) direct \\nor secondary toxic effects on body organs and systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or  mental disorder that is directly attributable to behaviour related \\nto hallucinogen intoxication on the part of the person to whom the diagnosis of \\nHarmful use of hallucinogens applies.  \\nExclusions:  Episode of harmful use of hallucinogens (6C49.0)  \\nHallucino gen dependence (6C49.2)',\n",
       " '6C49.1Z  Harmful pattern of use of hallucinogens, unspecified',\n",
       " '6C49.2  Hallucinogen dependence  \\nHallucinogen dependence is a disorder of regulation of hallucinogen use arising \\nfrom repeated or continuous use of hallucinogens. The char acteristic feature is a \\nstrong internal drive to use hallucinogens, which is manifested by impaired ability to \\ncontrol use, increasing priority given to use over other activities and persistence of \\nuse despite harm or negative consequences. These experienc es are often \\naccompanied by a subjective sensation of urge or craving to use hallucinogens. The \\nfeatures of dependence are usually evident over a period of at least 12 months but \\nthe diagnosis may be made if hallucinogens use is continuous (daily or almost  daily) \\nfor at least 3 months.  \\nExclusions:  Episode of harmful use of hallucinogens (6C49.0)  \\nHarmful pattern of use of hallucinogens (6C49.1)',\n",
       " '6C49.20  Hallucinogen dependence, current use  \\nCurrent hallucinogen dependence with hallucinogen use within the past  month.  \\nExclusions:  Episode of harmful use of hallucinogens (6C49.0)  \\nHarmful pattern of use of hallucinogens (6C49.1)  \\n 510  ICD-11 MMS',\n",
       " '6C49.21  Hallucinogen dependence, early full remission  \\nAfter a diagnosis of Hallucinogen dependence, and often following a treatment \\nepiso de or other intervention (including self -help intervention), the individual has \\nbeen abstinent from hallucinogens during a period lasting between 1 and 12 \\nmonths.  \\nExclusions:  Episode of harmful use of hallucinogens (6C49.0)  \\nHarmful pattern of use of halluc inogens (6C49.1)',\n",
       " '6C49.22  Hallucinogen dependence, sustained partial remission  \\nAfter a diagnosis of Hallucinogen dependence, and often following a treatment \\nepisode or other intervention (including self -help intervention), there is a significant \\nreduction in hallucinogen consumption for more than 12 months, such that even \\nthough intermittent or continuing hallucinogen use has occurred during this period, \\nthe definitional requirements for dependence have not been met.  \\nExclusions:  Episode of harmful use of hallucinogens (6C49.0)  \\nHarmful pattern of use of hallucinogens (6C49.1)',\n",
       " '6C49.23  Hallucinogen dependence, sustained full remission  \\nAfter a diagnosis of Hallucinogen dependence, and often following a treatment \\nepisode or other inte rvention (including self -intervention), the person has been \\nabstinent from hallucinogens for 12 months or longer.  \\nExclusions:  Episode of harmful use of hallucinogens (6C49.0)  \\nHarmful pattern of use of hallucinogens (6C49.1)',\n",
       " '6C49.2Z  Hallucinogen dependence, unspecified',\n",
       " '6C49.3  Hallucinogen intoxication  \\nHallucinogen intoxication is a clinically significant transient condition that develops \\nduring or shortly after the consumption  of hallucinogens that is characterised by \\ndisturbances in consciousness, cognition, perception, affect, behaviour, or \\ncoordination. These disturbances are caused by the known pharmacological effects \\nof hallucinogens and their intensity is closely related to the amount of hallucinogen \\nconsumed. They are time -limited and abate as the hallucinogen is cleared from the \\nbody. Presenting features may include hallucinations, illusions, perceptual changes \\nsuch as depersonalisation, derealization, or synesthesias (b lending of senses, such \\nas a visual stimulus evoking a smell), anxiety, depressed or dysphoric mood, ideas \\nof reference, paranoid ideation, impaired judgment, palpitations, sweating, blurred \\nvision, tremors and incoordination. Physical signs may include ta chycardia, elevated \\nblood pressure, and pupillary dilatation. In rare instances, hallucinogen intoxication \\nmay facilitate suicidal ideation and behaviour.  \\nCoding Note:  Code also the causing condition  \\nExclusions:  hallucinogens poisoning (NE60)  \\nPossession tr ance disorder (6B63)  \\n ICD-11 MMS  511',\n",
       " '6C49.4  Hallucinogen -induced delirium  \\nHallucinogen -induced delirium is characterised by an acute state of disturbed \\nattention and awareness with specific features of delirium that develops during or \\nsoon after substance intoxication or  during the use of hallucinogens. The amount \\nand duration of hallucinogen use must be capable of producing delirium. The \\nsymptoms are not better explained by a primary mental disorder, by use of or \\nwithdrawal from a different substance, or by another healt h condition that is not \\nclassified under Mental, behavioural and neurodevelopmental disorders.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C49.5  Hallucinogen -induced psychotic disorder  \\nHallucinogen -induced psychotic disorder is characterised by psychoti c symptoms \\n(e.g. delusions, hallucinations, disorganised thinking, grossly disorganised \\nbehaviour) that develop during or soon after intoxication with hallucinogens. The \\nintensity or duration of the symptoms is substantially in excess of psychotic -like \\ndisturbances of perception, cognition, or behaviour that are characteristic of \\nhallucinogen intoxication. The amount and duration of hallucinogen use must be \\ncapable of producing psychotic symptoms. The symptoms are not better explained \\nby a primary mental di sorder (e.g. Schizophrenia, a Mood disorder with psychotic \\nsymptoms), as might be the case if the psychotic symptoms preceded the onset of \\nthe hallucinogen use, if the symptoms persist for a substantial period of time after \\ncessation of the hallucinogen us e, or if there is other evidence of a pre -existing \\nprimary mental disorder with psychotic symptoms (e.g. a history of prior episodes \\nnot associated with hallucinogen use).  \\nCoding Note:  Code also the causing condition  \\nExclusions:  Psychotic disorder induced by other specified psychoactive \\nsubstance (6C4E.6)  \\nAlcohol -induced psychotic disorder (6C40.6)',\n",
       " '6C49.6  Certain specified hallucinogen -induced mental or behavioural disorders  \\nCoding Note:  Code also the causing condition',\n",
       " '6C49.60  Hallucinogen -induced mood disorder  \\nHallucinogen -induced mood disorder is characterised by mood symptoms (e.g., \\ndepressed or elevated mood, decreased engagement in pleasurable activities, \\nincreased or decreased energy levels) that develop during or soon aft er intoxication \\nwith hallucinogens. The intensity or duration of the symptoms is substantially in \\nexcess of mood disturbances that are characteristic of hallucinogen intoxication. \\nThe amount and duration of hallucinogen use must be capable of producing moo d \\nsymptoms. The symptoms are not better explained by a primary mental disorder \\n(e.g., a Depressive disorder, a Bipolar disorder, Schizoaffective disorder), as might \\nbe the case if the mood symptoms preceded the onset of the hallucinogen use, if \\nthe symptom s persist for a substantial period of time after cessation of the \\nhallucinogen use, or if there is other evidence of a pre -existing primary mental \\ndisorder with mood symptoms (e.g., a history of prior episodes not associated with \\nhallucinogen use).  \\nCoding Note:  Code also the causing condition  \\n 512  ICD-11 MMS',\n",
       " '6C49.61  Hallucinogen -induced anxiety disorder  \\nHallucinogen -induced anxiety disorder is characterised by anxiety symptoms (e.g., \\napprehension or worry, fear, physiological symptoms of excessive autonomic \\narousal, avoid ance behaviour) that develop during or soon after intoxication with \\nhallucinogens. The intensity or duration of the symptoms is substantially in excess \\nof anxiety symptoms that are characteristic of hallucinogen intoxication. The amount \\nand duration of hal lucinogen use must be capable of producing anxiety symptoms. \\nThe symptoms are not better explained by a primary mental disorder (e.g., an \\nAnxiety and Fear -Related Disorder, a Depressive Disorder with prominent anxiety \\nsymptoms), as might be the case if the  anxiety symptoms preceded the onset of the \\nhallucinogen use, if the symptoms persist for a substantial period of time after \\ncessation of the hallucinogen use, or if there is other evidence of a pre -existing \\nprimary mental disorder with anxiety symptoms (e .g., a history of prior episodes not \\nassociated with hallucinogen use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C49.Y  Other specified disorders due to use of hallucinogens',\n",
       " '6C49.Z  Disorders due to use of hallucinogens, unspecified',\n",
       " '6C4A   Disorder s due to use of nicotine  \\nDisorders due to use of nicotine are characterised by the pattern and consequences \\nof nicotine use. Nicotine is the active dependence -producing constituent of the \\ntobacco plant, Nicotiana tabacum. Nicotine is used overwhelmingly th rough \\nsmoking cigarettes. Increasingly, it is also used in electronic cigarettes that vaporize \\nnicotine dissolved in a carrier solvent for inhalation (i.e., “vaping”). Pipe smoking, \\nchewing tobacco and inhaling snuff are minor forms of use. Nicotine is a h ighly \\npotent addictive compound and is the third most common psychoactive substance \\nused worldwide after caffeine and alcohol. Nicotine Dependence and Nicotine \\nWithdrawal are well described and Nicotine -Induced Mental Disorders are \\nrecognized.',\n",
       " '6C4A.0  Epis ode of harmful use of nicotine  \\nAn episode of nicotine use that has caused damage to a person’s physical or \\nmental health. Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) direct or secondary toxic effects on body organs and systems; or (2) a \\nharmful route  of administration. This diagnosis should not be made if the harm is \\nattributed to a known pattern of nicotine use.  \\nExclusions:  Nicotine dependence (6C4A.2)  \\nHarmful pattern of use of nicotine (6C4A.1)  \\nHarmful effects of or exposure to noxious substances, c hiefly \\nnonmedicinal as to source, not elsewhere classified \\n(NE61)  \\n ICD-11 MMS  513',\n",
       " '6C4A.1  Harmful pattern of use of nicotine  \\nA pattern of nicotine use that has caused damage to a person’s physical or mental \\nhealth. The pattern of nicotine use is evident over a period of a t least 12 months if \\nsubstance use is episodic or at least one month if use is continuous (i.e., daily or \\nalmost daily). Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) direct or secondary toxic effects on body organs and s ystems; or (2) a \\nharmful route of administration.  \\nExclusions:  Nicotine dependence (6C4A.2)  \\nEpisode of harmful use of nicotine (6C4A.0)',\n",
       " '6C4A.10  Harmful pattern of use of nicotine, episodic  \\nA pattern of episodic or intermittent nicotine use that has caused damage to a \\nperson’s physical or mental health. The pattern of episodic nicotine use is evident \\nover a period of at least 12 months. Harm to health of the individual occurs due to \\none or mo re of the following: (1) direct or secondary toxic effects on body organs \\nand systems; or (2) a harmful route of administration.  \\nExclusions:  Episode of harmful use of nicotine (6C4A.0)  \\nNicotine dependence (6C4A.2)',\n",
       " '6C4A.11  Harmful pattern of use of nicotin e, continuous  \\nA pattern of continuous (daily or almost daily) nicotine use that has caused damage \\nto a person’s physical or mental health. The pattern of continuous nicotine use is \\nevident over a period of at least one month. Harm to health of the individu al occurs \\ndue to one or more of the following: (1) direct or secondary toxic effects on body \\norgans and systems; or (2) a harmful route of administration.  \\nExclusions:  Episode of harmful use of nicotine (6C4A.0)  \\nNicotine dependence (6C4A.2)',\n",
       " '6C4A.1Z  Harmful  pattern of use of nicotine, unspecified',\n",
       " '6C4A.2  Nicotine dependence  \\nNicotine dependence is a disorder of regulation of nicotine use arising from \\nrepeated or continuous use of nicotine. The characteristic feature is a strong \\ninternal drive to use nicotine,  which is manifested by impaired ability to control use, \\nincreasing priority given to use over other activities and persistence of use despite \\nharm or negative consequences. These experiences are often accompanied by a \\nsubjective sensation of urge or cravi ng to use nicotine. Physiological features of \\ndependence may also be present, including tolerance to the effects of nicotine, \\nwithdrawal symptoms following cessation or reduction in use of nicotine, or \\nrepeated use of nicotine or pharmacologically similar substances to prevent or \\nalleviate withdrawal symptoms. The features of dependence are usually evident \\nover a period of at least 12 months but the diagnosis may be made if nicotine use is \\ncontinuous (daily or almost daily) for at least 3 months.  \\nExclusions : Episode of harmful use of nicotine (6C4A.0)  \\nHarmful pattern of use of nicotine (6C4A.1)  \\n 514  ICD-11 MMS',\n",
       " '6C4A.20  Nicotine dependence, current use  \\nCurrent nicotine dependence with nicotine use within the past month.  \\nExclusions:  Episode of harmful use of nicotine (6C4A.0)  \\nHarmful pattern of use of nicotine (6C4A.1)',\n",
       " '6C4A.21  Nicotine dependence, early full remission  \\nAfter a diagnosis of nicotine dependence, and often following a treatment episode \\nor other intervention (including self -help intervention), the individual has b een \\nabstinent from nicotine during a period lasting between 1 and 12 months.  \\nExclusions:  Episode of harmful use of nicotine (6C4A.0)  \\nHarmful pattern of use of nicotine (6C4A.1)',\n",
       " '6C4A.22  Nicotine dependence, sustained partial remission  \\nAfter a diagnosis of nicotine dependence, and often following a treatment episode \\nor other intervention (including self -help intervention), there is a significant reduction \\nin nicotine consumption for more than 12 months, such that even though \\nintermittent or continuing nicoti ne use has occurred during this period, the \\ndefinitional requirements for dependence have not been met.  \\nExclusions:  Episode of harmful use of nicotine (6C4A.0)  \\nHarmful pattern of use of nicotine (6C4A.1)',\n",
       " '6C4A.23  Nicotine dependence, sustained full remission  \\nAfter a diagnosis of nicotine dependence, and often following a treatment episode \\nor other intervention (including self -intervention), the person has been abstinent \\nfrom nicotine for 12 months or longer.  \\nExclus ions:  Episode of harmful use of nicotine (6C4A.0)  \\nHarmful pattern of use of nicotine (6C4A.1)',\n",
       " '6C4A.2Z  Nicotine dependence, unspecified',\n",
       " '6C4A.3  Nicotine intoxication  \\nNicotine intoxication is a clinically significant transient condition that develops during  \\nor shortly after the consumption of nicotine that is characterised by disturbances in \\nconsciousness, cognition, perception, affect, behaviour, or coordination. These \\ndisturbances are caused by the known pharmacological effects of nicotine and their \\nintens ity is closely related to the amount of nicotine consumed. They are time -\\nlimited and abate as nicotine is cleared from the body. Presenting features may \\ninclude restlessness, psychomotor agitation, anxiety, cold sweats, headache, \\ninsomnia, palpitations, pa resthesias, nausea or vomiting, abdominal cramps, \\nconfusion, bizarre dreams, burning sensations in the mouth, and salivation. In rare \\ninstances, paranoid ideation, perceptual disturbances, convulsions or coma may \\noccur. Nicotine intoxication occurs more co mmonly in naïve (non -tolerant) users or \\namong those taking higher than accustomed doses.  \\nCoding Note:  Code also the causing condition  \\nInclusions:  \"Bad trips\" due to nicotine  \\nExclusions:  intoxication meaning poisoning (NE61)  \\nPossession trance disorder (6B63 ) \\n ICD-11 MMS  515',\n",
       " '6C4A.4  Nicotine withdrawal  \\nNicotine withdrawal is a clinically significant cluster of symptoms, behaviours and/or \\nphysiological features, varying in degree of severity and duration, that occurs upon \\ncessation or reduction of use of nicotine (typically u sed as a constituent of tobacco) \\nin individuals who have developed Nicotine dependence or have used nicotine for a \\nprolonged period or in large amounts. Presenting features of Nicotine withdrawal \\nmay include dysphoric or depressed mood, insomnia, irritabil ity, anger, anxiety, \\ndifficulty concentrating, restlessness, bradycardia, increased appetite, and craving \\nfor tobacco (or other nicotine -containing products). Other physical symptoms may \\ninclude increased cough and mouth ulceration.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4A.Y  Other specified disorders due to use of nicotine',\n",
       " '6C4A.Z  Disorders due to use of nicotine, unspecified',\n",
       " '6C4B   Disorders due to use of volatile inhalants  \\nDisorders due to use of volatile inhalants are characterised by the pa ttern and \\nconsequences of volatile inhalant use. Volatile inhalants include a range of \\ncompounds that are in the gaseous or vapour phase at ambient temperatures and \\ninclude various organic solvents, glues, gasoline (petrol), nitrites and gases such as \\nnitrous oxide, trichloroethane, butane, toluene, fluorocarbons, ether and halothane. \\nThey have a range of pharmacological properties but are predominantly central \\nnervous system depressants, with many also having vasoactive effects. They tend \\nto be used by you nger persons and may be used when access to alternative \\npsychoactive substances is difficult or impossible. Volatile Inhalant Intoxication is \\nwell recognized. Volatile inhalants have dependence -producing properties and \\nVolatile Inhalant Dependence and Vola tile Inhalant Withdrawal is recognized \\nalthough comparatively uncommon worldwide. Volatile Inhalant -Induced Mental \\nDisorders are described. They may also cause neurocognitive impairment, including \\nDementia.',\n",
       " '6C4B.0  Episode of harmful use of volatile inhalants  \\nAn episode of volatile inhalant use or unintentional exposure (e.g., occupational \\nexposure) that has caused damage to a person’s physical or mental health or has \\nresulted in behaviour leading to harm to the heal th of others. Harm to health of the \\nindividual occurs due to one or more of the following: (1) behaviour related to \\nintoxication; (2) direct or secondary toxic effects on body organs and systems; or (3) \\na harmful route of administration. Harm to health of others includes any form of \\nphysical harm, including trauma, or mental disorder that is directly attributable to \\nbehaviour due to volatile inhalant intoxication on the part of the person to whom the \\ndiagnosis of single episode of harmful use applies. This diagnosis should not be \\nmade if the harm is attributed to a known pattern of volatile inhalant use.  \\nExclusions:  Harmful pattern of use of volatile inhalants (6C4B.1)  \\nVolatile inhalant dependence (6C4B.2)  \\n 516  ICD-11 MMS',\n",
       " '6C4B.1  Harmful pattern of use of volatile inhalants  \\nA pattern of volatile inhalant use that has caused damage to a person’s physical or \\nmental health. The pattern of volatile inhalant use is evident over a period of at least \\n12 months if substance use is episodic or at least one month if use is continuous \\n(i.e., daily or almost daily). Harm to health of the individual occurs due to one or \\nmore of the following: (1) behaviour related to intoxication; (1) direct or secondary \\ntoxic effects on body organs and systems; or (2) a harmful route of administration. \\nHarm to health of others includes any form of physical harm, including trauma, or \\nmental disorder that is directly attributable to behaviour related to volatile inhalant \\nintoxication on the part of the person to whom the diagnosis of Harmful pattern of \\nuse of volatile inhalants applies.  \\nExclusions:  Volatile inhalant dependence (6C4B.2)  \\nEpisode of harmful use of volatile inhalants (6C4B.0)',\n",
       " '6C4B.10  Harmful pattern of use of volatile inhalants, episodic  \\nA pattern of episodic or intermittent volatile inhalant use that has caused damage to \\na person’s physical or mental health or has resulted in behaviour leading to harm to \\nthe health of others. The pattern of episodic volatile inhalant use is evident over a  \\nperiod of at least 12 months. Harm to health of the individual occurs due to one or \\nmore of the following: (1) behaviour related to intoxication; (2) direct or secondary \\ntoxic effects on body organs and systems; or (3) a harmful route of administration. \\nHarm to health of others includes any form of physical harm, including trauma, or \\nmental disorder that is directly attributable to behaviour related to volatile inhalant \\nintoxication on the part of the person to whom the diagnosis of Harmful pattern of \\nuse of volatile inhalants applies.  \\nExclusions:  Episode of harmful use of volatile inhalants (6C4B.0)  \\nVolatile inhalant dependence (6C4B.2)',\n",
       " '6C4B.11  Harmful pattern of use of volatile inhalants, continuous  \\nA pattern of continuous (daily or almost daily) volatil e inhalant use that has caused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of continuous volatile inhalant use is \\nevident over a period of at least one month. Harm to heal th of the individual occurs \\ndue to one or more of the following: (1) behaviour related to intoxication; (2) direct \\nor secondary toxic effects on body organs and systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form o f physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour related \\nto volatile inhalant intoxication on the part of the person to whom the diagnosis of \\nHarmful pattern of use of volatile inhalants applies.  \\nExclusions:  Episode of harmful use of volatile inhalants (6C4B.0)  \\nVolatile inhalant dependence (6C4B.2)',\n",
       " '6C4B.1Z  Harmful pattern of use of volatile inhalants, unspecified  \\n ICD-11 MMS  517',\n",
       " '6C4B.2  Volatile inhalant dependence  \\nVolatile inhalant dependence is a disorder of regulation of volatile inhalant use \\narising from repeated or continuous use of volatile inhalants. The characteristic \\nfeature is a strong internal drive to use volatile inhalants, which is manifested by \\nimpaired ability to control use, increasing priority given to use o ver other activities \\nand persistence of use despite harm or negative consequences. These experiences \\nare often accompanied by a subjective sensation of urge or craving to use volatile \\ninhalants. Physiological features of dependence may also be present, inc luding \\ntolerance to the effects of volatile inhalants, withdrawal symptoms following \\ncessation or reduction in use of volatile inhalants, or repeated use of volatile \\ninhalants or pharmacologically similar substances to prevent or alleviate withdrawal \\nsympt oms. The features of dependence are usually evident over a period of at least \\n12 months but the diagnosis may be made if volatile inhalant use is continuous \\n(daily or almost daily) for at least 3 months.  \\nExclusions:  Episode of harmful use of volatile inhal ants (6C4B.0)  \\nHarmful pattern of use of volatile inhalants (6C4B.1)',\n",
       " '6C4B.20  Volatile inhalant dependence, current use  \\nCurrent volatile inhalant dependence with volatile inhalant use within the past \\nmonth.  \\nExclusions:  Episode of harmful use of volatile inhalants (6C4B.0)  \\nHarmful pattern of use of volatile inhalants (6C4B.1)',\n",
       " '6C4B.21  Volatile inhalant dependence, early full  remission  \\nAfter a diagnosis of volatile inhalant dependence, and often following a treatment \\nepisode or other intervention (including self -help intervention), the individual has \\nbeen abstinent from volatile inhalants during a period lasting between1 and 1 2 \\nmonths.  \\nExclusions:  Episode of harmful use of volatile inhalants (6C4B.0)  \\nHarmful pattern of use of volatile inhalants (6C4B.1)',\n",
       " '6C4B.22  Volatile inhalant dependence, sustained partial remission  \\nAfter a diagnosis of Volatile inhalant dependence, and ofte n following a treatment \\nepisode or other intervention (including self -help intervention), there is a significant \\nreduction in volatile inhalant consumption for more than 12 months, such that even \\nthough intermittent or continuing volatile inhalant use has occurred during this \\nperiod, the definitional requirements for dependence have not been met.  \\nExclusions:  Episode of harmful use of volatile inhalants (6C4B.0)  \\nHarmful pattern of use of volatile inhalants (6C4B.1)',\n",
       " '6C4B.23  Volatile inhalant dependence, sust ained full remission  \\nAfter a diagnosis of Volatile inhalant dependence, and often following a treatment \\nepisode or other intervention (including self -intervention), the person has been \\nabstinent from volatile inhalants for 12 months or longer.  \\nExclusions:  Episode of harmful use of volatile inhalants (6C4B.0)  \\nHarmful pattern of use of volatile inhalants (6C4B.1)',\n",
       " '6C4B.2Z  Volatile inhalant dependence, unspecified  \\n 518  ICD-11 MMS',\n",
       " '6C4B.3  Volatile inhalant intoxication  \\nVolatile inhalant intoxication is a clinically significant transient condition that \\ndevelops during or shortly after the consumption of a volatile inhalant that is \\ncharacterised by disturbances in consciousness, cognition, perception, affect, \\nbehaviour, or  coordination. These disturbances are caused by the known \\npharmacological effects of volatile inhalants and their intensity is closely related to \\nthe amount of volatile inhalant consumed. They are time -limited and abate as the \\nvolatile inhalant is cleared from the body. Presenting features may include euphoria, \\nimpaired judgment, aggression, somnolence, stupor or coma, dizziness, tremor, \\nlack of coordination, slurred speech, unsteady gait, lethargy and apathy, \\npsychomotor retardation, and visual disturbance s. Muscle weakness and diplopia \\nmay occur. Use of volatile inhalants may cause cardiac arrhythmia, cardiac arrest, \\nand death. Inhalants containing lead (e.g. some forms of petrol/gasoline) may cause \\nconfusion, irritability, coma and seizures.  \\nCoding Note:  Code also the causing condition  \\nExclusions:  Possession trance disorder (6B63)',\n",
       " '6C4B.4  Volatile inhalant withdrawal  \\nVolatile inhalant withdrawal is a clinically significant cluster of symptoms, \\nbehaviours and/or physiological features, varying in degree of severity and duration, \\nthat occurs upon cessation or reduction of use of volatile inhalants in individuals \\nwho have developed Volatile inhalant dependence or have used volatile inhalants \\nfor a prolonged period or in large amounts. Presenting features of Vo latile inhalant \\nwithdrawal may include insomnia, anxiety, irritability, dysphoric mood, shakiness, \\nperspiration, nausea, and transient illusions.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4B.5  Volatile inhalant -induced delirium  \\nVolatile inhalant -induced delirium is characterised by an acute state of disturbed \\nattention and awareness with specific features of delirium that develops during or \\nsoon after substance intoxication or withdrawal or duri ng the use of volatile \\ninhalants. The amount and duration of volatile inhalant use must be capable of \\nproducing delirium. The symptoms are not better explained by a primary mental \\ndisorder, by use of or withdrawal from a different substance, or by another health \\ncondition that is not classified under Mental, behavioural and neurodevelopmental \\ndisorders.  \\nCoding Note:  This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desire d to identify the \\npresence of dementia in diseases classified elsewhere.  \\nWhen dementia is due to multiple aetiologies, code all that apply.  \\n ICD-11 MMS  519',\n",
       " '6C4B.6  Volatile inhalant -induced psychotic disorder  \\nVolatile inhalant -induced psychotic disorder is characterised b y psychotic symptoms \\n(e.g. delusions, hallucinations, disorganized thinking, grossly disorganized \\nbehaviour) that develop during or soon after intoxication with or withdrawal from \\nvolatile inhalants. The intensity or duration of the symptoms is substantial ly in \\nexcess of psychotic -like disturbances of perception, cognition, or behaviour that are \\ncharacteristic of Volatile inhalant intoxication or Volatile inhalant withdrawal. The \\namount and duration of volatile inhalant use must be capable of producing psyc hotic \\nsymptoms. The symptoms are not better explained by a primary mental disorder \\n(e.g. Schizophrenia, a Mood disorder with psychotic symptoms), as might be the \\ncase if the psychotic symptoms preceded the onset of the volatile inhalant use, if \\nthe symptom s persist for a substantial period of time after cessation of the volatile \\ninhalant use or withdrawal, or if there is other evidence of a pre -existing primary \\nmental disorder with psychotic symptoms (e.g. a history of prior episodes not \\nassociated with vol atile inhalant use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4B.7  Certain specified volatile inhalants -induced mental or behavioural disorders  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4B.70  Volatile inhalant -induced mood disorder  \\nVolatile in halant -induced mood disorder is characterised by mood symptoms (e.g., \\ndepressed or elevated mood, decreased engagement in pleasurable activities, \\nincreased or decreased energy levels) that develop during or soon after intoxication \\nwith or withdrawal from v olatile inhalants. The intensity or duration of the symptoms \\nis substantially in excess of mood disturbances that are characteristic of Volatile \\ninhalant intoxication or Volatile inhalant withdrawal. The amount and duration of \\nvolatile inhalant use must be  capable of producing mood symptoms. The symptoms \\nare not better explained by a primary mental disorder (e.g., a Depressive disorder, a \\nBipolar disorder, Schizoaffective disorder), as might be the case if the mood \\nsymptoms preceded the onset of the volatil e inhalant use, if the symptoms persist \\nfor a substantial period of time after cessation of the volatile inhalant use or \\nwithdrawal, or if there is other evidence of a pre -existing primary mental disorder \\nwith mood symptoms (e.g., a history of prior episod es not associated with volatile \\ninhalant use).  \\nCoding Note:  Code also the causing condition  \\n 520  ICD-11 MMS',\n",
       " '6C4B.71  Volatile inhalant -induced anxiety disorder  \\nVolatile inhalant -induced anxiety disorder is characterised by anxiety symptoms \\n(e.g., apprehension or worry, fe ar, physiological symptoms of excessive autonomic \\narousal, avoidance behaviour) that develop during or soon after intoxication with or \\nwithdrawal from volatile inhalants. The intensity or duration of the symptoms is \\nsubstantially in excess of anxiety sympt oms that are characteristic of Volatile \\ninhalant intoxication or Volatile inhalant withdrawal. The amount and duration of \\nvolatile inhalant use must be capable of producing anxiety symptoms. The \\nsymptoms are not better explained by a primary mental disorde r (e.g., an Anxiety \\nand Fear -Related Disorder, a Depressive Disorder with prominent anxiety \\nsymptoms), as might be the case if the anxiety symptoms preceded the onset of the \\nvolatile inhalant use, if the symptoms persist for a substantial period of time af ter \\ncessation of the volatile inhalant use or withdrawal, or if there is other evidence of a \\npre-existing primary mental disorder with anxiety symptoms (e.g., a history of prior \\nepisodes not associated with volatile inhalant use).  \\nCoding Note:  Code also th e causing condition',\n",
       " '6C4B.Y  Other specified disorders due to use of volatile inhalants',\n",
       " '6C4B.Z  Disorders due to use of volatile inhalants, unspecified',\n",
       " '6C4C   Disorders due to use of MDMA or related drugs, including MDA  \\nDisorders due to use of MDMA or re lated drugs, including MDA are characterised \\nby the pattern and consequences of MDMA or related drug use. MDMA is \\nmethylene -dioxymethamphetamine and is a common drug of abuse in many \\ncountries especially among young people. It is predominantly available in  tablet \\nform known as ‘ecstasy’. Pharmacologically, MDMA has stimulant and \\nempathogenic properties and these encourage its use among young people for \\nsocial and other interactions. Considering its wide prevalence in many countries and \\namong many sub -groups  of young people, MDMA and Related Drug Dependence \\nand MDMA and Related Drug Withdrawal are comparatively uncommon. \\nSubstance -Induced Mental Disorders may arise from its use. Several analogues of \\nMDMA exist, including MDA (methylene -dioxyamphetamine).  \\nExclusions:  Hazardous use of MDMA or related drugs (QE11.6)',\n",
       " '6C4C.0  Episode of harmful use of MDMA or related drugs, including MDA  \\nAn episode of use of MDMA or related drugs, including MDA, that has caused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. Harm to health of the individual occurs due to one or \\nmore of the following: (1) behaviour related to intoxication; (2) direct or secondary \\ntoxic effects on body organs and systems; or (3) a harmful route of administration. \\nHarm to health of others includes any form of physical harm, including trauma, or \\nmental disorder that is directly attributable to behaviour due to intoxication with \\nMDMA or related drugs, including MDA, on the part of th e person to whom the \\ndiagnosis of single episode of harmful use applies. This diagnosis should not be \\nmade if the harm is attributed to a known pattern of use of MDMA or related drugs, \\nincluding MDA.  \\nExclusions:  Harmful pattern of use of MDMA or related drugs, including \\nMDA (6C4C.1)  \\nMDMA or related drug dependence, including MDA (6C4C.2)  \\n ICD-11 MMS  521',\n",
       " '6C4C.1  Harmful pattern of use of MDMA or related drugs, including MDA  \\nA pattern of use of MDMA or related drugs, including MDA,  that has caused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of use of MDMA or related drugs is \\nevident over a period of at least 12 months if use is episodic or at least one month if \\nuse is continuous (i.e., daily or almost daily). Harm to health of the individual occurs \\ndue to one or more of the following: (1) behaviour related to intoxication; (2) direct \\nor secondary toxic effects on body organs and systems; or (3) a har mful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour related \\nto MDMA or related drug intoxication on the part of the person to whom the \\ndiagnosis of Harmful pattern of use of MDMA or related drugs, including MDA \\napplies.  \\nExclusions:  MDMA or related drug dependence, including MDA (6C4C.2)  \\nEpisode of harmful use of MDMA or related drugs, including \\nMDA (6C4C.0)',\n",
       " '6C4C.10  Harmful use of MDMA or r elated drugs, including MDA, episodic  \\nA pattern of episodic or intermittent use of MDMA or related drugs, including MDA, \\nthat has caused damage to a person’s physical or mental health or has resulted in \\nbehaviour leading to harm to the health of others. Th e pattern of episodic use of \\nMDMA or related drugs is evident over a period of at least 12 months. Harm to \\nhealth of the individual occurs due to one or more of the following: (1) behaviour \\nrelated to intoxication; (2) direct or secondary toxic effects on body organs and \\nsystems; or (3) a harmful route of administration. Harm to health of others includes \\nany form of physical harm, including trauma, or mental disorder that is directly \\nattributable to behaviour related to MDMA or related drug intoxication on the part of \\nthe person to whom the diagnosis of Harmful pattern of use of MDMA or related \\ndrugs, including MDA applies.  \\nExclusions:  Episode of harmful use of MDMA or related drugs, including \\nMDA (6C4C.0)  \\nMDMA or related drug dependence, including MDA (6C4C .2)',\n",
       " '6C4C.11  Harmful use of MDMA or related drugs, including MDA, continuous  \\nA pattern of continuous (daily or almost daily) use of MDMA or related drugs, \\nincluding MDA, that has caused damage to a person’s physical or mental health or \\nhas resulted in beha viour leading to harm to the health of others. The pattern of \\ncontinuous use of MDMA or related drugs is evident over a period of at least one \\nmonth. Harm to health of the individual occurs due to one or more of the following: \\n(1) behaviour related to into xication; (2) direct or secondary toxic effects on body \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including trauma, or mental disorder that \\nis directly attributable to behavio ur related to MDMA or related drug intoxication on \\nthe part of the person to whom the diagnosis of Harmful pattern of use of MDMA or \\nrelated drugs, including MDA applies.  \\nExclusions:  Episode of harmful use of MDMA or related drugs, including \\nMDA (6C4C.0)  \\nMDMA or related drug dependence, including MDA (6C4C.2)',\n",
       " '6C4C.1Z  Harmful pattern of use of MDMA or related drugs, including MDA, unspecified  \\n 522  ICD-11 MMS',\n",
       " '6C4C.2  MDMA or related drug dependence, including MDA  \\nMDMA or related drug dependence, including MDA is a disorder of regulation of \\nMDMA or related drug use arising from repeated or continuous use of MDMA or \\nrelated drugs. The characteristic feature is a strong internal drive to use MDMA or \\nrelated drugs, which is manifested by impaired ability to control use, increasi ng \\npriority given to use over other activities and persistence of use despite harm or \\nnegative consequences. These experiences are often accompanied by a subjective \\nsensation of urge or craving to use MDMA or related drugs. Physiological features \\nof depend ence may also be present, including tolerance to the effects of MDMA or \\nrelated drugs, withdrawal symptoms following cessation or reduction in use of \\nMDMA or related drugs, or repeated use of MDMA or pharmacologically similar \\nsubstances to prevent or allev iate withdrawal symptoms. The features of \\ndependence are usually evident over a period of at least 12 months but the \\ndiagnosis may be made if MDMA or related drug use is continuous (daily or almost \\ndaily) for at least 3 months.  \\nExclusions:  Episode of harmf ul use of MDMA or related drugs, including \\nMDA (6C4C.0)  \\nHarmful pattern of use of MDMA or related drugs, including \\nMDA (6C4C.1)',\n",
       " '6C4C.20  MDMA or related drug dependence, including MDA, current use  \\nCurrent MDMA or related drug dependence, including MDA, with MDMA or related \\ndrug use within the past month.  \\nExclusions:  Episode of harmful use of MDMA or related drugs, including \\nMDA (6C4C.0)  \\nHarmful pattern of use of MDMA or related drugs, including \\nMDA (6C4C.1)',\n",
       " '6C4C.21  MDMA or related drug dependence, including MDA, early full remission  \\nAfter a diagnosis of MDMA or related drug dependence, including MDA, and often \\nfollowing a treatment episode or other intervention (including self -help intervention), \\nthe individual has been abstinent from MDMA or related drug dependence, \\nincluding MDA, during a period lasting from between 1 and 12 months.  \\nExclusions:  Episode of harmful use of MDMA or related drugs, including \\nMDA (6C4C.0)  \\nHarmful pattern of use of MDMA or  related drugs, including \\nMDA (6C4C.1)',\n",
       " '6C4C.22  MDMA or related drug dependence, including MDA, sustained partial remission  \\nAfter a diagnosis of MDMA or related drug dependence, including MDA, and often \\nfollowing a treatment episode or other intervention ( including self -help intervention), \\nthere is a significant reduction in consumption of MDMA or related drugs, including \\nMDA, for more than 12 months, such that even though intermittent or continuing use \\nof MDMA or related drugs, including MDA, has occurred during this period, the \\ndefinitional requirements for dependence have not been met.  \\nExclusions:  Episode of harmful use of MDMA or related drugs, including \\nMDA (6C4C.0)  \\nHarmful pattern of use of MDMA or related drugs, including \\nMDA (6C4C.1)  \\n ICD-11 MMS  523',\n",
       " '6C4C.23  MDMA or related drug dependence, including MDA, sustained full remission  \\nAfter a diagnosis of MDMA or related drug dependence, including MDA, and often \\nfollowing a treatment episode or other intervention (including self -intervention), the \\nperson has been a bstinent from MDMA or related drugs, including MDA, for 12 \\nmonths or longer.  \\nExclusions:  Episode of harmful use of MDMA or related drugs, including \\nMDA (6C4C.0)  \\nHarmful pattern of use of MDMA or related drugs, including \\nMDA (6C4C.1)',\n",
       " '6C4C.2Z  MDMA or relate d drug dependence, including MDA, unspecified',\n",
       " '6C4C.3  MDMA or related drug intoxication, including MDA  \\nMDMA or related drug intoxication, including MDA is a clinically significant transient \\ncondition that develops during or shortly after the consumption of  MDMA or related \\ndrugs that is characterised by disturbances in consciousness, cognition, perception, \\naffect, behaviour, or coordination. These disturbances are caused by the known \\npharmacological effects of MDMA or related drugs and their intensity is clo sely \\nrelated to the amount of MDMA or a related drug consumed. They are time -limited \\nand abate as MDMA or a related drug is cleared from the body. Presenting features \\nmay include increased or inappropriate sexual interest and activity, anxiety, \\nrestlessnes s, agitation, and sweating. In rare instances, usually in severe \\nintoxication, use of MDMA or related drugs, including MDA can result in dystonia \\nand seizures. Sudden death is a rare but recognised complication.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4C.4  MDMA or related drug withdrawal, including MDA  \\nMDMA or related drug withdrawal, including MDA is a clinically significant cluster of \\nsymptoms, behaviours and/or physiological features, varying in degree of severity \\nand duration, that occurs upon cessation or reduction of use of MDMA or related \\ndrugs in  individuals who have developed MDMA or related drug dependence or \\nhave used MDMA or related drugs for a prolonged period or in large amounts. \\nPresenting features of MDMA or related drug withdrawal may include fatigue, \\nlethargy, hypersomnia or insomnia, de pressed mood, anxiety, irritability, craving, \\ndifficulty in concentrating, and appetite disturbance.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4C.5  MDMA or related drug -induced delirium, including MDA  \\nMDMA or related drug -induced delirium, including MDA is characterised by an acute \\nstate of disturbed attention and awareness with specific features of delirium that \\ndevelops during or soon after substance intoxication or during the use of MDMA or \\nrelated drugs. The amount and duration of MDMA or related drug use must be \\ncapable of producing delirium. The symptoms are not better explained by a primary \\nmental disorder, by use of or withdrawal from a different substance, or by another \\nhealth condition that is not classified under Mental, behavioural and \\nneurodevelopmental disorders.  \\nCoding Note:  Code also the causing condition  \\n 524  ICD-11 MMS',\n",
       " '6C4C.6  MDMA or related drug -induced psychotic disorder, including MDA  \\nMDMA or related drug -induced psychotic disorder, including MDA is characterised \\nby psychotic symptoms (e.g., delus ions, hallucinations, disorganised thinking, \\ngrossly disorganised behaviour) that develop during or soon after intoxication with \\nMDMA or related drugs. The intensity or duration of the symptoms is substantially in \\nexcess of psychotic -like disturbances of p erception, cognition, or behaviour that are \\ncharacteristic of MDMA or related drug intoxication. The amount and duration of \\nMDMA or related drug use must be capable of producing psychotic symptoms. The \\nsymptoms are not better explained by a primary mental disorder (e.g., \\nSchizophrenia, a Mood disorder with psychotic symptoms), as might be the case if \\nthe psychotic symptoms preceded the onset of the MDMA or related drug use, if the \\nsymptoms persist for a substantial period of time after cessation of the MDMA  or \\nrelated drug use, or if there is other evidence of a pre -existing primary mental \\ndisorder with psychotic symptoms (e.g., a history of prior episodes not associated \\nwith MDMA or related drug use, including MDA).  \\nCoding Note:  Code also the causing condit ion',\n",
       " '6C4C.7  Certain specified MDMA or related drug -induced mental or behavioural \\ndisorders, including MDA  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4C.70  MDMA or related drug -induced mood disorder, including MDA  \\nMDMA or related drug -induced mood diso rder, including MDA is characterised by \\nmood symptoms (e.g., depressed or elevated mood, decreased engagement in \\npleasurable activities, increased or decreased energy levels) that develop during or \\nsoon after intoxication with MDMA or related drugs. The in tensity or duration of the \\nsymptoms is substantially in excess of mood disturbances that are characteristic of \\nMDMA or related drug intoxication, including MDA. The amount and duration of \\nMDMA or related drug use must be capable of producing mood symptoms.  The \\nsymptoms are not better explained by a primary mental disorder (e.g., a Depressive \\ndisorder, a Bipolar disorder, Schizoaffective disorder), as might be the case if the \\nmood symptoms preceded the onset of the MDMA or related drug use, if the \\nsymptoms p ersist for a substantial period of time after cessation of the MDMA or \\nrelated drug use, or if there is other evidence of a pre -existing primary mental \\ndisorder with mood symptoms (e.g., a history of prior episodes not associated with \\nMDMA or related drug use).  \\nCoding Note:  Code also the causing condition  \\n ICD-11 MMS  525',\n",
       " '6C4C.71  MDMA or related drug -induced anxiety disorder  \\nMDMA or related drug -induced anxiety disorder, including MDA is characterised by \\nanxiety symptoms (e.g., apprehension or worry, fear, physiological sy mptoms of \\nexcessive autonomic arousal, avoidance behaviour) that develop during or soon \\nafter intoxication with MDMA or related drugs. The intensity or duration of the \\nsymptoms is substantially in excess of anxiety symptoms that are characteristic of \\nMDMA or related drug intoxication, including MDA. The amount and duration of \\nMDMA or related drug use must be capable of producing anxiety symptoms. The \\nsymptoms are not better explained by a primary mental disorder (e.g., an Anxiety \\nand fear -related disorder, a Depressive disorder with prominent anxiety symptoms), \\nas might be the case if the anxiety symptoms preceded the onset of the MDMA or \\nrelated drug use, if the symptoms persist for a substantial period of time after \\ncessation of the MDMA or related drug us e, or if there is other evidence of a pre -\\nexisting primary mental disorder with anxiety symptoms (e.g., a history of prior \\nepisodes not associated with MDMA or related drug use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4C.Y  Other specified disorder s due to use of MDMA or related drugs, including \\nMDA',\n",
       " '6C4C.Z  Disorders due to use of MDMA or related drugs, including MDA, unspecified',\n",
       " '6C4D   Disorders due to use of dissociative drugs including ketamine and \\nphencyclidine [PCP]  \\nDisorders due to use of dissociative drugs including ketamine and phencyclidine \\n[PCP] are characterised by the pattern and consequences of dissociative drug use. \\nDissociative drugs include ketamine and phencyclidine (PCP) and their \\n(comparatively rare) che mical analogues. Ketamine is an intravenous anaesthetic \\nwidely used in low - and middle -income countries, particularly in Africa, and in \\nemergency situations. Ketamine is also undergoing evaluation for treatment of \\nsome mental disorders (e.g., treatment res istant Depressive Disorders). It is also a \\nwidespread drug of nonmedical use in many countries and may be taken by the oral \\nor nasal routes or injected. It produces a sense of euphoria but depending on the \\ndose, emergent hallucinations and dissociation are  recognised as unpleasant side \\neffects. Phencyclidine has a more restricted worldwide distribution and also has \\neuphoric and dissociative effects. Its use may result in bizarre behaviour \\nuncharacteristic for the individual, including self -harm. Dissociativ e Drug \\nDependence is described but a withdrawal syndrome is not recognized by most \\nauthorities. Several Dissociative Drug -Induced Mental Disorders are recognised.  \\nExclusions:  Hazardous use of dissociative drugs including ketamine or \\nPCP (QE11.7)  \\n 526  ICD-11 MMS',\n",
       " '6C4D.0  Episode of harmful use of dissociative drugs including ketamine or PCP  \\nAn episode of use of a dissociative drug, including Ketamine and PCP, that has \\ncaused damage to a person’s  physical or mental health or has resulted in behaviour \\nleading to harm to the health of others. Harm to health of the individual occurs due \\nto one or more of the following: (1) behaviour related to intoxication; (2) direct or \\nsecondary toxic effects on bo dy organs and systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour due to \\nintoxication with a dissociative drug, incl uding Ketamine and PCP, on the part of the \\nperson to whom the diagnosis of single episode of harmful use applies. This \\ndiagnosis should not be made if the harm is attributed to a known pattern of use of \\ndissociative drugs, including Ketamine and PCP.  \\nExclu sions:  Dissociative drug dependence including ketamine or PCP \\n(6C4D.2)  \\nHarmful pattern of use of dissociative drugs, including \\nketamine or PCP (6C4D.1)',\n",
       " '6C4D.1  Harmful pattern of use of dissociative drugs, including ketamine or PCP  \\nA pattern of use of diss ociative drugs, including ketamine and phencyclidine (PCP), \\nthat has caused damage to a person’s physical or mental health or has resulted in \\nbehaviour leading to harm to the health of others. The pattern of dissociative drug \\nuse is evident over a period o f at least 12 months if use is episodic or at least one \\nmonth if use is continuous (i.e., daily or almost daily). Harm to health of the \\nindividual occurs due to one or more of the following: (1) behaviour related to \\nintoxication; (2) direct or secondary to xic effects on body organs and systems; or (3) \\na harmful route of administration. Harm to health of others includes any form of \\nphysical harm, including trauma, or mental disorder that is directly attributable to \\nbehaviour related to dissociative drug into xication on the part of the person to whom \\nthe diagnosis of Harmful pattern of use of dissociative drugs, including ketamine \\nand PCP applies.  \\nExclusions:  Dissociative drug dependence including ketamine or PCP \\n(6C4D.2)  \\nEpisode of harmful use of dissociative  drugs including \\nketamine or PCP (6C4D.0)  \\n ICD-11 MMS  527',\n",
       " '6C4D.10  Harmful pattern of use of dissociative drugs including ketamine or PCP, episodic  \\nA pattern of episodic or intermittent use of dissociative drugs, including ketamine \\nand phencyclidine (PCP), that has caused  damage to a person’s physical or mental \\nhealth or has resulted in behaviour leading to harm to the health of others. The \\npattern of episodic use of dissociative drugs is evident over a period of at least 12 \\nmonths. Harm to health of the individual occurs due to one or more of the following: \\n(1) behaviour related to intoxication; (2) direct or secondary toxic effects on body \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including t rauma, or mental disorder that \\nis directly attributable to behaviour related to dissociative drug intoxication on the \\npart of the person to whom the diagnosis of Harmful pattern of use of dissociative \\ndrugs, including ketamine and PCP applies.  \\nExclusions:  Episode of harmful use of dissociative drugs including \\nketamine or PCP (6C4D.0)  \\nDissociative drug dependence including ketamine or PCP \\n(6C4D.2)',\n",
       " '6C4D.11  Harmful pattern of use of dissociative drugs including ketamine or PCP, continuous  \\nA pattern of continu ous (daily or almost daily) use of dissociative drugs, including \\nketamine and phencyclidine (PCP), that has caused damage to a person’s physical \\nor mental health or has resulted in behaviour leading to harm to the health of others. \\nThe pattern of continuou s use of dissociative drugs is evident over a period of at \\nleast one month. Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effects \\non body organs and systems ; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of physical harm, including trauma, or mental \\ndisorder that is directly attributable to behaviour related to dissociative drug \\nintoxication on the part of the person to whom the diagnosis of Harmful pattern of \\nuse of dissociative drugs, including ketamine and PCP applies.  \\nExclusions:  Episode of harmful use of dissociative drugs including \\nketamine or PCP (6C4D.0)  \\nDissociative drug dependence including ketamine or PCP \\n(6C4D .2)',\n",
       " '6C4D.1Z  Harmful pattern of use of dissociative drugs, including ketamine or PCP, unspecified  \\n 528  ICD-11 MMS',\n",
       " '6C4D.2  Dissociative drug dependence including ketamine or PCP  \\nDissociative drug dependence including ketamine or PCP is a disorder of regulation \\nof dissociat ive drug use arising from repeated or continuous use of dissociative \\ndrugs. The characteristic feature is a strong internal drive to use dissociative drugs, \\nwhich is manifested by impaired ability to control use, increasing priority given to \\nuse over other  activities and persistence of use despite harm or negative \\nconsequences. These experiences are often accompanied by a subjective \\nsensation of urge or craving to use dissociative drugs. The features of dependence \\nare usually evident over a period of at lea st 12 months but the diagnosis may be \\nmade if dissociative drugs use is continuous (daily or almost daily) for at least 3 \\nmonths.  \\nExclusions:  Episode of harmful use of dissociative drugs including \\nketamine or PCP (6C4D.0)  \\nHarmful pattern of use of dissocia tive drugs, including \\nketamine or PCP (6C4D.1)',\n",
       " '6C4D.20  Dissociative drug dependence including Ketamine or PCP, current use  \\nDissociative drug dependence including Ketamine and PCP, current use refers to \\nuse of dissociative drugs within the past month.  \\nExclusions:  Episode of harmful use of dissociative drugs including \\nketamine or PCP (6C4D.0)  \\nHarmful pattern of use of dissociati ve drugs, including \\nketamine or PCP (6C4D.1)',\n",
       " '6C4D.21  Dissociative drug dependence including ketamine or PCP, early full remission  \\nAfter a diagnosis of Dissociative drug dependence including ketamine and PCP, \\nand often following a treatment episode or othe r intervention (including self -help \\nintervention), the individual has been abstinent from dissociative drugs during a \\nperiod lasting between 1 and 12 months.  \\nExclusions:  Episode of harmful use of dissociative drugs including \\nketamine or PCP (6C4D.0)  \\nHarmful pattern of use of dissociative drugs, including \\nketamine or PCP (6C4D.1)',\n",
       " '6C4D.22  Dissociative drug dependence including Ketamine or PCP, sustained partial \\nremission  \\nAfter a diagnosis of Dissociative drug dependence including Ketamine and PCP, \\nand often following a treatment episode or other intervention (including self -help \\nintervention), there is a significant reduction in dissociative drug consumption for \\nmore than 12 months, such that even though intermittent or continuing dissociative \\ndrug use has occurred during this period, the definitional requirements for \\ndependence have not been met.  \\nExclusions:  Episode of harmful use of dissociative drugs including \\nketamine or PCP (6C4D.0)  \\nHarmful pattern of use of dissociative drugs, including \\nketamine or  PCP (6C4D.1)  \\n ICD-11 MMS  529',\n",
       " '6C4D.23  Dissociative drug dependence including Ketamine or PCP, sustained full remission  \\nAfter a diagnosis of Dissociative drug dependence including Ketamine and PCP, \\nand often following a treatment episode or other intervention (including s elf-\\nintervention), the person has been abstinent from dissociative drugs for 12 months \\nor longer.  \\nExclusions:  Episode of harmful use of dissociative drugs including \\nketamine or PCP (6C4D.0)  \\nHarmful pattern of use of dissociative drugs, including \\nketamine o r PCP (6C4D.1)',\n",
       " '6C4D.2Z  Dissociative drug dependence including ketamine or PCP, unspecified',\n",
       " '6C4D.3  Dissociative drug intoxication including Ketamine or PCP  \\nDissociative drug intoxication including Ketamine and PCP is a clinically significant \\ntransient con dition that develops during or shortly after the consumption of a \\ndissociative drug that is characterised by disturbances in consciousness, cognition, \\nperception, affect, behaviour, or coordination. These disturbances are caused by \\nthe known pharmacologica l effects of a dissociative drug and their intensity is \\nclosely related to the amount of the dissociative drug consumed. They are time -\\nlimited and abate as the dissociative drug is cleared from the body. Presenting \\nfeatures may include aggression, impulsiv eness, unpredictability, anxiety, \\npsychomotor agitation, impaired judgment, numbness or diminished responsiveness \\nto pain, slurred speech, and dystonia. Physical signs include nystagmus (repetitive, \\nuncontrolled eye movements), tachycardia, elevated blood pressure, numbness, \\nataxia, dysarthria, and muscle rigidity. In rare instances, use of dissociative drugs \\nincluding Ketamine and PCP can result in seizures.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4D.4  Dissociative drug -induced delirium including k etamine or PCP  \\nDissociative drug -induced delirium including Ketamine or PCP is characterised by \\nan acute state of disturbed attention and awareness with specific features of \\ndelirium that develops during or soon after substance intoxication or during the use \\nof dissociat ive drugs. The amount and duration of dissociative drug use must be \\ncapable of producing delirium. The symptoms are not better explained by a primary \\nmental disorder, by use of or withdrawal from a different substance, or by another \\nhealth condition that i s not classified under Mental, behavioural and \\nneurodevelopmental disorders.  \\nCoding Note:  Code also the causing condition  \\n 530  ICD-11 MMS',\n",
       " '6C4D.5  Dissociative drug -induced psychotic disorder including Ketamine or PCP  \\nDissociative drug -induced psychotic disorder including Ketamine or PCP is \\ncharacterised by psychotic symptoms (e.g., delusions, hallucinations, disorganised \\nthinking, grossly disorganised behaviour) that develop during or soon after \\nintoxication with dissociative drugs. The intensity or duration of the symptom s is \\nsubstantially in excess of psychotic -like disturbances of perception, cognition, or \\nbehaviour that are characteristic of Dissociative drug intoxication. The amount and \\nduration of Dissociative drug use must be capable of producing psychotic \\nsymptoms. The symptoms are not better explained by a primary mental disorder \\n(e.g., Schizophrenia, a Mood disorder with psychotic symptoms), as might be the \\ncase if the psychotic symptoms preceded the onset of the dissociative drug use, if \\nthe symptoms persist for a  substantial period of time after cessation of the \\ndissociative drug use, or if there is other evidence of a pre -existing primary mental \\ndisorder with psychotic symptoms (e.g., a history of prior episodes not associated \\nwith dissociative drug use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4D.6  Certain specified dissociative drug -induced mental or behavioural disorders, \\nincluding ketamine and phencyclidine [PCP]  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4D.60  Dissociative drug -induced mood disor der including Ketamine or PCP  \\nDissociative drug -induced mood disorder including Ketamine or PCP is \\ncharacterised by mood symptoms (e.g., depressed or elevated mood, decreased \\nengagement in pleasurable activities, increased or decreased energy levels) that \\ndevelop during or soon after intoxication with dissociative drugs. The intensity or \\nduration of the symptoms is substantially in excess of mood disturbances that are \\ncharacteristic of Dissociative drug intoxication. The amount and duration of \\nDissociative drug use must be capable of producing mood symptoms. The \\nsymptoms are not better explained by a primary mental disorder (e.g., a Depressive \\ndisorder, a Bipolar disorder, Schizoaffective disorder), as might be the case if the \\nmood symptoms preceded the onse t of the dissociative drug use, if the symptoms \\npersist for a substantial period of time after cessation of the dissociative drug use, \\nor if there is other evidence of a pre -existing primary mental disorder with mood \\nsymptoms (e.g., a history of prior epis odes not associated with dissociative drug \\nuse).  \\nCoding Note:  Code also the causing condition  \\n ICD-11 MMS  531',\n",
       " '6C4D.61  Dissociative drug -induced anxiety disorder including Ketamine or PCP  \\nDissociative drug -induced anxiety disorder including Ketamine or PCP is \\ncharacterise d by anxiety symptoms (e.g., apprehension or worry, fear, physiological \\nsymptoms of excessive autonomic arousal, avoidance behaviour) that develop \\nduring or soon after intoxication with dissociative drugs. The intensity or duration of \\nthe symptoms is subst antially in excess of anxiety symptoms that are characteristic \\nof Dissociative drug intoxication. The amount and duration of Dissociative drug use \\nmust be capable of producing anxiety symptoms. The symptoms are not better \\nexplained by a primary mental diso rder (e.g., an Anxiety and Fear -Related Disorder, \\na Depressive Disorder with prominent anxiety symptoms), as might be the case if \\nthe anxiety symptoms preceded the onset of the dissociative drug use, if the \\nsymptoms persist for a substantial period of time  after cessation of the dissociative \\ndrug use, or if there is other evidence of a pre -existing primary mental disorder with \\nanxiety symptoms (e.g., a history of prior episodes not associated with dissociative \\ndrug use).  \\nCoding Note:  Code also the causing c ondition',\n",
       " '6C4D.Y  Other specified disorders due to use of dissociative drugs including ketamine \\nand phencyclidine [PCP]',\n",
       " '6C4D.Z  Disorders due to use of dissociative drugs including ketamine and \\nphencyclidine [PCP], unspecified',\n",
       " '6C4E   Disorders due to use of other specified psychoactive substances, \\nincluding medications  \\nDisorders due to use of other specified psychoactive substances, including \\nmedications are characterised by the pattern and consequences of psychoactive \\nsubstances that are not included among the major substance classes specifically \\nidentified. Examples include khat, antidepressants, medications with anticholinergic \\nproperties (e.g., benztropine), and some antihistamines.',\n",
       " '6C4E.0  Episode of harmful use of other specified psychoactive substance  \\nAn episode of use of a specified psychoactive substance or medication that is not \\nincluded in the other substance classes specifically identified under Disorders Due \\nto Substance Use that has caused damage to a person’s physical or m ental health \\nor has resulted in behaviour leading to harm to the health of others. Harm to health \\nof the individual occurs due to one or more of the following: (1) behaviour related to \\nsubstance intoxication or psychoactive medication use; (2) direct or se condary toxic \\neffects on body organs and systems; or (3) a harmful route of administration. Harm \\nto health of others includes any form of physical harm, including trauma, or mental \\ndisorder that is directly attributable to behaviour related to substance in toxication or \\npsychoactive medication use on the part of the person to whom the diagnosis of \\nsingle episode of harmful use of other specified psychoactive substance applies. \\nThis diagnosis should not be made if the harm is attributed to a known pattern of \\nuse of the specified psychoactive substance.  \\nExclusions:  Harmful pattern of use of other specified psychoactive \\nsubstance (6C4E.1)  \\nOther specified psychoactive substance dependence (6C4E.2)  \\n 532  ICD-11 MMS',\n",
       " '6C4E.1  Harmful pattern of use of other specified psychoactive substance  \\nA pattern of use of a specified psychoactive substance or medication that is not \\nincluded in the other substance classes specifically identified under Disorders Due \\nto Substance Use that has caused damage to a person’s physical or mental health \\nor has resulted in behaviour leading to harm to the health of others. The pattern of \\nsubstance use is evident over a period of at least 12 months if use is episodic or at \\nleast one month if use is conti nuous (i.e., daily or almost daily). Harm to health of \\nthe individual occurs due to one or more of the following: (1) behaviour related to \\nintoxication; (2) direct or secondary toxic effects on body organs and systems; or (3) \\na harmful route of administrat ion. Harm to health of others includes any form of \\nphysical harm, including trauma, or mental disorder that is directly attributable to \\nbehaviour related to intoxication due to the specified substance or medication on \\nthe part of the person to whom the dia gnosis of Harmful pattern of use of other \\nspecified psychoactive substance applies.  \\nExclusions:  Other specified psychoactive substance dependence (6C4E.2)  \\nEpisode of harmful use of other specified psychoactive \\nsubstance (6C4E.0)',\n",
       " '6C4E.10  Harmful pattern of  use of other specified psychoactive substance, episodic  \\nA pattern of episodic or intermittent use of a specified psychoactive substance or \\nmedication that is not included in the other substance classes specifically identified \\nunder Disorders Due to Substa nce Abuse that has caused damage to a person’s \\nphysical or mental health or has resulted in behaviour leading to harm to the health \\nof others. The pattern of episodic substance use is evident over a period of at least \\n12 months. Harm to health of the indiv idual occurs due to one or more of the \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effects \\non body organs and systems; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of physical harm , including trauma, or mental \\ndisorder that is directly attributable to behaviour related to intoxication due to the \\nspecified substance or medication on the part of the person to whom the diagnosis \\nof Harmful pattern of use of other specified psychoactive  substance applies.  \\nExclusions:  Episode of harmful use of other specified psychoactive \\nsubstance (6C4E.0)  \\nOther specified psychoactive substance dependence (6C4E.2)  \\n ICD-11 MMS  533',\n",
       " '6C4E.11  Harmful pattern of use of other specified psychoactive substance, continuous  \\nA pat tern of continuous (daily or almost daily) use of a specified psychoactive \\nsubstance or medication that is not included in the other substance classes \\nspecifically identified under Disorders Due to Substance Use that has caused \\ndamage to a person’s physica l or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of continuous substance use is evident \\nover a period of at least one month. Harm to health of the individual occurs due to \\none or more of the following: (1 ) behaviour related to intoxication; (2) direct or \\nsecondary toxic effects on body organs and systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is direc tly attributable to behaviour related \\nto intoxication due to the specified substance or medication on the part of the \\nperson to whom the diagnosis of Harmful pattern of use of other specified \\npsychoactive substance applies.  \\nExclusions:  Episode of harmful u se of other specified psychoactive \\nsubstance (6C4E.0)  \\nOther specified psychoactive substance dependence (6C4E.2)',\n",
       " '6C4E.1Z  Harmful pattern of use of other specified psychoactive substance, unspecified',\n",
       " '6C4E.2  Other specified psychoactive substance dependenc e \\nOther specified psychoactive substance dependence is a disorder of regulation of \\nuse of a specified substance arising from repeated or continuous use of the \\nspecified substance. The characteristic feature is a strong internal drive to use the \\nspecified s ubstance, which is manifested by impaired ability to control use, \\nincreasing priority given to use over other activities and persistence of use despite \\nharm or negative consequences. These experiences are often accompanied by a \\nsubjective sensation of urge  or craving to use the specified substance. Physiological \\nfeatures of dependence may also be present, including tolerance to the effects of \\nthe specified substance, withdrawal symptoms following cessation or reduction in \\nuse of the specified substance, or repeated use of the specified substance or \\npharmacologically similar substances to prevent or alleviate withdrawal symptoms. \\nThe features of dependence are usually evident over a period of at least 12 months \\nbut the diagnosis may be made if use of the spec ified substance is continuous (daily \\nor almost daily) for at least 3 months.  \\nExclusions:  Episode of harmful use of other specified psychoactive \\nsubstance (6C4E.0)  \\nHarmful pattern of use of other specified psychoactive \\nsubstance (6C4E.1)',\n",
       " '6C4E.20  Other spec ified psychoactive substance dependence, current use  \\nCurrent Other specified psychoactive substance dependence, with use of the \\nspecified psychoactive substance within the past month.  \\nExclusions:  Episode of harmful use of other specified psychoactive \\nsubst ance (6C4E.0)  \\nHarmful pattern of use of other specified psychoactive \\nsubstance (6C4E.1)  \\n 534  ICD-11 MMS',\n",
       " '6C4E.21  Other specified psychoactive substance dependence, early full remission  \\nAfter a diagnosis of Other specified psychoactive substance dependence, and often \\nfollowing a treatment episode or other intervention (including self -help intervention), \\nthe individual has been abstinent from the specified substance during a period \\nlasting  between 1 and 12 months.  \\nExclusions:  Episode of harmful use of other specified psychoactive \\nsubstance (6C4E.0)  \\nHarmful pattern of use of other specified psychoactive \\nsubstance (6C4E.1)',\n",
       " '6C4E.22  Other specified psychoactive substance dependence, sustained partial remission  \\nAfter a diagnosis of Other specified psychoactive substance dependence, and often \\nfollowing a treatment episode or other intervention (including self -help intervention), \\nthere is a significant reduction in consumption of the specified substance for more \\nthan 12 months, such that even though intermittent or continuing substance use has \\noccurred duri ng this period, the definitional requirements for dependence have not \\nbeen met.  \\nExclusions:  Episode of harmful use of other specified psychoactive \\nsubstance (6C4E.0)  \\nHarmful pattern of use of other specified psychoactive \\nsubstance (6C4E.1)',\n",
       " '6C4E.23  Other s pecified psychoactive substance dependence, sustained full remission  \\nAfter a diagnosis of Other specified psychoactive substance dependence, and often \\nfollowing a treatment episode or other intervention (including self -intervention), the \\nperson has been ab stinent from the specified substance for 12 months or longer.  \\nExclusions:  Episode of harmful use of other specified psychoactive \\nsubstance (6C4E.0)  \\nHarmful pattern of use of other specified psychoactive \\nsubstance (6C4E.1)',\n",
       " '6C4E.2Z  Other specified psychoact ive substance dependence, unspecified',\n",
       " '6C4E.3  Other specified psychoactive substance intoxication  \\nOther specified psychoactive substance intoxication is a clinically significant \\ntransient condition that develops during or shortly after the consumption of a  \\nspecified psychoactive substance or medication that is characterised by \\ndisturbances in level of consciousness, cognition, perception, affect, behaviour, or \\ncoordination. These disturbances are caused by the known pharmacological effects \\nof the specified psychoactive substance and their intensity is closely related to the \\namount of the specified psychoactive substance consumed. They are time -limited \\nand abate as the specified substance is cleared from the body.  \\nCoding Note:  Code also the causing condition  \\n ICD-11 MMS  535',\n",
       " '6C4E.4  Other specified psychoactive substance withdrawal  \\nOther specified psychoactive substance withdrawal is a clinically significant cluster \\nof symptoms, behaviours and/or physiological features, varying in degree of severity \\nand duration, that occurs u pon cessation or reduction of use of the specified \\nsubstance in individuals who have developed dependence or have used the \\nspecified substance for a prolonged period or in large amounts. Other specified \\npsychoactive substance withdrawal can also occur when  prescribed psychoactive \\nmedications have been used in standard therapeutic doses. The specific features of \\nthe withdrawal state depend on the pharmacological properties of the specified \\nsubstance.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4E.40  Othe r specified psychoactive substance withdrawal, uncomplicated  \\nThe development of a withdrawal state not accompanied by perceptual \\ndisturbances or seizures following cessation or reduction of use of the specified \\nsubstance.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4E.41  Other specified psychoactive substance withdrawal, with perceptual disturbances  \\nThe development of a withdrawal state accompanied by perceptual disturbances \\nbut not by seizures following cessation or reduction of us e of the specified \\nsubstance.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4E.42  Other specified psychoactive substance withdrawal, with seizures  \\nThe development of a withdrawal state accompanied by seizures but not by \\nperceptual disturbances following cessation or reduction of use of the specified \\nsubstance.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4E.43  Other specified psychoactive substance withdrawal, with perceptual disturbances \\nand seizures  \\nThe development of a withdrawal state accompanied b y both perceptual \\ndisturbances and seizures following cessation or reduction of use of the specified \\nsubstance.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4E.4Z  Other specified psychoactive substance withdrawal, unspecified  \\nCoding Note:  Code also the causing condition  \\n 536  ICD-11 MMS',\n",
       " '6C4E.5  Delirium induced by other specified psychoactive substance including \\nmedications  \\nDelirium induced by other specified psychoactive substance is characterised by an \\nacute state of disturbed attention and awareness with specific features of delirium \\nthat develops during or soon after substance intoxication or withdrawal or during the \\nuse of a specified psychoactive substance. The amount and duration of use of the \\nspecified substance must be capable of producing delirium. The symptoms are not \\nbetter explained by a primary mental disorder, by use of or withdrawal from a \\ndifferent substance, or by another health condition that is not classified under \\nMental, behavioural and neurodevelopmental disorders.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4E.6  Psychotic disorder induced by other specified psychoactive substance  \\nPsychotic disorder i nduced by other specified psychoactive substance is \\ncharacterised by psychotic symptoms (e.g., delusions, hallucinations, disorganised \\nthinking, grossly disorganised behaviour) that develop during or soon after \\nintoxication with or withdrawal from a specif ied psychoactive substance. The \\nintensity or duration of the symptoms is substantially in excess of psychotic -like \\ndisturbances of perception, cognition, or behaviour that are characteristic of \\nintoxication with or withdrawal from a specified psychoactive substance. The \\namount and duration of use of the specified psychoactive substance must be \\ncapable of producing psychotic symptoms. The symptoms are not better explained \\nby a primary mental disorder (e.g., Schizophrenia, a Mood disorder with psychotic \\nsympt oms), as might be the case if the psychotic symptoms preceded the onset of \\nthe use of the specified psychoactive substance, if the symptoms persist for a \\nsubstantial period of time after cessation of the use of the specified psychoactive \\nsubstance or withd rawal from the specified psychoactive substance, or if there is \\nother evidence of a pre -existing primary mental disorder with psychotic symptoms \\n(e.g., a history of prior episodes not associated with the use of the specified \\npsychoactive substance).  \\nCoding  Note:  Code also the causing condition',\n",
       " '6C4E.7  Certain other specified psychoactive substance -induced mental or \\nbehavioural disorders  \\nCoding Note:  Code also the causing condition  \\n ICD-11 MMS  537',\n",
       " '6C4E.70  Mood disorder induced by other specified psychoactive substance  \\nMood disorder induced by other specified psychoactive substance is characterised \\nby mood symptoms (e.g., depressed or elevated mood, decreased engagement in \\npleasurable activities, increased o r decreased energy levels) that develop during or \\nsoon after intoxication with or withdrawal from a specified psychoactive substance. \\nThe intensity or duration of the symptoms is substantially in excess of mood \\ndisturbances that are characteristic of intox ication with or withdrawal from a \\nspecified psychoactive substance. The amount and duration of use of the specified \\npsychoactive substance must be capable of producing mood symptoms. The \\nsymptoms are not better explained by a primary mental disorder (e.g.,  a Depressive \\ndisorder, a Bipolar disorder, Schizoaffective disorder), as might be the case if the \\nmood symptoms preceded the onset of the use of the specified psychoactive \\nsubstance, if the symptoms persist for a substantial period of time after cessation  of \\nthe use of the specified psychoactive substance or withdrawal from the specified \\npsychoactive substance, or if there is other evidence of a pre -existing primary \\nmental disorder with mood symptoms (e.g., a history of prior episodes not \\nassociated with t he use of the specified psychoactive substance).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4E.71  Anxiety disorder induced by other specified psychoactive substance  \\nAnxiety disorder induced by other specified psychoactive substance is \\ncharacterised by  anxiety symptoms (e.g., apprehension or worry, fear, physiological \\nsymptoms of excessive autonomic arousal, avoidance behaviour) that develop \\nduring or soon after intoxication with or withdrawal from a specified psychoactive \\nsubstance. The intensity or du ration of the symptoms is substantially in excess of \\nanxiety symptoms that are characteristic of intoxication with or withdrawal from a \\nspecified psychoactive substance. The amount and duration of use of the specified \\npsychoactive substance must be capable  of producing anxiety symptoms. The \\nsymptoms are not better explained by a primary mental disorder (e.g., an Anxiety \\nand fear -related disorder, a Depressive disorder with prominent anxiety symptoms), \\nas might be the case if the anxiety symptoms preceded th e onset of the use of the \\nspecified psychoactive substance, if the symptoms persist for a substantial period of \\ntime after cessation of the use of the specified psychoactive substance or \\nwithdrawal from the specified psychoactive substance, or if there is other evidence \\nof a pre -existing primary mental disorder with anxiety symptoms (e.g., a history of \\nprior episodes not associated with the use of the specified psychoactive substance).  \\nCoding Note:  Code also the causing condition  \\n 538  ICD-11 MMS',\n",
       " '6C4E.72  Obsessive -compulsi ve or related disorder induced by other specified psychoactive \\nsubstance  \\nObsessive -compulsive or related disorder induced by other specified psychoactive \\nsubstance is characterised by either repetitive intrusive thoughts or preoccupations, \\nnormally associa ted with anxiety and typically accompanied by repetitive behaviours \\nperformed in response, or by recurrent and habitual actions directed at the \\nintegument (e.g., hair pulling, skin picking) that develop during or soon after \\nintoxication with or withdrawal from a specified psychoactive substance. The \\nintensity or duration of the symptoms is substantially in excess of analogous \\ndisturbances that are characteristic of intoxication with or withdrawal from the \\nspecified psychoactive substance. The amount and dur ation of the specified \\npsychoactive substance use must be capable of producing obsessive -compulsive or \\nrelated symptoms. The symptoms are not better explained by a primary mental \\ndisorder (in particular an Obsessive -compulsive or related disorder), as migh t be the \\ncase if the symptoms preceded the onset of the specified psychoactive substance \\nuse, if the symptoms persist for a substantial period of time after cessation of use or \\nwithdrawal of the specified psychoactive substance, or if there is other eviden ce of a \\npre-existing primary mental disorder with obsessive -compulsive or related \\nsymptoms (e.g., a history of prior episodes not associated with specified \\npsychoactive substance use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4E.73  Impulse control d isorder induced by other specified psychoactive substance  \\nImpulse control disorder induced by other specified psychoactive substance is \\ncharacterised by persistently repeated behaviours in which there is recurrent failure \\nto resist an impulse, drive, or ur ge to perform an act that is rewarding to the person, \\nat least in the short -term, despite longer -term harm either to the individual or to \\nothers (e.g., fire setting or stealing without apparent motive, repetitive sexual \\nbehaviour, aggressive outbursts) tha t develop during or soon after intoxication with \\nor withdrawal from a specified psychoactive substance. The intensity or duration of \\nthe symptoms is substantially in excess of disturbances of impulse control that are \\ncharacteristic of intoxication with or withdrawal from the specified psychoactive \\nsubstance. The amount and duration of the specified psychoactive substance use \\nmust be capable of producing disturbances of impulse control. The symptoms are \\nnot better explained by a primary mental disorder (e.g. , an Impulse control disorder, \\na Disorder due to addictive behaviours), as might be the case if the impulse control \\ndisturbances preceded the onset of the specified psychoactive substance use, if the \\nsymptoms persist for a substantial period of time after cessation of use or \\nwithdrawal of the specified psychoactive substance, or if there is other evidence of a \\npre-existing primary mental disorder with impulse control symptoms (e.g., a history \\nof prior episodes not associated with specified psychoactive subs tance use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4E.Y  Other specified disorders due to use of other specified psychoactive \\nsubstances, including medications',\n",
       " '6C4E.Z  Disorders due to use of other specified psychoactive substances, including \\nmedic ations, unspecified  \\n ICD-11 MMS  539',\n",
       " '6C4F   Disorders due to use of multiple specified psychoactive substances, \\nincluding medications  \\nDisorders due to use of multiple specified psychoactive substances, including \\nmedications are characterised by the pattern and consequen ces of multiple \\npsychoactive substances. Although this grouping is provided for coding purposes, in \\nmost clinical situations it is recommended that multiple specific disorders due to \\nsubstance use be assigned rather than using categories from this grouping .',\n",
       " '6C4F.0  Episode of harmful use of multiple specified psychoactive substances  \\nAn episode of use of multiple specified psychoactive substances or medications that \\nare not included in the other substance classes specifically identified under Disorder \\nDue to  Substance Use that has caused damage to a person’s physical or mental \\nhealth or has resulted in behaviour leading to harm to the health of others. Harm to \\nhealth of the individual occurs due to one or more of the following: (1) behaviour \\nrelated to multip le substance intoxication or psychoactive medication use; (2) direct \\nor secondary toxic effects on body organs and systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental d isorder that is directly attributable to behaviour due to \\nmultiple substance intoxication or psychoactive medication use on the part of the \\nperson to whom the diagnosis of single episode of harmful use of multiple specified \\npsychoactive substances applies.  This diagnosis should not be made if the harm is \\nattributed to a known pattern of use of the multiple psychoactive substances.  \\nExclusions:  Harmful pattern of use of multiple specified psychoactive \\nsubstances (6C4F.1)  \\nMultiple specified psychoactive substa nces dependence \\n(6C4F.2)',\n",
       " '6C4F.1  Harmful pattern of use of multiple specified psychoactive substances  \\nA pattern of use of multiple specified psychoactive substances or medications that \\nare not included in the other substance classes specifically identified under \\nDisorders Due to Substance Use that has caused damage to a person’s physical or \\nmental health o r has resulted in behaviour leading to harm to the health of others. \\nThe pattern of substance use is evident over a period of at least 12 months if use is \\nepisodic or at least one month if use is continuous (i.e., daily or almost daily). Harm \\nto health of the individual occurs due to one or more of the following: (1) behaviour \\nrelated to multiple substance intoxication or psychoactive medication use; (2) direct \\nor secondary toxic effects on body organs and systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour related \\nto multiple substance intoxication or psychoactive medication use on the part of the \\nperson to whom the dia gnosis of Harmful pattern of use of multiple specified \\npsychoactive substances applies.  \\nExclusions:  Episode of harmful use of multiple specified psychoactive \\nsubstances (6C4F.0)  \\nMultiple specified psychoactive substances dependence \\n(6C4F.2)  \\n 540  ICD-11 MMS',\n",
       " '6C4F.10  Harmfu l pattern of use of multiple specified psychoactive substances, episodic  \\nA pattern of episodic or intermittent use of a specified psychoactive substance or \\nmedication that is not included in the other substance classes specifically identified \\nunder Disorde rs Due to Substance Use that has caused damage to a person’s \\nphysical or mental health or has resulted in behaviour leading to harm to the health \\nof others. The pattern of episodic substance use is evident over a period of at least \\n12 months. Harm to healt h of the individual occurs due to one or more of the \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effects \\non body organs and systems; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of  physical harm, including trauma, or mental \\ndisorder that is directly attributable to behaviour related to intoxication due to the \\nspecified substance or medication on the part of the person to whom the diagnosis \\nof Harmful pattern of use of other specifie d psychoactive substance applies.  \\nExclusions:  Episode of harmful use of multiple specified psychoactive \\nsubstances (6C4F.0)  \\nMultiple specified psychoactive substances dependence \\n(6C4F.2)',\n",
       " '6C4F.11  Harmful pattern of use of multiple specified psychoactive su bstances, continuous  \\nA pattern of continuous (daily or almost daily) use of multiple specified psychoactive \\nsubstances or medications that are not included in the other substance classes \\nspecifically identified under Disorders Due to Substance Use that has  caused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of continuous substance use is evident \\nover a period of at least one month. Harm to health of the individual occurs due  to \\none or more of the following: (1) behaviour related to multiple substance intoxication \\nor psychoactive medication use; (2) direct or secondary toxic effects on body \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including trauma, or mental disorder that \\nis directly attributable to behaviour related to multiple substance intoxication or \\npsychoactive medication use on the part of the person to whom the diagnosis of \\nHarmful pattern  of multiple specified psychoactive substances applies.  \\nExclusions:  Episode of harmful use of multiple specified psychoactive \\nsubstances (6C4F.0)  \\nMultiple specified psychoactive substances dependence \\n(6C4F.2)',\n",
       " '6C4F.1Z  Harmful pattern of use of multiple spe cified psychoactive substances, unspecified  \\n ICD-11 MMS  541',\n",
       " '6C4F.2  Multiple specified psychoactive substances dependence  \\nMultiple specified psychoactive substance dependence is a disorder of regulation of \\nuse of multiple specified substances arising from repeated or cont inuous use of the \\nspecified substances. The characteristic feature is a strong internal drive to use the \\nspecified substances, which is manifested by impaired ability to control use, \\nincreasing priority given to use over other activities and persistence of  use despite \\nharm or negative consequences. These experiences are often accompanied by a \\nsubjective sensation of urge or craving to use the specified substances. \\nPhysiological features of dependence may also be present, including tolerance to \\nthe effects o f the specified substances, withdrawal symptoms following cessation or \\nreduction in use of the specified substances, or repeated use of the specified \\nsubstances or pharmacologically similar substances to prevent or alleviate \\nwithdrawal symptoms. The featur es of dependence are usually evident over a \\nperiod of at least 12 months but the diagnosis may be made if use of the specified \\nsubstances is continuous (daily or almost daily) for at least 3 months.  \\nExclusions:  Episode of harmful use of multiple specified psychoactive \\nsubstances (6C4F.0)  \\nHarmful pattern of use of multiple specified psychoactive \\nsubstances (6C4F.1)',\n",
       " '6C4F.20  Multiple specified psychoactive substances dependence, current use  \\nExclusions:  Episode of harmful use of multiple specified psychoactive  \\nsubstances (6C4F.0)  \\nHarmful pattern of use of multiple specified psychoactive \\nsubstances (6C4F.1)',\n",
       " '6C4F.21  Multiple specified psychoactive substances dependence, early full remission  \\nExclusions:  Episode of harmful use of multiple specified psychoactive \\nsubstances (6C4F.0)  \\nHarmful pattern of use of multiple specified psychoactive \\nsubstances (6C4F.1)',\n",
       " '6C4F.22  Multiple specified psychoactive substances dependence, sustained partial \\nremission  \\nExclusions:  Episode of harmful use of multiple specified psychoactive \\nsubstances (6C4F.0)  \\nHarmful pattern of use of multiple specified psychoactive \\nsubstances (6C4F.1)',\n",
       " '6C4F .23 Multiple specified psychoactive substances dependence, sustained full remission  \\nExclusions:  Episode of harmful use of multiple specified psychoactive \\nsubstances (6C4F.0)  \\nHarmful pattern of use of multiple specified psychoactive \\nsubstances (6C4F.1)',\n",
       " '6C4F.2Z  Multiple specified psychoactive substances dependence, unspecified  \\n 542  ICD-11 MMS',\n",
       " '6C4F.3  Intoxication due to multiple specified psychoactive substances  \\nIntoxication due to multiple specified psychoactive substances is a clinically \\nsignificant transient condition that develops during or shortly after the consumption \\nof multiple specified substances or medications that is characterised by \\ndisturbances in co nsciousness, cognition, perception, affect, behaviour, or \\ncoordination. These disturbances are caused by the known pharmacological effects \\nof the multiple specified psychoactive substances and their intensity is closely \\nrelated to the amount of the substan ces consumed. They are time -limited and abate \\nas the multiple specified substances are cleared from the body.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4F.4  Multiple specified psychoactive substances withdrawal  \\nMultiple specified psychoactive substan ce withdrawal is a clinically significant \\ncluster of symptoms, behaviours and physiological features, varying in degree of \\nseverity and duration, that occurs upon cessation or reduction of use of multiple \\nspecified substances in individuals who have develo ped dependence or have used \\nthe specified substances for a prolonged period or in large amounts. Multiple \\nspecified psychoactive substance withdrawal can also occur when prescribed \\npsychoactive medications have been used in standard therapeutic doses. The \\nspecific features of the withdrawal state depend on the pharmacological properties \\nof the specified substances and their interactions.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4F.40  Multiple specified psychoactive substances withdrawal, uncomplicate d \\nCoding Note:  Code also the causing condition',\n",
       " '6C4F.41  Multiple specified psychoactive substances withdrawal, with perceptual \\ndisturbances  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4F.42  Multiple specified psychoactive substances withdrawal, with se izures  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4F.43  Multiple specified psychoactive substances withdrawal, with perceptual \\ndisturbances and seizures  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4F.4Y  Other specified multiple specified psychoactive substances withdrawal  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4F.4Z  Multiple specified psychoactive substances withdrawal, unspecified  \\nCoding Note:  Code also the causing condition  \\n ICD-11 MMS  543',\n",
       " '6C4F.5  Delirium ind uced by multiple specified psychoactive substances including \\nmedications  \\nDelirium induced by multiple specified psychoactive substances is characterised by \\nan acute state of disturbed attention and awareness with specific features of \\ndelirium that develops  during or soon after substance intoxication or withdrawal or \\nduring the use of multiple specified substances. The amount and duration of use of \\nthe multiple specified substances must be capable of producing delirium. The \\nsymptoms are not better explained by a primary mental disorder, by use of or \\nwithdrawal from a substance other than those specified, or by another health \\ncondition that is not classified under Mental, behavioural and neurodevelopmental \\ndisorders. Note that this diagnosis applies only to th ose situations in which delirium \\nis present but it cannot be determined which of multiple psychoactive substances is \\nthe cause of the delirium. In cases of multiple psychoactive substance use in which \\nmore than one specific substance can be identified as a  cause of the delirium, the \\ncorresponding specific substance -induced delirium diagnoses should be given \\ninstead.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4F.6  Psychotic disorder induced by multiple specified psychoactive substances  \\nPsychotic disorde r induced by multiple specified psychoactive substances is \\ncharacterised by psychotic symptoms (e.g., delusions, hallucinations, disorganised \\nthinking, grossly disorganised behaviour) that develop during or soon after \\nintoxication with or withdrawal from m ultiple specified psychoactive substances. The \\nintensity or duration of the symptoms is substantially in excess of psychotic -like \\ndisturbances of perception, cognition, or behaviour that are characteristic of \\nintoxication with or withdrawal from multiple s pecified psychoactive substances. The \\namount and duration of use of the multiple specified psychoactive substances must \\nbe capable of producing psychotic symptoms. The symptoms are not better \\nexplained by a primary mental disorder (e.g., Schizophrenia, a M ood disorder with \\npsychotic symptoms), as might be the case if the psychotic symptoms preceded the \\nonset of the use of the multiple specified psychoactive substances, if the symptoms \\npersist for a substantial period of time after cessation of the use of th e multiple \\nspecified psychoactive substances or withdrawal from the multiple specified \\npsychoactive substances, or if there is other evidence of a pre -existing primary \\nmental disorder with psychotic symptoms (e.g., a history of prior episodes not \\nassociate d with the use of the multiple specified psychoactive substances).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4F.7  Certain multiple specified psychoactive substances -induced mental or \\nbehavioural disorders  \\nCoding Note:  Code also the causing condition  \\n 544  ICD-11 MMS',\n",
       " '6C4F.70  Mood disorder induced by multiple specified psychoactive substances  \\nMood disorder induced by multiple specified psychoactive substances is \\ncharacterised by mood symptoms (e.g., depressed or elevated mood, decreased \\nengagement in pleasurable activi ties, increased or decreased energy levels) that \\ndevelop during or soon after intoxication with or withdrawal from multiple specified \\npsychoactive substances. The intensity or duration of the symptoms is substantially \\nin excess of mood disturbances that ar e characteristic of intoxication with or \\nwithdrawal from multiple specified psychoactive substances. The amount and \\nduration of use of the multiple specified psychoactive substances must be capable \\nof producing mood symptoms. The symptoms are not better ex plained by a primary \\nmental disorder (e.g., a Depressive disorder, a Bipolar disorder, Schizoaffective \\ndisorder), as might be the case if the mood symptoms preceded the onset of the \\nuse of the multiple specified psychoactive substances, if the symptoms per sist for a \\nsubstantial period of time after cessation of the use of the multiple specified \\npsychoactive substances or withdrawal from the multiple specified psychoactive \\nsubstances, or if there is other evidence of a pre -existing primary mental disorder \\nwith mood symptoms (e.g., a history of prior episodes not associated with the use of \\nthe multiple specified psychoactive substances).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4F.71  Anxiety disorder induced by multiple specified psychoactive substances  \\nAnxiety disorder induced by multiple specified psychoactive substances is \\ncharacterised by anxiety symptoms (e.g., apprehension or worry, fear, physiological \\nsymptoms of excessive auton omic arousal, avoidance behaviour) that develop \\nduring or soon after intoxication with or withdrawal from multiple specified \\npsychoactive substances. The intensity or duration of the symptoms is substantially \\nin excess of anxiety symptoms that are characte ristic of intoxication with or \\nwithdrawal from multiple specified psychoactive substances. The amount and \\nduration of use of the multiple specified psychoactive substances must be capable \\nof producing anxiety symptoms. The symptoms are not better explained  by a \\nprimary mental disorder (e.g., an Anxiety and fear -related disorder, a Depressive \\ndisorder with prominent anxiety symptoms), as might be the case if the anxiety \\nsymptoms preceded the onset of the use of the multiple specified psychoactive \\nsubstances,  if the symptoms persist for a substantial period of time after cessation \\nof the use of the multiple specified psychoactive substances or withdrawal from the \\nmultiple specified psychoactive substances, or if there is other evidence of a pre -\\nexisting primar y mental disorder with anxiety symptoms (e.g., a history of prior \\nepisodes not associated with the use of the multiple specified psychoactive \\nsubstances).  \\nCoding Note:  Code also the causing condition  \\n ICD-11 MMS  545',\n",
       " '6C4F.72  Obsessive -compulsive or related disorder induced by multiple specified \\npsychoactive substances  \\nObsessive -compulsive or related disorder induced by multiple specified \\npsychoactive substances is characterised by either repetitive intrusive thoughts or \\npreocc upations, normally associated with anxiety and typically accompanied by \\nrepetitive behaviours performed in response, or by recurrent and habitual actions \\ndirected at the integument (e.g., hair pulling, skin picking) that develop during or \\nsoon after intoxi cation with or withdrawal from multiple specified psychoactive \\nsubstances. The intensity or duration of the symptoms is substantially in excess of \\nanalogous disturbances that are characteristic of intoxication with or withdrawal \\nfrom the multiple specified  psychoactive substances. The amount and duration of \\nthe multiple specified psychoactive substances use must be capable of producing \\nobsessive -compulsive or related symptoms. The symptoms are not better explained \\nby a primary mental disorder (in particular  an Obsessive -compulsive or related \\ndisorder), as might be the case if the symptoms preceded the onset of the use of \\nmultiple specified psychoactive substances, if the symptoms persist for a substantial \\nperiod of time after cessation of the multiple specif ied psychoactive substance use \\nor withdrawal, or if there is other evidence of a pre -existing primary mental disorder \\nwith obsessive -compulsive or related symptoms (e.g., a history of prior episodes not \\nassociated with multiple specified psychoactive subst ances use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4F.73  Impulse control syndrome induced by multiple specified psychoactive substances  \\nImpulse control disorder induced by multiple specified psychoactive substances is \\ncharacterised by persistently  repeated behaviours in which there is recurrent failure \\nto resist an impulse, drive, or urge to perform an act that is rewarding to the person, \\nat least in the short -term, despite longer -term harm either to the individual or to \\nothers (e.g., fire setting or stealing without apparent motive, repetitive sexual \\nbehaviour, aggressive outbursts) that develop during or soon after intoxication with \\nor withdrawal from multiple specified psychoactive substances. The intensity or \\nduration of the symptoms is substant ially in excess of disturbances of impulse \\ncontrol that are characteristic of intoxication with or withdrawal from the multiple \\nspecified psychoactive substances. The amount and duration of the multiple \\nspecified psychoactive substances use must be capable  of producing disturbances \\nof impulse control. The symptoms are not better explained by a primary mental \\ndisorder (e.g., an Impulse control disorder, a Disorder due to addictive behaviours), \\nas might be the case if the impulse control disturbances preceded  the onset of the \\nuse of multiple specified psychoactive substances, if the symptoms persist for a \\nsubstantial period of time after cessation of the multiple specified psychoactive \\nsubstance use or withdrawal, or if there is other evidence of a pre -existin g primary \\nmental disorder with impulse control symptoms (e.g., a history of prior episodes not \\nassociated with multiple specified psychoactive substances use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4F.Y  Other specified disorders due to use of mul tiple specified psychoactive \\nsubstances, including medications',\n",
       " '6C4F.Z  Disorders due to use of multiple specified psychoactive substances, \\nincluding medications, unspecified  \\n 546  ICD-11 MMS',\n",
       " '6C4G   Disorders due to use of unknown or unspecified psychoactive \\nsubstances  \\nDisorders due to use of unknown or unspecified psychoactive substances are \\ncharacterised by the pattern and consequences of psychoactive substance use \\nwhen the specific substance is unknown or unspecified. These categories may be \\nused in clinical situations  in which it is clear that the disturbance is due to substance \\nuse but the specific class of substance is unknown. Once the relevant substance is \\nidentified, the disturbance should be recoded under the appropriate substance \\nclass.',\n",
       " '6C4G.0  Episode of harmfu l use of unknown or unspecified psychoactive substances  \\nAn episode of use of an unknown or unspecified psychoactive substance that has \\ncaused damage to a person’s physical or mental health or has resulted in behaviour \\nleading to harm to the health of other s. Harm to health of the individual occurs due \\nto one or more of the following: (1) behaviour related to intoxication or withdrawal; \\n(2) direct or secondary toxic effects on body organs and systems; or (3) a harmful \\nroute of administration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour due to \\nsubstance intoxication or withdrawal on the part of the person to whom the \\ndiagnosis of single episode of harmful use appli es. This diagnosis should not be \\nmade if the harm is attributed to a known pattern of use of the unknown or \\nunspecified psychoactive substance.  \\nExclusions:  Harmful pattern of use of unknown or unspecified psychoactive \\nsubstance (6C4G.1)  \\nUnknown or unspecif ied psychoactive substance dependence \\n(6C4G.2)',\n",
       " '6C4G.1  Harmful pattern of use of unknown or unspecified psychoactive substance  \\nA pattern of use of an unknown or unspecified psychoactive substance that has \\ncaused damage to a person’s physical or mental heal th or has resulted in behaviour \\nleading to harm to the health of others. The pattern of substance use is evident over \\na period of at least 12 months if use is episodic or at least one month if use is \\ncontinuous (i.e., daily or almost daily). Harm to health  of the individual occurs due to \\none or more of the following: (1) behaviour related to intoxication; (2) direct or \\nsecondary toxic effects on body organs and systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour related \\nto substance intoxication on the part of the person to whom the diagnosis of \\nHarmful pattern of use of unknown or unspecified psychoactive substance appl ies. \\nExclusions:  Episode of harmful use of unknown or unspecified \\npsychoactive substances (6C4G.0)  \\nUnknown or unspecified psychoactive substance dependence \\n(6C4G.2)  \\n ICD-11 MMS  547',\n",
       " '6C4G.10  Harmful pattern of use of unknown or unspecified psychoactive substance, episodic  \\nA pattern of episodic or intermittent use of an unknown or unspecified psychoactive \\nsubstance that has caused damage to a person’s physical or mental health or has \\nresulted in behaviour leading to harm to the health of others. The pattern of episodic \\nsubst ance use is evident over a period of at least 12 months. Harm to health of the \\nindividual occurs due to one or more of the following: (1) behaviour related to \\nintoxication; (2) direct or secondary toxic effects on body organs and systems; or (3) \\na harmful route of administration. Harm to health of others includes any form of \\nphysical harm, including trauma, or mental disorder that is directly attributable to \\nbehaviour related to substance intoxication on the part of the person to whom the \\ndiagnosis of Harmf ul pattern of use of unknown or unspecified psychoactive \\nsubstance applies.  \\nExclusions:  Episode of harmful use of unknown or unspecified \\npsychoactive substances (6C4G.0)  \\nUnknown or unspecified psychoactive substance dependence \\n(6C4G.2)',\n",
       " '6C4G.11  Harmful pattern of use of unknown or unspecified psychoactive substance, \\ncontinuous  \\nA pattern of continuous (daily or almost daily) use of an unknown or unspecified \\npsychoactive sub stance that has caused damage to a person’s physical or mental \\nhealth or has resulted in behaviour leading to harm to the health of others. The \\npattern of continuous substance use is evident over a period of at least one month. \\nHarm to health of the indivi dual occurs due to one or more of the following: (1) \\nbehaviour related to intoxication; (2) direct or secondary toxic effects on body \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm,  including trauma, or mental disorder that \\nis directly attributable to behaviour related to substance intoxication on the part of \\nthe person to whom the diagnosis of Harmful pattern of use of unknown or \\nunspecified psychoactive substance applies.  \\nExclusion s: Episode of harmful use of unknown or unspecified \\npsychoactive substances (6C4G.0)  \\nUnknown or unspecified psychoactive substance dependence \\n(6C4G.2)',\n",
       " '6C4G.1Z  Harmful pattern of use of unknown or unspecified psychoactive substance, \\nunspecified  \\n 548  ICD-11 MMS',\n",
       " '6C4G.2  Unknown or unspecified psychoactive substance dependence  \\nUnknown or unspecified psychoactive substance dependence is a disorder of \\nregulation of use of an unknown or unspecified substance arising from repeated or \\ncontinuous use of the substance. The characteristic feature is a strong internal drive \\nto use the unknown or unspecified substance, which is manifested by impaired \\nability to control use, increasing priorit y given to use over other activities and \\npersistence of use despite harm or negative consequences. These experiences are \\noften accompanied by a subjective sensation of urge or craving to use the unknown \\nor unspecified substance. The features of dependence are usually evident over a \\nperiod of at least 12 months but the diagnosis may be made if use of the unknown \\nor unspecified substance is continuous (daily or almost daily) for at least 3 months.  \\nExclusions:  Episode of harmful use of unknown or unspecified \\npsychoactive substances (6C4G.0)  \\nHarmful pattern of use of unknown or unspecified psychoactive \\nsubstance (6C4G.1)',\n",
       " '6C4G.20  Unknown or unspecified psychoactive substance dependence, current use  \\nCurrent dependence on an unknown or unspecified psychoactive sub stance, with \\nuse of the substance within the past month.  \\nExclusions:  Episode of harmful use of unknown or unspecified \\npsychoactive substances (6C4G.0)  \\nHarmful pattern of use of unknown or unspecified psychoactive \\nsubstance (6C4G.1)',\n",
       " '6C4G.21  Unknown or unsp ecified psychoactive substance dependence, early full remission  \\nAfter a diagnosis of Unknown or unspecified psychoactive substance dependence, \\nand often following a treatment episode or other intervention (including self -help \\nintervention), the individual has been abstinent from the substance during a period \\nlasting between 1 and 12 months.  \\nExclusions:  Episode of harmful use of unknown or unspecified \\npsychoactive substances (6C4G.0)  \\nHarmful pattern of use of unknown or unspecified psychoactive \\nsubstance (6C 4G.1)',\n",
       " '6C4G.22  Unknown or unspecified psychoactive substance dependence, sustained partial \\nremission  \\nAfter a diagnosis of Unknown or unspecified psychoactive substance dependence, \\nand often following a treatment episode or other intervention (including sel f-help \\nintervention), there is a significant reduction in consumption of the substance for \\nmore than 12 months, such that even though intermittent or continuing use of the \\nsubstance has occurred during this period, the definitional requirements for \\ndepende nce have not been met.  \\nExclusions:  Episode of harmful use of unknown or unspecified \\npsychoactive substances (6C4G.0)  \\nHarmful pattern of use of unknown or unspecified psychoactive \\nsubstance (6C4G.1)  \\n ICD-11 MMS  549',\n",
       " '6C4G.23  Unknown or unspecified psychoactive substance dependence, sustained full \\nremission  \\nAfter a diagnosis of Unknown or unspecified psychoactive substance dependence, \\nsustained full remission, and often following a treatment episode or other \\nintervention (including self -intervention), the person has been abstinent from the \\nsubstance for 12 months or longer.  \\nExclusions:  Episode of harmful use of unknown or unspecified \\npsycho active substances (6C4G.0)  \\nHarmful pattern of use of unknown or unspecified psychoactive \\nsubstance (6C4G.1)',\n",
       " '6C4G.2Z  Unknown or unspecified psychoactive substance dependence, substance and state \\nof remission unspecified',\n",
       " '6C4G.3  Intoxication due to unknown or unspecified psychoactive substance  \\nIntoxication due to unknown or unspecified psychoactive substance is a transient \\ncondition that develops during or shortly after the administration of an unknown or \\nunspecified psychoactive substance that is characteri sed by disturbances in level of \\nconsciousness, cognition, perception, affect or behaviour, or other \\npsychophysiological functions and responses. This diagnosis should be made only \\nwhen there is strong evidence that an unidentified substance has been taken and \\nthe features cannot be accounted for by another disorder or disease.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4G.4  Withdrawal due to unknown or unspecified psychoactive substance  \\nWithdrawal due to unknown or unspecified psychoactive substance is  a clinically \\nsignificant cluster of symptoms, behaviours and/or physiological features, varying in \\ndegree of severity and duration, that occurs upon cessation or reduction of use of \\nan unknown or unspecified substance in individuals who have developed \\ndependence or have used the unknown or unspecified substance for a prolonged \\nperiod or in large amounts. Withdrawal due to unknown or unspecified psychoactive \\nsubstance can also occur when prescribed psychoactive medications have been \\nused in standard therape utic doses. The specific features of the withdrawal state \\ndepend on the pharmacological properties of the unknown or unspecified \\nsubstance.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4G.40  Withdrawal due to unknown or unspecified psychoactive substanc e, uncomplicated  \\nAll diagnostic requirements for Withdrawal due to unknown or unspecified \\npsychoactive substance are met and the withdrawal state is not accompanied by \\nperceptual disturbances or seizures.  \\nCoding Note:  Code also the causing condition  \\n 550  ICD-11 MMS',\n",
       " '6C4G.41  Withdrawal due to unknown or unspecified psychoactive substance, with perceptual \\ndisturbances  \\nAll diagnostic requirements for Withdrawal due to unknown or unspecified \\npsychoactive substance are met and the withdrawa l state is accompanied by \\nperceptual disturbances (e.g., visual or tactile hallucinations or illusions) with intact \\nreality testing. There is no evidence of confusion and other diagnostic requirements \\nfor Delirium are not met. The withdrawal state is not a ccompanied by seizures.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4G.42  Withdrawal due to unknown or unspecified psychoactive substance, with seizures  \\nAll diagnostic requirements for Withdrawal due to unknown or unspecified \\npsychoactive substance are  met and the withdrawal state is accompanied by \\nseizures (i.e., generalised tonic -clonic seizures) but not by perceptual disturbances.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4G.43  Withdrawal due to unknown or unspecified psychoactive, with perceptual \\ndisturbances and seizures  \\nThe development of a withdrawal syndrome accompanied by both perceptual \\ndisturbances and seizures following cessation or reduction of use of the unknown or \\nunspecified substance.  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4G.4Z  Withdrawal due to unknown or unspecified psychoactive substance, unspecified  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4G.5  Delirium induced by unknown or unspecified psychoact ive substance  \\nDelirium induced by unknown or unspecified psychoactive substance is \\ncharacterised by an acute state of disturbed attention and awareness with specific \\nfeatures of delirium that develops during or soon after substance intoxication or \\nwithdraw al or during the use of an unknown or unspecified substance. The \\nsymptoms are not better explained by a primary mental disorder, by use of or \\nwithdrawal from another substance, or by another health condition that is not \\nclassified under Mental, behavioural  and neurodevelopmental disorders.  \\nCoding Note:  Code also the causing condition  \\n ICD-11 MMS  551',\n",
       " '6C4G.6  Psychotic disorder induced by unknown or unspecified psychoactive \\nsubstance  \\nPsychotic disorder induced by unknown or unspecified psychoactive substance is \\ncharacterised  by psychotic symptoms (e.g., delusions, hallucinations, disorganised \\nthinking, grossly disorganised behaviour) that develop during or soon after \\nintoxication with or withdrawal from an unknown or unspecified psychoactive \\nsubstance. The symptoms are not be tter explained by a primary mental disorder \\n(e.g., Schizophrenia, a Mood disorder with psychotic symptoms), as might be the \\ncase if the psychotic symptoms preceded the onset of the use of the unknown or \\nunspecified psychoactive substance, if the symptoms p ersist for a substantial period \\nof time after cessation of the use of the unknown or unspecified psychoactive \\nsubstance or withdrawal from the unknown or unspecified psychoactive substance, \\nor if there is other evidence of a pre -existing primary mental dis order with psychotic \\nsymptoms (e.g., a history of prior episodes not associated with the use of the \\nunknown or unspecified psychoactive substance).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4G.7  Certain unknown or unspecified psychoactive substance -induced mental or \\nbehavioural disorders  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4G.70  Mood disorder induced by unknown or unspecified psychoactive substance  \\nMood disorder induced by unknown or unspecified psychoactive substance is \\ncharacterised by m ood symptoms (e.g., depressed or elevated mood, decreased \\nengagement in pleasurable activities, increased or decreased energy levels) that \\ndevelop during or soon after intoxication with or withdrawal from a specified \\npsychoactive substance. The symptoms ar e not better explained by a primary \\nmental disorder (e.g., a Depressive disorder, a Bipolar disorder, Schizoaffective \\ndisorder), as might be the case if the mood symptoms preceded the onset of the \\nuse of the unknown or unspecified psychoactive substance, i f the symptoms persist \\nfor a substantial period of time after cessation of the use of the unknown or \\nunspecified psychoactive substance or withdrawal from the unknown or unspecified \\npsychoactive substance, or if there is other evidence of a pre -existing pr imary \\nmental disorder with mood symptoms (e.g., a history of prior episodes not \\nassociated with the use of the unknown or unspecified psychoactive substance).  \\nCoding Note:  Code also the causing condition  \\n 552  ICD-11 MMS',\n",
       " '6C4G.71  Anxiety disorder induced by unknown or unsp ecified psychoactive substance  \\nAnxiety disorder induced by unknown or unspecified psychoactive substance is \\ncharacterised by anxiety symptoms (e.g., apprehension or worry, fear, physiological \\nsymptoms of excessive autonomic arousal, avoidance behaviour) th at develop \\nduring or soon after intoxication with or withdrawal from an unknown or unspecified \\npsychoactive substance. The symptoms are not better explained by a primary \\nmental disorder (e.g., an Anxiety and fear -related disorder, a Depressive disorder \\nwith prominent anxiety symptoms), as might be the case if the anxiety symptoms \\npreceded the onset of the use of the unknown or unspecified psychoactive \\nsubstance, if the symptoms persist for a substantial period of time after cessation of \\nthe use of the unkno wn or unspecified psychoactive substance or withdrawal from \\nthe unknown or unspecified psychoactive substance, or if there is other evidence of \\na pre -existing primary mental disorder with anxiety symptoms (e.g., a history of prior \\nepisodes not associated w ith the use of the unknown or unspecified psychoactive \\nsubstance).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4G.72  Obsessive -compulsive or related disorder induced by unknown or unspecified \\npsychoactive substance  \\nObsessive -compulsive or related disorder induced by unknown or unspecified \\npsychoactive substance is characterised by either repetitive intrusive thoughts or \\npreoccupations, normally associated with anxiety and typically accompanied by \\nrepetitive behaviour s performed in response, or by recurrent and habitual actions \\ndirected at the integument (e.g., hair pulling, skin picking) that develop during or \\nsoon after intoxication with or withdrawal from an unknown or unspecified \\npsychoactive substance. The symptom s are not better explained by a primary \\nmental disorder (in particular an Obsessive -compulsive or related disorder), as \\nmight be the case if the symptoms preceded the onset of the unknown or \\nunspecified psychoactive substance use, if the symptoms persist f or a substantial \\nperiod of time after cessation of use or withdrawal of the unknown or unspecified \\npsychoactive substance, or if there is other evidence of a pre -existing primary \\nmental disorder with obsessive -compulsive or related symptoms (e.g., a histor y of \\nprior episodes not associated with the unknown or unspecified psychoactive \\nsubstance use).  \\nCoding Note:  Code also the causing condition  \\n ICD-11 MMS  553',\n",
       " '6C4G.73  Impulse control disorder induced by unknown or unspecified psychoactive \\nsubstance  \\nImpulse control disorder induced by unknown or unspecified psychoactive \\nsubstance is characterised by persistently repeated behaviours in which there is \\nrecurrent failure to resist an impulse, drive, or urge to perform an act that is \\nrewarding to the perso n, at least in the short -term, despite longer -term harm either \\nto the individual or to others (e.g., fire setting or stealing without apparent motive, \\nrepetitive sexual behaviour, aggressive outbursts) that develop during or soon after \\nintoxication with or  withdrawal from an unknown or unspecified psychoactive \\nsubstance. The symptoms are not better explained by a primary mental disorder \\n(e.g., an Impulse control disorder, a Disorder due to addictive behaviours), as might \\nbe the case if the impulse control d isturbances preceded the onset of the unknown \\nor unspecified psychoactive substance use, if the symptoms persist for a substantial \\nperiod of time after cessation of use or withdrawal of the unknown or unspecified \\npsychoactive substance, or if there is othe r evidence of a pre -existing primary \\nmental disorder with impulse control symptoms (e.g., a history of prior episodes not \\nassociated with the unknown or unspecified psychoactive substance use).  \\nCoding Note:  Code also the causing condition',\n",
       " '6C4G.Y  Other spe cified disorders due to use of unknown or unspecified psychoactive \\nsubstances',\n",
       " '6C4G.Z  Disorders due to use of unknown or unspecified psychoactive substances, \\nunspecified',\n",
       " '6C4H   Disorders due to use of non -psychoactive substances  \\nDisorders due to use of non-psychoactive substances are characterised by the \\npattern and consequences of non -medical use of non -psychoactive substances. \\nNon-psychoactive substances include laxatives, anabolic steroids, growth hormone, \\nerythropoietin, and non -steroidal anti -inflam matory drugs. They may also include \\nproprietary or over -the-counter medicines and folk remedies. Non -medical use of \\nthese substances may be associated with harm to the individual due to the direct or \\nsecondary toxic effects of the non -psychoactive substanc e on body organs and \\nsystems, or a harmful route of administration (e.g., infections due to intravenous \\nself-administration). They are not associated with intoxication or with a dependence \\nor withdrawal syndrome and are not recognized causes of substance -induced \\nmental disorders.',\n",
       " '6C4H.0  Episode of harmful use of non -psychoactive substances  \\nAn episode of use of a non -psychoactive substance that has caused damage to a \\nperson’s physical or mental health. Harm to health of the individual occurs due to \\ndirect o r secondary toxic effects on body organs and systems or a harmful route of \\nadministration. This diagnosis should not be made if the harm is attributed to a \\nknown pattern of non -psychoactive substance use.  \\nExclusions:  Harmful pattern of use of non -psychoact ive substances \\n(6C4H.1)  \\n 554  ICD-11 MMS',\n",
       " '6C4H.1  Harmful pattern of use of non -psychoactive substances  \\nA pattern of use of non -psychoactive substances that has caused clinically \\nsignificant harm to a person’s physical or mental health. The pattern of use is \\nevident over a period of at least 12 months if use is episodic and at least one month \\nif use is continuous (i.e., daily or almost daily). Harm may be caused by the direct or \\nsecondary toxic effects of the substance on body organs and systems, or a harmful \\nroute of admini stration.  \\nExclusions:  Harmful pattern of use of other specified psychoactive \\nsubstance (6C4E.1)  \\nEpisode of harmful use of non -psychoactive substances \\n(6C4H.0)',\n",
       " '6C4H.10  Harmful pattern of use of non -psychoactive substances, episodic  \\nA pattern of episodic or  intermittent use of a non -psychoactive substance that has \\ncaused damage to a person’s physical or mental health. The pattern of episodic or \\nintermittent use of the non -psychoactive substance is evident over a period of at \\nleast 12 months. Harm may be caus ed by the direct or secondary toxic effects on \\nbody organs and systems, or a harmful route of administration.',\n",
       " '6C4H.11  Harmful pattern of use of non -psychoactive substances, continuous  \\nA pattern of continuous use of a non -psychoactive substance (daily or a lmost daily) \\nthat has caused damage to a person’s physical or mental health. The pattern of \\ncontinuous use of the non -psychoactive substance is evident over a period of at \\nleast one month. Harm may be caused by the direct or secondary toxic effects on \\nbody  organs and systems, or a harmful route of administration.',\n",
       " '6C4H.1Z  Harmful pattern of use of non -psychoactive substances, unspecified',\n",
       " '6C4H.Y  Other specified disorders due to use of non -psychoactive substances',\n",
       " '6C4H.Z  Disorders due to use of non -psychoactive substances, unspecified',\n",
       " '6C4Y   Other specified disorders due to substance use',\n",
       " '6C4Z   Disorders due to substance use, unspecified  \\n ICD-11 MMS  555 \\n Disorders due to addictive behaviours (6C50 ‑6C5Z)  \\nDisorders due to addictive behaviours are recognizable and clinically significant syndromes \\nassociated with distress or interference with personal functions that develop as a result of repetitive \\nrewarding beh aviours other than the use of dependence -producing substances. Disorders due to \\naddictive behaviours include gambling disorder and gaming disorder, which may involve both online \\nand offline behaviour.  \\nExclusions:  Compulsive sexual behaviour disorder (6C72)  \\nParaphilic disorders  (6D30‑6D3Z)',\n",
       " '6C50   Gambling disorder  \\nGambling disorder is characterised by a pattern of persistent or recurrent gambling \\nbehaviour, which may be online (i.e., over the internet) or offline, manifested by:  \\n1. impaired control over gambling (e.g., onset, frequency, intensity, duration, \\ntermination, context);  \\n2. increasing priority given to gambling to the extent that gambling takes \\nprecedence over other life interests and daily activities; and  \\n3. continuation  or escalation of gambling despite the occurrence of negative \\nconsequences.  \\nThe pattern of gambling behaviour may be continuous or episodic and recurrent. \\nThe pattern of gambling behaviour results in significant distress or in significant \\nimpairment in per sonal, family, social, educational, occupational or other important \\nareas of functioning. The gambling behaviour and other features are normally \\nevident over a period of at least 12 months in order for a diagnosis to be assigned, \\nalthough the required dura tion may be shortened if all diagnostic requirements are \\nmet and symptoms are severe.  \\nInclusions:  Compulsive gambling  \\nExclusions:  Bipolar type I disorder (6A60)  \\nBipolar type II disorder (6A61)  \\nHazardous gambling or betting (QE21)',\n",
       " '6C50.0  Gambling disorder,  predominantly offline  \\nGambling disorder, predominantly offline is characterised by a pattern of persistent or recurrent \\ngambling behaviour that is not primarily conducted over the internet and is manifested by:  \\n1. impaired control over gambling (e.g., onset, frequency, intensity, duration, termination, \\ncontext);  \\n2. increasing priority given to gambling to the extent that gambling takes precedence over other \\nlife interests and daily activities; and  \\n3. continuation or escalation of gambling despite the occurrence of negative consequences. The \\nbehaviour pattern is of sufficient severity to result in significant impairment in personal, family, \\nsocial, educational, occupational or other important areas of functioning.  \\nThe pattern of gambling behaviour may be continuous or episodic and recurren t. The gambling \\nbehaviour and other features are normally evident over a period of at least 12 months in order for a \\ndiagnosis to be assigned, although the required duration may be shortened if all diagnostic \\nrequirements are met and symptoms are severe.  \\nExclusions:  Hazardous gambling or betting (QE21)  \\n 556  ICD-11 MMS',\n",
       " '6C50.1  Gambling disorder, predominantly online  \\nGambling disorder, predominantly online is characterised by a pattern of persistent or recurrent \\ngambling behaviour that is primarily conducted over the internet and is manifested by:  \\n1. impaired control over gambling (e.g., onset, frequency, intensity, durat ion, termination, \\ncontext);  \\n2. increasing priority given to gambling to the extent that gambling takes precedence over other \\nlife interests and daily activities; and  \\n3. continuation or escalation of gambling despite the occurrence of negative consequences. The \\nbehaviour pattern is of sufficient severity to result in significant impairment in personal, family, \\nsocial, educational, occupational or other important areas of functioning.  \\nThe pattern of gambling behaviour may be continuous or episodic and recurrent. Th e gambling \\nbehaviour and other features are normally evident over a period of at least 12 months in order for a \\ndiagnosis to be assigned, although the required duration may be shortened if all diagnostic \\nrequirements are met and symptoms are severe.  \\nExclusions:  Hazardous gambling or betting (QE21)',\n",
       " '6C50.Z  Gambling disorder, unspecified',\n",
       " '6C51   Gaming disorder  \\nGaming disorder is characterised by a pattern of persistent or recurrent gaming \\nbehaviour (‘digital gaming’ or ‘video -gaming’), which may be online (i.e., over the \\ninternet) or offline, manifested by:  \\n1. impaired control over gaming (e.g., onset, frequency , intensity, duration, \\ntermination, context);  \\n2. increasing priority given to gaming to the extent that gaming takes precedence \\nover other life interests and daily activities; and  \\n3. continuation or escalation of gaming despite the occurrence of negative \\nconsequences.  \\nThe pattern of gaming behaviour may be continuous or episodic and recurrent. The \\npattern of gaming behaviour results in marked distress or significant impairment in \\npersonal, family, social, educational, occupational, or other important areas of \\nfunctioning. The gaming behaviour and other features are normally evident over a \\nperiod of at least 12 months in order for a diagnosis to be assigned, although the \\nrequired duration may be shortened if all diagnostic requirements are met and \\nsymptoms ar e severe.  \\nExclusions:  Hazardous gaming (QE22)  \\nBipolar type I disorder (6A60)  \\nBipolar type II disorder (6A61)',\n",
       " '6C51.0  Gaming disorder, predominantly online  \\nGaming disorder, predominantly online is characterised by a pattern of persistent or recurrent gaming \\nbehaviour (‘digital gaming’ or ‘video -gaming’) that is primarily conducted over the internet and is \\nmanifested by:  \\n1. impaired control over gaming (e.g., ons et, frequency, intensity, duration, termination, context);  \\n2. increasing priority given to gaming to the extent that gaming takes precedence over other life \\ninterests and daily activities; and  ICD-11 MMS  557 \\n 3. continuation or escalation of gaming despite the occurrence of neg ative consequences. The \\nbehaviour pattern is of sufficient severity to result in significant impairment in personal, family, \\nsocial, educational, occupational or other important areas of functioning.  \\nThe pattern of gaming behaviour may be continuous or epi sodic and recurrent. The gaming behaviour \\nand other features are normally evident over a period of at least 12 months in order for a diagnosis to \\nbe assigned, although the required duration may be shortened if all diagnostic requirements are met \\nand sympto ms are severe.',\n",
       " '6C51.1  Gaming disorder, predominantly offline  \\nGaming disorder, predominantly offline is characterised by a pattern of persistent or recurrent gaming \\nbehaviour (‘digital gaming’ or ‘video -gaming’) that is not primarily conducted over the internet and is \\nmanifested by:  \\n1. impaired control over gaming (e.g. , onset, frequency, intensity, duration, termination, context);  \\n2. increasing priority given to gaming to the extent that gaming takes precedence over other life \\ninterests and daily activities; and  \\n3. continuation or escalation of gaming despite the occurrence o f negative consequences. The \\nbehaviour pattern is of sufficient severity to result in significant impairment in personal, family, \\nsocial, educational, occupational or other important areas of functioning.  \\nThe pattern of gaming behaviour may be continuous o r episodic and recurrent. The gaming behaviour \\nand other features are normally evident over a period of at least 12 months in order for a diagnosis to \\nbe assigned, although the required duration may be shortened if all diagnostic requirements are met \\nand s ymptoms are severe.',\n",
       " '6C51.Z  Gaming disorder, unspecified',\n",
       " '6C5Y   Other  specified disorders due to addictive behaviours',\n",
       " '6C5Z   Disorders due to addictive behaviours, unspecified  \\n 558  ICD-11 MMS  \\n Impulse control disorders (6C70 ‑6C7Z)  \\nImpulse control disorders are characterised by the repeated failure to resist an impulse, drive, or urge \\nto perform an act that is rewarding to the person, at least in the short -term, despite consequences \\nsuch as longer -term harm either to the individual o r to others, marked distress about the behaviour \\npattern, or significant impairment in personal, family, social, educational, occupational, or other \\nimportant areas of functioning. Impulse Control Disorders involve a range of specific behaviours, \\nincluding  fire-setting, stealing, sexual behaviour, and explosive outbursts.  \\nCoded Elsewhere:  Substance -induced impulse control disorders  \\nGambling disorder (6C50)  \\nGaming disorder (6C51)  \\nSecondary impulse control syndrome (6E66)  \\nBody -focused repetitive behaviour disorders (6B25)',\n",
       " '6C70   Pyromania  \\nPyromania is characterised by a recurrent failure to control strong impulses to set \\nfires, resulting in multiple acts of, or attempts at, settin g fire to property or other \\nobjects, in the absence of an apparent motive (e.g., monetary gain, revenge, \\nsabotage, political statement, attracting attention or recognition). There is an \\nincreasing sense of tension or affective arousal prior to instances of  fire setting, \\npersistent fascination or preoccupation with fire and related stimuli (e.g., watching \\nfires, building fires, fascination with firefighting equipment), and a sense of pleasure, \\nexcitement, relief or gratification during, and immediately after  the act of setting the \\nfire, witnessing its effects, or participating in its aftermath. The behaviour is not \\nbetter explained by intellectual impairment, another mental and behavioural \\ndisorder, or substance intoxication.  \\nInclusions:  pathological fire -setting \\nExclusions:  Conduct -dissocial disorder (6C91)  \\nBipolar type I disorder (6A60)  \\nSchizophrenia or other primary psychotic disorders  \\n(6A20‑6A2Z)  \\nFire-setting as the reason for observation for suspected mental \\nor behavioural disorders, ruled out (QA02.3)',\n",
       " '6C71   Kleptomania  \\nKleptomania is characterised by a recurrent failure to control strong impulses to \\nsteal objects in the absence of an apparent motive (e.g., objects are not acquired \\nfor personal use or monetary gain). There is an increasing sense of ten sion or \\naffective arousal before instances of theft and a sense of pleasure, excitement, \\nrelief, or gratification during and immediately after the act of stealing. The behaviour \\nis not better explained by intellectual impairment, another mental and behavio ural \\ndisorder, or substance intoxication.  \\nCoding Note:  If stealing occurs within the context of conduct -dissocial disorder or a manic \\nepisode, Kleptomania should not be diagnosed separately.  \\nInclusions:  pathological stealing  \\nExclusions:  shoplifting as the reason for observation for suspected mental \\ndisorder, ruled out (QA02.3)  \\n ICD-11 MMS  559',\n",
       " '6C72   Compulsive sexual behaviour disorder  \\nCompulsive sexual behaviour disorder is characterised by a persistent pattern of \\nfailure to control intense, repetitive sexual impulses or urges resulting in repetitive \\nsexual behaviour. Symptoms may include repetitive sexual activities becoming a \\ncentral focus of the person’s life to the point of neglecting health and personal care \\nor other interests, activities and responsibilities; nume rous unsuccessful efforts to \\nsignificantly reduce repetitive sexual behaviour; and continued repetitive sexual \\nbehaviour despite adverse consequences or deriving little or no satisfaction from it. \\nThe pattern of failure to control intense, sexual impulses or urges and resulting \\nrepetitive sexual behaviour is manifested over an extended period of time (e.g., 6 \\nmonths or more), and causes marked distress or significant impairment in personal, \\nfamily, social, educational, occupational, or other important areas  of functioning. \\nDistress that is entirely related to moral judgments and disapproval about sexual \\nimpulses, urges, or behaviours is not sufficient to meet this requirement.  \\nExclusions:  Paraphilic disorders  (6D30‑6D3Z)',\n",
       " '6C73   Intermittent explosive disorder  \\nIntermittent explosive disorder is characterised by repeated brief episodes of verbal \\nor physical aggression or destruction of property that represent a failure to control \\naggressive impulses, with the intensity of the outbu rst or degree of aggressiveness \\nbeing grossly out of proportion to the provocation or precipitating psychosocial \\nstressors. The symptoms are not better explained by another mental, behavioural, \\nor neurodevelopmental disorder and are not part of a pattern o f chronic anger and \\nirritability (e.g., in oppositional defiant disorder). The behaviour pattern is of \\nsufficient severity to result in significant impairment in personal, family, social, \\neducational, occupational or other important areas of functioning.  \\nExclusions:  Oppositional defiant disorder (6C90)',\n",
       " '6C7Y   Other specified impulse control disorders',\n",
       " '6C7Z   Impulse control disorders, unspecified  \\n 560  ICD-11 MMS  \\n Disruptive behaviour or dissocial disorders (6C90 ‑6C9Z)  \\nDisruptive behaviour and dissocial disorders are c haracterised by persistent behaviour problems that \\nrange from markedly and persistently defiant, disobedient, provocative or spiteful (i.e., disruptive) \\nbehaviours to those that persistently violate the basic rights of others or major age -appropriate \\nsocie tal norms, rules, or laws (i.e., dissocial). Onset of Disruptive and dissocial disorders is \\ncommonly, though not always, during childhood.',\n",
       " '6C90   Oppositional defiant disorder  \\nOppositional defiant disorder is a persistent pattern (e.g., 6 months or more)  of \\nmarkedly defiant, disobedient, provocative or spiteful behaviour that occurs more \\nfrequently than is typically observed in individuals of comparable age and \\ndevelopmental level and that is not restricted to interaction with siblings. \\nOppositional defia nt disorder may be manifest in prevailing, persistent angry or \\nirritable mood, often accompanied by severe temper outbursts or in headstrong, \\nargumentative and defiant behaviour. The behaviour pattern is of sufficient severity \\nto result in significant impa irment in personal, family, social, educational, \\noccupational or other important areas of functioning',\n",
       " '6C90.0  Oppositional defiant disorder with chronic irritability -anger  \\nAll definitional requirements for oppositional defiant disorder are met. This form o f \\noppositional defiant disorder is characterised by prevailing, persistent angry or \\nirritable mood that may be present independent of any apparent provocation. The \\nnegative mood is often accompanied by regularly occurring severe temper outbursts \\nthat are g rossly out of proportion in intensity or duration to the provocation. Chronic \\nirritability and anger are characteristic of the individual’s functioning nearly every \\nday, are observable across multiple settings or domains of functioning (e.g., home, \\nschool,  social relationships), and are not restricted to the individual’s relationship \\nwith his/her parents or guardians. The pattern of chronic irritability and anger is not \\nlimited to occasional episodes (e.g., developmentally typical irritability) or discrete \\nperiods (e.g., irritable mood in the context of manic or depressive episodes).',\n",
       " '6C90.00  Oppositional defiant disorder with chronic irritability -anger with limited prosocial \\nemotions  \\nAll definitional requirements for oppositional defiant disorder with chronic irritability -\\nanger are met. In addition, the individual exhibits characteristics that  are sometimes \\nreferred to as ‘callous and unemotional’. These characteristics include a lack of \\nempathy or sensitivity to the feelings of others and a lack of concern for others’ \\ndistress; a lack of remorse, shame or guilt over their own behaviour (unless  \\nprompted by being apprehended), a relative indifference to the probability of \\npunishment; a lack of concern over poor performance in school or work; and limited \\nexpression of emotions, particularly positive or loving feelings toward others, or only \\ndoing so in ways that seem shallow, insincere, or instrumental.',\n",
       " '6C90.01  Oppositional defiant disorder with chronic irritability -anger with typical prosocial \\nemotions  \\nAll definitional requirements for oppositional defiant disorder with chronic irritability -\\nanger  are met. The individual does not exhibit characteristics referred to as ‘callous \\nand unemotional’, such as lack of empathy or sensitivity to the feelings of others \\nand a lack of concern for others’ distress.',\n",
       " '6C90.0Z  Oppositional defiant disorder with chr onic irritability -anger, unspecified  \\n ICD-11 MMS  561',\n",
       " '6C90.1  Oppositional defiant disorder without chronic irritability -anger  \\nMeets all definitional requirements for oppositional defiant disorder. This form of \\noppositional defiant disorder is not characterised by prevaili ng, persistent, angry or \\nirritable mood, but does feature headstrong, argumentative, and defiant behaviour.',\n",
       " '6C90.10  Oppositional defiant disorder without chronic irritability -anger with limited prosocial \\nemotions  \\nAll definitional requirements for oppositional defiant disorder without chronic \\nirritability -anger are met. In addition, the individual exhibits characteristic s that are \\nsometimes referred to as ‘callous and unemotional’. These characteristics include a \\nlack of empathy or sensitivity to the feelings of others and a lack of concern for \\nothers’ distress; a lack of remorse, shame or guilt over their own behaviour ( unless \\nprompted by being apprehended), a relative indifference to the probability of \\npunishment; a lack of concern over poor performance in school or work; and limited \\nexpression of emotions, particularly positive or loving feelings toward others, or only \\ndoing so in ways that seem shallow, insincere, or instrumental. This pattern is \\npervasive across situations and relationships (i.e., the qualifier should not be \\napplied based on a single characteristic, a single relationship, or a single instance of \\nbehavi our) and is persistent over time (e.g., at least 1 year).',\n",
       " '6C90.11  Oppositional defiant disorder without chronic irritability -anger with typical prosocial \\nemotions  \\nAll definitional requirements for oppositional defiant disorder without chronic \\nirritability -anger are met. The individual does not exhibit characteristics referred to \\nas ‘callous and unemotional’, such as lack of empathy or sensitivity to the feelings \\nof others and a lack of concern for others’ distress.',\n",
       " '6C90.1Z  Oppositional defiant disorder wi thout chronic irritability -anger, unspecified',\n",
       " '6C90.Z  Oppositional defiant disorder, unspecified',\n",
       " '6C91   Conduct -dissocial disorder  \\nConduct -dissocial disorder is characterised by a repetitive and persistent pattern of \\nbehaviour in which the basic rights of others or major age -appropriate societal \\nnorms, rules, or laws are violated such as aggression towards people or animals; \\ndestruction of property; deceitfulness or theft; and serious violations of rules. The \\nbehaviour pattern is of sufficient severity t o result in significant impairment in \\npersonal, family, social, educational, occupational or other important areas of \\nfunctioning. To be diagnosed, the behaviour pattern must be enduring over a \\nsignificant period of time (e.g., 12 months or more). Isolated  dissocial or criminal \\nacts are thus not in themselves grounds for the diagnosis.',\n",
       " '6C91.0  Conduct -dissocial disorder, childhood onset  \\nConduct -dissocial disorder, childhood onset is characterised by a repetitive and \\npersistent pattern of behaviour in which the basic rights of others or major age -\\nappropriate societal norms, rules, or laws are violated such as aggression towards \\npeople or animals; destruction of property; deceitfulness or theft; and serious \\nviolations of rules. To be diagnosed, features of the  disorder must be present during \\nchildhood prior to adolescence (e.g., before 10 years of age) and the behaviour \\npattern must be enduring over a significant period of time (e.g., 12 months or more). \\nIsolated dissocial or criminal acts are thus not in thems elves grounds for the \\ndiagnosis.  \\n 562  ICD-11 MMS',\n",
       " '6C91.00  Conduct -dissocial disorder, childhood onset with limited prosocial emotions  \\nMeets all definitional requirements for Conduct -dissocial disorder, childhood onset. \\nIn addition, the individual exhibits characteristics that are sometimes referred to as \\n‘callous and unemotional’. These characteristics include a lack of empathy or \\nsensitivity to the feelings of others and a lack of concern for others’ distress; a lack \\nof remorse, shame or guilt over their own behaviour (un less prompted by being \\napprehended), a relative indifference to the probability of punishment; a lack of \\nconcern over poor performance in school or work; and limited expression of \\nemotions, particularly positive or loving feelings toward others, or only do ing so in \\nways that seem shallow, insincere, or instrumental.',\n",
       " '6C91.01  Conduct -dissocial disorder, childhood onset with typical prosocial emotions  \\nAll definitional requirements for conduct -dissocial disorder, childhood onset are met. \\nThe individual does no t exhibit characteristics referred to as ‘callous and \\nunemotional’, such as lack of empathy or sensitivity to the feelings of others and a \\nlack of concern for others’ distress.',\n",
       " '6C91.0Z  Conduct -dissocial disorder, childhood onset, unspecified',\n",
       " '6C91.1  Condu ct-dissocial disorder, adolescent onset  \\nConduct -dissocial disorder, adolescent onset is characterised by a repetitive and \\npersistent pattern of behaviour in which the basic rights of others or major age -\\nappropriate societal norms, rules, or laws are violat ed such as aggression towards \\npeople or animals; destruction of property; deceitfulness or theft; and serious \\nviolations of rules. No features of the disorder are present during childhood prior to \\nadolescence (e.g., before 10 years of age). To be diagnosed , the behaviour pattern \\nmust be enduring over a significant period of time (e.g., 12 months or more). \\nIsolated dissocial or criminal acts are thus not in themselves grounds for the \\ndiagnosis.',\n",
       " '6C91.10  Conduct -dissocial disorder, adolescent onset with limit ed prosocial emotions  \\nAll definitional requirements for conduct -dissocial disorder, adolescent onset are \\nmet. In addition, the individual exhibits characteristics that are sometimes referred \\nto as ‘callous and unemotional’. These characteristics include a lack of empathy or \\nsensitivity to the feelings of others and a lack of concern for others’ distress; a lack \\nof remorse, shame or guilt over their own behaviour (unless prompted by being \\napprehended), a relative indifference to the probability of punishment; a lack of \\nconcern ov er poor performance in school or work; and limited expression of \\nemotions, particularly positive or loving feelings toward others, or only doing so in \\nways that seem shallow, insincere, or instrumental.',\n",
       " '6C91.11  Conduct -dissocial disorder, adolescent onset  with typical prosocial emotions  \\nAll definitional requirements for conduct -dissocial disorder, adolescent onset are \\nmet. The individual does not exhibit characteristics referred to as ‘callous and \\nunemotional’, such as lack of empathy or sensitivity to the  feelings of others and a \\nlack of concern for others’ distress.',\n",
       " '6C91.1Y  Other specified conduct -dissocial disorder, adolescent onset',\n",
       " '6C91.Z  Conduct -dissocial disorder, unspecified',\n",
       " '6C9Y   Other specified disruptive behaviour or dissocial disorders  \\n ICD-11 MMS  563',\n",
       " '6C9Z   Disruptive behaviour or dissocial disorders, unspecified  \\n \\nPersonality disorders and related traits (6D10 ‑6D11.5)  \\nCoded Elsewhere:  Secondary personality change (6E68)',\n",
       " '6D10   Personality  disorder  \\nPersonality disorder is characterised by problems in functioning of aspects of the \\nself (e.g., identity, self -worth, accuracy of self -view, self -direction), and/or \\ninterpersonal dysfunction (e.g., ability to develop and maintain close and mutuall y \\nsatisfying relationships, ability to understand others’ perspectives and to manage \\nconflict in relationships) that have persisted over an extended period of time (e.g., 2 \\nyears or more). The disturbance is manifest in patterns of cognition, emotional \\nexperience, emotional expression, and behaviour that are maladaptive (e.g., \\ninflexible or poorly regulated) and is manifest across a range of personal and social \\nsituations (i.e., is not limited to specific relationships or social roles). The patterns of \\nbeha viour characterizing the disturbance are not developmentally appropriate and \\ncannot be explained primarily by social or cultural factors, including socio -political \\nconflict. The disturbance is associated with substantial distress or significant \\nimpairment in personal, family, social, educational, occupational or other important \\nareas of functioning.',\n",
       " '6D10.0  Mild personality disorder  \\nAll general diagnostic requirements for Personality Disorder are met. Disturbances \\naffect some areas of personality functionin g but not others (e.g., problems with self -\\ndirection in the absence of problems with stability and coherence of identity or self -\\nworth), and may not be apparent in some contexts. There are problems in many \\ninterpersonal relationships and/or in performance of expected occupational and \\nsocial roles, but some relationships are maintained and/or some roles carried out. \\nSpecific manifestations of personality disturbances are generally of mild severity. \\nMild Personality Disorder is typically not associated with s ubstantial harm to self or \\nothers, but may be associated with substantial distress or with impairment in \\npersonal, family, social, educational, occupational or other important areas of \\nfunctioning that is either limited to circumscribed areas (e.g., romant ic relationships; \\nemployment) or present in more areas but milder.  \\n 564  ICD-11 MMS',\n",
       " '6D10.1  Moderate personality disorder  \\nAll general diagnostic requirements for Personality Disorder are met. Disturbances \\naffect multiple areas of personality functioning (e.g., identity or sense of self, ability \\nto form intimate relationships, ability to control impulses and modulate behaviour). \\nHowever, some areas of personality functioning may be relatively less affected. \\nThere are marked problems in most interpersonal relationships and th e \\nperformance of most expected social and occupational roles is compromised to \\nsome degree. Relationships are likely to be characterised by conflict, avoidance, \\nwithdrawal, or extreme dependency (e.g., few friendships maintained, persistent \\nconflict in wor k relationships and consequent occupational problems, romantic \\nrelationships characterised by serious disruption or inappropriate submissiveness). \\nSpecific manifestations of personality disturbance are generally of moderate \\nseverity. Moderate Personality D isorder is sometimes associated with harm to self \\nor others, and is associated with marked impairment in personal, family, social, \\neducational, occupational or other important areas of functioning, although \\nfunctioning in circumscribed areas may be maintai ned.',\n",
       " '6D10.2  Severe personality disorder  \\nAll general diagnostic requirements for Personality Disorder are met. There are \\nsevere disturbances in functioning of the self (e.g., sense of self may be so unstable \\nthat individuals report not having a sense of wh o they are or so rigid that they refuse \\nto participate in any but an extremely narrow range of situations; self view may be \\ncharacterised by self -contempt or be grandiose or highly eccentric). Problems in \\ninterpersonal functioning seriously affect virtuall y all relationships and the ability and \\nwillingness to perform expected social and occupational roles is absent or severely \\ncompromised. Specific manifestations of personality disturbance are severe and \\naffect most, if not all, areas of personality functio ning. Severe Personality Disorder \\nis often associated with harm to self or others, and is associated with severe \\nimpairment in all or nearly all areas of life, including personal, family, social, \\neducational, occupational, and other important areas of func tioning.',\n",
       " '6D10.Z  Personality disorder, severity unspecified',\n",
       " '6D11   Prominent personality traits or patterns  \\nTrait domain qualifiers may be applied to Personality Disorders or Personality \\nDifficulty to describe the characteristics of the individual’s personality that are most \\nprominent and that contribute to personality disturbance. Trait domains are \\ncontinuous w ith normal personality characteristics in individuals who do not have \\nPersonality Disorder or Personality Difficulty. Trait domains are not diagnostic \\ncategories, but rather represent a set of dimensions that correspond to the \\nunderlying structure of perso nality. As many trait domain qualifiers may be applied \\nas necessary to describe personality functioning. Individuals with more severe \\npersonality disturbance tend to have a greater number of prominent trait domains.  \\n ICD-11 MMS  565',\n",
       " '6D11.0  Negative affectivity in personal ity disorder or personality difficulty  \\nThe core feature of the Negative Affectivity trait domain is the tendency to \\nexperience a broad range of negative emotions. Common manifestations of \\nNegative Affectivity, not all of which may be present in a given ind ividual at a given \\ntime, include: experiencing a broad range of negative emotions with a frequency \\nand intensity out of proportion to the situation; emotional lability and poor emotion \\nregulation; negativistic attitudes; low self -esteem and self -confidence ; and \\nmistrustfulness.  \\nCoding Note:  This category should ONLY be used in combination with a Personality disorder \\ncategory (Mild, Moderate, or Severe) or Personality difficulty.',\n",
       " '6D11.1  Detachment in personality disorder or personality difficulty  \\nThe core f eature of the Detachment trait domain is the tendency to maintain \\ninterpersonal distance (social detachment) and emotional distance (emotional \\ndetachment). Common manifestations of Detachment, not all of which may be \\npresent in a given individual at a give n time, include: social detachment (avoidance \\nof social interactions, lack of friendships, and avoidance of intimacy); and emotional \\ndetachment (reserve, aloofness, and limited emotional expression and experience).  \\nCoding Note:  This category should ONLY be  used in combination with a Personality disorder \\ncategory (Mild, Moderate, or Severe) or Personality difficulty.',\n",
       " \"6D11.2  Dissociality in personality disorder or personality difficulty  \\nThe core feature of the Dissociality trait domain is disregard for the r ights and \\nfeelings of others, encompassing both self -centeredness and lack of empathy. \\nCommon manifestations of Dissociality, not all of which may be present in a given \\nindividual at a given time, include: self -centeredness (e.g., sense of entitlement, \\nexpectation of others’ admiration, positive or negative attention -seeking behaviours, \\nconcern with one's own needs, desires and comfort and not those of others); and \\nlack of empathy (i.e., indifference to whether one’s actions inconvenience or hurt \\nothers, wh ich may include being deceptive, manipulative, and exploitative of others, \\nbeing mean and physically aggressive, callousness in response to others' suffering, \\nand ruthlessness in obtaining one’s goals).  \\nCoding Note:  This category should ONLY be used in com bination with a Personality disorder \\ncategory (Mild, Moderate, or Severe) or Personality difficulty.\",\n",
       " '6D11.3  Disinhibition in personality disorder or personality difficulty  \\nThe core feature of the Disinhibition trait domain is the tendency to act rashly ba sed \\non immediate external or internal stimuli (i.e., sensations, emotions, thoughts), \\nwithout consideration of potential negative consequences. Common manifestations \\nof Disinhibition, not all of which may be present in a given individual at a given time, \\ninclude: impulsivity; distractibility; irresponsibility; recklessness; and lack of \\nplanning.  \\nCoding Note:  This category should ONLY be used in combination with a Personality disorder \\ncategory (Mild, Moderate, or Severe) or Personality difficulty.  \\n 566  ICD-11 MMS',\n",
       " '6D11.4  Anankastia in personality disorder or personality difficulty  \\nThe core feature of the Anankastia trait domain is a narrow focus on one’s rigid \\nstandard of perfection and of right and wrong, and on controlling one’s own and \\nothers’ behaviour and controlling si tuations to ensure conformity to these standards. \\nCommon manifestations of Anankastia, not all of which may be present in a given \\nindividual at a given time, include: perfectionism (e.g., concern with social rules, \\nobligations, and norms of right and wrong , scrupulous attention to detail, rigid, \\nsystematic, day -to-day routines, hyper -scheduling and planfulness, emphasis on \\norganisation, orderliness, and neatness); and emotional and behavioural constraint \\n(e.g., rigid control over emotional expression, stubb ornness and inflexibility, risk -\\navoidance, perseveration, and deliberativeness).  \\nCoding Note:  This category should ONLY be used in combination with a Personality disorder \\ncategory (Mild, Moderate, or Severe) or Personality difficulty.',\n",
       " '6D11.5  Borderline pattern  \\nThe Borderline pattern specifier may be applied to individuals whose pattern of \\npersonal ity disturbance is characterised by a pervasive pattern of instability of \\ninterpersonal relationships, self -image, and affects, and marked impulsivity, as \\nindicated by many of the following: Frantic efforts to avoid real or imagined \\nabandonment; A pattern of unstable and intense interpersonal relationships; Identity \\ndisturbance, manifested in markedly and persistently unstable self -image or sense \\nof self; A tendency to act rashly in states of high negative affect, leading to \\npotentially self -damaging behavi ours; Recurrent episodes of self -harm; Emotional \\ninstability due to marked reactivity of mood; Chronic feelings of emptiness; \\nInappropriate intense anger or difficulty controlling anger; Transient dissociative \\nsymptoms or psychotic -like features in situati ons of high affective arousal.  \\nCoding Note:  This category should ONLY be used in combination with a Personality disorder \\ncategory (Mild, Moderate, or Severe) or Personality difficulty.  \\n \\nParaphilic disorders (6D30 ‑6D3Z)  \\nParaphilic disorders are characterised by persistent and intense patterns of atypical sexual arousal, \\nmanifested by sexual thoughts, fantasies, urges, or behaviours, the focus of which involves others \\nwhose age or status renders them unwilling or unable to  consent and on which the person has acted \\nor by which he or she is markedly distressed. Paraphilic disorders may include arousal patterns \\ninvolving solitary behaviours or consenting individuals only when these are associated with marked \\ndistress that is n ot simply a result of rejection or feared rejection of the arousal pattern by others or \\nwith significant risk of injury or death.  \\nInclusions:  paraphilias',\n",
       " '6D30   Exhibitionistic disorder  \\nExhibitionistic disorder is characterised by a sustained, focused an d intense pattern \\nof sexual arousal —as manifested by persistent sexual thoughts, fantasies, urges, or \\nbehaviours —that involves exposing one’s genitals to an unsuspecting individual in \\npublic places, usually without inviting or intending closer contact. In addition, in \\norder for Exhibitionistic Disorder to be diagnosed, the individual must have acted on \\nthese thoughts, fantasies or urges or be markedly distressed by them. \\nExhibitionistic Disorder specifically excludes consensual exhibitionistic behaviours \\nthat occur with the consent of the person or persons involved as well as socially \\nsanctioned forms of exhibitionism.  \\n ICD-11 MMS  567',\n",
       " '6D31   Voyeuristic disorder  \\nVoyeuristic disorder is characterised by a sustained, focused and intense pattern of \\nsexual arousal —as manifes ted by persistent sexual thoughts, fantasies, urges, or \\nbehaviours —that involves observing an unsuspecting individual who is naked, in the \\nprocess of disrobing, or engaging in sexual activity. In addition, in order for \\nVoyeuristic Disorder to be diagnosed,  the individual must have acted on these \\nthoughts, fantasies or urges or be markedly distressed by them. Voyeuristic \\nDisorder specifically excludes consensual voyeuristic behaviours that occur with the \\nconsent of the person or persons being observed.',\n",
       " '6D32   Pedophilic disorder  \\nPedophilic disorder is characterised by a sustained, focused, and intense pattern of \\nsexual arousal —as manifested by persistent sexual thoughts, fantasies, urges, or \\nbehaviours —involving pre -pubertal children. In addition, in order  for Pedophilic \\nDisorder to be diagnosed, the individual must have acted on these thoughts, \\nfantasies or urges or be markedly distressed by them. This diagnosis does not \\napply to sexual behaviours among pre - or post -pubertal children with peers who are \\nclose in age.',\n",
       " '6D33   Coercive sexual sadism disorder  \\nCoercive sexual sadism disorder is characterised by a sustained, focused and \\nintense pattern of sexual arousal —as manifested by persistent sexual thoughts, \\nfantasies, urges or behaviours —that involves th e infliction of physical or \\npsychological suffering on a non -consenting person. In addition, in order for \\nCoercive Sexual Sadism Disorder to be diagnosed, the individual must have acted \\non these thoughts, fantasies or urges or be markedly distressed by the m. Coercive \\nSexual Sadism Disorder specifically excludes consensual sexual sadism and \\nmasochism.',\n",
       " '6D34   Frotteuristic disorder  \\nFrotteuristic disorder is characterised by a sustained, focused and intense pattern of \\nsexual arousal —as manifested by persist ent sexual thoughts, fantasies, urges, or \\nbehaviours —that involves touching or rubbing against a non -consenting person in \\ncrowded public places. In addition, in order for Frotteuristic Disorder to be \\ndiagnosed, the individual must have acted on these thoug hts, fantasies or urges or \\nbe markedly distressed by them. Frotteuristic Disorder specifically excludes \\nconsensual touching or rubbing that occurs with the consent of the person or \\npersons involved.',\n",
       " '6D35   Other paraphilic disorder involving non -consent ing individuals  \\nOther paraphilic disorder involving non -consenting individuals is characterised by a \\npersistent and intense pattern of atypical sexual arousal — manifested by sexual \\nthoughts, fantasies, urges, or behaviours — in which the focus of the arou sal \\npattern involves others who are unwilling or unable to consent but that is not \\nspecifically described in any of the other named Paraphilic Disorders categories \\n(e.g., arousal patterns involving corpses or animals). The individual must have \\nacted on the se thoughts, fantasies or urges or be markedly distressed by them. The \\ndisorder specifically excludes sexual behaviours that occur with the consent of the \\nperson or persons involved, provided that they are considered able to provide such \\nconsent.  \\n 568  ICD-11 MMS',\n",
       " '6D36   Paraphilic disorder involving solitary behaviour or consenting \\nindividuals  \\nParaphilic disorder involving solitary behaviour or consenting individuals is \\ncharacterised by a persistent and intense pattern of atypical sexual arousal — \\nmanifested by sexual th oughts, fantasies, urges, or behaviours — that involves \\nconsenting adults or solitary behaviours. One of the following two elements must be \\npresent: 1) the person is markedly distressed by the nature of the arousal pattern \\nand the distress is not simply a consequence of rejection or feared rejection of the \\narousal pattern by others; or 2) the nature of the paraphilic behaviour involves \\nsignificant risk of injury or death either to the individual or to the partner (e.g., \\nasphyxophilia).',\n",
       " '6D3Z   Paraphilic disorders, unspecified  \\n \\nFactitious disorders (6D50 ‑6D5Z)  \\nFactitious disorders are characterised by intentionally feigning, falsifying, inducing, or aggravating \\nmedical, psychological, or behavioural signs and symptoms or injury in oneself or in another per son, \\nmost commonly a child dependent, associated with identified deception. A pre -existing disorder or \\ndisease may be present, but the individual intentionally aggravates existing symptoms or falsifies or \\ninduces additional symptoms. Individuals with facti tious disorder seek treatment or otherwise present \\nthemselves or another person as ill, injured, or impaired based on the feigned, falsified, or self -\\ninduced signs, symptoms, or injuries. The deceptive behaviour is not solely motivated by obvious \\nexternal rewards or incentives (e.g., obtaining disability payments or evading criminal prosecution). \\nThis is in contrast to Malingering, in which obvious external rewards or incentives motivate the \\nbehaviour.  \\nExclusions:  Malingering (QC30)',\n",
       " '6D50   Factitious disorder imposed on self  \\nFactitious disorder imposed on self is characterised by feigning, falsifying, or \\ninducing medical, psychological, or behavioural signs and symptoms or injury \\nassociated with identified deception. If a pre -existing disord er or disease is present, \\nthe individual intentionally aggravates existing symptoms or falsifies or induces \\nadditional symptoms. The individual seeks treatment or otherwise presents himself \\nor herself as ill, injured, or impaired based on the feigned, fals ified, or self -induced \\nsigns, symptoms, or injuries. The deceptive behaviour is not solely motivated by \\nobvious external rewards or incentives (e.g., obtaining disability payments or \\nevading criminal prosecution). This is in contrast to Malingering, in whi ch obvious \\nexternal rewards or incentives motivate the behaviour  \\nInclusions:  Münchhausen syndrome  \\nExclusions:  Excoriation disorder (6B25.1)  \\nMalingering (QC30)  \\n ICD-11 MMS  569',\n",
       " '6D51   Factitious disorder imposed on another  \\nFactitious disorder imposed on another is characterised by feigning, falsifying, or \\ninducing medical, psychological, or behavioural signs and symptoms or injury in \\nanother person, most commonly a child dependent, associated with identified \\ndeception. If a pre-existing disorder or disease is present in the other person, the \\nindividual intentionally aggravates existing symptoms or falsifies or induces \\nadditional symptoms. The individual seeks treatment for the other person or \\notherwise presents him or her as ill, injured, or impaired based on the feigned, \\nfalsified, or induced signs, symptoms, or injuries. The deceptive behaviour is not \\nsolely motivated by obvious external rewards or incentives (e.g., obtaining disability \\npayments or avoiding criminal prosecut ion for child or elder abuse).  \\nCoding Note:  The diagnosis of Factitious Disorder Imposed on Another is assigned to the \\nindividual who is feigning, falsifying or inducing the symptoms in another person, not \\nto the person who is presented as having the sympt oms. Occasionally the individual \\ninduces or falsifies symptoms in a pet rather than in another person.  \\nExclusions:  Malingering (QC30)',\n",
       " '6D5Z   Factitious disorders, unspecified  \\n \\nNeurocognitive disorders (6D70 ‑6E0Z)  \\nNeurocognitive disorders are characteris ed by primary clinical deficits in cognitive functioning that are \\nacquired rather than developmental. That is, neurocognitive disorders do not include disorders \\ncharacterised by deficits in cognitive function that are present from birth or that typically a rise during \\nthe developmental period, which are classified in the grouping neurodevelopmental disorders. Rather, \\nneurocognitive disorders represent a decline from a previously attained level of functioning. Although \\ncognitive deficits are present in many m ental disorders (e.g., schizophrenia, bipolar disorders), only \\ndisorders whose core features are cognitive are included in the neurocognitive disorders grouping. In \\ncases where the underlying pathology and aetiology for neurocognitive disorders can be dete rmined, \\nthe identified etiology should be classified separately.  \\nExclusions:  Neurodevelopmental disorders  (6A00‑6A0Z)  \\nCoded Elsewhere:  Secondary neurocognitive syndrome (6E67)',\n",
       " '6D70   Delirium  \\nDelirium is characterized by a disturbance of attention, orien tation, and awareness \\nthat develops within a short period of time, typically presenting as significant \\nconfusion or global neurocognitive impairment, with transient symptoms that may \\nfluctuate depending on the underlying causal condition or etiology. Delir ium often \\nincludes disturbance of behaviour and emotion, and may include impairment in \\nmultiple cognitive domains. A disturbance of the sleep -wake cycle, including \\nreduced arousal of acute onset or total sleep loss with reversal of the sleep -wake \\ncycle, ma y also be present. Delirium may be caused by the direct physiological \\neffects of a medical condition not classified under mental, behavioural or \\nneurodevelopmental disorders, by the direct physiological effects of a substance or \\nmedication, including withd rawal, or by multiple or unknown etiological factors.  \\n 570  ICD-11 MMS',\n",
       " '6D70.0  Delirium due to disease classified elsewhere  \\nAll definitional requirements for delirium are met. There is evidence from history, \\nphysical examination, or laboratory findings that Delirium is cau sed by the direct \\nphysiological consequences of a disorder or disease classified elsewhere.  \\nCoding Note:  Identified etiology should be classified separately.',\n",
       " '6D70.1  Delirium due to psychoactive substances including medications  \\nAll definitional requirement s for delirium are met. There is evidence from history, \\nphysical examination, or laboratory findings that the delirium is caused by the direct \\nphysiological effects of a substance or medication (including withdrawal). If the \\nspecific substance inducing the  delirium has been identified, it should be classified \\nusing the appropriate subcategory (e.g., alcohol -induced delirium).  \\nCoded Elsewhere:  Alcohol -induced delirium (6C40.5)  \\nCannabis -induced delirium (6C41.5)  \\nSynthetic cannabinoid -induced delirium (6C42.5)  \\nOpioid -induced delirium (6C43.5)  \\nSedative, hypnotic or anxiolytic -induced delirium (6C44.5)  \\nCocaine -induced delirium (6C45.5)  \\nStimulant -induced delirium including amphetamines, \\nmethamphetamine or methcathinon e (6C46.5)  \\nSynthetic cathinone -induced delirium (6C47.5)  \\nHallucinogen -induced delirium (6C49.4)  \\nVolatile inhalant -induced delirium (6C4B.5)  \\nMDMA or related drug -induced delirium, including MDA \\n(6C4C.5)  \\nDissociative drug -induced delirium including ketamine or PCP \\n(6C4D.4)  \\nDelirium induced by other specified psychoactive substance \\nincluding medications (6C4E.5)  \\nDelirium induced by multiple specified psychoactive \\nsubstances including medications (6C4F.5)  \\nDelirium induced by unknown or unspecified psychoactive \\nsubstance (6C4G.5)',\n",
       " '6D70.2  Delirium due to multiple etiological factors  \\nAll definitional requirements for delirium are met. There is evidence from history, \\nphysical examination, or laboratory findings that the delirium is attributable to \\nmultiple etiologic al factors, which may include disorders or diseases not classified \\nunder mental and behavioural disorders, substance intoxication or withdrawal, or a \\nmedication.  \\nCoding Note:  Identified etiologies should be classified separately.',\n",
       " '6D70.Y  Delirium, other specified cause',\n",
       " '6D70.Z  Delirium, unspecified or unknown cause  \\n ICD-11 MMS  571',\n",
       " '6D71   Mild neurocognitive disorder  \\nMild neurocognitive disorder is characterized by mild impairment in one or more \\ncognitive domains relative to that expected given the indi vidual’s age and general \\npremorbid level of cognitive functioning, which represents a decline from the \\nindividual’s previous level of functioning. Diagnosis is based on report from the \\npatient, informant, or clinical observation, and is accompanied by obje ctive evidence \\nof impairment by quantified clinical assessment or standardized cognitive testing. \\nCognitive impairment is not severe enough to significantly interfere with an \\nindividual’s ability to perform activities related to personal, family, social, \\neducational, and/or occupational functioning or other important functional areas. \\nCognitive impairment is not attributable to normal aging and may be static, \\nprogressive, or may resolve or improve depending on underlying cause or \\ntreatment. Cognitive impair ment may be attributable to an underlying acquired \\ndisease of the nervous system, a trauma, an infection or other disease process \\naffecting the brain, use of specific substances or medications, nutritional deficiency \\nor exposure to toxins, or the etiology may be undetermined. The impairment is not \\ndue to current substance intoxication or withdrawal.  \\nCoding Note:  Code also the causing condition',\n",
       " '6D72   Amnestic disorder  \\nAmnestic disorder is characterised by prominent memory impairment relative to \\nexpectations for age and general premorbid level of cognitive functioning, which \\nrepresents a decline from the individual’s previous level of functioning, in the \\nabsence of other  significant cognitive impairment. It is manifested by a deficit in \\nacquiring, learning, and/or retaining new information, and may include the inability \\nto recall previously learned information, without disturbance of consciousness, \\naltered mental status, or delirium. Recent memory is typically more disturbed than \\nremote memory, and the ability to immediately recall a limited amount of information \\nis usually relatively preserved. The memory impairment is severe enough to result \\nin significant impairment in personal, family, social, educational, occupational, or \\nother important areas of functioning. It is presumed to be attributable to an \\nunderlying acquired disease of the nervous system, a trauma, an infection or other \\ndisease process affecting the brain, to  use of specific substances or medications, \\nnutritional deficiency or exposure to toxins, or the etiology may be undetermined. \\nThe impairment is not due to current substance intoxication or withdrawal.  \\nExclusions:  Delirium (6D70)  \\nDementia  (6D80‑6D8Z)  \\nMild neurocognitive disorder (6D71)  \\n 572  ICD-11 MMS',\n",
       " '6D72.0  Amnestic disorder due to diseases classified elsewhere  \\nAll definitional requirements for amnestic disorder are met. The memory symptoms \\nare judged to be the direct pathophysiological consequence of a medical condition  \\nnot classified under mental, behavioural and neurodevelopmental disorders, based \\non evidence from the history, physical examination, or laboratory findings. The \\nsymptoms are not better explained by Delirium, Dementia, another mental disorder \\n(e.g., Schizo phrenia or Other Primary Psychotic Disorder, a Mood Disorder) or the \\neffects of a medication or substance, including withdrawal effects. The symptoms \\nare sufficiently severe to be a specific focus of clinical attention. The identified \\netiological medical c ondition should be classified separately.  \\nCoding Note:  Code also the causing condition  \\nExclusions:  amnesia: retrograde (MB21.11)  \\nKorsakoff syndrome, alcohol -induced or unspecified (8D44)  \\nDissociative amnesia (6B61)  \\nAnterograde amnesia (MB21.10)  \\namnesia NOS  (MB21.1)',\n",
       " '6D72.1  Amnestic disorder due to psychoactive substances including medications  \\nAll definitional requirements for amnestic disorder are met. The memory symptoms \\nare judged to be the direct consequence of psychoactive substance use. The \\nintensity a nd duration of substance use must be known to be capable of producing \\nmemory impairment. The memory impairment may develop during or soon after \\nsubstance intoxication or withdrawal, but its intensity and duration are substantially \\nin excess of those normal ly associated with these conditions. The symptoms are not \\nbetter accounted for by another disorder or medical condition, as might be the case \\nif the amnestic symptoms preceded the onset of substance use.  \\nCoding Note:  Code also the causing condition',\n",
       " '6D72.1 0 Amnestic disorder due to use of alcohol  \\nAll definitional requirements for amnestic disorder are met. The memory symptoms \\nare judged to be the direct consequence of alcohol use. The intensity and duration \\nof alcohol use must be known to be capable of prod ucing memory impairment. The \\nmemory impairment may develop during or soon after alcohol intoxication or \\nwithdrawal, but its intensity and duration are substantially in excess of those \\nnormally associated with these conditions. The symptoms are not better a ccounted \\nfor by another disorder or medical condition, as might be the case if the amnestic \\nsymptoms preceded the onset of the alcohol use.  \\nCoding Note:  This category should not be used to describe cognitive changes due to thiamine \\ndeficiency associated wi th chronic alcohol use.  \\nExclusions:  Korsakoff syndrome (5B5A.11)  \\nWernicke -Korsakoff Syndrome (5B5A.1)  \\n ICD-11 MMS  573',\n",
       " '6D72.11  Amnestic disorder due to use of sedatives, hypnotics or anxiolytics  \\nAll definitional requirements for amnestic disorder are met. The memory sympt oms \\nare judged to be the direct consequence of use of sedatives, hypnotics or \\nanxiolytics. The intensity and duration of use of sedatives, hypnotics or anxiolytics \\nmust be known to be capable of producing memory impairment. The memory \\nimpairment may develo p during or soon after sedative, hypnotic or anxiolytic \\nintoxication or withdrawal, but its intensity and duration are substantially in excess \\nof those normally associated with these conditions. The symptoms are not better \\naccounted for by another disorder  or medical condition, as might be the case if the \\namnestic symptoms preceded the onset of use of sedatives, hypnotics or \\nanxiolytics.  \\nCoding Note:  Code also the causing condition',\n",
       " '6D72.12  Amnestic disorder due to other specified psychoactive substance including \\nmedications  \\nAll definitional requirements for amnestic disorder are met. The memory symptoms \\nare judged to be the direct consequence of use of a specified psychoactive \\nsubstance other than alcohol; sedatives, hypnotics or anxiolytics; or volatile \\ninhalants. The intens ity and duration of use of the specified psychoactive substance \\nmust be known to be capable of producing memory impairment. The memory \\nimpairment may develop during or soon after specified psychoactive substance \\nintoxication or withdrawal, but its intensit y and duration are substantially in excess \\nof those normally associated with these conditions. The symptoms are not better \\naccounted for by another disorder or medical condition, as might be the case if the \\namnestic symptoms preceded the onset of the speci fied psychoactive substance.',\n",
       " '6D72.13  Amnestic disorder due to use of volatile inhalants  \\nAll definitional requirements for amnestic disorder are met. The memory symptoms \\nare judged to be the direct consequence of use of volatile inhalants. The intensity \\nand duration of use of volatile inhalants must be known to be capable of producing \\nmemory impairment. The memory impairment may develop during or soon after \\nvolatile inhalant intoxication or withdrawal, but its intensity and duration are \\nsubstantially in exc ess of those normally associated with these conditions. The \\nsymptoms are not better accounted for by another disorder or medical condition, as \\nmight be the case if the amnestic symptoms preceded the onset of use of volatile \\ninhalants.',\n",
       " '6D72.Y  Amnestic diso rder, other specified cause',\n",
       " '6D72.Z  Amnestic disorder, unknown or unspecified cause  \\n 574  ICD-11 MMS  \\n Dementia (6D80 ‑6D8Z)  \\nDementia is characterized by the presence of marked impairment in two or more cognitive domains \\nrelative to that expected given the individual’s age a nd general premorbid level of cognitive \\nfunctioning, which represents a decline from the individual’s previous level of functioning. Memory \\nimpairment is present in most forms of dementia, but cognitive impairment is not restricted to memory \\n(i.e., there i s impairment in other areas such as executive functions, attention, language, social \\ncognition and judgment, psychomotor speed, visuoperceptual or visuospatial abilities). \\nNeurobehavioural changes may also be present and, in some forms of dementia, may be the \\npresenting symptom. Cognitive impairment is not attributable to normal aging and is severe enough to \\nsignificantly interfere with independence in an individual’s performance of activities of daily living. The \\ncognitive impairment is presumed to be attr ibutable to an underlying acquired disease of the nervous \\nsystem, a trauma, an infection or other disease process affecting the brain, or to use of specific \\nsubstances or medications, nutritional deficiency or exposure to toxins, or the etiology may be \\nundetermined. The impairment is not due to current substance intoxication or withdrawal.  \\nCoding Note:  This category should only be used for primary tabulation, if the aetiology of the \\ndementia is unknown. If the aetiology of the dementia is known code to the \\naetiology of the dementia for primary tabulation.  \\nWhen dementia is due to multiple aetiologies, code all that apply.  \\nInclusions:  Dementia NOS  \\nExclusions:  Coma (MB20.1)  \\nDelirium (6D70)  \\nDisorders of intellectual development (6A00)  \\nNeurodevelopmental disorde rs (6A00‑6A0Z)  \\nStupor (MB20.0)  \\nAgeing associated decline in intrinsic capacity (MG2A)',\n",
       " '6D80   Dementia due to Alzheimer disease  \\nDementia due to Alzheimer disease is the most common form of dementia. Onset is \\ninsidious with memory impairment typically repo rted as the initial presenting \\ncomplaint. The characteristic course is a slow but steady decline from a previous \\nlevel of cognitive functioning with impairment in additional cognitive domains (such \\nas executive functions, attention, language, social cognit ion and judgment, \\npsychomotor speed, visuoperceptual or visuospatial abilities) emerging with disease \\nprogression. Dementia due to Alzheimer disease may be accompanied by mental \\nand behavioural symptoms such as depressed mood and apathy in the initial stag es \\nof the disease and may be accompanied by psychotic symptoms, irritability, \\naggression, confusion, abnormalities of gait and mobility, and seizures at later \\nstages. Positive genetic testing, family history and gradual cognitive decline are \\nsuggestive of Dementia due to Alzheimer disease.  \\nCoding Note:  This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified els ewhere.  \\n ICD-11 MMS  575',\n",
       " '6D80.0  Dementia due to Alzheimer disease with early onset  \\nDementia due to Alzheimer disease in which symptoms emerge before the age of \\n65 years. It is relatively rare, representing less than 5% of all cases, and may be \\ngenetically determined (autosomal dominant Alzheimer disease). Clinical \\npresentation may be sim ilar to cases with later onset, but progression of cognitive \\ndeficits may be more rapid.  \\nCoding Note:  This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identi fy the \\npresence of dementia in diseases classified elsewhere.  \\nWhen dementia is due to multiple aetiologies, code all that apply.',\n",
       " '6D80.1  Dementia due to Alzheimer disease with late onset  \\nDementia due to Alzheimer disease that develops at the age of 65 year s or above. \\nThis is the most common pattern, representing more than 95% of all cases.  \\nCoding Note:  This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere.  \\nWhen dementia is due to multiple aetiologies, code all that apply.',\n",
       " '6D80.2  Alzheimer disease dementia, mixed type, with cerebrovascular disease  \\nDementia due to Alzheimer disease and concomitant cer ebrovascular disease.  \\nCoding Note:  This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere.  \\nWhen dementia is due to multiple aetiologies, code all that apply.',\n",
       " '6D80.3  Alzheimer disease dementia, mixed type, with other nonvascular aetiologies  \\nDementia due to Alzheimer disease with other concomitant pathology, not including \\ncerebrovascular disease.  \\nCoding Note:  This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is  desired to identify the \\npresence of dementia in diseases classified elsewhere.  \\nWhen dementia is due to multiple aetiologies, code all that apply.',\n",
       " '6D80.Z  Dementia due to Alzheimer disease, onset unknown or unspecified  \\nCoding Note:  This category should nev er be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere.  \\n 576  ICD-11 MMS',\n",
       " '6D81   Dementia due to cerebrovascular disease  \\nDementia due t o brain parenchyma injury resulting from cerebrovascular disease \\n(ischemic or haemorrhagic). The onset of the cognitive deficits is temporally related \\nto one or more vascular events. Cognitive decline is typically most prominent in \\nspeed of information pro cessing, complex attention, and frontal -executive \\nfunctioning. There is evidence of the presence of cerebrovascular disease \\nconsidered to be sufficient to account for the neurocognitive deficits from history, \\nphysical examination and neuroimaging.  \\nCoding N ote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere.  \\nExclusions:  Alzheimer disease demen tia, mixed type, with cerebrovascular \\ndisease (6D80.2)',\n",
       " '6D82   Dementia due to Lewy body disease  \\nDementia preceding or occurring within one year after the onset of motor \\nparkinsonian signs in the setting of Lewy body disease. Characterized by presence \\nof Lewy bodies, which are intraneuronal inclusions containing α -synuclein and \\nubiquitin in the brain stem, limbic area, forebrain, and neocortex. Onset is insidious \\nwith attentional and executive functioning deficits often present. These cognitive \\ndeficits are often accompanied by visual hallucinations and symptoms of REM sleep \\nbehaviour disorder. Halluci nations in other sensory modalities, depressive \\nsymptoms, and delusions may also be present. The symptom presentation usually \\nvaries significantly over the course of days necessitating longitudinal assessment \\nand differentiation from delirium. Spontaneous onset of Parkinsonism within \\napproximately 1 year of the onset of cognitive symptoms is common.  \\nCoding Note:  This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to  identify the \\npresence of dementia in diseases classified elsewhere.  \\nWhen dementia is due to multiple aetiologies, code all that apply.',\n",
       " '6D83   Frontotemporal dementia  \\nFrontotemporal dementia (FTD) is a group of primary neurodegenerative disorders \\nprimar ily affecting the frontal and temporal lobes. Onset is typically insidious with a \\ngradual and worsening course. Several syndromic variants (some with an identified \\ngenetic basis or familiality) are described that include presentations with \\npredominantly ma rked personality and behavioral changes (such as executive \\ndysfunction, apathy, deterioration of social cognition, repetitive behaviours, and \\ndietary changes), predominantly language deficits (that include semantic, \\nagrammatic/nonfluent, and logopenic form s), predominantly movement -related \\ndeficits (progressive supranuclear palsy, corticobasal degeneration, multiple \\nsystems atrophy, or amyotrophic lateral sclerosis), or a combination of these \\ndeficits. Memory function often remains relatively intact, partic ularly during the early \\nstages of the disorder.  \\nCoding Note:  This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases c lassified elsewhere.  \\nWhen dementia is due to multiple aetiologies, code all that apply.  \\n ICD-11 MMS  577',\n",
       " '6D84   Dementia due to psychoactive substances including medications  \\nDementia due to psychoactive substances including medications includes forms of \\ndementia that ar e judged to be a direct consequence of substance use and that \\npersist beyond the usual duration of action or withdrawal syndrome associated with \\nthe substance. The amount and duration of substance use must be sufficient to \\nproduce the cognitive impairment.  The cognitive impairment is not better accounted \\nfor by a disorder that is not induced by substances such as a dementia due to \\nanother medical condition.  \\nCoding Note:  This category should never be used in primary tabulation. The codes are provided \\nfor use  as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere.  \\nWhen dementia is due to multiple aetiologies, code all that apply.  \\nExclusions:  Dementia due to exposure to heavy metals and othe r toxins \\n(6D85.2)',\n",
       " '6D84.0  Dementia due to use of alcohol  \\nDementia due to use of alcohol is characterised by the development of persistent \\ncognitive impairments (e.g., memory problems, language impairment, and an \\ninability to perform complex motor tasks) th at meet the definitional requirements of \\nDementia that are judged to be a direct consequence of alcohol use and that persist \\nbeyond the usual duration of alcohol intoxication or acute withdrawal. The intensity \\nand duration of alcohol use must have been suf ficient to produce the cognitive \\nimpairment. The cognitive impairment is not better accounted for by a disorder or \\ndisease that is not induced by alcohol such as a dementia due to another disorder \\nor disease classified elsewhere.  \\nCoding Note:  This category  should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere.  \\nWhen dementia is due to multiple aetiologies, code al l that apply.  \\nThis category should not be used to describe cognitive changes due to thiamine \\ndeficiency associated with chronic alcohol use.  \\nInclusions:  Alcohol -induced dementia  \\nExclusions:  Wernicke -Korsakoff Syndrome (5B5A.1)  \\nKorsakoff syndrome (5B5A.11)  \\n 578  ICD-11 MMS',\n",
       " '6D84.1  Dementia due to use of sedatives, hypnotics or anxiolytics  \\nDementia due to use of sedatives, hypnotics or anxiolytics is characterised by the \\ndevelopment of persistent cognitive impairments (e.g., memory problems, language \\nimpairment, and an inability to perform complex motor tasks) that meet the \\ndefinitional requ irements of Dementia that are judged to be a direct consequence of \\nsedative, hypnotic, or anxiolytic use and that persist beyond the usual duration of \\naction or withdrawal syndrome associated with the substance. The amount and \\nduration of sedative, hypnoti c, or anxiolytic use must be sufficient to produce the \\ncognitive impairment. The cognitive impairment is not better accounted for by a \\ndisorder that is not induced by sedatives, hypnotics, or anxiolytics such as a \\ndementia due to another medical condition.  \\nCoding Note:  This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere.  \\nWhen dementia is due to multiple aetiologies, code all that apply.  \\nInclusions:  Late-onset psychoactive substance -induced psychotic disorder',\n",
       " '6D84.2  Dementia due to use of volatile inhalants  \\nDementia due to use of volatile inhalants is characterised by the development of \\npersistent cognitive impairments (e.g., memory problems, language impairment, \\nand an inability to perform complex motor tasks) that meet the definitional \\nrequirements of Dementia that are judged to be a direct consequence of inhalant \\nuse or exposure and that persist beyond the usual duration of action or withdrawal \\nsyndrome associated with the substance. The amount and duration of inhalant use \\nor exposure must be sufficient to be capable of producing the cognitive impairment. \\nThe cognitive im pairment is not better accounted for by a disorder that is not \\ninduced by volatile inhalants such as a dementia due to another medical condition.  \\nCoding Note:  This category should never be used in primary tabulation. The codes are provided \\nfor use as suppl ementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere.  \\nWhen dementia is due to multiple aetiologies, code all that apply.',\n",
       " '6D84.Y  Dementia due to other specified psychoactive substance  \\nCoding Note:  This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere.  \\nWhen dementia is due to multiple a etiologies, code all that apply.',\n",
       " '6D85   Dementia due to diseases classified elsewhere  \\nCoding Note:  This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identi fy the \\npresence of dementia in diseases classified elsewhere.  \\nWhen dementia is due to multiple aetiologies, code all that apply.  \\n ICD-11 MMS  579',\n",
       " '6D85.0  Dementia due to Parkinson disease  \\nDementia due to Parkinson disease develops among individuals with idiopathic \\nParkinso n disease and is characterized by impairment in attention, memory, \\nexecutive and visuo -spatial functions. Mental and behavioral symptoms such as \\nchanges in affect, apathy and hallucinations may also be present. Onset is insidious \\nand the course is one of g radual worsening of symptoms.  \\nCoding Note:  This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewher e. \\nWhen dementia is due to multiple aetiologies, code all that apply.',\n",
       " '6D85.1  Dementia due to Huntington disease  \\nDementia due to Huntington disease occurs as part of a widespread degeneration \\nof the brain due to a trinucleotide repeat expansion in the HTT gene, which is \\ntransmitted through autosomal dominance. Onset of symptoms is insidious typically \\nin the third and fourth decade of life with gradual and slow progression. Initial \\nsymptoms typically include impairments in executive functions with relative s paring \\nof memory, prior to the onset of motor deficits (bradykinesia and chorea) \\ncharacteristic of Huntington disease.  \\nCoding Note:  This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional code s when it is desired to identify the \\npresence of dementia in diseases classified elsewhere.  \\nWhen dementia is due to multiple aetiologies, code all that apply.  \\nInclusions:  Dementia in Huntington chorea',\n",
       " '6D85.2  Dementia due to exposure to heavy metals and ot her toxins  \\nDementia due to exposure to heavy metals and other toxins caused by toxic \\nexposure to specific heavy metals such as aluminium from dialysis water, lead, \\nmercury or manganese. The characteristic cognitive impairments in Dementia due \\nto exposure to heavy met als and other toxins depend on the specific heavy metal or \\ntoxin that the individual has been exposed to but can affect any cognitive domain. \\nOnset of symptoms is related to exposure and progression can be rapid especially \\nwith acute exposure. In many case s, symptoms are reversible when exposure is \\nidentified and ceases. Investigations such as brain imaging or neurophysiological \\ntesting may be abnormal. Lead poisoning is associated with abnormalities on brain \\nimaging including widespread calcification and i ncreased signal on MRI T2 -\\nweighted images of periventricular white matter, basal ganglia hypothalamus and \\npons. Dementia due to aluminium toxicity may demonstrate characteristic \\nparoxysmal high -voltage delta EEG changes. Examination may make evident other \\nfeatures such as peripheral neuropathy in the case of lead, arsenic, or mercury.  \\nCoding Note:  This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere.  \\nWhen dementia is due to multiple aetiologies, code all that apply.  \\nExclusions:  Dementia due to psychoactive substances including \\nmedications (6D84)  \\n 580  ICD-11 MMS',\n",
       " '6D85.3  Dementia due to human immunodeficiency virus  \\nDementia due to human immunodeficiency virus develops during the course of \\nconfirmed HIV disease, in the absence of a concurrent illness or condition other \\nthan HIV infection that could explain the clinical features. Although a variety of \\npatterns of cognit ive deficit are possible depending on where the HIV pathogenic \\nprocesses have occurred, typically deficits follow a subcortical pattern with \\nimpairments in executive function, processing speed, attention, and learning new \\ninformation. The course of Dementi a due to human immunodeficiency virus varies \\nincluding resolution of symptoms, gradual decline in functioning, improvement, or \\nfluctuation in symptoms. Rapid decline in cognitive functioning is rare with the \\nadvent of antiretroviral medications.  \\nCoding Not e: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere.  \\nWhen dementia is due to multiple aeti ologies, code all that apply.',\n",
       " '6D85.4  Dementia due to multiple sclerosis  \\nDementia due to multiple sclerosis is a neurodegenerative disease due to the \\ncerebral effects of multiple sclerosis, a demyelinating disease. Onset of symptoms \\nis insidious and not secondary to the functional impairment attributable to the \\nprimary disease (i.e., multiple sclerosis). Cognitive impairments vary according to \\nthe location of demyelination but typically include deficits in processing speed, \\nmemory, attention, and aspects of executive functioning.  \\nCoding Note:  This category should never be used i n primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere.  \\nWhen dementia is due to multiple aetiologies, code all that apply.',\n",
       " '6D85.5  Dementia due to prion disease  \\nDementia due to prion disease is a primary neurodegenerative disease caused by a \\ngroup of spongiform encephalopathies resulting from abnormal prion protein \\naccumulation in the brain. These can be sporadic, genetic (caused by mu tations in \\nthe prion -protein gene), or transmissible (acquired from an infected individual). \\nOnset is insidious and there is a rapid progression of symptoms and impairment \\ncharacterised by cognitive deficits, ataxia, and motor symptoms (myoclonus, \\nchorea, or dystonia). Diagnosis is typically made on the basis of brain imaging \\nstudies, presence of characteristic proteins in spinal fluid, EEG, or genetic testing.  \\nCoding Note:  This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere.  \\nWhen dementia is due to multiple aetiologies, code all that apply.  \\n ICD-11 MMS  581',\n",
       " '6D85.6  Dementia due to normal pressure hydrocephalus  \\nDem entia due to normal pressure hydrocephalus results from excess accumulation \\nof cerebrospinal fluid in the brain as a result of idiopathic, non -obstructive causes \\nbut can also be secondary to haemorrhage, infection or inflammation. Progression \\nis gradual bu t intervention (e.g., shunt) may result in improvement of symptoms, \\nespecially if administered earlier in the course of the condition. Typically, cognitive \\nimpairments include reduced processing speed and deficits in executive functioning \\nand attention. Th ese symptoms are also typically accompanied by gait \\nabnormalities and urinary incontinence. Brain imaging to reveal ventricular volume \\nand characterize brain displacement is often necessary to confirm the diagnosis.  \\nCoding Note:  This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere.  \\nWhen dementia is due to multiple aetiologies, code all that apply.',\n",
       " '6D85.7  Dementia due to injury to the head  \\nDementia due to injury to the head is caused by damage inflicted on the tissues of \\nthe brain as the direct or indirect result of an external force. Trauma to the brain is \\nknown to have resulted in loss of consciou sness, amnesia, disorientation and \\nconfusion, or neurological signs. The symptoms characteristic of Dementia due to \\ninjury to the head must arise immediately following the trauma or after the individual \\ngains consciousness and must persist beyond the acute  post-injury period. \\nCognitive deficits vary depending on the specific brain areas affected and the \\nseverity of the injury but can include impairments in attention, memory, executive \\nfunctioning, personality, processing speed, social cognition, and languag e abilities.  \\nCoding Note:  This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere.  \\nWhen dementia is due to multiple aetiologies, code all that apply.',\n",
       " '6D85.8  Dementia due to pellagra  \\nDementia due to pellagra is caused by persistent lack of vitamin B3 (niacin) or \\ntryptophan either in the diet or due to poor absorption in the gastrointesti nal tract \\ndue to disease (e.g., Crohn disease) or due to the effects of some medications \\n(e.g., isoniazid). Core signs of pellagra include dermatological changes (sensitivity \\nto sunlight, lesions, alopecia, and oedema) and diarrhoea. With prolonged \\nnutriti onal deficiency cognitive symptoms that include aggressivity, motor \\ndisturbances (ataxia and restlessness), confusion, and weakness are observed. \\nTreatment with nutritional supplementation (e.g., niacin) typically results in reversal \\nof symptoms.  \\nCoding No te: Code also the causing condition  \\n 582  ICD-11 MMS',\n",
       " '6D85.9  Dementia due to Down syndrome  \\nDementia due to Down syndrome is a neurodegenerative disorder related to the \\nimpact of abnormal increased production and accumulation of amyloid precursor \\nprotein (APP) leading to fo rmation of beta -amyloid plaques and tau tangles. APP \\ngene expression is increased due to its location on chromosome 21, which is \\nabnormally triplicated in Down syndrome. Cognitive deficits and neuropathological \\nfeatures are similar to those observed in Alz heimer disease. Onset is typically after \\nthe fourth decade of life with a gradual decline in functioning, and may impact 50% \\nor more of individuals with Down syndrome.  \\nCoding Note:  This category should never be used in primary tabulation. The codes are pro vided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere.  \\nWhen dementia is due to multiple aetiologies, code all that apply.',\n",
       " '6D85.Y  Dementia due to other specified diseases  classified elsewhere  \\nCoding Note:  This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere.  \\nWhen dementia is due to multiple aetiologies, code all that apply.',\n",
       " '6D86   Behavioural or psychological disturbances in dementia  \\nIn addition to the cognitive disturbances characteristic of dementia, the current \\nclinical picture includes clinically significant  behavioural or psychological \\ndisturbances.  \\nCoding Note:  These categories should never be used in primary tabulation. The codes are \\nprovided for use as supplementary or additional codes when it is desired to identify \\nthe presence of behavioural or psycholo gical disturbance in dementia.  \\nCode all that apply.  \\nExclusions:  Secondary mental or behavioural syndromes associated with \\ndisorders or diseases classified elsewhere  (6E60‑6E6Z)',\n",
       " '6D86.0  Psychotic symptoms in dementia  \\nIn addition to the cognitive disturbances characteristic of dementia, the current \\nclinical picture includes clinically significant delusions or hallucinations.  \\nExclusions:  Schizophrenia or other primary psychotic disorders  \\n(6A20‑6A2Z)  \\nSecondary psychotic s yndrome (6E61)',\n",
       " '6D86.1  Mood symptoms in dementia  \\nIn addition to the cognitive disturbances characteristic of dementia, the current \\nclinical picture includes clinically significant mood symptoms such as depressed \\nmood, elevated mood, or irritable mood.  \\nExclusions:  Mood disorders  (6A60‑6A8Z)  \\nSecondary mood  syndrome (6E62)  \\n ICD-11 MMS  583',\n",
       " '6D86.2  Anxiety symptoms in dementia  \\nIn addition to the cognitive disturbances characteristic of dementia, the current \\nclinical picture includes clinically significant symptoms of anxiety or worry.  \\nExclusions:  Anxiety or fear -related disor ders (6B00‑6B0Z)  \\nSecondary anxiety syndrome (6E63)',\n",
       " '6D86.3  Apathy in dementia  \\nIn addition to the cognitive disturbances characteristic of dementia, the current \\nclinical picture includes clinically significant indifference or lack of interest.  \\nExclusions:  Mood disorders  (6A60‑6A8Z)  \\nSecondary mood syndrome (6E62)',\n",
       " '6D86.4  Agitation or aggression in dementia  \\nIn addition to the cognitive disturbances characteristic of dementia, the current \\nclinical picture includes: 1) clinically significant excessive psychomoto r activity \\naccompanied by increased tension; or 2) hostile or violent behaviour.',\n",
       " '6D86.5  Disinhibition in dementia  \\nIn addition to the cognitive disturbances characteristic of dementia, the current \\nclinical picture includes clinically significant lack of re straint manifested in disregard \\nfor social conventions, impulsivity, and poor risk assessment.',\n",
       " '6D86.6  Wandering in dementia  \\nIn addition to the cognitive disturbances characteristic of dementia, the current \\nclinical picture includes clinically significant wandering that puts the person at risk of \\nharm.',\n",
       " '6D86.Y  Other specified behavioural or psychological disturbances in dementia  \\nCoding Note:  These categories should never be used in primary tabulation. The codes are \\nprovided for use as supplementary or addit ional codes when it is desired to identify \\nthe presence of behavioural or psychological disturbance in dementia.  \\nCode all that apply.',\n",
       " '6D86.Z  Behavioural or psychological disturbances in dementia, unspecified  \\nCoding Note:  These categories should never be used in primary tabulation. The codes are \\nprovided for use as supplementary or additional codes when it is desired to identify \\nthe presence of behavioural or psychological disturbance in dementia.  \\nCode all that apply.',\n",
       " '6D8Y   Dementia, other specified cause  \\nCoding Note:  This category should only be used for primary tabulation, if the aetiology of the \\ndementia is unknown. If the aetiology of the dementia is known code to the \\naetiology of the dementia for primary tabulation.  \\nWhen dementia is due to multiple aetiologies, co de all that apply.  \\n 584  ICD-11 MMS',\n",
       " '6D8Z   Dementia, unknown or unspecified cause  \\nCoding Note:  This category should only be used for primary tabulation, if the aetiology of the \\ndementia is unknown. If the aetiology of the dementia is known code to the \\naetiology of the d ementia for primary tabulation.  \\nWhen dementia is due to multiple aetiologies, code all that apply.',\n",
       " '6E0Y   Other specified neurocognitive disorders',\n",
       " '6E0Z   Neurocognitive disorders, unspecified  \\n \\nMental or behavioural disorders associated with pregnanc y, childbirth or the puerperium \\n(6E20‑6E2Z)  \\nSyndromes associated with pregnancy or the puerperium (commencing within about 6 weeks after \\ndelivery) that involve significant mental and behavioural features. If the symptoms meet the diagnostic \\nrequirements fo r a specific mental disorder, that diagnosis should also be assigned.  \\nCoded Elsewhere:  Psychological disorder related to obstetric fistula (GC04.1Y)',\n",
       " '6E20   Mental or behavioural disorders associated with pregnancy, childbirth \\nor the puerperium, without p sychotic symptoms  \\nA syndrome associated with pregnancy or the puerperium (commencing within \\nabout 6 weeks after delivery) that involves significant mental and behavioural \\nfeatures, most commonly depressive symptoms. The syndrome does not include \\ndelusions,  hallucinations, or other psychotic symptoms. If the symptoms meet the \\ndiagnostic requirements for a specific mental disorder, that diagnosis should also be \\nassigned. This designation should not be used to describe mild and transient \\ndepressive symptoms th at do not meet the diagnostic requirements for a depressive \\nepisode, which may occur soon after delivery (so -called postpartum blues).  \\nCoding Note:  Code also the causing condition',\n",
       " '6E21   Mental or behavioural disorders associated with pregnancy, childbi rth \\nor the puerperium, with psychotic symptoms  \\nA syndrome associated with pregnancy or the puerperium (commencing within \\nabout 6 weeks after delivery) that involves significant mental and behavioural \\nfeatures, including delusions, hallucinations, or other psychotic symptoms. Mood \\nsymptoms (depressive and/or manic) are also typically present. If the symptoms \\nmeet the diagnostic requirements for a specific mental disorder, that diagnosis \\nshould also be assigned.  \\nCoding Note:  Code also the causing condition',\n",
       " '6E2Z   Mental or behavioural disorders associated with pregnancy, childbirth \\nor the puerperium, unspecified  \\n ICD-11 MMS  585',\n",
       " '6E40   Psychological or behavioural factors affecting disorders or diseases \\nclassified elsewhere  \\nPsychological and behavioural factors affecting disorders or diseases classified \\nelsewhere are those that may adversely affect the manifestation, treatment, or \\ncourse  of a condition classified in another chapter of the ICD. These factors may \\nadversely affect the manifestation, treatment, or course of the disorder or disease \\nclassified in another chapter by: interfering with the treatment of the disorder or \\ndisease by a ffecting treatment adherence or care seeking; constituting an additional \\nhealth risk; or influencing the underlying pathophysiology to precipitate or \\nexacerbate symptoms or otherwise necessitate medical attention. This diagnosis \\nshould be assigned only whe n the factors increase the risk of suffering, disability, or \\ndeath and represent a focus of clinical attention, and should be assigned together \\nwith the diagnosis for the relevant other condition.  \\nInclusions:  Psychological factors affecting physical condit ions \\nExclusions:  Mental or behavioural disorders associated with pregnancy, \\nchildbirth or the puerperium  (6E20‑6E2Z)',\n",
       " '6E40.0  Mental disorder affecting disorders or diseases classified elsewhere  \\nAll diagnostic requirements for Psychological or behavioural f actors affecting \\ndisorders or diseases classified elsewhere are met. The individual is diagnosed with \\na mental, behavioural, or neurodevelopmental disorder that adversely affects the \\nmanifestation, treatment, or course of a disorder or disease classified i n another \\nchapter (e.g., a woman with Bulimia Nervosa and Type 1 diabetes mellitus who \\nskips insulin doses as a way to avoid weight gain that would otherwise be caused \\nby her binge eating).',\n",
       " '6E40.1  Psychological symptoms affecting disorders or diseases cla ssified elsewhere  \\nAll diagnostic requirements for Psychological or behavioural factors affecting \\ndisorders or diseases classified elsewhere are met. The individual exhibits \\npsychological symptoms that do not meet the diagnostic requirements for a mental, \\nbehavioural, or neurodevelopmental disorder that adversely affect the \\nmanifestation, treatment, or course of a disorder or disease classified in another \\nchapter (e.g., depressive symptoms interfering with rehabilitation following surgery).',\n",
       " '6E40.2  Personali ty traits or coping style affecting disorders or diseases classified \\nelsewhere  \\nAll diagnostic requirements for Psychological or behavioural factors affecting \\ndisorders or diseases classified elsewhere are met. The individual exhibits \\npersonality traits or coping styles that do not meet the diagnostic requirements for a \\nmental, behavioural, or neurodevelopmental disorder that adversely affect the \\nmanifestation, treatment, or course of a disorder or disease classified in another \\nchapter (e.g., pathological de nial of the need for surgery in a patient with cancer; \\nhostile, pressured behaviour contributing to heart disease).  \\n 586  ICD-11 MMS',\n",
       " '6E40.3  Maladaptive health behaviours affecting disorders or diseases classified \\nelsewhere  \\nAll diagnostic requirements for Psychological or behavioural factors affecting \\ndisorders or diseases classified elsewhere are met. The individual exhibits \\nmaladaptive health behaviours that adversely affect the manifestation, treatment, or \\ncourse of a disorder or disease classified in another chapter (e. g., overeating, lack \\nof exercise).',\n",
       " '6E40.4  Stress -related physiological response affecting disorders or diseases \\nclassified elsewhere  \\nAll diagnostic requirements for Psychological or behavioural factors affecting \\ndisorders or diseases classified elsewhere are met. The individual exhibits stress -\\nrelated physiological responses that adversely affect the manifestation, treatment, \\nor course of a disorder or disease classified in another chapter (e.g., stress -related \\nexacerbation of ulcer, hypertension, arrhythmia, or tension headache).',\n",
       " '6E40.Y  Other specified psychological or behavioural factors affecting disorders or \\ndiseases classified else where',\n",
       " '6E40.Z  Psychological or behavioural factors affecting disorders or diseases \\nclassified elsewhere, unspecified  \\n ICD-11 MMS  587 \\n Secondary mental or behavioural syndromes associated with disorders or diseases \\nclassified elsewhere (6E60 ‑6E6Z)  \\nThis grouping includes sy ndromes characterised by the presence of prominent psychological or \\nbehavioural symptoms judged to be direct pathophysiological consequences of a medical condition \\nnot classified under mental and behavioural disorders, based on evidence from the history, p hysical \\nexamination, or laboratory findings. The symptoms are not accounted for by delirium or by another \\nmental and behavioural disorder, and are not a psychologically mediated response to a severe \\nmedical condition (e.g., adjustment disorder or anxiety s ymptoms in response to being diagnosed with \\na life -threatening illness). These categories should be used in addition to the diagnosis for the \\npresumed underlying disorder or disease when the psychological and behavioural symptoms are \\nsufficiently severe to  warrant specific clinical attention.  \\nExclusions:  Acute pain (MG31)  \\nBodily distress disorder (6C20)  \\nChronic pain (MG30)  \\nCoded Elsewhere:  Delirium due to disease classified elsewhere (6D70.0)',\n",
       " '6E60   Secondary neurodevelopmental syndrome  \\nA syndrome that involves significant neurodevelopmental features that do not fulfill \\nthe diagnostic requirements of any of the specific neurodevelopmental disorders \\nthat is judged to be a direct pathophysiological cons equence of a health condition \\nnot classified under mental and behavioural disorders (e.g., autistic -like features in \\nRett syndrome; aggression and self -mutilation in Lesch -Nyhan syndrome, \\nabnormalities in language development in Williams syndrome), based o n evidence \\nfrom the history, physical examination, or laboratory findings.  \\nThis category should be used in addition to the diagnosis for the presumed \\nunderlying disorder or disease when the neurodevelopmental problems are \\nsufficiently severe to warrant spe cific clinical attention.  \\nCoding Note:  Code also the causing condition  \\nExclusions:  Autism spectrum disorder (6A02)  \\nDisorders of intellectual development (6A00)  \\nStereotyped movement disorder (6A06)',\n",
       " '6E60.0  Secondary speech or language syndrome  \\nA syndrome th at involves significant features related to speech or language \\ndevelopment that do not fulfill the diagnostic requirements of any of the specific \\ndevelopmental speech or language disorders that is judged to be a direct \\npathophysiological consequence of a h ealth condition not classified under mental \\nand behavioural disorders, based on evidence from the history, physical \\nexamination, or laboratory findings. Possible etiologies include a disease of the \\nnervous system, sensory impairment, brain injury or infect ion. \\nCoding Note:  This diagnosis should be assigned in addition to the diagnosis for the presumed \\nunderlying disorder or disease when the neurodevelopmental problems are \\nsufficiently severe to warrant specific clinical attention.',\n",
       " '6E60.Y  Other specified se condary neurodevelopmental syndrome  \\nCoding Note:  Code also the causing condition  \\n 588  ICD-11 MMS',\n",
       " '6E60.Z  Secondary neurodevelopmental syndrome, unspecified  \\nCoding Note:  Code also the causing condition',\n",
       " '6E61   Secondary psychotic syndrome  \\nA syndrome characterised by the presence of prominent hallucinations or delusions \\njudged to be a direct pathophysiological consequence of a health condition not \\nclassified under mental and behavioural disorders, based on evidence from the \\nhistory, physical examination, or laboratory find ings. The symptoms are not \\naccounted for by delirium or by another mental and behavioural disorder, and are \\nnot a psychologically mediated response to a severe medical condition (e.g., an \\nacute stress reaction in response to a life -threatening diagnosis). This category \\nshould be used in addition to the diagnosis for the presumed underlying disorder or \\ndisease when the psychotic symptoms are sufficiently severe to warrant specific \\nclinical attention.  \\nCoding Note:  Code also the causing condition  \\nExclusions:  Acute and transient psychotic disorder (6A23)  \\nDelirium (6D70)  \\nMood disorders  (6A60‑6A8Z)',\n",
       " '6E61.0  Secondary psychotic syndrome, with hallucinations  \\nA syndrome characterised by the presence of prominent hallucinations that is \\njudged to be a direct pathophysiological consequence of a health condition not \\nclassified under mental and behavioural disorders, based on evidence from the \\nhistory, physical exam ination, or laboratory findings. Delusions are not a prominent \\naspect of the clinical presentation. The symptoms are not accounted for by delirium \\nor by another mental and behavioural disorder, and are not a psychologically \\nmediated response to a severe me dical condition (e.g., an acute stress reaction in \\nresponse to a life -threatening diagnosis). This category should be used in addition \\nto the diagnosis for the presumed underlying disorder or disease when the \\npsychotic symptoms are sufficiently severe to w arrant specific clinical attention.  \\nCoding Note:  Code also the causing condition  \\nExclusions:  Delirium (6D70)  \\nMood disorders  (6A60‑6A8Z)  \\n ICD-11 MMS  589',\n",
       " '6E61.1  Secondary psychotic syndrome, with delusions  \\nA syndrome characterised by the presence of prominent delusions tha t is judged to \\nbe a direct pathophysiological consequence of a health condition not classified \\nunder mental and behavioural disorders, based on evidence from the history, \\nphysical examination, or laboratory findings. Hallucinations are not a prominent \\naspe ct of the clinical presentation. The symptoms are not accounted for by delirium \\nor by another mental and behavioural disorder, and are not a psychologically \\nmediated response to a severe medical condition (e.g., an acute stress reaction in \\nresponse to a li fe-threatening diagnosis). This category should be used in addition \\nto the diagnosis for the presumed underlying disorder or disease when the \\npsychotic symptoms are sufficiently severe to warrant specific clinical attention.  \\nCoding Note:  Code also the caus ing condition  \\nExclusions:  Delirium (6D70)  \\nMood disorders  (6A60‑6A8Z)',\n",
       " '6E61.2  Secondary psychotic syndrome, with hallucinations and delusions  \\nA syndrome characterised by the presence of both prominent hallucinations and \\nprominent delusions that is judged to  be a direct pathophysiological consequence of \\na health condition not classified under mental and behavioural disorders, based on \\nevidence from the history, physical examination, or laboratory findings. The \\nsymptoms are not accounted for by delirium or by another mental and behavioural \\ndisorder, and are not a psychologically mediated response to a severe medical \\ncondition (e.g., an acute stress reaction in response to a life -threatening diagnosis). \\nThis category should be used in addition to the diagnosis f or the presumed \\nunderlying disorder or disease when the psychotic symptoms are sufficiently severe \\nto warrant specific clinical attention.  \\nCoding Note:  Code also the causing condition  \\nExclusions:  Delirium (6D70)  \\nMood disorders  (6A60‑6A8Z)',\n",
       " '6E61.3  Secondary  psychotic syndrome, with unspecified symptoms  \\nCoding Note:  Code also the causing condition',\n",
       " '6E62   Secondary mood syndrome  \\nA syndrome characterised by the presence of prominent mood symptoms (i.e., \\ndepression, elevated mood, irritability) judged to be a  direct pathophysiological \\nconsequence of a health condition not classified under mental and behavioural \\ndisorders, based on evidence from the history, physical examination, or laboratory \\nfindings. The symptoms are not accounted for by delirium or by anoth er mental and \\nbehavioural disorder, and are not a psychologically mediated response to a severe \\nmedical condition (e.g., depressive symptoms in response to a life -threatening \\ndiagnosis). This category should be used in addition to the diagnosis for the \\npresumed underlying disorder or disease when the mood symptoms are sufficiently \\nsevere to warrant specific clinical attention.  \\nCoding Note:  Code also the causing condition  \\nExclusions:  Adjustment disorder (6B43)  \\nDelirium (6D70)  \\n 590  ICD-11 MMS',\n",
       " '6E62.0  Secondary mood syndrome, with depressive symptoms  \\nA syndrome characterised by the presence of prominent depressive symptoms such \\nas persistently depressed mood, loss of interest in previously enjoyable activities, or \\nsigns such as tearful and downtrodden a ppearance that is judged to be a direct \\npathophysiological consequence of a health condition not classified under mental \\nand behavioural disorders based on evidence from the history, physical \\nexamination, or laboratory findings. The symptoms are not accoun ted for by \\ndelirium or by another mental and behavioural disorder, and are not a \\npsychologically mediated response to a severe medical condition (e.g., depressive \\nsymptoms in response to a life -threatening diagnosis). This category should be \\nused in additi on to the diagnosis for the presumed underlying disorder or disease \\nwhen the mood symptoms are sufficiently severe to warrant specific clinical \\nattention.  \\nCoding Note:  Code also the causing condition  \\nExclusions:  Adjustment disorder (6B43)  \\nDelirium (6D70)',\n",
       " '6E62.1  Secondary mood syndrome, with manic symptoms  \\nA syndrome characterised by the presence of prominent manic symptoms such as \\nelevated, euphoric, irritable, or expansive mood states, rapid changes among \\ndifferent mood states (i.e., mood lability), or in creased energy or activity that is \\njudged to be a direct pathophysiological consequence of a health condition not \\nclassified under mental and behavioural disorders based on evidence from the \\nhistory, physical examination, or laboratory findings.  \\nCoding Not e: Code also the causing condition  \\nInclusions:  mood syndrome due to disorders or diseases not classified \\nunder Mental and behavioural disorders, with manic \\nsymptoms  \\nExclusions:  Adjustment disorder (6B43)  \\nDelirium (6D70)  \\n ICD-11 MMS  591',\n",
       " '6E62.2  Secondary mood syndrome, with mixed symptoms  \\nA syndrome characterised by th e presence of both manic and depressive \\nsymptoms, either occurring together or alternating from day to day or over the \\ncourse of a day that is judged to be a direct pathophysiological consequence of a \\nhealth condition not classified under mental and behavi oural disorders based on \\nevidence from the history, physical examination, or laboratory findings. Manic \\nsymptoms may include elevated, euphoric, irritable, or expansive mood states, rapid \\nchanges among different mood states (i.e., mood lability), or increa sed energy or \\nactivity. Depressive symptoms may include persistently depressed mood, loss of \\ninterest in previously enjoyable activities, or signs such as tearful or downtrodden \\nappearance. The symptoms are not accounted for by delirium or by another menta l \\nand behavioural disorder, and are not a psychologically mediated response to a \\nsevere medical condition (e.g., depressive symptoms in response to a life -\\nthreatening diagnosis). This category should be used in addition to the diagnosis for \\nthe presumed un derlying disorder or disease when the mood symptoms are \\nsufficiently severe to warrant specific clinical attention.  \\nCoding Note:  Code also the causing condition  \\nExclusions:  Adjustment disorder (6B43)  \\nDelirium (6D70)',\n",
       " '6E62.3  Secondary mood syndrome, with un specified symptoms  \\nCoding Note:  Code also the causing condition  \\nExclusions:  Adjustment disorder (6B43)  \\nDelirium (6D70)',\n",
       " '6E63   Secondary anxiety syndrome  \\nA syndrome characterised by the presence of prominent anxiety symptoms judged \\nto be a direct pathoph ysiological consequence of a health condition not classified \\nunder mental and behavioural disorders, based on evidence from the history, \\nphysical examination, or laboratory findings. The symptoms are not accounted for \\nby delirium or by another mental and b ehavioural disorder, and are not a \\npsychologically mediated response to a severe medical condition (e.g., anxiety \\nsymptoms or panic attacks in response to a life -threatening diagnosis). This \\ncategory should be used in addition to the diagnosis for the pres umed underlying \\ndisorder or disease when the anxiety symptoms are sufficiently severe to warrant \\nspecific clinical attention.  \\nCoding Note:  Code also the causing condition  \\nExclusions:  Adjustment disorder (6B43)  \\nDelirium (6D70)  \\n 592  ICD-11 MMS',\n",
       " '6E64   Secondary obsessive -compulsive or related syndrome  \\nA syndrome characterised by the presence of prominent obsessions, compulsions, \\nhoarding, skin picking, hair pulling, other body -focused repetitive behaviours, or \\nother symptoms characteristic of obsessive -compulsive and related disorder that is \\njudged to be the direct pathophysiological consequence of a disorder or disease not \\nclassified under Mental and behavioural disorders, based on evidence from the \\nhistory, physical examination, or laboratory findings.  The symptoms are not \\naccounted for by Delirium or by another Mental and behavioural disorder, and are \\nnot a psychologically mediated response to a severe medical condition (e.g., \\nrepetitive ruminations in response to a life -threatening diagnosis). This ca tegory \\nshould be used in addition to the diagnosis for the presumed underlying disorder or \\ndisease when the obsessive -compulsive or related symptoms are sufficiently severe \\nto warrant specific clinical attention.  \\nCoding Note:  Code also the causing conditio n \\nExclusions:  Delirium (6D70)  \\nObsessive -compulsive or related disorder induced by other \\nspecified psychoactive substance (6C4E.72)  \\nTic disorders (8A05)',\n",
       " '6E65   Secondary dissociative syndrome  \\nA syndrome characterised by the presence of prominent dissocia tive symptoms \\n(e.g., depersonalization, derealization) that is judged to be the direct \\npathophysiological consequence of a health condition not classified under mental \\nand behavioural disorders, based on evidence from the history, physical \\nexamination, or laboratory findings. The symptoms are not accounted for by \\ndelirium or by another mental and behavioural disorder, and are not a \\npsychologically mediated response to a severe medical condition (e.g., as part of an \\nacute stress reaction in response to a lif e-threatening diagnosis). This category \\nshould be used in addition to the diagnosis for the presumed underlying disorder or \\ndisease when the dissociative symptoms are sufficiently severe to warrant specific \\nclinical attention.  \\nCoding Note:  Code also the ca using condition  \\nExclusions:  Delirium (6D70)  \\nAcute stress reaction (QE84)']"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "split_text(content)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain.text_splitter import TextSplitter\n",
    "\n",
    "class DisorderTextSplitter(TextSplitter):\n",
    "    def split_text(self, text: str) -> list[str]:\n",
    "        # Split the text into paragraphs\n",
    "        paragraphs = text.split('\\n')\n",
    "        \n",
    "        # Initialize variables\n",
    "        chunks = []\n",
    "        current_chunk = \"\"\n",
    "        \n",
    "        for paragraph in paragraphs:\n",
    "            # Check if the paragraph starts with a disorder code (e.g., 6A00.3)\n",
    "            if re.match(r'^\\s*6[A-Z]\\d{2}(\\.\\d+)?([A-Z])?(?!\\s+ICD-11 MMS)', paragraph):\n",
    "                # If we have a current chunk, add it to the list of chunks\n",
    "                if current_chunk:\n",
    "                    chunks.append(current_chunk.strip())\n",
    "                # Start a new chunk with this paragraph\n",
    "                current_chunk = paragraph\n",
    "            else:\n",
    "                # If it's not a new disorder, add to the current chunk\n",
    "                current_chunk += \"\\n\" + paragraph\n",
    "        \n",
    "        # Add the last chunk if it exists\n",
    "        if current_chunk:\n",
    "            chunks.append(current_chunk.strip())\n",
    "        \n",
    "        return chunks\n",
    "\n",
    "# Usage\n",
    "text_splitter = DisorderTextSplitter()\n",
    "all_splits = text_splitter.split_documents(books)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Document(metadata={'source': './input/c06.pdf', 'page': 1}, page_content='6A00   Disorders of intellectual development'), Document(metadata={'source': './input/c06.pdf', 'page': 1}, page_content='6A00.0  Disorder of intellectual development, mild'), Document(metadata={'source': './input/c06.pdf', 'page': 2}, page_content='6A00.1  Disorder of intellectual development, moderate'), Document(metadata={'source': './input/c06.pdf', 'page': 2}, page_content='6A00.2  Disorder of intellectual development, severe'), Document(metadata={'source': './input/c06.pdf', 'page': 2}, page_content='6A00.3  Disord er of intellectual development, profound'), Document(metadata={'source': './input/c06.pdf', 'page': 3}, page_content='6A00.4  Disorder of intellectual development, provisional'), Document(metadata={'source': './input/c06.pdf', 'page': 3}, page_content='6A00.Z  Disorders of intellectual development, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 3}, page_content='6A01   Developmental speech or language disorders'), Document(metadata={'source': './input/c06.pdf', 'page': 3}, page_content='6A01.0  Developmental speech sound disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 4}, page_content='6A01.1  Developmental speech fluency disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 4}, page_content='6A01.2  Developmental language disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 4}, page_content='6A01.20  Developmental language disorder with imp airment of receptive and expressive'), Document(metadata={'source': './input/c06.pdf', 'page': 5}, page_content='6A01.21  Developmental language disorder with impairment of mainly expressive language'), Document(metadata={'source': './input/c06.pdf', 'page': 5}, page_content='6A01.22  Developmental language disorder with impairment of mainly pragmatic language'), Document(metadata={'source': './input/c06.pdf', 'page': 5}, page_content='6A01.23  Developmental language disorder, with other specified language impairment'), Document(metadata={'source': './input/c06.pdf', 'page': 6}, page_content='6A01.Y  Other specified developmental speech or language disorders'), Document(metadata={'source': './input/c06.pdf', 'page': 6}, page_content='6A01.Z  Developmental speech or language disorders, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 6}, page_content='6A02   Autism spectrum disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 6}, page_content='6A02.0  Autism spectrum disorder without disorder of intellectual development and'), Document(metadata={'source': './input/c06.pdf', 'page': 6}, page_content='6A02.1  Autism spectrum disorder with disorder of intellectual development and with'), Document(metadata={'source': './input/c06.pdf', 'page': 6}, page_content='6A02.2  Autism spectrum disorder without disorder of intellectual development and'), Document(metadata={'source': './input/c06.pdf', 'page': 6}, page_content='6A02.3  Autism spectrum disorder with disorder of intellectual development and with'), Document(metadata={'source': './input/c06.pdf', 'page': 7}, page_content='6A02.5  Autism spectrum disorder with disorder of intellectual development and with'), Document(metadata={'source': './input/c06.pdf', 'page': 7}, page_content='6A02.Y  Other specified autism spectrum disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 7}, page_content='6A02.Z  Autism spectrum disorder, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 7}, page_content='6A03   Developmental learning disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 7}, page_content='6A03.0  Developmental learning disorder with impairment in reading'), Document(metadata={'source': './input/c06.pdf', 'page': 8}, page_content='6A03.1  Developmental learning disorder with impairment in written expression'), Document(metadata={'source': './input/c06.pdf', 'page': 8}, page_content='6A03.2  Developmental learning disorder with impairment in mathematics'), Document(metadata={'source': './input/c06.pdf', 'page': 8}, page_content='6A03.3  Developmental learning disorder with other specified impairment of learning'), Document(metadata={'source': './input/c06.pdf', 'page': 8}, page_content='6A03.Z  Developmental learning disorder, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 9}, page_content='6A04   Developmental motor coordination disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 9}, page_content='6A05   Attention deficit hyperactivity disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 10}, page_content='6A05.0  Attention deficit hyperactivity disorder, predominantly inattentive'), Document(metadata={'source': './input/c06.pdf', 'page': 10}, page_content='6A05.1  Attention deficit hyperactivity disorder, predominantly hyperactive -impulsive'), Document(metadata={'source': './input/c06.pdf', 'page': 10}, page_content='6A05.2  Attention deficit hyperactivity disorder, combined presentation'), Document(metadata={'source': './input/c06.pdf', 'page': 10}, page_content='6A05.Y  Attention deficit hyperactivity disorder, o ther specified presentation'), Document(metadata={'source': './input/c06.pdf', 'page': 10}, page_content='6A05.Z  Attention deficit hyperactivity disorder, presentation unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 10}, page_content='6A06   Stereotyped movement disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 11}, page_content='6A06.0  Stereotyped movement disorder without self -injury'), Document(metadata={'source': './input/c06.pdf', 'page': 11}, page_content='6A06.1  Stereotyped movement disorder with self -injury'), Document(metadata={'source': './input/c06.pdf', 'page': 11}, page_content='6A06.Z  Stereotyped movement disorder, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 12}, page_content='6A20   Schizophrenia'), Document(metadata={'source': './input/c06.pdf', 'page': 12}, page_content='6A20.0  Schizophrenia, first episode'), Document(metadata={'source': './input/c06.pdf', 'page': 12}, page_content='6A20.00  Schizophrenia, first episode, currently symptomatic'), Document(metadata={'source': './input/c06.pdf', 'page': 13}, page_content='6A20.01  Schizophrenia, first episode, in partial remission'), Document(metadata={'source': './input/c06.pdf', 'page': 13}, page_content='6A20.02  Schizophrenia, first episode, in full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 13}, page_content='6A20.0Z  Schizophrenia, first episode, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 13}, page_content='6A20.1  Schizophrenia, multiple episodes'), Document(metadata={'source': './input/c06.pdf', 'page': 13}, page_content='6A20.10  Schizophrenia, multiple episodes, currently symptomatic'), Document(metadata={'source': './input/c06.pdf', 'page': 13}, page_content='6A20.11  Schizophrenia, multiple episodes, in partial remission'), Document(metadata={'source': './input/c06.pdf', 'page': 13}, page_content='6A20.12  Schizophrenia, multiple episodes, in full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 13}, page_content='6A20.1Z  Schizophrenia, multiple episodes, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 13}, page_content='6A20.2  Schizophrenia, continuous'), Document(metadata={'source': './input/c06.pdf', 'page': 14}, page_content='6A20.20  Schizophrenia, continuous, currently symptomatic'), Document(metadata={'source': './input/c06.pdf', 'page': 14}, page_content='6A20.21  Schizophrenia, continuous, in partial remission'), Document(metadata={'source': './input/c06.pdf', 'page': 14}, page_content='6A20.22  Schizophrenia, continuous, in full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 14}, page_content='6A20.2Z  Schizophrenia, continuous, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 14}, page_content='6A20.Y  Other specified episode of schizophrenia'), Document(metadata={'source': './input/c06.pdf', 'page': 14}, page_content='6A20.Z  Schizophrenia, episode unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 14}, page_content='6A21   Schizoaffective disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 14}, page_content='6A21.0  Schizoaffective disorder, first episode'), Document(metadata={'source': './input/c06.pdf', 'page': 15}, page_content='6A21.00  Schizoaffective disorder, first episode, currently symptomatic'), Document(metadata={'source': './input/c06.pdf', 'page': 15}, page_content='6A21.01  Schizoaffective disorder, first episode, in partial remission'), Document(metadata={'source': './input/c06.pdf', 'page': 15}, page_content='6A21.02  Schizoaffective disorder, first episode, in full remi ssion'), Document(metadata={'source': './input/c06.pdf', 'page': 15}, page_content='6A21.0Z  Schizoaffective disorder, first episode, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 15}, page_content='6A21.1  Schizoaffective disorder, multiple episodes'), Document(metadata={'source': './input/c06.pdf', 'page': 15}, page_content='6A21.10  Schizoaffective disorder, multiple episodes, currently symptomatic'), Document(metadata={'source': './input/c06.pdf', 'page': 15}, page_content='6A21.11  Schiz oaffective disorder, multiple episodes, in partial remission'), Document(metadata={'source': './input/c06.pdf', 'page': 15}, page_content='6A21.12  Schizoaffective disorder, multiple episodes, in full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 15}, page_content='6A21.1Z  Schizoaffective disorder, multiple episodes, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 16}, page_content='6A21.2  Schizoaffective disorder, continuous'), Document(metadata={'source': './input/c06.pdf', 'page': 16}, page_content='6A21.20  Schizoaffective disorder, continuous, currently symptomatic'), Document(metadata={'source': './input/c06.pdf', 'page': 16}, page_content='6A21.21  Schizoaffective disorder, continuous, in partial remissio n'), Document(metadata={'source': './input/c06.pdf', 'page': 16}, page_content='6A21.22  Schizoaffective disorder, continuous, in full remissio n'), Document(metadata={'source': './input/c06.pdf', 'page': 16}, page_content='6A21.2Z  Schizoaffective disorder, continuous, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 16}, page_content='6A21.Y  Other specified schizoaffective disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 16}, page_content='6A21.Z  Schizoaffective disorder, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 16}, page_content='6A22   Schizotypal disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 17}, page_content='6A23   Acute and transient psychotic disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 17}, page_content='6A23.0  Acute and transient psychotic disorder, first episode'), Document(metadata={'source': './input/c06.pdf', 'page': 17}, page_content='6A23.00  Acute and transient psychotic disorder, first episode, currently symptom atic'), Document(metadata={'source': './input/c06.pdf', 'page': 17}, page_content='6A23.01  Acute and transient psychotic disorder, first episode, in  partial remission'), Document(metadata={'source': './input/c06.pdf', 'page': 17}, page_content='6A23.02  Acute and transient psychotic disorder, first episode, in full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 17}, page_content='6A23.0Z  Acute and transient psychotic disorder, first episode, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 17}, page_content='6A23.1  Acute and transient psychotic disorder, multiple episodes'), Document(metadata={'source': './input/c06.pdf', 'page': 17}, page_content='6A23.10  Acute and transient psychotic disorder, multiple episodes, currently symptomatic'), Document(metadata={'source': './input/c06.pdf', 'page': 18}, page_content='6A23.11  Acute and transient psychotic disorder, multiple episodes,  in partial remission'), Document(metadata={'source': './input/c06.pdf', 'page': 18}, page_content='6A23.12  Acute and tra nsient psychotic disorder, multiple episodes, in full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 18}, page_content='6A23.1Z  Acute and transient psychotic disorder, multiple episodes, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 18}, page_content='6A23.Y  Other specified acute and transient psychotic disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 18}, page_content='6A23.Z  Acut e and transient psychotic disorder, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 18}, page_content='6A24   Delusional disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 18}, page_content='6A24.0  Delusional disorder, currently symptom atic'), Document(metadata={'source': './input/c06.pdf', 'page': 18}, page_content='6A24.1  Delusional disorder, in partial remission'), Document(metadata={'source': './input/c06.pdf', 'page': 19}, page_content='6A24.2  Delusional disorder, in full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 19}, page_content='6A24.Z  Delusional disorder, unspeci fied'), Document(metadata={'source': './input/c06.pdf', 'page': 19}, page_content='6A25   Symptomatic manifestations of primary psychotic disorders'), Document(metadata={'source': './input/c06.pdf', 'page': 19}, page_content='6A25.0  Positive symptoms in primary psychotic disorders'), Document(metadata={'source': './input/c06.pdf', 'page': 19}, page_content='6A25.1  Negative symptoms in primary psychotic disorders'), Document(metadata={'source': './input/c06.pdf', 'page': 20}, page_content='6A25.2  Depressive mood symptoms in primary psychotic disorders'), Document(metadata={'source': './input/c06.pdf', 'page': 20}, page_content='6A25.3  Manic mood symptoms in primary psychotic disorders'), Document(metadata={'source': './input/c06.pdf', 'page': 20}, page_content='6A25.4  Psychomotor symptoms in primary psychotic disorders'), Document(metadata={'source': './input/c06.pdf', 'page': 21}, page_content='6A25.5  Cognitive symptoms in primary psychotic disorders'), Document(metadata={'source': './input/c06.pdf', 'page': 21}, page_content='6A40   Catatonia associated with another mental disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 22}, page_content='6A41   Catatonia induced by substances or medications'), Document(metadata={'source': './input/c06.pdf', 'page': 23}, page_content='6A60   Bipolar type I disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 24}, page_content='6A60.0  Bipolar type I disorder, current episode manic, wit hout psychotic symptoms'), Document(metadata={'source': './input/c06.pdf', 'page': 24}, page_content='6A60.1  Bipolar t ype I disorder, current episode manic, with psychotic symptoms'), Document(metadata={'source': './input/c06.pdf', 'page': 24}, page_content='6A60.2  Bipolar type I disorder, current episode hypomanic'), Document(metadata={'source': './input/c06.pdf', 'page': 25}, page_content='6A60.3  Bipolar type I disorder, current episode depressive, mild'), Document(metadata={'source': './input/c06.pdf', 'page': 25}, page_content='6A60.4  Bipolar type I disorder, current episode depressive, moderate without'), Document(metadata={'source': './input/c06.pdf', 'page': 25}, page_content='6A60.5  Bipolar type I disorder, current episode  depressive, moderate with psychotic'), Document(metadata={'source': './input/c06.pdf', 'page': 26}, page_content='6A60.6  Bipolar type I disorder, current episode depressive, severe without psychotic'), Document(metadata={'source': './input/c06.pdf', 'page': 26}, page_content='6A60.7  Bipolar type I disorder, current episode depressive, severe with psychotic'), Document(metadata={'source': './input/c06.pdf', 'page': 26}, page_content='6A60.8  Bipolar type I disorder, current episode depressive, unspecified severity'), Document(metadata={'source': './input/c06.pdf', 'page': 27}, page_content='6A60.9  Bipolar type I disorder, current episode mix ed, without psychotic symptoms'), Document(metadata={'source': './input/c06.pdf', 'page': 27}, page_content='6A60.A  Bipolar type I disorder, current episode mixed, with psychotic symptoms'), Document(metadata={'source': './input/c06.pdf', 'page': 27}, page_content='6A60.B  Bipolar type I disorder, currently in partial remission, most recent episode'), Document(metadata={'source': './input/c06.pdf', 'page': 27}, page_content='6A60.C  Bipolar type I disorder, currently in partial remission, most recent episode'), Document(metadata={'source': './input/c06.pdf', 'page': 28}, page_content='6A60.D  Bipolar type I disorder, currently in partial rem ission, most recent episode'), Document(metadata={'source': './input/c06.pdf', 'page': 28}, page_content='6A60.E  Bipolar type I disorder, currently in partial remission, most recent episode'), Document(metadata={'source': './input/c06.pdf', 'page': 28}, page_content='6A60.F  Bipolar type I disorder, currently in full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 28}, page_content='6A60.Y  Other specified bipolar type I disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 28}, page_content='6A60.Z  Bipolar type I disorder, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 28}, page_content='6A61   Bipolar type II disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 29}, page_content='6A61.0  Bipolar type II disorder, current epi sode hypomanic'), Document(metadata={'source': './input/c06.pdf', 'page': 29}, page_content='6A61.1  Bipolar type II disorder, current episode depressive, mild'), Document(metadata={'source': './input/c06.pdf', 'page': 29}, page_content='6A61.2  Bipolar type II disorder, c urrent episode depressive, moderate without'), Document(metadata={'source': './input/c06.pdf', 'page': 30}, page_content='6A61.3  Bipolar type II disorder, current episode depressive, moderate w ith psychotic'), Document(metadata={'source': './input/c06.pdf', 'page': 30}, page_content='6A61.4  Bipolar type II disorder, current episode depressive, severe without psychotic'), Document(metadata={'source': './input/c06.pdf', 'page': 30}, page_content='6A61.5  Bipolar type II disorder, current episode depressive, severe with psychotic'), Document(metadata={'source': './input/c06.pdf', 'page': 31}, page_content='6A61.6  Bipolar type II disorder, current episode depr essive, unspecified severity'), Document(metadata={'source': './input/c06.pdf', 'page': 31}, page_content='6A61.7  Bipolar type II disorder, currently in partial remission, most recent episode'), Document(metadata={'source': './input/c06.pdf', 'page': 31}, page_content='6A61 .8 Bipolar type II disorder, currently in partial remission, most recent episode'), Document(metadata={'source': './input/c06.pdf', 'page': 31}, page_content='6A61.9  Bipolar type II disorder, currently in partial remission, most recent episode'), Document(metadata={'source': './input/c06.pdf', 'page': 31}, page_content='6A61.A  Bipolar type II disorder, currently in full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 31}, page_content='6A61.Y  Other specified bipolar type II disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 31}, page_content='6A61.Z  Bipolar type II disorder, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 32}, page_content='6A62   Cyclothymic disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 32}, page_content='6A70   Single episode depressive disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 33}, page_content='6A70.0  Single episode depressive disorder, mild'), Document(metadata={'source': './input/c06.pdf', 'page': 33}, page_content='6A70.1  Single episode depressive disorder, moderate, without psychotic symptoms'), Document(metadata={'source': './input/c06.pdf', 'page': 33}, page_content='6A70.2  Single episode depressive disorder, moderate, with psychotic symptoms'), Document(metadata={'source': './input/c06.pdf', 'page': 34}, page_content='6A70.3  Single episode depressive disorder, severe, without psychotic symptoms'), Document(metadata={'source': './input/c06.pdf', 'page': 34}, page_content='6A70.4  Single episode depressive disorder, severe, with psychotic symptoms'), Document(metadata={'source': './input/c06.pdf', 'page': 34}, page_content='6A70.5  Single episode depressive disorder, unspecified severity'), Document(metadata={'source': './input/c06.pdf', 'page': 35}, page_content='6A70.6  Single episode depressive disorder, curren tly in partial remission'), Document(metadata={'source': './input/c06.pdf', 'page': 35}, page_content='6A70.7  Single episode depressive disorder, currently in full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 35}, page_content='6A70.Y  Other specified single episode depressive disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 35}, page_content='6A70.Z  Single episode depressive disorder, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 35}, page_content='6A71   Recurrent depressive disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 35}, page_content='6A71.0  Recurrent depressive disorder, current episode mild'), Document(metadata={'source': './input/c06.pdf', 'page': 36}, page_content='6A71.1  Recurrent depressive disorder, current episode moderate, without psychotic'), Document(metadata={'source': './input/c06.pdf', 'page': 36}, page_content='6A71.2  Recurrent depressive disorder, current episode moderate, with psychotic'), Document(metadata={'source': './input/c06.pdf', 'page': 37}, page_content='6A71. 3 Recurrent depressive disorder, current episode severe, without psychotic'), Document(metadata={'source': './input/c06.pdf', 'page': 37}, page_content='6A71.4  Recurrent depressive disorder, current episode severe, with psychotic'), Document(metadata={'source': './input/c06.pdf', 'page': 38}, page_content='6A71.5  Recurrent depressive disorder, current episode, unspecified severity'), Document(metadata={'source': './input/c06.pdf', 'page': 38}, page_content='6A71.6  Recurrent depressive disorder, currently in partial remission'), Document(metadata={'source': './input/c06.pdf', 'page': 38}, page_content='6A71.7  Recurrent depressive disorder, currently in full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 38}, page_content='6A71.Y  Other specified recurrent depressive disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 38}, page_content='6A71.Z  Recurrent depressive disorder, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 38}, page_content='6A72   Dysthymic disor der'), Document(metadata={'source': './input/c06.pdf', 'page': 39}, page_content='6A73   Mixed depressive and anxiety disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 39}, page_content='6A80   Symptomatic and course presentations for mood episodes in mood'), Document(metadata={'source': './input/c06.pdf', 'page': 39}, page_content='6A80.0  Prominent anxiety symptoms in mood episodes'), Document(metadata={'source': './input/c06.pdf', 'page': 40}, page_content='6A80.1  Panic attacks in mood episodes'), Document(metadata={'source': './input/c06.pdf', 'page': 40}, page_content='6A80.2  Current depressive episode persistent'), Document(metadata={'source': './input/c06.pdf', 'page': 40}, page_content='6A80.3  Current depressive episode with melancholia'), Document(metadata={'source': './input/c06.pdf', 'page': 40}, page_content='6A80.4  Seasonal pattern of mood episode onset'), Document(metadata={'source': './input/c06.pdf', 'page': 41}, page_content='6A80.5  Rapid cycling'), Document(metadata={'source': './input/c06.pdf', 'page': 41}, page_content='6B00   Generalised anxiety disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 42}, page_content='6B01   Panic disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 42}, page_content='6B02   Agoraphobia'), Document(metadata={'source': './input/c06.pdf', 'page': 42}, page_content='6B03   Specific phobia'), Document(metadata={'source': './input/c06.pdf', 'page': 43}, page_content='6B04   Social anxiety di sorder'), Document(metadata={'source': './input/c06.pdf', 'page': 43}, page_content='6B05   Separation anxiety disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 43}, page_content='6B06   Selective mutism'), Document(metadata={'source': './input/c06.pdf', 'page': 44}, page_content='6B20   Obsessive -compulsive disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 44}, page_content='6B20.0  Obsessive -compulsive disorder with fair to good insight'), Document(metadata={'source': './input/c06.pdf', 'page': 44}, page_content='6B20.1  Obsessive -compulsive disorder with poor to absent insight'), Document(metadata={'source': './input/c06.pdf', 'page': 44}, page_content='6B20.Z  Obsessive -compulsive disorder, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 45}, page_content='6B21   Body d ysmorphic disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 45}, page_content='6B21.0  Body dysmorphic disorder with fair to good insight'), Document(metadata={'source': './input/c06.pdf', 'page': 45}, page_content='6B21.1  Body dysmorphic disord er with poor to absent insight'), Document(metadata={'source': './input/c06.pdf', 'page': 45}, page_content='6B21.Z  Body dysmorphic disorder, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 45}, page_content='6B22   Olfactory reference disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 46}, page_content='6B22.0  Olfactory reference disorder with fair to good insight'), Document(metadata={'source': './input/c06.pdf', 'page': 46}, page_content='6B22.1  Olfactory reference disorder with poor to absent insight'), Document(metadata={'source': './input/c06.pdf', 'page': 46}, page_content='6B22.Z  Olfactory reference disorder, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 46}, page_content='6B23   Hypochondriasis'), Document(metadata={'source': './input/c06.pdf', 'page': 46}, page_content='6B23.0  Hypochondriasis wi th fair to good insight'), Document(metadata={'source': './input/c06.pdf', 'page': 46}, page_content='6B23.1  Hypochondriasis with poor to absent insight'), Document(metadata={'source': './input/c06.pdf', 'page': 46}, page_content='6B23.Z  Hypochondriasis, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 47}, page_content='6B24   Hoarding disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 47}, page_content='6B24.0  Hoarding disorder with fair to good insight'), Document(metadata={'source': './input/c06.pdf', 'page': 47}, page_content='6B24.1  Hoarding disorder w ith poor to absent insight'), Document(metadata={'source': './input/c06.pdf', 'page': 47}, page_content='6B24.Z  Hoarding disorder, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 47}, page_content='6B25   Body -focused repetitive behaviour disorder s'), Document(metadata={'source': './input/c06.pdf', 'page': 47}, page_content='6B25.0  Trichotillomania'), Document(metadata={'source': './input/c06.pdf', 'page': 48}, page_content='6B25.1  Excoriation disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 48}, page_content='6B25.Y  Other specified body -focused repet itive behaviour disorders'), Document(metadata={'source': './input/c06.pdf', 'page': 48}, page_content='6B25.Z  Body -focused repetitive behaviour disorders, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 49}, page_content='6B40   Post traumatic stress disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 49}, page_content='6B41   Complex post traumatic stress disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 50}, page_content='6B42   Prolonged grief disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 50}, page_content='6B43   Adjustment disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 51}, page_content='6B44   Reactive attachment disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 51}, page_content='6B45   Disinhibited social engagement disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 52}, page_content='6B60   Dissociative neurological symptom disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 52}, page_content='6B60.0  Dissociative neurological symptom disorder, with visual disturbance'), Document(metadata={'source': './input/c06.pdf', 'page': 52}, page_content='6B60.1  Dissociative neurological symptom disorder, with auditory disturbance'), Document(metadata={'source': './input/c06.pdf', 'page': 52}, page_content='6B60.2  Dissociative neurological symptom disorder, with vertigo or dizziness'), Document(metadata={'source': './input/c06.pdf', 'page': 53}, page_content='6B60.3  Dissociative neurological symptom disorder, with other sensory disturbance'), Document(metadata={'source': './input/c06.pdf', 'page': 53}, page_content='6B60.4  Dissociative neurological symptom disorder, with non -epileptic seizures'), Document(metadata={'source': './input/c06.pdf', 'page': 53}, page_content='6B60.5  Dissociative neurological symptom disorder, with speech disturbance'), Document(metadata={'source': './input/c06.pdf', 'page': 53}, page_content='6B60.6  Dissociative neurological symptom disorder, with paresis or weakness'), Document(metadata={'source': './input/c06.pdf', 'page': 53}, page_content='6B60.7  Dissociative ne urological symptom disorder, with gait disturbance'), Document(metadata={'source': './input/c06.pdf', 'page': 53}, page_content='6B60.8  Dissociative neurological symptom disorder, with movement disturbance'), Document(metadata={'source': './input/c06.pdf', 'page': 54}, page_content='6B60.80  Dissociative neurologi cal symptom disorder, with chorea'), Document(metadata={'source': './input/c06.pdf', 'page': 54}, page_content='6B60.81  Dissociative neurological symptom disorder, with myoc lonus'), Document(metadata={'source': './input/c06.pdf', 'page': 54}, page_content='6B60.82  Dissociative neurological symptom disorder, with tremor'), Document(metadata={'source': './input/c06.pdf', 'page': 54}, page_content='6B60.83  Dissociative neurological symptom disorder, with dystonia'), Document(metadata={'source': './input/c06.pdf', 'page': 54}, page_content='6B60.84  Dissociative n eurological symptom disorder, with facial spasm'), Document(metadata={'source': './input/c06.pdf', 'page': 54}, page_content='6B60.85  Dissociative neurological symptom disorder, with Parkinsonism'), Document(metadata={'source': './input/c06.pdf', 'page': 54}, page_content='6B60.8Y  Dissociati ve neurological symptom disorder, with other specified movement'), Document(metadata={'source': './input/c06.pdf', 'page': 55}, page_content='6B60.8Z  Dissociative neurological symptom disorder, with unspecified movement'), Document(metadata={'source': './input/c06.pdf', 'page': 55}, page_content='6B60.9  Dissociative neurological symptom disorder, with cognitive symptoms'), Document(metadata={'source': './input/c06.pdf', 'page': 55}, page_content='6B60.Y  Dissociative neurological symptom disorder, with other specified symptoms'), Document(metadata={'source': './input/c06.pdf', 'page': 55}, page_content='6B60.Z  Dissociative neurological symptom disorder, with unspecified symptoms'), Document(metadata={'source': './input/c06.pdf', 'page': 55}, page_content='6B61   Dissociative amnesia'), Document(metadata={'source': './input/c06.pdf', 'page': 55}, page_content='6B61.0  Dissociative amnesia with dissociative fugue'), Document(metadata={'source': './input/c06.pdf', 'page': 55}, page_content='6B61.1  Dissociative amnesia without dissociative fugue'), Document(metadata={'source': './input/c06.pdf', 'page': 55}, page_content='6B61.Z  Dissociative amnesia, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 56}, page_content='6B62   Trance disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 56}, page_content='6B63   Possession trance disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 57}, page_content='6B64   Dissociative identity disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 57}, page_content='6B65   Partial dissociative identity disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 58}, page_content='6B66   Depersonalization -derealization disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 58}, page_content='6B80   Anorexia Nervosa'), Document(metadata={'source': './input/c06.pdf', 'page': 59}, page_content='6B80.0  Anorexia Nervosa with significantly low body weight'), Document(metadata={'source': './input/c06.pdf', 'page': 59}, page_content='6B80.00  Anorexia Nervosa w ith significantly low body weight, restricting pattern'), Document(metadata={'source': './input/c06.pdf', 'page': 59}, page_content='6B80.01  Anorexia Nervosa with significantly low body weight, binge -purge pattern'), Document(metadata={'source': './input/c06.pdf', 'page': 59}, page_content='6B80.0Z  Anorexia Nervosa with significantly low body weight, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 59}, page_content='6B80.1  Anorexia Nervosa with dangerously low body weight'), Document(metadata={'source': './input/c06.pdf', 'page': 59}, page_content='6B80.10  Anorexia Nervosa with dangerously low body weight, restricting pattern'), Document(metadata={'source': './input/c06.pdf', 'page': 59}, page_content='6B80.11  Anorexia Nervosa with dangerously low body weight, binge -purge pattern'), Document(metadata={'source': './input/c06.pdf', 'page': 60}, page_content='6B80.1Z  Anorexia Nervosa with dangerously low body weight, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 60}, page_content='6B80.2  Anorexia Nervosa in recovery with normal body weight'), Document(metadata={'source': './input/c06.pdf', 'page': 60}, page_content='6B80.Y  Other specified anorexia Nervosa'), Document(metadata={'source': './input/c06.pdf', 'page': 60}, page_content='6B80.Z  Anorexia Nervosa, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 60}, page_content='6B81   Bulimia N ervosa'), Document(metadata={'source': './input/c06.pdf', 'page': 60}, page_content='6B82   Binge eating disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 61}, page_content='6B83   Avoidant -restrictive food intake di sorder'), Document(metadata={'source': './input/c06.pdf', 'page': 61}, page_content='6B84   Pica'), Document(metadata={'source': './input/c06.pdf', 'page': 61}, page_content='6B85   Rumination -regurgitation disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 62}, page_content='6C00   Enuresis'), Document(metadata={'source': './input/c06.pdf', 'page': 62}, page_content='6C00.0  Nocturnal enuresis'), Document(metadata={'source': './input/c06.pdf', 'page': 62}, page_content='6C00.1  Diurnal enuresis'), Document(metadata={'source': './input/c06.pdf', 'page': 63}, page_content='6C00.2  Nocturnal and diurnal enuresis'), Document(metadata={'source': './input/c06.pdf', 'page': 63}, page_content='6C00.Z  Enuresis, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 63}, page_content='6C01   Encopresis'), Document(metadata={'source': './input/c06.pdf', 'page': 63}, page_content='6C01.0  Encopresis with constipation or overflow incontinence'), Document(metadata={'source': './input/c06.pdf', 'page': 63}, page_content='6C01.1  Encopresis without constipation or overflow incontinence'), Document(metadata={'source': './input/c06.pdf', 'page': 63}, page_content='6C01.Z  Encopresis, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 64}, page_content='6C20   Bodily distress disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 65}, page_content='6C20.0  Mild bodily distress disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 65}, page_content='6C20.1  Moderate bodily distress disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 65}, page_content='6C20.2  Severe bodily distress disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 65}, page_content='6C20.Z  Bodily distress disorder, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 65}, page_content='6C21   Body integrity dysphoria'), Document(metadata={'source': './input/c06.pdf', 'page': 66}, page_content='6C40   Disorders due to use of alcohol'), Document(metadata={'source': './input/c06.pdf', 'page': 67}, page_content='6C40.0  Episode of harmful use of alcohol'), Document(metadata={'source': './input/c06.pdf', 'page': 67}, page_content='6C40.1  Harmful pattern of use of alcohol'), Document(metadata={'source': './input/c06.pdf', 'page': 67}, page_content='6C40.10  Harmful pattern of use of alcohol, epis odic'), Document(metadata={'source': './input/c06.pdf', 'page': 68}, page_content='6C40.11  Harmful pattern of use of alcohol, continuous'), Document(metadata={'source': './input/c06.pdf', 'page': 68}, page_content='6C40.1Z  Harmful pattern of use of alcohol, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 68}, page_content='6C40.2  Alcohol dependence'), Document(metadata={'source': './input/c06.pdf', 'page': 68}, page_content='6C40.20  Alcohol dependence, current use, continuous'), Document(metadata={'source': './input/c06.pdf', 'page': 68}, page_content='6C40.21  Alcohol dependence, current use,  episodic'), Document(metadata={'source': './input/c06.pdf', 'page': 69}, page_content='6C40.22  Alcohol dependence, early full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 69}, page_content='6C40.23  Alcohol dependence, sustained partial remission'), Document(metadata={'source': './input/c06.pdf', 'page': 69}, page_content='6C40.24  Alcohol dependence, sustained full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 69}, page_content='6C40.2Z  Alcohol dependence, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 69}, page_content='6C40.3  Alcohol intoxication'), Document(metadata={'source': './input/c06.pdf', 'page': 70}, page_content='6C40.4  Alcohol withdrawal'), Document(metadata={'source': './input/c06.pdf', 'page': 70}, page_content='6C40.40  Alcohol withdrawal, uncomplicated'), Document(metadata={'source': './input/c06.pdf', 'page': 70}, page_content='6C40.41  Alcohol withdrawal with perceptual disturbances'), Document(metadata={'source': './input/c06.pdf', 'page': 70}, page_content='6C40.42  Alcohol withdrawal with seizures'), Document(metadata={'source': './input/c06.pdf', 'page': 70}, page_content='6C40.43  Alcohol withdrawal with perceptual disturbances and seizures'), Document(metadata={'source': './input/c06.pdf', 'page': 70}, page_content='6C40.4Z  Alcohol withdrawal, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 71}, page_content='6C40.5  Alcohol -induced delirium'), Document(metadata={'source': './input/c06.pdf', 'page': 71}, page_content='6C40.6  Alcohol -induced psychotic disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 71}, page_content='6C40.60  Alcohol -induced psychotic disorder with hallucinations'), Document(metadata={'source': './input/c06.pdf', 'page': 72}, page_content='6C40.61  Alcohol -induced psychotic disorder with delusions'), Document(metadata={'source': './input/c06.pdf', 'page': 72}, page_content='6C40.62  Alcohol -induced psychotic disorder with mixed psychotic symptoms'), Document(metadata={'source': './input/c06.pdf', 'page': 72}, page_content='6C40.6Z  Alcohol -induced psychotic disorder, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 72}, page_content='6C40.7  Certain specified alcohol -induced mental or behavioural disorders'), Document(metadata={'source': './input/c06.pdf', 'page': 72}, page_content='6C40.70  Alcohol -induced mood disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 73}, page_content='6C40.71  Alcohol -induced anxiety disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 73}, page_content='6C40.Y  Othe r specified disorders due to use of alcohol'), Document(metadata={'source': './input/c06.pdf', 'page': 73}, page_content='6C40.Z  Disorders due to use of alcohol, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 73}, page_content='6C41   Disorders due to use of cannabis'), Document(metadata={'source': './input/c06.pdf', 'page': 74}, page_content='6C41.0  Episode of harmful use of cannabis'), Document(metadata={'source': './input/c06.pdf', 'page': 74}, page_content='6C41.1  Harmful pattern of use of cannabis'), Document(metadata={'source': './input/c06.pdf', 'page': 74}, page_content='6C41.10  Harmful pattern of use of cannabis, episodic'), Document(metadata={'source': './input/c06.pdf', 'page': 75}, page_content='6C41.11  Harmful pattern of use of cannabis, continuous'), Document(metadata={'source': './input/c06.pdf', 'page': 75}, page_content='6C41.1Z  Harmful pattern of us e of cannabis, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 75}, page_content='6C41.2  Cannabis dependence'), Document(metadata={'source': './input/c06.pdf', 'page': 75}, page_content='6C41.20  Cannabis dependence, current use'), Document(metadata={'source': './input/c06.pdf', 'page': 75}, page_content='6C41.21  Cannabis dependence, early full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 76}, page_content='6C41.22  Cannabis dependence, sustained partial remission'), Document(metadata={'source': './input/c06.pdf', 'page': 76}, page_content='6C41.23  Cannabis dependence, sustained full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 76}, page_content='6C41.2Z  Cannabis dependence, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 76}, page_content='6C41.3  Cannabis intoxication'), Document(metadata={'source': './input/c06.pdf', 'page': 76}, page_content='6C41.4  Cannabis withdrawal'), Document(metadata={'source': './input/c06.pdf', 'page': 77}, page_content='6C41.5  Cannabis -induced delirium'), Document(metadata={'source': './input/c06.pdf', 'page': 77}, page_content='6C41.6  Cannabis -induced psychotic disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 77}, page_content='6C41.7  Certain specified cannabis -induced mental or behavioural disorders'), Document(metadata={'source': './input/c06.pdf', 'page': 77}, page_content='6C41.70  Cannabis -induced mood disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 78}, page_content='6C41.71  Cannabis -induced anxiety disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 78}, page_content='6C41.Y  Other specified disorders due to use of cannabis'), Document(metadata={'source': './input/c06.pdf', 'page': 78}, page_content='6C41.Z  Disorders due to use of cannabis, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 78}, page_content='6C42   Disorders due to use of synthetic cannabinoids'), Document(metadata={'source': './input/c06.pdf', 'page': 78}, page_content='6C42.0  Episode of harmful use of synthetic cannabinoids'), Document(metadata={'source': './input/c06.pdf', 'page': 79}, page_content='6C42.1  Harmful pattern of use of synthetic cannabinoids'), Document(metadata={'source': './input/c06.pdf', 'page': 79}, page_content='6C42.10  Harmful pattern of use of synthetic cannabinoids, episodic'), Document(metadata={'source': './input/c06.pdf', 'page': 79}, page_content='6C42.11  Harmful pattern of use of synthetic canna binoids, continuous'), Document(metadata={'source': './input/c06.pdf', 'page': 79}, page_content='6C42.1Y  Other specified harmful pattern of use of synthetic cannabinoids'), Document(metadata={'source': './input/c06.pdf', 'page': 79}, page_content='6C42.1Z  Harmful pattern of use of synthetic cannabinoids, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 80}, page_content='6C42.2  Synthetic cannabinoid dependence'), Document(metadata={'source': './input/c06.pdf', 'page': 80}, page_content='6C42.20  Synthetic cannabinoid dependence, current use'), Document(metadata={'source': './input/c06.pdf', 'page': 80}, page_content='6C42.21  Synthetic cannabinoid dependence, early full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 80}, page_content='6C42.22  Synthetic cannabinoid dependence, sustained partial remission'), Document(metadata={'source': './input/c06.pdf', 'page': 80}, page_content='6C42.23  Synthetic cannabinoid depend ence, sustained full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 81}, page_content='6C42.2Y  Other specified synthetic cannabinoid dependence'), Document(metadata={'source': './input/c06.pdf', 'page': 81}, page_content='6C42.2Z  Synthetic cannabinoid dependence, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 81}, page_content='6C42. 3 Synthetic cannabinoid intoxication'), Document(metadata={'source': './input/c06.pdf', 'page': 81}, page_content='6C42.4  Synthetic cannabinoid withdrawal'), Document(metadata={'source': './input/c06.pdf', 'page': 81}, page_content='6C42.5  Synthetic cannabinoid -induced delirium'), Document(metadata={'source': './input/c06.pdf', 'page': 82}, page_content='6C42.6  Synthetic cannabinoid -induced psychotic disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 82}, page_content='6C42.7  Certain specified synthetic cannabinoids -induced mental or behavioural'), Document(metadata={'source': './input/c06.pdf', 'page': 82}, page_content='6C42.70  Synthetic cannabinoid -induced mood disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 83}, page_content='6C42.71  Synthetic cannabinoid -induced anxiety disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 83}, page_content='6C42.Y  Other specified disorders due to use of synthetic cannabinoids'), Document(metadata={'source': './input/c06.pdf', 'page': 83}, page_content='6C42.Z  Disorders due to use of synthetic cannabinoids, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 83}, page_content='6C43   Disorders due to use of opioids'), Document(metadata={'source': './input/c06.pdf', 'page': 84}, page_content='6C43.0  Episode of harmful use of opioids'), Document(metadata={'source': './input/c06.pdf', 'page': 84}, page_content='6C43.1  Harmful pattern of use of opioids'), Document(metadata={'source': './input/c06.pdf', 'page': 84}, page_content='6C43.10  Harmful pattern of use of opioids, episodic'), Document(metadata={'source': './input/c06.pdf', 'page': 85}, page_content='6C43.11  Harmful pattern of use of opioids, continuous'), Document(metadata={'source': './input/c06.pdf', 'page': 85}, page_content='6C43.1Z  Harmfu l pattern of use of opioids, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 85}, page_content='6C43.2  Opioid dependence'), Document(metadata={'source': './input/c06.pdf', 'page': 85}, page_content='6C43.20  Opioid dependence, current use'), Document(metadata={'source': './input/c06.pdf', 'page': 85}, page_content='6C43.21  Opioid dependence, early full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 86}, page_content='6C43.22  Opioid dependence, sustained part ial remission'), Document(metadata={'source': './input/c06.pdf', 'page': 86}, page_content='6C43.23  Opioid dependence, sustained full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 86}, page_content='6C43.2Z  Opioid dependence, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 86}, page_content='6C43.3  Opioid intoxication'), Document(metadata={'source': './input/c06.pdf', 'page': 87}, page_content='6C43.4  Opioid withdrawal'), Document(metadata={'source': './input/c06.pdf', 'page': 87}, page_content='6C43.5  Opioid -induced delirium'), Document(metadata={'source': './input/c06.pdf', 'page': 87}, page_content='6C43.6  Opioid -induced psychotic disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 87}, page_content='6C43.7  Certain specified opioid -induced mental or behavioural disorders'), Document(metadata={'source': './input/c06.pdf', 'page': 88}, page_content='6C43.70  Opioid -induced mood disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 88}, page_content='6C43.71  Opioid -induced anxiety disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 88}, page_content='6C43.Y  Other specified disorders due to use of opioids'), Document(metadata={'source': './input/c06.pdf', 'page': 88}, page_content='6C43.Z  Disorders due to use of opioids, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 88}, page_content='6C44   Disorders due to use of sedatives, hypnotics or anxiolytics'), Document(metadata={'source': './input/c06.pdf', 'page': 89}, page_content='6C44.0  Episode of harmful use of sedatives, hypnotics or anxiolytics'), Document(metadata={'source': './input/c06.pdf', 'page': 89}, page_content='6C44.1  Harmful pattern of use of sedatives, hypnotics or anxiolytics'), Document(metadata={'source': './input/c06.pdf', 'page': 89}, page_content='6C44.10  Harmful pattern of use of sedatives, hypnotics or anxiolytics, episodic'), Document(metadata={'source': './input/c06.pdf', 'page': 90}, page_content='6C44.11  Harmful pattern of use of sedatives, hypnotics or anxiolytics, continuous'), Document(metadata={'source': './input/c06.pdf', 'page': 90}, page_content='6C44.1Z  Harmful pattern of use of sedatives, hypnotics or anxiolytics, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 90}, page_content='6C44.2  Sedative, hypnotic or anxiolytic dependence'), Document(metadata={'source': './input/c06.pdf', 'page': 90}, page_content='6C44.20  Sedative, hypnotic or anxiolytic dependence, current use'), Document(metadata={'source': './input/c06.pdf', 'page': 91}, page_content='6C44.21  Sedative, hypn otic or anxiolytic dependence, early full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 91}, page_content='6C44.22  Sedative,  hypnotic or anxiolytic dependence, sustained partial remission'), Document(metadata={'source': './input/c06.pdf', 'page': 91}, page_content='6C44.23  Sedative, hypnotic or anxiolytic dependence, sustained full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 91}, page_content='6C44.2Z  Sedative, hypnotic or anxiolytic dependence, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 92}, page_content='6C44.3  Sedative, hypnotic or anxiolytic intoxication'), Document(metadata={'source': './input/c06.pdf', 'page': 92}, page_content='6C44.4  Sedative, hypnotic or anxiolytic withdrawal'), Document(metadata={'source': './input/c06.pdf', 'page': 92}, page_content='6C44.40  Sedative, hypnotic or anxiolytic withdrawal, uncomplicated'), Document(metadata={'source': './input/c06.pdf', 'page': 93}, page_content='6C44.41  Sedative, hypnotic or anxiolytic withdrawal, with perceptual disturbances'), Document(metadata={'source': './input/c06.pdf', 'page': 93}, page_content='6C44.42  Sedative, hypnotic or anxiolytic withdrawal, with seizures'), Document(metadata={'source': './input/c06.pdf', 'page': 93}, page_content='6C44.43  Sedative, hypnotic or anxiolytic withdrawal, with perceptual disturbances and'), Document(metadata={'source': './input/c06.pdf', 'page': 93}, page_content='6C44.4Z  Sedative, hypnotic or anxiolytic withdrawal, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 93}, page_content='6C44.5  Sedative, hypnotic or anxiolytic -induced delirium'), Document(metadata={'source': './input/c06.pdf', 'page': 94}, page_content='6C44.6  Sedative, hypnotic or anxiolytic -induced psychotic disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 94}, page_content='6C44.7  Certain specified sedatives, hypnotics  or anxiolytic -induced mental or'), Document(metadata={'source': './input/c06.pdf', 'page': 94}, page_content='6C44.70  Sedative, hypnotic or anxiolytic -induced mood disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 95}, page_content='6C44.71  Sedative, hypnotic or anxiolytic -induced anxiety disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 95}, page_content='6C44.Y  Other specified disorders due to use of sedatives,  hypnotics or anxiolytics'), Document(metadata={'source': './input/c06.pdf', 'page': 95}, page_content='6C44.Z  Disorders due to use of sedatives, hypnotics or anxiolytics, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 95}, page_content='6C45   Disorders due to use of cocaine'), Document(metadata={'source': './input/c06.pdf', 'page': 96}, page_content='6C45.0  Episode of harmful use of cocaine'), Document(metadata={'source': './input/c06.pdf', 'page': 96}, page_content='6C45.1  Harmful pattern of use of cocaine'), Document(metadata={'source': './input/c06.pdf', 'page': 96}, page_content='6C45.10  Harmful pattern of use of cocaine, episodic'), Document(metadata={'source': './input/c06.pdf', 'page': 97}, page_content='6C45.11  Harmful pattern of use of cocaine, continuous'), Document(metadata={'source': './input/c06.pdf', 'page': 97}, page_content='6C45.1Z  Harmful pattern of use of cocaine, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 97}, page_content='6C45.2  Cocaine dependence'), Document(metadata={'source': './input/c06.pdf', 'page': 97}, page_content='6C45.20  Cocaine dependence, current use'), Document(metadata={'source': './input/c06.pdf', 'page': 97}, page_content='6C45.21  Cocaine dependence, early full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 98}, page_content='6C45.22  Cocaine dependence, sustained partial remission'), Document(metadata={'source': './input/c06.pdf', 'page': 98}, page_content='6C45.23  Cocaine dependence, sustained full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 98}, page_content='6C45.2Z  Cocaine dependence, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 98}, page_content='6C45.3  Cocaine intoxication'), Document(metadata={'source': './input/c06.pdf', 'page': 98}, page_content='6C45.4  Cocaine withdrawal'), Document(metadata={'source': './input/c06.pdf', 'page': 99}, page_content='6C45.5  Cocaine -induced delirium'), Document(metadata={'source': './input/c06.pdf', 'page': 99}, page_content='6C45.6  Cocaine -induced psychotic disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 99}, page_content='6C45.60  Cocaine -induced psychotic disorder with hallucinations'), Document(metadata={'source': './input/c06.pdf', 'page': 99}, page_content='6C45.61  Cocaine -induced psychotic disorder with delusions'), Document(metadata={'source': './input/c06.pdf', 'page': 100}, page_content='6C45.62  Cocaine -induced psychotic disorder with mixed psychotic symptoms'), Document(metadata={'source': './input/c06.pdf', 'page': 100}, page_content='6C45.6Z  Cocaine -induced psychotic disorder, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 100}, page_content='6C45.7  Certain specified cocaine -induced mental or behavioural disorders'), Document(metadata={'source': './input/c06.pdf', 'page': 100}, page_content='6C45.70  Cocaine -induced mood disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 100}, page_content='6C45.71  Cocaine -induced anxiety disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 101}, page_content='6C45.72  Cocaine -induced obsessive -compulsive or related disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 101}, page_content='6C45.73  Cocaine -induced impulse control disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 101}, page_content='6C45.Y  Other specified disorders due to use of cocaine'), Document(metadata={'source': './input/c06.pdf', 'page': 101}, page_content='6C45.Z  Disorders due to use of cocaine, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 102}, page_content='6C46   Disorders due to use of stimulants including amphetamines,'), Document(metadata={'source': './input/c06.pdf', 'page': 102}, page_content='6C46.0  Episode of harmful use of stimulants including amphetamines,'), Document(metadata={'source': './input/c06.pdf', 'page': 103}, page_content='6C46.1  Harmful pattern of use of  stimulants including amphetamines,'), Document(metadata={'source': './input/c06.pdf', 'page': 103}, page_content='6C46.10  Harmful pattern of use of stimulants including amphetamines, methamphetamine or'), Document(metadata={'source': './input/c06.pdf', 'page': 104}, page_content='6C46.11  Harmful pattern of use of stimulants including amphetamines, methamphetamine or'), Document(metadata={'source': './input/c06.pdf', 'page': 104}, page_content='6C46.1Z  Harmful pattern of use of stimulants including amphetamines, methamphetamine'), Document(metadata={'source': './input/c06.pdf', 'page': 104}, page_content='6C46.2  Stimulant dependence including amphetamines, methamphetamine or'), Document(metadata={'source': './input/c06.pdf', 'page': 105}, page_content='6C46.20  Stimulant dependence including amphetamines, methamphetamine or'), Document(metadata={'source': './input/c06.pdf', 'page': 105}, page_content='6C46.21  Stimulant dependence including amphetamines, methamphetamine or'), Document(metadata={'source': './input/c06.pdf', 'page': 105}, page_content='6C46.22  Stimulant dependence including amphet amines, methamphetamine or'), Document(metadata={'source': './input/c06.pdf', 'page': 105}, page_content='6C46.23  Stimulant dependence including amphetamines, methamphetamine or'), Document(metadata={'source': './input/c06.pdf', 'page': 105}, page_content='6C46.2Z  Stimulant dependence including amphetamines, metham phetamine or'), Document(metadata={'source': './input/c06.pdf', 'page': 106}, page_content='6C46.3  Stimulant intoxication including amphetamines, methamphetamine or'), Document(metadata={'source': './input/c06.pdf', 'page': 106}, page_content='6C46.4  Stimulant with drawal including amphetamines, methamphetamine or'), Document(metadata={'source': './input/c06.pdf', 'page': 107}, page_content='6C46.5  Stimulant -induced delirium including amphetamines, methamphetamine or'), Document(metadata={'source': './input/c06.pdf', 'page': 107}, page_content='6C46.6  Stimulant -induced psychotic disorder including amphetamines,'), Document(metadata={'source': './input/c06.pdf', 'page': 108}, page_content='6C46.60  Stimulant -induced psychotic disorder including amphetamines, methamphetamine'), Document(metadata={'source': './input/c06.pdf', 'page': 108}, page_content='6C46.61  Stimulant -induced psychotic disorder including amphetamines, methamphetamine'), Document(metadata={'source': './input/c06.pdf', 'page': 109}, page_content='6C46.62  Stimulant -induced psychotic disorder including amphetamines but excluding'), Document(metadata={'source': './input/c06.pdf', 'page': 109}, page_content='6C46.6Z  Stimulant -induced psychotic disorder including amphetamines, methamphetamine'), Document(metadata={'source': './input/c06.pdf', 'page': 109}, page_content='6C46.7  Certain specified stimulant -induced mental or behavioural disorders including'), Document(metadata={'source': './input/c06.pdf', 'page': 109}, page_content='6C46.70  Stimulant -induced mood disorder including amphetamines, methamphetamine or'), Document(metadata={'source': './input/c06.pdf', 'page': 110}, page_content='6C46.71  Stimulant -induced anxiety disorder including amphetamines, methamphetamine or'), Document(metadata={'source': './input/c06.pdf', 'page': 110}, page_content='6C46.72  Stimulant -induced obsessive -compulsive or rela ted disorder including'), Document(metadata={'source': './input/c06.pdf', 'page': 111}, page_content='6C46.73  Stimulant -induced impulse control disorder including amphetamines,'), Document(metadata={'source': './input/c06.pdf', 'page': 111}, page_content='6C46.Y  Other specified disorders due to use of stimulants including amphetamines,'), Document(metadata={'source': './input/c06.pdf', 'page': 111}, page_content='6C46.Z  Disorders due to use of stimulants including amphetamines,'), Document(metadata={'source': './input/c06.pdf', 'page': 111}, page_content='6C47   Disorders due to use of synthetic cathinones'), Document(metadata={'source': './input/c06.pdf', 'page': 111}, page_content='6C47.0  Episode of harmful use of synthetic cathinones'), Document(metadata={'source': './input/c06.pdf', 'page': 112}, page_content='6C47.1  Harmful pattern of use of synthetic cathinones'), Document(metadata={'source': './input/c06.pdf', 'page': 112}, page_content='6C47.10  Harmful pattern of use of synthetic cathinones, episodic'), Document(metadata={'source': './input/c06.pdf', 'page': 112}, page_content='6C47.11  Harmful use of synthetic cathinones, continuous'), Document(metadata={'source': './input/c06.pdf', 'page': 112}, page_content='6C47.1Y  Other specified harmful pattern of use of synthetic cathinones'), Document(metadata={'source': './input/c06.pdf', 'page': 112}, page_content='6C47.1Z  Harmful pattern of use of synthetic cathinones, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 113}, page_content='6C47.2  Synthetic cathinone dependence'), Document(metadata={'source': './input/c06.pdf', 'page': 113}, page_content='6C47.20  Synthetic cathinone dependence, current use'), Document(metadata={'source': './input/c06.pdf', 'page': 113}, page_content='6C47.21  Synthetic cathinone dependence, early full remissi on'), Document(metadata={'source': './input/c06.pdf', 'page': 113}, page_content='6C47.22  Synthetic cathinone dependence, sustained partial remission'), Document(metadata={'source': './input/c06.pdf', 'page': 113}, page_content='6C47.23  Synthetic cathinone dependence, sustained full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 113}, page_content='6C47.2Y  Other specified syntheti c cathinone dependence'), Document(metadata={'source': './input/c06.pdf', 'page': 114}, page_content='6C47.2Z  Synthetic cathinone dependence, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 114}, page_content='6C47.3  Synthetic cathinone intoxication'), Document(metadata={'source': './input/c06.pdf', 'page': 114}, page_content='6C47.4  Synthetic cathinone withdrawal'), Document(metadata={'source': './input/c06.pdf', 'page': 114}, page_content='6C47.5  Synthetic cathinone -induced delirium'), Document(metadata={'source': './input/c06.pdf', 'page': 115}, page_content='6C47.6  Synthetic cathinone -induced psychotic disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 115}, page_content='6C47.60  Synthetic cathinone -induced psyc hotic disorder with hallucinations'), Document(metadata={'source': './input/c06.pdf', 'page': 115}, page_content='6C47.61  Synthetic cathinone -induced psychotic disorder with delusions'), Document(metadata={'source': './input/c06.pdf', 'page': 115}, page_content='6C47.62  Synthetic cathinone -induced psychotic disorder with mixed psychotic symptoms'), Document(metadata={'source': './input/c06.pdf', 'page': 115}, page_content='6C47.6Z  Synthetic cathinone -induced psychotic disorder, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 116}, page_content='6C47.7  Certain specified synthetic cathinone -induced mental or behavioural'), Document(metadata={'source': './input/c06.pdf', 'page': 116}, page_content='6C47.70  Synthetic c athinone -induced mood disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 116}, page_content='6C47.71  Synthetic cathinone -induced anxiety disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 117}, page_content='6C47.72  Synthetic cathinone -induced obsessive -compulsive or related syndrome'), Document(metadata={'source': './input/c06.pdf', 'page': 117}, page_content='6C47.73  Synthetic cathinon e-induced impulse control disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 117}, page_content='6C47.Y  Other specified disorders due to use of synthetic cathinones'), Document(metadata={'source': './input/c06.pdf', 'page': 117}, page_content='6C47.Z  Disorders due to use of synthetic cathinones, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 118}, page_content='6C48   Disorders due to use of caffeine'), Document(metadata={'source': './input/c06.pdf', 'page': 118}, page_content='6C48.0 Episode of harmful use of caffeine'), Document(metadata={'source': './input/c06.pdf', 'page': 118}, page_content='6C48.1  Harmful pattern of use of caffeine'), Document(metadata={'source': './input/c06.pdf', 'page': 118}, page_content='6C48.10  Harmful pattern of use of caffeine, episodic'), Document(metadata={'source': './input/c06.pdf', 'page': 118}, page_content='6C48.11  Harmful pattern of use of caffeine, continuous'), Document(metadata={'source': './input/c06.pdf', 'page': 119}, page_content='6C48.1Z  Harmful pattern of use of caffeine, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 119}, page_content='6C48.2  Caffeine intoxication'), Document(metadata={'source': './input/c06.pdf', 'page': 119}, page_content='6C48.3  Caffeine w ithdrawal'), Document(metadata={'source': './input/c06.pdf', 'page': 119}, page_content='6C48.4  Certain specified caffeine -induced mental or behavioural disorders'), Document(metadata={'source': './input/c06.pdf', 'page': 119}, page_content='6C48.40  Caffeine -induced anxiety disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 119}, page_content='6C48.Y  Other specified disorders due to use of caffeine'), Document(metadata={'source': './input/c06.pdf', 'page': 119}, page_content='6C48.Z  Disorders due to use of caffeine, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 120}, page_content='6C49   Disorders due to use of hallucinogens'), Document(metadata={'source': './input/c06.pdf', 'page': 120}, page_content='6C49.0  Episode of harmful use of hallucinogens'), Document(metadata={'source': './input/c06.pdf', 'page': 120}, page_content='6C49.1  Harmful pattern of use of hallucinogens'), Document(metadata={'source': './input/c06.pdf', 'page': 121}, page_content='6C49.10  Harmful pattern of use of hallucinogens, episodic'), Document(metadata={'source': './input/c06.pdf', 'page': 121}, page_content='6C49.11  Harmful pattern of use of hallucinogens, continuous'), Document(metadata={'source': './input/c06.pdf', 'page': 121}, page_content='6C49.1Z  Harmful pattern of use of hallucinogens, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 121}, page_content='6C49.2  Hallucinogen dependence'), Document(metadata={'source': './input/c06.pdf', 'page': 121}, page_content='6C49.20  Hallucinogen dependence, current use'), Document(metadata={'source': './input/c06.pdf', 'page': 122}, page_content='6C49.21  Hallucinogen dependence, early full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 122}, page_content='6C49.22  Hallucinogen dependence, sustained partial remission'), Document(metadata={'source': './input/c06.pdf', 'page': 122}, page_content='6C49.23  Hallucinogen dependence, sustained full remission'), Document(metadata={'source': './input/c06.pdf', 'page': 122}, page_content='6C49.2Z  Hallucinogen dependence, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 122}, page_content='6C49.3  Hallucinogen intoxication'), Document(metadata={'source': './input/c06.pdf', 'page': 123}, page_content='6C49.4  Hallucinogen -induced delirium'), Document(metadata={'source': './input/c06.pdf', 'page': 123}, page_content='6C49.5  Hallucinogen -induced psychotic disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 123}, page_content='6C49.6  Certain specified hallucinogen -induced mental or behavioural disorders'), Document(metadata={'source': './input/c06.pdf', 'page': 123}, page_content='6C49.60  Hallucinogen -induced mood disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 124}, page_content='6C49.61  Hallucinogen -induced anxiety disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 124}, page_content='6C49.Y  Other specified disorders due to use of hallucinogens'), Document(metadata={'source': './input/c06.pdf', 'page': 124}, page_content='6C49.Z  Disorders due to use of hallucinogens, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 167}, page_content='6C50   Gambling disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 167}, page_content='6C50.0  Gambling disorder,  predominantly offline'), Document(metadata={'source': './input/c06.pdf', 'page': 168}, page_content='6C50.1  Gambling disorder, predominantly online'), Document(metadata={'source': './input/c06.pdf', 'page': 168}, page_content='6C50.Z  Gambling disorder, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 168}, page_content='6C51   Gaming disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 168}, page_content='6C51.0  Gaming disorder, predominantly online'), Document(metadata={'source': './input/c06.pdf', 'page': 169}, page_content='6C51.1  Gaming disorder, predominantly offline'), Document(metadata={'source': './input/c06.pdf', 'page': 169}, page_content='6C51.Z  Gaming disorder, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 170}, page_content='6C70   Pyromania'), Document(metadata={'source': './input/c06.pdf', 'page': 170}, page_content='6C71   Kleptomania'), Document(metadata={'source': './input/c06.pdf', 'page': 171}, page_content='6C72   Compulsive sexual behaviour disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 171}, page_content='6C73   Intermittent explosive disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 172}, page_content='6C90   Oppositional defiant disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 172}, page_content='6C90.0  Oppositional defiant disorder with chronic irritability -anger'), Document(metadata={'source': './input/c06.pdf', 'page': 172}, page_content='6C90.00  Oppositional defiant disorder with chronic irritability -anger with limited prosocial'), Document(metadata={'source': './input/c06.pdf', 'page': 172}, page_content='6C90.01  Oppositional defiant disorder with chronic irritability -anger with typical prosocial'), Document(metadata={'source': './input/c06.pdf', 'page': 172}, page_content='6C90.0Z  Oppositional defiant disorder with chr onic irritability -anger, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 173}, page_content='6C90.1  Oppositional defiant disorder without chronic irritability -anger'), Document(metadata={'source': './input/c06.pdf', 'page': 173}, page_content='6C90.10  Oppositional defiant disorder without chronic irritability -anger with limited prosocial'), Document(metadata={'source': './input/c06.pdf', 'page': 173}, page_content='6C90.11  Oppositional defiant disorder without chronic irritability -anger with typical prosocial'), Document(metadata={'source': './input/c06.pdf', 'page': 173}, page_content='6C90.1Z  Oppositional defiant disorder wi thout chronic irritability -anger, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 173}, page_content='6C90.Z  Oppositional defiant disorder, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 173}, page_content='6C91   Conduct -dissocial disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 173}, page_content='6C91.0  Conduct -dissocial disorder, childhood onset'), Document(metadata={'source': './input/c06.pdf', 'page': 174}, page_content='6C91.00  Conduct -dissocial disorder, childhood onset with limited prosocial emotions'), Document(metadata={'source': './input/c06.pdf', 'page': 174}, page_content='6C91.01  Conduct -dissocial disorder, childhood onset with typical prosocial emotions'), Document(metadata={'source': './input/c06.pdf', 'page': 174}, page_content='6C91.0Z  Conduct -dissocial disorder, childhood onset, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 174}, page_content='6C91.1  Condu ct-dissocial disorder, adolescent onset'), Document(metadata={'source': './input/c06.pdf', 'page': 174}, page_content='6C91.10  Conduct -dissocial disorder, adolescent onset with limit ed prosocial emotions'), Document(metadata={'source': './input/c06.pdf', 'page': 174}, page_content='6C91.11  Conduct -dissocial disorder, adolescent onset  with typical prosocial emotions'), Document(metadata={'source': './input/c06.pdf', 'page': 174}, page_content='6C91.1Y  Other specified conduct -dissocial disorder, adolescent onset'), Document(metadata={'source': './input/c06.pdf', 'page': 174}, page_content='6C91.Z  Conduct -dissocial disorder, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 175}, page_content='6D10   Personality  disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 175}, page_content='6D10.0  Mild personality disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 176}, page_content='6D10.1  Moderate personality disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 176}, page_content='6D10.2  Severe personality disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 176}, page_content='6D10.Z  Personality disorder, severity unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 176}, page_content='6D11   Prominent personality traits or patterns'), Document(metadata={'source': './input/c06.pdf', 'page': 177}, page_content='6D11.0  Negative affectivity in personal ity disorder or personality difficulty'), Document(metadata={'source': './input/c06.pdf', 'page': 177}, page_content='6D11.1  Detachment in personality disorder or personality difficulty'), Document(metadata={'source': './input/c06.pdf', 'page': 177}, page_content='6D11.2  Dissociality in personality disorder or personality difficulty'), Document(metadata={'source': './input/c06.pdf', 'page': 177}, page_content='6D11.3  Disinhibition in personality disorder or personality difficulty'), Document(metadata={'source': './input/c06.pdf', 'page': 178}, page_content='6D11.4  Anankastia in personality disorder or personality difficulty'), Document(metadata={'source': './input/c06.pdf', 'page': 178}, page_content='6D11.5  Borderline pattern'), Document(metadata={'source': './input/c06.pdf', 'page': 178}, page_content='6D30   Exhibitionistic disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 179}, page_content='6D31   Voyeuristic disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 179}, page_content='6D32   Pedophilic disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 179}, page_content='6D33   Coercive sexual sadism disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 179}, page_content='6D34   Frotteuristic disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 179}, page_content='6D35   Other paraphilic disorder involving non -consent ing individuals'), Document(metadata={'source': './input/c06.pdf', 'page': 180}, page_content='6D36   Paraphilic disorder involving solitary behaviour or consenting'), Document(metadata={'source': './input/c06.pdf', 'page': 180}, page_content='6D50   Factitious disorder imposed on self'), Document(metadata={'source': './input/c06.pdf', 'page': 181}, page_content='6D51   Factitious disorder imposed on another'), Document(metadata={'source': './input/c06.pdf', 'page': 181}, page_content='6D70   Delirium'), Document(metadata={'source': './input/c06.pdf', 'page': 182}, page_content='6D70.0  Delirium due to disease classified elsewhere'), Document(metadata={'source': './input/c06.pdf', 'page': 182}, page_content='6D70.1  Delirium due to psychoactive substances including medications'), Document(metadata={'source': './input/c06.pdf', 'page': 182}, page_content='6D70.2  Delirium due to multiple etiological factors'), Document(metadata={'source': './input/c06.pdf', 'page': 182}, page_content='6D70.Y  Delirium, other specified cause'), Document(metadata={'source': './input/c06.pdf', 'page': 182}, page_content='6D70.Z  Delirium, unspecified or unknown cause'), Document(metadata={'source': './input/c06.pdf', 'page': 183}, page_content='6D71   Mild neurocognitive disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 183}, page_content='6D72   Amnestic disorder'), Document(metadata={'source': './input/c06.pdf', 'page': 184}, page_content='6D72.0  Amnestic disorder due to diseases classified elsewhere'), Document(metadata={'source': './input/c06.pdf', 'page': 184}, page_content='6D72.1  Amnestic disorder due to psychoactive substances including medications'), Document(metadata={'source': './input/c06.pdf', 'page': 184}, page_content='6D72.1 0 Amnestic disorder due to use of alcohol'), Document(metadata={'source': './input/c06.pdf', 'page': 185}, page_content='6D72.11  Amnestic disorder due to use of sedatives, hypnotics or anxiolytics'), Document(metadata={'source': './input/c06.pdf', 'page': 185}, page_content='6D72.12  Amnestic disorder due to other specified psychoactive substance including'), Document(metadata={'source': './input/c06.pdf', 'page': 185}, page_content='6D72.13  Amnestic disorder due to use of volatile inhalants'), Document(metadata={'source': './input/c06.pdf', 'page': 185}, page_content='6D72.Y  Amnestic diso rder, other specified cause'), Document(metadata={'source': './input/c06.pdf', 'page': 185}, page_content='6D72.Z  Amnestic disorder, unknown or unspecified cause'), Document(metadata={'source': './input/c06.pdf', 'page': 186}, page_content='6D80   Dementia due to Alzheimer disease'), Document(metadata={'source': './input/c06.pdf', 'page': 187}, page_content='6D80.0  Dementia due to Alzheimer disease with early onset'), Document(metadata={'source': './input/c06.pdf', 'page': 187}, page_content='6D80.1  Dementia due to Alzheimer disease with late onset'), Document(metadata={'source': './input/c06.pdf', 'page': 187}, page_content='6D80.2  Alzheimer disease dementia, mixed type, with cerebrovascular disease'), Document(metadata={'source': './input/c06.pdf', 'page': 187}, page_content='6D80.3  Alzheimer disease dementia, mixed type, with other nonvascular aetiologies'), Document(metadata={'source': './input/c06.pdf', 'page': 187}, page_content='6D80.Z  Dementia due to Alzheimer disease, onset unknown or unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 188}, page_content='6D81   Dementia due to cerebrovascular disease'), Document(metadata={'source': './input/c06.pdf', 'page': 188}, page_content='6D82   Dementia due to Lewy body disease'), Document(metadata={'source': './input/c06.pdf', 'page': 188}, page_content='6D83   Frontotemporal dementia'), Document(metadata={'source': './input/c06.pdf', 'page': 189}, page_content='6D84   Dementia due to psychoactive substances including medications'), Document(metadata={'source': './input/c06.pdf', 'page': 189}, page_content='6D84.0  Dementia due to use of alcohol'), Document(metadata={'source': './input/c06.pdf', 'page': 190}, page_content='6D84.1  Dementia due to use of sedatives, hypnotics or anxiolytics'), Document(metadata={'source': './input/c06.pdf', 'page': 190}, page_content='6D84.2  Dementia due to use of volatile inhalants'), Document(metadata={'source': './input/c06.pdf', 'page': 190}, page_content='6D84.Y  Dementia due to other specified psychoactive substance'), Document(metadata={'source': './input/c06.pdf', 'page': 190}, page_content='6D85   Dementia due to diseases classified elsewhere'), Document(metadata={'source': './input/c06.pdf', 'page': 191}, page_content='6D85.0  Dementia due to Parkinson disease'), Document(metadata={'source': './input/c06.pdf', 'page': 191}, page_content='6D85.1  Dementia due to Huntington disease'), Document(metadata={'source': './input/c06.pdf', 'page': 191}, page_content='6D85.2  Dementia due to exposure to heavy metals and ot her toxins'), Document(metadata={'source': './input/c06.pdf', 'page': 192}, page_content='6D85.3  Dementia due to human immunodeficiency virus'), Document(metadata={'source': './input/c06.pdf', 'page': 192}, page_content='6D85.4  Dementia due to multiple sclerosis'), Document(metadata={'source': './input/c06.pdf', 'page': 192}, page_content='6D85.5  Dementia due to prion disease'), Document(metadata={'source': './input/c06.pdf', 'page': 193}, page_content='6D85.6  Dementia due to normal pressure hydrocephalus'), Document(metadata={'source': './input/c06.pdf', 'page': 193}, page_content='6D85.7  Dementia due to injury to the head'), Document(metadata={'source': './input/c06.pdf', 'page': 193}, page_content='6D85.8  Dementia due to pellagra'), Document(metadata={'source': './input/c06.pdf', 'page': 194}, page_content='6D85.9  Dementia due to Down syndrome'), Document(metadata={'source': './input/c06.pdf', 'page': 194}, page_content='6D85.Y  Dementia due to other specified diseases  classified elsewhere'), Document(metadata={'source': './input/c06.pdf', 'page': 194}, page_content='6D86   Behavioural or psychological disturbances in dementia'), Document(metadata={'source': './input/c06.pdf', 'page': 194}, page_content='6D86.0  Psychotic symptoms in dementia'), Document(metadata={'source': './input/c06.pdf', 'page': 194}, page_content='6D86.1  Mood symptoms in dementia'), Document(metadata={'source': './input/c06.pdf', 'page': 195}, page_content='6D86.2  Anxiety symptoms in dementia'), Document(metadata={'source': './input/c06.pdf', 'page': 195}, page_content='6D86.3  Apathy in dementia'), Document(metadata={'source': './input/c06.pdf', 'page': 195}, page_content='6D86.4  Agitation or aggression in dementia'), Document(metadata={'source': './input/c06.pdf', 'page': 195}, page_content='6D86.5  Disinhibition in dementia'), Document(metadata={'source': './input/c06.pdf', 'page': 195}, page_content='6D86.6  Wandering in dementia'), Document(metadata={'source': './input/c06.pdf', 'page': 195}, page_content='6D86.Y  Other specified behavioural or psychological disturbances in dementia'), Document(metadata={'source': './input/c06.pdf', 'page': 195}, page_content='6D86.Z  Behavioural or psychological disturbances in dementia, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 196}, page_content='6E20   Mental or behavioural disorders associated with pregnancy, childbirth'), Document(metadata={'source': './input/c06.pdf', 'page': 196}, page_content='6E21   Mental or behavioural disorders associated with pregnancy, childbi rth'), Document(metadata={'source': './input/c06.pdf', 'page': 197}, page_content='6E40   Psychological or behavioural factors affecting disorders or diseases'), Document(metadata={'source': './input/c06.pdf', 'page': 197}, page_content='6E40.0  Mental disorder affecting disorders or diseases classified elsewhere'), Document(metadata={'source': './input/c06.pdf', 'page': 197}, page_content='6E40.1  Psychological symptoms affecting disorders or diseases cla ssified elsewhere'), Document(metadata={'source': './input/c06.pdf', 'page': 197}, page_content='6E40.2  Personali ty traits or coping style affecting disorders or diseases classified'), Document(metadata={'source': './input/c06.pdf', 'page': 198}, page_content='6E40.3  Maladaptive health behaviours affecting disorders or diseases classified'), Document(metadata={'source': './input/c06.pdf', 'page': 198}, page_content='6E40.4  Stress -related physiological response affecting disorders or diseases'), Document(metadata={'source': './input/c06.pdf', 'page': 198}, page_content='6E40.Y  Other specified psychological or behavioural factors affecting disorders or'), Document(metadata={'source': './input/c06.pdf', 'page': 198}, page_content='6E40.Z  Psychological or behavioural factors affecting disorders or diseases'), Document(metadata={'source': './input/c06.pdf', 'page': 199}, page_content='6E60   Secondary neurodevelopmental syndrome'), Document(metadata={'source': './input/c06.pdf', 'page': 199}, page_content='6E60.0  Secondary speech or language syndrome'), Document(metadata={'source': './input/c06.pdf', 'page': 199}, page_content='6E60.Y  Other specified se condary neurodevelopmental syndrome'), Document(metadata={'source': './input/c06.pdf', 'page': 200}, page_content='6E60.Z  Secondary neurodevelopmental syndrome, unspecified'), Document(metadata={'source': './input/c06.pdf', 'page': 200}, page_content='6E61   Secondary psychotic syndrome'), Document(metadata={'source': './input/c06.pdf', 'page': 200}, page_content='6E61.0  Secondary psychotic syndrome, with hallucinations'), Document(metadata={'source': './input/c06.pdf', 'page': 201}, page_content='6E61.1  Secondary psychotic syndrome, with delusions'), Document(metadata={'source': './input/c06.pdf', 'page': 201}, page_content='6E61.2  Secondary psychotic syndrome, with hallucinations and delusions'), Document(metadata={'source': './input/c06.pdf', 'page': 201}, page_content='6E61.3  Secondary  psychotic syndrome, with unspecified symptoms'), Document(metadata={'source': './input/c06.pdf', 'page': 201}, page_content='6E62   Secondary mood syndrome'), Document(metadata={'source': './input/c06.pdf', 'page': 202}, page_content='6E62.0  Secondary mood syndrome, with depressive symptoms'), Document(metadata={'source': './input/c06.pdf', 'page': 202}, page_content='6E62.1  Secondary mood syndrome, with manic symptoms'), Document(metadata={'source': './input/c06.pdf', 'page': 203}, page_content='6E62.2  Secondary mood syndrome, with mixed symptoms'), Document(metadata={'source': './input/c06.pdf', 'page': 203}, page_content='6E62.3  Secondary mood syndrome, with un specified symptoms'), Document(metadata={'source': './input/c06.pdf', 'page': 203}, page_content='6E63   Secondary anxiety syndrome'), Document(metadata={'source': './input/c06.pdf', 'page': 204}, page_content='6E64   Secondary obsessive -compulsive or related syndrome'), Document(metadata={'source': './input/c06.pdf', 'page': 204}, page_content='6E65   Secondary dissociative syndrome')]\n"
     ]
    }
   ],
   "source": [
    "print(all_splits)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_text_splitters import RecursiveCharacterTextSplitter\n",
    "\n",
    "text_splitter = RecursiveCharacterTextSplitter(chunk_size=500, chunk_overlap=0)\n",
    "all_splits = text_splitter.split_documents(books)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**Ollama embeddings and Chroma vector store**\n",
    "We will use Langchain to convert the text into the embedding and store it in the Chroma database.\n",
    "\n",
    "We are using the Ollama Llama 3 model as an embedding model.\n",
    "\n",
    "\n",
    "from langchain_chroma import Chroma"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "OllamaEmbeddings: 100%|██████████| 1353/1353 [51:20<00:00,  2.28s/it]\n"
     ]
    }
   ],
   "source": [
    "from langchain_chroma import Chroma\n",
    "from langchain_community.embeddings import OllamaEmbeddings\n",
    "\n",
    "vectorstore = Chroma.from_documents(\n",
    "    documents=all_splits,\n",
    "    embedding=OllamaEmbeddings(model=\"llama3\", show_progress=True),\n",
    "    persist_directory=\"./chroma_db\",\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**TEST**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "OllamaEmbeddings: 100%|██████████| 1/1 [00:02<00:00,  2.31s/it]\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[Document(metadata={'page': 42, 'source': 'C:/tmp/c06.pdf'}, page_content='Hypochondriasis (6B23)'),\n",
       " Document(metadata={'page': 107, 'source': 'C:/tmp/c06.pdf'}, page_content='Disorders due to use of caffeine (6C48)'),\n",
       " Document(metadata={'page': 69, 'source': 'C:/tmp/c06.pdf'}, page_content='Possession trance disorder (6B63)'),\n",
       " Document(metadata={'page': 7, 'source': 'C:/tmp/c06.pdf'}, page_content='Exclusions:  Disorders of intellectual development (6A00)')]"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "question = \"What is anxiety?\"\n",
    "docs = vectorstore.similarity_search(question)\n",
    "docs"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**Building Langchain chains for Q&A retrieval system**\n",
    "To build a proper question-and-answer retrieval system, we will use Langchain chains and start adding the modules.\n",
    "\n",
    "In our Q&A chain, we will\n",
    "\n",
    "Use vector store as the retriever and format the results.\n",
    "After that, we will provide the RAG prompt. You can easily pull that from the Langchain Hub.\n",
    "Then, we will provide the Ollama Llama 3 inference function.\n",
    "In the end, we will parse the results only to display the response.\n",
    "Simply put, before passing it through the Llama 3 model, your question will be provided with context using the similarity search and RAG prompt."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\david\\AppData\\Local\\Packages\\PythonSoftwareFoundation.Python.3.11_qbz5n2kfra8p0\\LocalCache\\local-packages\\Python311\\site-packages\\langsmith\\client.py:312: LangSmithMissingAPIKeyWarning: API key must be provided when using hosted LangSmith API\n",
      "  warnings.warn(\n"
     ]
    }
   ],
   "source": [
    "from langchain import hub\n",
    "from langchain_community.llms import Ollama\n",
    "from langchain_core.output_parsers import StrOutputParser\n",
    "from langchain_core.runnables import RunnablePassthrough\n",
    "\n",
    "llm = Ollama(model=\"llama3\")\n",
    "\n",
    "retriever = vectorstore.as_retriever()\n",
    "\n",
    "\n",
    "def format_docs(docs):\n",
    "    return \"\\n\\n\".join(doc.page_content for doc in docs)\n",
    "\n",
    "\n",
    "rag_prompt = hub.pull(\"rlm/rag-prompt\")\n",
    "qa_chain = (\n",
    "    {\"context\": retriever | format_docs, \"question\": RunnablePassthrough()}\n",
    "    | rag_prompt\n",
    "    | llm\n",
    "    | StrOutputParser()\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**Testing the Q&A retrieval chain**\n",
    "Ask relevant questions about books to understand more about the story."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "OllamaEmbeddings: 100%|██████████| 1/1 [00:02<00:00,  2.35s/it]\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "'Based on the context, it appears that mental, behavioral, or neurodevelopmental disorders are being described. Specifically, these are disorders that affect the manifestation, treatment, or course of another disorder or disease classified elsewhere in the chapters.'"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "question = \"from the context, which type of disease are being described?\"\n",
    "qa_chain.invoke(question)\n",
    "#question = \"which are anorexia symptoms?\"\n",
    "#qa_chain.invoke(question)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
